{
  "file_name": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
  "total_pages": 86,
  "pdf_type": "normal",
  "font_analysis": {
    "font_sizes_frequency": {
      "22.29315948486328": 5,
      "21.94206428527832": 1,
      "8.992650032043457": 2,
      "14.039999961853027": 5,
      "8.039999961853027": 60,
      "21.959999084472656": 6,
      "12.72218132019043": 9,
      "12.829745292663574": 9,
      "11.879393577575684": 52,
      "12.960000038146973": 47,
      "12.0": 19,
      "8.759956359863281": 94,
      "9.960000038146973": 1441,
      "17.758378982543945": 1,
      "11.039999961853027": 1272,
      "15.0": 2,
      "18.0": 7,
      "15.960000038146973": 2,
      "13.799982070922852": 49,
      "12.839439392089844": 2,
      "10.797332763671875": 2,
      "8.279999732971191": 2
    },
    "heading_sizes": [
      22.29315948486328,
      21.959999084472656,
      18.0,
      15.960000038146973,
      15.0,
      14.039999961853027,
      13.799982070922852,
      12.960000038146973,
      12.839439392089844,
      12.829745292663574,
      12.72218132019043,
      12.0,
      11.879393577575684,
      11.039999961853027,
      10.797332763671875
    ]
  },
  "table_analysis": {
    "total_tables": 19,
    "tables_info": [
      {
        "bbox": [
          118.91999816894531,
          217.68943786621094,
          475.50628662109375,
          692.543212890625
        ],
        "num_rows": 8,
        "num_cols": 2
      },
      {
        "bbox": [
          119.5199966430664,
          261.8399963378906,
          476.1618347167969,
          557.9519653320312
        ],
        "num_rows": 8,
        "num_cols": 4
      },
      {
        "bbox": [
          124.68000030517578,
          596.13037109375,
          481.3967590332031,
          656.1303100585938
        ],
        "num_rows": 4,
        "num_cols": 2
      },
      {
        "bbox": [
          114.72000122070312,
          225.09034729003906,
          483.7962951660156,
          703.2903442382812
        ],
        "num_rows": 24,
        "num_cols": 4
      },
      {
        "bbox": [
          117.7199935913086,
          527.6103515625,
          476.6390380859375,
          676.1703491210938
        ],
        "num_rows": 8,
        "num_cols": 3
      },
      {
        "bbox": [
          117.47999572753906,
          357.9303283691406,
          479.6399841308594,
          628.6503295898438
        ],
        "num_rows": 5,
        "num_cols": 3
      },
      {
        "bbox": [
          115.68000030517578,
          314.6103515625,
          475.4999084472656,
          619.5303344726562
        ],
        "num_rows": 3,
        "num_cols": 2
      },
      {
        "bbox": [
          125.39999389648438,
          261.09033203125,
          481.39752197265625,
          668.0103149414062
        ],
        "num_rows": 20,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          193.41033935546875,
          481.39752197265625,
          691.5303344726562
        ],
        "num_rows": 26,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          185.850341796875,
          480.5575256347656,
          684.330322265625
        ],
        "num_rows": 25,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          171.21034240722656,
          481.39752197265625,
          684.4503173828125
        ],
        "num_rows": 21,
        "num_cols": 2
      },
      {
        "bbox": [
          125.39999389648438,
          168.9303436279297,
          480.5575256347656,
          682.0503540039062
        ],
        "num_rows": 22,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          155.9703369140625,
          481.39752197265625,
          688.7703247070312
        ],
        "num_rows": 30,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          173.9703369140625,
          480.0769958496094,
          684.9302978515625
        ],
        "num_rows": 25,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          173.9703369140625,
          481.39752197265625,
          684.9302978515625
        ],
        "num_rows": 28,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          164.9703369140625,
          481.39752197265625,
          679.7703247070312
        ],
        "num_rows": 25,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          173.9703369140625,
          481.39752197265625,
          679.7703247070312
        ],
        "num_rows": 22,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          157.41033935546875,
          481.39752197265625,
          686.3703002929688
        ],
        "num_rows": 22,
        "num_cols": 3
      },
      {
        "bbox": [
          125.39999389648438,
          164.9703369140625,
          480.5575256347656,
          361.1703186035156
        ],
        "num_rows": 11,
        "num_cols": 3
      }
    ]
  },
  "text_blocks": [
    {
      "text": "산전검사 중",
      "font_size": 22.29315948486328,
      "font_name": "H2hdrM",
      "bbox": [
        231.3546142578125,
        264.54046630859375,
        374.066162109375,
        286.47650146484375
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스(CMV)",
      "font_size": 22.29315948486328,
      "font_name": "H2hdrM",
      "bbox": [
        166.94952392578125,
        304.09722900390625,
        438.470947265625,
        326.03326416015625
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 의료기기",
      "font_size": 22.29315948486328,
      "font_name": "H2hdrM",
      "bbox": [
        181.5815887451172,
        343.65399169921875,
        415.92333984375,
        365.59002685546875
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허가심사 가이드라인",
      "font_size": 22.29315948486328,
      "font_name": "H2hdrM",
      "bbox": [
        181.5815887451172,
        383.21075439453125,
        415.92352294921875,
        405.14678955078125
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(민원인 안내서]",
      "font_size": 22.29315948486328,
      "font_name": "H2hdrM",
      "bbox": [
        210.4859161376953,
        422.7675476074219,
        387.25885009765625,
        444.7035827636719
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2018. 7.",
      "font_size": 21.94206428527832,
      "font_name": "H2hdrM",
      "bbox": [
        255.34161376953125,
        566.250732421875,
        339.5438232421875,
        588.186767578125
      ],
      "page_num": 1,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발간등록번호",
      "font_size": 8.992650032043457,
      "font_name": "Haansoft Batang",
      "bbox": [
        151.7177734375,
        161.2981414794922,
        205.68850708007812,
        170.28831481933594
      ],
      "page_num": 1,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안내서-0649-02",
      "font_size": 8.992650032043457,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.00303649902344,
        175.9221649169922,
        215.37179565429688,
        184.91233825683594
      ],
      "page_num": 1,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침서ᆞ안내서 제ᆞ개정 점검표",
      "font_size": 14.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        194.0399932861328,
        159.06808471679688,
        404.0406799316406,
        173.1080780029297
      ],
      "page_num": 2,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        133.44000244140625,
        186.12942504882812,
        148.4402313232422,
        196.82325744628906
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        200.51998901367188,
        179.64942932128906,
        455.4667663574219,
        190.34326171875
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인(민원인 안내서)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        278.1600036621094,
        192.4894256591797,
        375.0496826171875,
        203.18325805664062
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아래에 해당하는 사항에 체크하여 주시기 바랍니다.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        204.1199951171875,
        205.0894317626953,
        394.26422119140625,
        215.78326416015625
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등록대상",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        124.91999816894531,
        335.2893981933594,
        156.96018981933594,
        345.9832458496094
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여부",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        132.95999145507812,
        348.0093994140625,
        148.92019653320312,
        358.7032470703125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        217.68943786621094,
        384.4267578125,
        228.38327026367188
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서가 있습니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.8000030517578,
        229.68942260742188,
        297.306640625,
        240.3832550048828
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        218.04942321777344,
        456.0002136230469,
        240.0232696533203
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        218.04942321777344,
        456.0002136230469,
        240.0232696533203
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        248.64942932128906,
        482.3463439941406,
        259.34326171875
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.0800018310547,
        260.6494140625,
        482.4667663574219,
        283.34326171875
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 그 사유를 아래에 기재해 주시기 바랍니다.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.0800018310547,
        260.6494140625,
        482.4667663574219,
        283.34326171875
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(사유 :                                                      )",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        284.6494140625,
        416.20965576171875,
        295.34326171875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령(법ㆍ시행령ㆍ시행규칙) 또는",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        304.32940673828125,
        305.9461364746094,
        315.02325439453125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.8000030517578,
        316.32940673828125,
        410.9461364746094,
        339.02325439453125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.8000030517578,
        316.32940673828125,
        410.9461364746094,
        339.02325439453125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        310.6894226074219,
        456.0002136230469,
        332.66326904296875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        310.6894226074219,
        456.0002136230469,
        332.66326904296875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        342.3694152832031,
        456.0002136230469,
        364.2232666015625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        342.3694152832031,
        456.0002136230469,
        364.2232666015625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        342.3694152832031,
        456.0002136230469,
        364.2232666015625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        366.84942626953125,
        404.8267517089844,
        377.54327392578125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.0800018310547,
        378.0093994140625,
        233.7380828857422,
        388.7032470703125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        366.84942626953125,
        456.0002136230469,
        388.7032470703125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        366.84942626953125,
        456.0002136230469,
        388.7032470703125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 외국 규정을 번역하거나 설명하는 내용입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        391.20941162109375,
        456.0002136230469,
        413.0632629394531
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        391.20941162109375,
        456.0002136230469,
        413.0632629394531
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        391.20941162109375,
        456.0002136230469,
        413.0632629394531
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        415.6894226074219,
        396.4267578125,
        426.3832702636719
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정리한 자료입니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.0800018310547,
        426.8493957519531,
        264.5468444824219,
        437.5432434082031
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        415.6894226074219,
        456.0002136230469,
        437.5432434082031
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        415.6894226074219,
        456.0002136230469,
        437.5432434082031
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        446.889404296875,
        460.626708984375,
        469.583251953125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        446.889404296875,
        460.626708984375,
        469.583251953125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        119.39999389648438,
        502.9294128417969,
        165.30487060546875,
        513.6232299804688
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구분",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        134.0399932861328,
        515.7694091796875,
        147.83984375,
        526.4631958007812
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        485.1694030761719,
        409.8004150390625,
        495.8632507324219
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무의 세부기준이나 절차를 제시하는 것입니까? (공무원용)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.1999969482422,
        496.44940185546875,
        388.0096740722656,
        507.14324951171875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예(☞지침서)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        485.1694030761719,
        475.50628662109375,
        507.14324951171875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        485.1694030761719,
        475.50628662109375,
        507.14324951171875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        516.6094360351562,
        409.79998779296875,
        527.30322265625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.1999969482422,
        527.8894653320312,
        412.506591796875,
        549.7432250976562
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것입니까? (민원인용)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.1999969482422,
        527.8894653320312,
        412.506591796875,
        549.7432250976562
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 예(☞안내서)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        522.2494506835938,
        476.22650146484375,
        544.1032104492188
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        522.2494506835938,
        476.22650146484375,
        544.1032104492188
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타 확인사",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        118.91999816894531,
        571.0894165039062,
        162.96018981933594,
        581.783203125
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        136.9199981689453,
        583.929443359375,
        144.95999145507812,
        594.6232299804688
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        559.2094116210938,
        392.46697998046875,
        569.9031982421875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원인을 구속하는 내용이 있습니까?",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.1999969482422,
        570.4894409179688,
        325.8980712890625,
        581.1832275390625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        559.2094116210938,
        456.0002136230469,
        581.1832275390625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        420.0,
        559.2094116210938,
        456.0002136230469,
        581.1832275390625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        173.63999938964844,
        590.0494384765625,
        479.63958740234375,
        600.7432250976562
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서 제ㆍ개정 절차를 진행하시기 바랍니다.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        190.0800018310547,
        602.0494384765625,
        336.1987609863281,
        612.7432250976562
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상기 사항에 대하여 확인하였음.",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        239.51998901367188,
        614.6494140625,
        359.9442138671875,
        625.3432006835938
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2018 년    7 월   31  일",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        234.59999084472656,
        640.3294067382812,
        353.5199890136719,
        651.023193359375
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "담당자",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        343.91998291015625,
        671.409423828125,
        398.277587890625,
        692.543212890625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확  인(부서장)",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        343.91998291015625,
        671.409423828125,
        398.277587890625,
        692.543212890625
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서 두 원",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        427.55999755859375,
        670.2094116210938,
        459.6000061035156,
        680.9031982421875
      ],
      "page_num": 2,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 원 규",
      "font_size": 8.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        427.3199768066406,
        683.0494384765625,
        459.8399963378906,
        693.7432250976562
      ],
      "page_num": 2,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목  차",
      "font_size": 21.959999084472656,
      "font_name": "Haansoft Batang",
      "bbox": [
        371.03997802734375,
        167.86956787109375,
        436.91998291015625,
        189.82957458496094
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ. 개요",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.1999969482422,
        235.91998291015625,
        439.1650085449219,
        251.47198486328125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.829745292663574,
      "font_name": "T5",
      "bbox": [
        151.1999969482422,
        235.91998291015625,
        439.1650085449219,
        251.47198486328125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.1999969482422,
        265.32000732421875,
        439.1650085449219,
        280.87200927734375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 12.829745292663574,
      "font_name": "T5",
      "bbox": [
        151.1999969482422,
        265.32000732421875,
        439.1650085449219,
        280.87200927734375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅲ. 관련 규정",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.1999969482422,
        294.7200012207031,
        438.92547607421875,
        310.2720031738281
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13",
      "font_size": 12.829745292663574,
      "font_name": "T5",
      "bbox": [
        151.1999969482422,
        294.7200012207031,
        438.92547607421875,
        310.2720031738281
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅳ. 신청서 기재 항목 및 기술문서 제출자료",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.1999969482422,
        324.1199951171875,
        438.92547607421875,
        339.6719970703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14",
      "font_size": 12.829745292663574,
      "font_name": "T5",
      "bbox": [
        151.1999969482422,
        324.1199951171875,
        438.92547607421875,
        339.6719970703125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제조․수입허가신청서",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        347.6399841308594,
        438.9366149902344,
        362.03997802734375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        347.6399841308594,
        438.9366149902344,
        362.03997802734375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 기술문서에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        369.239990234375,
        438.9366149902344,
        383.62799072265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        369.239990234375,
        438.9366149902344,
        383.62799072265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재항목",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.1999969482422,
        396.7200012207031,
        438.92547607421875,
        412.2720031738281
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16",
      "font_size": 12.829745292663574,
      "font_name": "T5",
      "bbox": [
        151.1999969482422,
        396.7200012207031,
        438.92547607421875,
        412.2720031738281
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 명칭",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        420.239990234375,
        438.9366149902344,
        434.62799072265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        420.239990234375,
        438.9366149902344,
        434.62799072265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 모양 및 구조",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        441.8399963378906,
        438.9366149902344,
        456.2279968261719
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        441.8399963378906,
        438.9366149902344,
        456.2279968261719
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 원재료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        463.44000244140625,
        438.9366149902344,
        477.8280029296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        463.44000244140625,
        438.9366149902344,
        477.8280029296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 제조방법",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        485.03997802734375,
        438.9366149902344,
        499.427978515625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "22",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        485.03997802734375,
        438.9366149902344,
        499.427978515625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 사용목적",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        506.6400146484375,
        438.9366149902344,
        521.0280151367188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "22",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        506.6400146484375,
        438.9366149902344,
        521.0280151367188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 사용방법",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        528.239990234375,
        438.9366149902344,
        542.6279907226562
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "23",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        528.239990234375,
        438.9366149902344,
        542.6279907226562
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 사용시 주의사항",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        549.8399658203125,
        438.9366149902344,
        564.2279663085938
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "25",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        549.8399658203125,
        438.9366149902344,
        564.2279663085938
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 포장단위",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        571.4400024414062,
        438.9366149902344,
        585.8280029296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "26",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        571.4400024414062,
        438.9366149902344,
        585.8280029296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 저장방법 및 사용기간",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        593.0399780273438,
        438.9366149902344,
        607.427978515625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "27",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        593.0399780273438,
        438.9366149902344,
        607.427978515625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. 시험규격",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        614.6400146484375,
        438.9366149902344,
        629.0280151367188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "28",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        614.6400146484375,
        438.9366149902344,
        629.0280151367188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11. 제조원",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.47999572753906,
        636.239990234375,
        438.9366149902344,
        650.6279907226562
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.47999572753906,
        636.239990234375,
        438.9366149902344,
        650.6279907226562
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅵ. 기술문서등의 심사를 위한 제출자료",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        216.3599853515625,
        442.7654724121094,
        231.9119873046875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 11,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "31",
      "font_size": 12.829745292663574,
      "font_name": "T5",
      "bbox": [
        151.55999755859375,
        216.3599853515625,
        442.7654724121094,
        231.9119873046875
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 10,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 개발경위, 측정원리·방법 및 국내․외 사용현황에",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        239.87998962402344,
        448.6805725097656,
        254.2799835205078
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        171.1199951171875,
        261.47998046875,
        442.776611328125,
        275.86798095703125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "34",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        171.1199951171875,
        261.47998046875,
        442.776611328125,
        275.86798095703125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 원재료 및 제조방법에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        283.0799865722656,
        442.776611328125,
        297.4679870605469
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "35",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        283.0799865722656,
        442.776611328125,
        297.4679870605469
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 사용목적에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        304.67999267578125,
        442.776611328125,
        319.0679931640625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "36",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        304.67999267578125,
        442.776611328125,
        319.0679931640625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 저장방법 및 사용기간(유효기간)에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        326.2799987792969,
        442.776611328125,
        340.6679992675781
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "36",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        326.2799987792969,
        442.776611328125,
        340.6679992675781
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 제품의 성능을 확인하기 위한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        347.8800048828125,
        442.776611328125,
        362.26800537109375
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "37",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        347.8800048828125,
        442.776611328125,
        362.26800537109375
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 시약의 취급자 안전에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        369.47998046875,
        442.776611328125,
        383.86798095703125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "38",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        369.47998046875,
        442.776611328125,
        383.86798095703125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 이미 허가받은 제품과 비교한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        391.0799865722656,
        442.776611328125,
        405.4679870605469
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "38",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        391.0799865722656,
        442.776611328125,
        405.4679870605469
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.1999969482422,
        418.55999755859375,
        442.7654724121094,
        434.11199951171875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40",
      "font_size": 12.829745292663574,
      "font_name": "T5",
      "bbox": [
        151.1999969482422,
        418.55999755859375,
        442.7654724121094,
        434.11199951171875
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 분석적 성능시험에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        442.0799865722656,
        442.776611328125,
        456.4679870605469
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        442.0799865722656,
        442.776611328125,
        456.4679870605469
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 임상적 성능시험에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        463.67999267578125,
        442.776611328125,
        478.0679931640625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "53",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        463.67999267578125,
        442.776611328125,
        478.0679931640625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 완제품의 품질관리 시험성적서 또는 시험에 관한",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        485.2799987792969,
        460.4401550292969,
        499.6679992675781
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        174.0,
        506.8800048828125,
        442.776611328125,
        521.2680053710938
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "59",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        174.0,
        506.8800048828125,
        442.776611328125,
        521.2680053710938
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 표준품질 및 검체보관 등에 관한 자료",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        528.47998046875,
        442.776611328125,
        542.8679809570312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "59",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        528.47998046875,
        442.776611328125,
        542.8679809570312
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 상관성 평가",
      "font_size": 11.879393577575684,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        156.83999633789062,
        550.0800170898438,
        442.776611328125,
        564.468017578125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60",
      "font_size": 11.879393577575684,
      "font_name": "T8",
      "bbox": [
        156.83999633789062,
        550.0800170898438,
        442.776611328125,
        564.468017578125
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅷ. 참고문헌",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        577.5599365234375,
        442.7654724121094,
        593.1119384765625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "63",
      "font_size": 12.829745292663574,
      "font_name": "T5",
      "bbox": [
        151.55999755859375,
        577.5599365234375,
        442.7654724121094,
        593.1119384765625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅸ. 부록",
      "font_size": 12.72218132019043,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        151.55999755859375,
        606.9599609375,
        442.7654724121094,
        622.511962890625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "66",
      "font_size": 12.829745292663574,
      "font_name": "T5",
      "bbox": [
        151.55999755859375,
        606.9599609375,
        442.7654724121094,
        622.511962890625
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        162.77459716796875,
        478.3197937011719,
        180.0124053955078
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        190.1345977783203,
        478.31988525390625,
        207.37240600585938
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        217.37460327148438,
        482.8799743652344,
        234.61241149902344
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입장을 기술한 것입니다.",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        244.73460388183594,
        261.7159423828125,
        261.972412109375
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        282.05462646484375,
        478.3193664550781,
        299.29241943359375
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        309.41461181640625,
        482.8774719238281,
        326.65240478515625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반드시 준수하셔야 하는 사항이 아님을 알려드립니다. 또한, 본 안",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        336.65460205078125,
        478.3199768066406,
        353.89239501953125
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        364.0146179199219,
        478.3196105957031,
        381.2524108886719
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        391.3746032714844,
        478.1999816894531,
        408.6123962402344
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라 달리 적용될 수 있음을 알려드립니다.",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        418.6146240234375,
        328.6759338378906,
        435.8524169921875
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        117.0,
        466.939453125,
        478.3199768066406,
        482.900390625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        141.1199951171875,
        482.5394287109375,
        478.3199768066406,
        529.7003784179688
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        141.1199951171875,
        482.5394287109375,
        478.3199768066406,
        529.7003784179688
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 관한 규정 제2조)",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        141.1199951171875,
        482.5394287109375,
        478.3199768066406,
        529.7003784179688
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        110.5199966430664,
        551.694580078125,
        489.2336730957031,
        568.9324340820312
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        110.5199966430664,
        586.2545776367188,
        429.55499267578125,
        603.492431640625
      ],
      "page_num": 5,
      "block_type": "heading",
      "level": 8,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전화번호: 043-719-4652~65",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        139.67999267578125,
        617.694580078125,
        310.1357727050781,
        634.9324340820312
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "팩스번호: 043-719-4650",
      "font_size": 12.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        139.67999267578125,
        638.5745849609375,
        286.1364440917969,
        655.8124389648438
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅰ. 개요",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        450.9599914550781,
        118.03440856933594,
        481.6860046386719,
        127.03440856933594
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 1 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 6,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ",
      "font_size": 21.959999084472656,
      "font_name": "T6",
      "bbox": [
        115.91999816894531,
        160.07998657226562,
        213.24000549316406,
        186.43199157714844
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개  요",
      "font_size": 17.758378982543945,
      "font_name": "H2hdrM",
      "bbox": [
        115.91999816894531,
        160.07998657226562,
        213.24000549316406,
        186.43199157714844
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 목적",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        250.69921875,
        150.95999145507812,
        262.69921875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        274.68328857421875,
        488.3557434082031,
        285.7232971191406
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        296.6432800292969,
        488.3560485839844,
        307.68328857421875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것을 목적으로 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        318.603271484375,
        227.73280334472656,
        329.6432800292969
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 적용범위",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        362.7792053222656,
        178.95608520507812,
        374.7792053222656
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        386.6432800292969,
        488.35638427734375,
        397.68328857421875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검출하는 자동분석기용 시약을 대상으로 한다. 과거에는 선천 풍진",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        408.603271484375,
        488.356689453125,
        419.6432800292969
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        430.68328857421875,
        488.3560485839844,
        441.7232971191406
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 CMV 감염이 가장 흔하게 되었다. 임신 중 산모가 CMV에 1차",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        452.6432800292969,
        488.35638427734375,
        463.68328857421875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        474.603271484375,
        488.2360534667969,
        485.6432800292969
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        496.68328857421875,
        488.3560485839844,
        507.7232971191406
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보인다. 선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        518.6432495117188,
        488.2362976074219,
        529.6832885742188
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        540.603271484375,
        484.67999267578125,
        551.643310546875
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        562.6832275390625,
        488.35699462890625,
        573.7232666015625
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        584.6432495117188,
        488.3565979003906,
        595.6832885742188
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다1). 산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        606.6032104492188,
        488.35699462890625,
        617.6432495117188
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사법과 양수에서 유전자를 검출하는 방법이 이용된다. 선천 CMV 감염의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        628.6832275390625,
        488.3567810058594,
        639.7232666015625
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        650.6432495117188,
        488.3560485839844,
        661.6832885742188
      ],
      "page_num": 6,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        672.6032104492188,
        475.05279541015625,
        683.6432495117188
      ],
      "page_num": 6,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) http://www.cdc.gov/cmv/congenital-infection.html",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        699.5543823242188,
        317.6131896972656,
        708.5543823242188
      ],
      "page_num": 6,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        120.31440734863281,
        414.9193115234375,
        129.3144073486328
      ],
      "page_num": 7,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 2 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 7,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산전검사 중 거대세포바이러스(CMV) 체외진단용",
      "font_size": 15.0,
      "font_name": "T12",
      "bbox": [
        117.36000061035156,
        156.47999572753906,
        477.239990234375,
        174.47999572753906
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기 허가심사 가이드라인(민원인 안내서)",
      "font_size": 15.0,
      "font_name": "T12",
      "bbox": [
        126.7199935913086,
        180.47999572753906,
        467.8949890136719,
        198.47999572753906
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제․개정",
      "font_size": 14.039999961853027,
      "font_name": "T12",
      "bbox": [
        120.1199951171875,
        218.16000366210938,
        179.63966369628906,
        235.00799560546875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "번호",
      "font_size": 14.039999961853027,
      "font_name": "T12",
      "bbox": [
        135.239990234375,
        229.44000244140625,
        414.35968017578125,
        257.447998046875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "승인일자",
      "font_size": 14.039999961853027,
      "font_name": "T12",
      "bbox": [
        135.239990234375,
        229.44000244140625,
        414.35968017578125,
        257.447998046875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주요 내용",
      "font_size": 14.039999961853027,
      "font_name": "T12",
      "bbox": [
        135.239990234375,
        229.44000244140625,
        414.35968017578125,
        257.447998046875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B1-2013-5",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        119.5199966430664,
        261.8399963378906,
        180.84280395507812,
        277.3919982910156
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-005",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        136.8000030517578,
        282.7200012207031,
        163.67904663085938,
        298.2720031738281
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2013.5.28.",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        205.55999755859375,
        261.8399963378906,
        262.2535400390625,
        277.3919982910156
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제정",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        220.67999267578125,
        282.7200012207031,
        247.0795135498047,
        298.2720031738281
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산전검사 중 CMV 검사시약",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        308.2799987792969,
        261.8399963378906,
        454.3193664550781,
        277.3919982910156
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가심가 가이드",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        337.67999267578125,
        282.7200012207031,
        425.03973388671875,
        298.2720031738281
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B1-2015-5",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        119.04000091552734,
        313.20001220703125,
        181.31797790527344,
        328.75201416015625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-186",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        136.8000030517578,
        333.9599914550781,
        163.67904663085938,
        349.5119934082031
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2015.2.",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        213.83999633789062,
        323.5199890136719,
        253.97454833984375,
        339.0719909667969
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "｢",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        286.44000244140625,
        302.760009765625,
        292.9200134277344,
        318.31201171875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기법 시행규칙｣",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        292.0799865722656,
        302.760009765625,
        403.44000244140625,
        318.31201171875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 ｢",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        408.0,
        302.760009765625,
        431.0400085449219,
        318.31201171875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        430.0799865722656,
        302.760009765625,
        476.1618347167969,
        318.31201171875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가․신고․심사 등에 관한 규정｣",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        292.55999755859375,
        323.5199890136719,
        470.1600036621094,
        339.0719909667969
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개정사항 반영",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        344.5199890136719,
        344.3999938964844,
        418.2005920410156,
        359.9519958496094
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서-",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        126.7199935913086,
        422.6399841308594,
        173.63328552246094,
        438.1919860839844
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0649-01",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        126.7199935913086,
        443.3999938964844,
        173.75833129882812,
        458.9519958496094
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2017.5.",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        213.83999633789062,
        432.9599914550781,
        253.97454833984375,
        448.5119934082031
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「산전검사 중",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        343.44000244140625,
        360.239990234375,
        419.27996826171875,
        375.7919921875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스(CMV) 체외진단용",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        287.8800048828125,
        381.0,
        474.8395080566406,
        396.552001953125
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 허가·심사",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        329.7599792480469,
        401.760009765625,
        432.9601135253906,
        417.31201171875
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드라인(민원인 안내서)」 명칭",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        291.47998046875,
        422.6399841308594,
        471.1195983886719,
        438.1919860839844
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "변경 및 제·개정 점검표 등 추가",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        295.44000244140625,
        443.3999938964844,
        467.2801208496094,
        458.9519958496094
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[근거: 「식품의약품안전처",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        312.0,
        464.1600036621094,
        450.7183837890625,
        479.7120056152344
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서등의 관리에 관한 규정」",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        297.6000061035156,
        485.0400085449219,
        464.9999694824219,
        500.5920104980469
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개정, ‘17.5.1.]",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        347.1600036621094,
        505.8000183105469,
        415.59869384765625,
        521.3519897460938
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서-",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        126.7199935913086,
        521.6399536132812,
        173.63328552246094,
        537.1919555664062
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0649-02",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        126.7199935913086,
        542.3999633789062,
        173.75833129882812,
        557.9519653320312
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2018.7.",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        216.59999084472656,
        521.6399536132812,
        298.44000244140625,
        547.511962890625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "｢",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        216.59999084472656,
        521.6399536132812,
        298.44000244140625,
        547.511962890625
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 허가․신고․심사 등에",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        297.6000061035156,
        521.6399536132812,
        470.7596130371094,
        537.1919555664062
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한 규정, ‘18.6.28.｣",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        287.8800048828125,
        542.3999633789062,
        393.9599914550781,
        557.9519653320312
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개정사항 반영",
      "font_size": 12.960000038146973,
      "font_name": "T13",
      "bbox": [
        398.8800048828125,
        542.3999633789062,
        474.8401184082031,
        557.9519653320312
      ],
      "page_num": 7,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.2799987792969,
        118.03440856933594,
        481.68621826171875,
        127.03440856933594
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 3 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ  용어의 정의",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        114.36000061035156,
        160.67999267578125,
        258.47998046875,
        187.03199768066406
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        204.2432861328125,
        488.3560485839844,
        215.2832794189453
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "돕기 위해 사용되는 것이므로 단순 참고용임",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        226.32327270507812,
        351.59967041015625,
        237.36326599121094
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "간섭 (Interference)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        270.2432861328125,
        211.29251098632812,
        281.2832946777344
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        292.3232727050781,
        484.6796875,
        303.36328125
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        314.28326416015625,
        462.35968017578125,
        325.3232727050781
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        336.2432861328125,
        484.67999267578125,
        347.2832946777344
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        358.3232727050781,
        488.3560485839844,
        369.36328125
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다른 원인에 기인하기도 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        380.28326416015625,
        279.2127990722656,
        391.3232727050781
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경계 사이클 (Threshold cycle, Ct)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        412.3232727050781,
        286.8927917480469,
        423.36328125
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        434.28326416015625,
        412.9200134277344,
        445.3232727050781
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        456.2432861328125,
        484.6796875,
        467.2832946777344
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 이루어진다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        478.3232727050781,
        202.1728057861328,
        489.36328125
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        500.28326416015625,
        484.67999267578125,
        511.3232727050781
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        522.2432250976562,
        484.67999267578125,
        533.2832641601562
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지고 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        544.3232421875,
        180.2128143310547,
        555.36328125
      ],
      "page_num": 8,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검출한계 (Limit of detection, LoD)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        576.2432250976562,
        288.69232177734375,
        587.2832641601562
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검출될 수 있는 분석 물질의 최소량",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        598.3232421875,
        291.9596862792969,
        609.36328125
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공란한계 (Limit of blank, LoB)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        630.2432250976562,
        265.7723388671875,
        641.2832641601562
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        652.3232421875,
        389.9996643066406,
        663.36328125
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        120.31440734863281,
        414.9193115234375,
        129.3144073486328
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 4 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "교차반응 (Cross-reactivity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        252.572509765625,
        176.76327514648438
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        484.67999267578125,
        198.84327697753906
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 항체가 반응하는 현상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        209.76327514648438,
        236.99998474121094,
        220.8032684326172
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기질효과 (Matrix effect)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        241.80328369140625,
        236.4944305419922,
        252.84327697753906
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        484.6796875,
        274.80328369140625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 미치는 경우",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        285.7232666015625,
        187.5599822998047,
        296.7632751464844
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        307.80328369140625,
        488.35638427734375,
        318.8432922363281
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요인이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        329.7632751464844,
        174.69281005859375,
        340.80328369140625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내부 대조물질 (Internal control)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        361.80328369140625,
        281.3571472167969,
        372.8432922363281
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        383.7632751464844,
        484.67999267578125,
        394.80328369140625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        405.7232666015625,
        488.3560485839844,
        416.7632751464844
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        427.80328369140625,
        488.2360534667969,
        438.8432922363281
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목적으로 사용한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        449.7632751464844,
        207.2128143310547,
        460.80328369140625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조물질 (Control / Control material)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        481.80328369140625,
        310.6365966796875,
        492.8432922363281
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정도 관리를 위해 이용되는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        503.7632751464844,
        279.0760498046875,
        514.8032836914062
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역분석법 (Immunoassay)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        535.80322265625,
        252.07894897460938,
        546.84326171875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        557.7632446289062,
        482.76007080078125,
        568.8032836914062
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        579.7232666015625,
        484.67999267578125,
        590.7633056640625
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        601.80322265625,
        484.6796875,
        612.84326171875
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        623.7632446289062,
        484.67999267578125,
        634.8032836914062
      ],
      "page_num": 9,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        645.7232666015625,
        189.31629943847656,
        656.7633056640625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.2799987792969,
        118.03440856933594,
        481.68621826171875,
        127.03440856933594
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 5 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바이어스 (Bias)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        192.0765380859375,
        176.76327514648438
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사 결과의 예상치와 허용된 기준치 사이의 차이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        363.4800109863281,
        198.84327697753906
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응성 (Reactivity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        219.72328186035156,
        210.43902587890625,
        230.76327514648438
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        241.80328369140625,
        434.8800048828125,
        252.84327697753906
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        487.5166015625,
        274.80328369140625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반정량분석 (Semiquantitative assay)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        295.80328369140625,
        301.0535583496094,
        306.8432922363281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        317.7632751464844,
        488.35662841796875,
        328.80328369140625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        339.7232666015625,
        488.3551940917969,
        350.7632751464844
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "grade 또는 class)로 표현된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        361.80328369140625,
        269.59661865234375,
        372.8432922363281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방해물질 (Interfering substances)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        393.7232666015625,
        292.2780456542969,
        404.7632751464844
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        415.80328369140625,
        488.3568115234375,
        426.8432922363281
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        437.7632751464844,
        484.67974853515625,
        448.80328369140625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 수 있는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        459.7232666015625,
        190.1997528076172,
        470.7632751464844
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보정 (Calibration)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        491.7632751464844,
        204.4365997314453,
        502.80328369140625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        513.7232666015625,
        484.6803283691406,
        524.7633056640625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        535.80322265625,
        488.3560485839844,
        546.84326171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확립하는 일련의 조작",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        557.7632446289062,
        220.5599822998047,
        568.8032836914062
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보정물질 (Calibration material / Calibrator)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        589.80322265625,
        338.1333312988281,
        600.84326171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        611.7632446289062,
        488.3566589355469,
        622.8032836914062
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        633.7232666015625,
        474.3600769042969,
        644.7633056640625
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        655.80322265625,
        484.6796875,
        666.84326171875
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        677.7632446289062,
        488.3560485839844,
        688.8032836914062
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        120.31440734863281,
        414.9193115234375,
        129.3144073486328
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 6 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정하는데 사용될 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        155.76327514648438,
        283.17279052734375,
        166.8032684326172
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        177.72328186035156,
        488.3558349609375,
        188.76327514648438
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가져야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        199.80328369140625,
        206.49281311035156,
        210.84327697753906
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        221.76327514648438,
        488.35736083984375,
        232.8032684326172
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용될 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        243.72328186035156,
        222.81280517578125,
        254.76327514648438
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        265.80328369140625,
        484.6961669921875,
        276.8432922363281
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와 ISO에서 사용되고 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        287.7632751464844,
        280.05279541015625,
        298.80328369140625
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석물질 (Analyte)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        319.80328369140625,
        204.93382263183594,
        330.8432922363281
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사실이 수행하는 검사의 물질 또는 구성요소",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        341.7632751464844,
        346.919677734375,
        352.80328369140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비정밀도 (Imprecision)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        373.80328369140625,
        227.37481689453125,
        384.8432922363281
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        395.7632751464844,
        416.59637451171875,
        406.80328369140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 표준편차나 변이계수 등의 숫자로 표시된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        417.7232666015625,
        350.1327819824219,
        428.7632751464844
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비특이도 (Nonspecificity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        449.7632751464844,
        243.79783630371094,
        460.80328369140625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        471.7232666015625,
        401.8796691894531,
        482.7632751464844
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        493.80328369140625,
        488.35662841796875,
        504.8432922363281
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효소, ionophore, 시약에 의해 발생한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        515.7632446289062,
        329.4927978515625,
        526.8032836914062
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "선별검사 (Screening test)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        547.80322265625,
        246.0923309326172,
        558.84326171875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        569.7632446289062,
        484.67999267578125,
        580.8032836914062
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        591.7232666015625,
        488.35638427734375,
        602.7633056640625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위한 체계적인 검사",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        613.80322265625,
        209.51998901367188,
        624.84326171875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신뢰구간 (Confidence interval)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        645.7232666015625,
        275.3563537597656,
        656.7633056640625
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        667.80322265625,
        488.3560485839844,
        678.84326171875
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것으로 예상되는 계산된 구간",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        689.7632446289062,
        258.9596862792969,
        700.8032836914062
      ],
      "page_num": 11,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.2799987792969,
        118.03440856933594,
        481.68621826171875,
        127.03440856933594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 7 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실시간 PCR (Real time polymerase chain reaction)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        385.27838134765625,
        176.76327514648438
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        488.3560485839844,
        198.84327697753906
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동시에 검출하는 PCR 방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        209.76327514648438,
        247.5599822998047,
        220.8032684326172
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 예측도 (Predictive value of positive result, PPV)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        241.80328369140625,
        399.5574645996094,
        252.84327697753906
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        488.3560485839844,
        274.80328369140625
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 결과를 보이는 비율(100을 곱한 값)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        285.7232666015625,
        322.1999816894531,
        296.7632751464844
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        307.80328369140625,
        484.67999267578125,
        318.8432922363281
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해 결정되는)의 유병률에 맞추어 해석해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        329.7632751464844,
        376.27630615234375,
        340.80328369140625
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        351.7232666015625,
        484.679443359375,
        362.7632751464844
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 100XTP/(TP+FP)로 계산된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        373.80328369140625,
        317.1327819824219,
        384.8432922363281
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진단정확도기준",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        272.8800048828125,
        403.5205993652344,
        440.82000732421875,
        414.0252990722656
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        252.1199951171875,
        425.9606018066406,
        448.1999816894531,
        436.4653015136719
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "음성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        252.1199951171875,
        425.9606018066406,
        448.1999816894531,
        436.4653015136719
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        252.1199951171875,
        425.9606018066406,
        448.1999816894531,
        436.4653015136719
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법 X",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        124.43999481201172,
        465.44061279296875,
        156.48092651367188,
        475.9453125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        183.1199951171875,
        451.04058837890625,
        473.2795104980469,
        461.5452880859375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "# 진양성 TP",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        183.1199951171875,
        451.04058837890625,
        473.2795104980469,
        461.5452880859375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "# 위양성 FP",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        183.1199951171875,
        451.04058837890625,
        473.2795104980469,
        461.5452880859375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진양성+ 위양성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        183.1199951171875,
        451.04058837890625,
        473.2795104980469,
        461.5452880859375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "음성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        183.1199951171875,
        479.2406005859375,
        379.9663391113281,
        489.74530029296875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "# 위음성 FN",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        183.1199951171875,
        479.2406005859375,
        379.9663391113281,
        489.74530029296875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "# 진음성 TN",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        183.1199951171875,
        479.2406005859375,
        379.9663391113281,
        489.74530029296875
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위음성 +",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        418.3199768066406,
        471.2005920410156,
        463.259765625,
        481.7052917480469
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진음성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        423.239990234375,
        487.1606140136719,
        453.239501953125,
        497.6653137207031
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        138.0,
        508.04058837890625,
        203.15951538085938,
        518.5452880859375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "진양성 +",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        242.0399932861328,
        500.0006103515625,
        287.0997619628906,
        510.50531005859375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위음성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        247.0800018310547,
        516.0806274414062,
        277.07952880859375,
        526.5853271484375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위양성 + 진음성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        312.6000061035156,
        508.04058837890625,
        441.76641845703125,
        518.5452880859375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        312.6000061035156,
        508.04058837890625,
        441.76641845703125,
        518.5452880859375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비교방법",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        290.0400085449219,
        550.5206298828125,
        440.94000244140625,
        561.0253295898438
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        255.72000122070312,
        575.360595703125,
        448.4399719238281,
        585.8652954101562
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "음성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        255.72000122070312,
        575.360595703125,
        448.4399719238281,
        585.8652954101562
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        255.72000122070312,
        575.360595703125,
        448.4399719238281,
        585.8652954101562
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "후보",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        136.1999969482422,
        605.9605712890625,
        161.21951293945312,
        616.4652709960938
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검사법",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        131.16000366210938,
        622.0405883789062,
        161.15951538085938,
        632.5452880859375
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        190.1999969482422,
        601.1605834960938,
        451.20794677734375,
        611.665283203125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "a",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        190.1999969482422,
        601.1605834960938,
        451.20794677734375,
        611.665283203125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "b",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        190.1999969482422,
        601.1605834960938,
        451.20794677734375,
        611.665283203125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "a + b",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        190.1999969482422,
        601.1605834960938,
        451.20794677734375,
        611.665283203125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "음성",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        190.1999969482422,
        627.3206176757812,
        450.977783203125,
        637.8253173828125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "c",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        190.1999969482422,
        627.3206176757812,
        450.977783203125,
        637.8253173828125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "d",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        190.1999969482422,
        627.3206176757812,
        450.977783203125,
        637.8253173828125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "c + d",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        190.1999969482422,
        627.3206176757812,
        450.977783203125,
        637.8253173828125
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        143.63999938964844,
        652.640625,
        441.2057800292969,
        663.1453247070312
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "a + c",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        143.63999938964844,
        652.640625,
        441.2057800292969,
        663.1453247070312
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "b + d",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        143.63999938964844,
        652.640625,
        441.2057800292969,
        663.1453247070312
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "n",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        143.63999938964844,
        652.640625,
        441.2057800292969,
        663.1453247070312
      ],
      "page_num": 12,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        120.31440734863281,
        414.9193115234375,
        129.3144073486328
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 8 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        449.40081787109375,
        166.8032684326172
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        177.72328186035156,
        449.8815612792969,
        188.76327514648438
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "총 일치율(Overall percent agreement)          = 100×(a+d)/n",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        199.80328369140625,
        448.2939147949219,
        210.84327697753906
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성 예측도 (Predictive value of negative result, NPV)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        231.72328186035156,
        403.9963073730469,
        242.76327514648438
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        253.80328369140625,
        484.67999267578125,
        264.8432922363281
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 값)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        275.7632751464844,
        143.52000427246094,
        286.80328369140625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        297.7232666015625,
        379.7727966308594,
        308.7632751464844
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "역가 (Titer)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        329.7632751464844,
        171.91714477539062,
        340.80328369140625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        351.7232666015625,
        488.3560485839844,
        362.7632751464844
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        373.80328369140625,
        484.67999267578125,
        384.8432922363281
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분율이 결합하는 항체의 희석율",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        395.7632751464844,
        269.99969482421875,
        406.80328369140625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 역가는 주로 분석물질 농도에 비례한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        417.7232666015625,
        328.17279052734375,
        428.7632751464844
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위양성 (False positive, FP)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        449.7632751464844,
        248.37246704101562,
        460.80328369140625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        471.7232666015625,
        427.51605224609375,
        482.7632751464844
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        493.80328369140625,
        389.0396728515625,
        504.8432922363281
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위음성 (False negative, FN)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        525.7232666015625,
        256.63763427734375,
        536.7633056640625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 환자나 양성 검체에서의 음성검사 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        547.80322265625,
        336.0,
        558.84326171875
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 민감도 (Clinical sensitivity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        579.7232666015625,
        289.6526184082031,
        590.7633056640625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        601.80322265625,
        467.8800048828125,
        612.84326171875
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 특이도 (Clinical specificity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        633.7232666015625,
        290.6141662597656,
        644.7633056640625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        655.80322265625,
        484.4400939941406,
        666.84326171875
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재조합항원 (Recombinant-derived antigens)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        687.7232666015625,
        342.6939392089844,
        698.7633056640625
      ],
      "page_num": 13,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.2799987792969,
        118.03440856933594,
        481.68621826171875,
        127.03440856933594
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 9 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        721.2903442382812,
        311.7449951171875,
        731.2503051757812
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        484.67999267578125,
        166.8032684326172
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "백질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        177.72328186035156,
        136.15606689453125,
        188.76327514648438
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재현성 (Reproducibility)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        209.76327514648438,
        232.77415466308594,
        220.8032684326172
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        231.72328186035156,
        484.5601806640625,
        242.76327514648438
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        410.9743957519531,
        274.80328369140625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        285.7232666015625,
        484.67999267578125,
        296.7632751464844
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하로 나타나는 현상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        307.80328369140625,
        209.51998901367188,
        318.8432922363281
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정량분석 (Quantitative assay)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        339.7232666015625,
        264.93389892578125,
        350.7632751464844
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체에서 분석물질의 농도를 측정할 수 있는 시스템",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        361.80328369140625,
        374.3996887207031,
        372.8432922363281
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        383.7632751464844,
        488.35638427734375,
        394.80328369140625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보간법(Interpolation)2)을 통해 이루어진다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.07999420166016,
        405.7232666015625,
        346.7727966308594,
        416.7632751464844
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정밀도 (Precision)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        437.7632751464844,
        203.97299194335938,
        448.80328369140625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        459.7232666015625,
        479.1601867675781,
        470.7632751464844
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        481.80328369140625,
        488.3560485839844,
        492.8432922363281
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        503.7632751464844,
        458.2799987792969,
        514.8032836914062
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정성분석 (Qualitative assay)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        535.80322265625,
        257.1335754394531,
        546.84326171875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        557.7632446289062,
        488.35638427734375,
        568.8032836914062
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시스템",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        579.7232666015625,
        147.19606018066406,
        590.7633056640625
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        601.80322265625,
        488.2355041503906,
        612.84326171875
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        623.7632446289062,
        488.3560485839844,
        634.8032836914062
      ],
      "page_num": 14,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의해 구해진다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        645.7232666015625,
        205.8766326904297,
        656.7633056640625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        699.5543823242188,
        483.0066223144531,
        708.5543823242188
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        120.31440734863281,
        414.9193115234375,
        129.3144073486328
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 10 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정확도 (Accuracy)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        203.85377502441406,
        176.76327514648438
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정치와 참값 사이의 일치도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        258.9596862792969,
        198.84327697753906
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        209.76327514648438,
        488.35638427734375,
        220.8032684326172
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "공인된 참고값(accepted reference value) 사이의 일치 근접도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        231.72328186035156,
        484.6796875,
        242.76327514648438
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(closeness of agreement)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        253.80328369140625,
        261.84088134765625,
        264.8432922363281
      ],
      "page_num": 15,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직선성 (Linearity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        285.7232666015625,
        199.41236877441406,
        296.7632751464844
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        307.80328369140625,
        488.35638427734375,
        318.8432922363281
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 능력",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        329.7632751464844,
        160.07998657226562,
        340.80328369140625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단 검사 (Diagnostic test)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        361.80328369140625,
        253.41342163085938,
        372.8432922363281
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        383.7632751464844,
        488.3560485839844,
        394.80328369140625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "손상 정도를 평가하기 위한 목적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        405.7232666015625,
        275.5199890136719,
        416.7632751464844
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 진단적 검체의 측정 또는 검사를 칭한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        427.80328369140625,
        337.276611328125,
        438.8432922363281
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진양성 (True positive, TP)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        459.7232666015625,
        248.83653259277344,
        470.7632751464844
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자의 질병 상태와 검사의 양성판정이 일치하는 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        481.80328369140625,
        385.44000244140625,
        492.8432922363281
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진음성 (True negative, TN)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        513.7232666015625,
        253.39678955078125,
        524.7633056640625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자의 질병 상태와 검사의 음성판정이 일치하는 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        535.80322265625,
        385.44000244140625,
        546.84326171875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정가능범위 (Analytical measurement range, AMR)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        567.7232666015625,
        385.63714599609375,
        578.7633056640625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        589.80322265625,
        488.35638427734375,
        600.84326171875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        611.7632446289062,
        446.0400085449219,
        622.8032836914062
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석적 특이도 (Analytical specificity)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        643.80322265625,
        307.0365905761719,
        654.84326171875
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        665.7632446289062,
        484.67999267578125,
        676.8032836914062
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되지 않는 분석법의 능력",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        687.7232666015625,
        236.99998474121094,
        698.7633056640625
      ],
      "page_num": 15,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ. 용어의 정의",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        422.2799987792969,
        118.03440856933594,
        481.68621826171875,
        127.03440856933594
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 11 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판정기준치 (Cut-off Value)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        165.72328186035156,
        251.13418579101562,
        176.76327514648438
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        187.80328369140625,
        488.3560485839844,
        198.84327697753906
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있는 경계값을 말한다. 정량검사에서는 측정 결과가 임상적 또는 분석적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        209.76327514648438,
        488.35638427734375,
        220.8032684326172
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        231.72328186035156,
        484.6796875,
        242.76327514648438
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는데 사용되는 측정물질의 정량값",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        253.80328369140625,
        291.9596862792969,
        264.8432922363281
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프라이머 (Primer)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        285.7232666015625,
        200.25283813476562,
        296.7632751464844
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        307.80328369140625,
        488.3572082519531,
        318.8432922363281
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        329.7632751464844,
        481.7727966308594,
        340.80328369140625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프로브 (Probe)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        361.80328369140625,
        189.7975311279297,
        372.8432922363281
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        383.7632751464844,
        488.35638427734375,
        394.80328369140625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동정하는 목적으로 사용된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        405.7232666015625,
        260.35662841796875,
        416.7632751464844
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원 (Antigen)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        437.7632751464844,
        187.3974609375,
        448.80328369140625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        459.7232666015625,
        476.9560546875,
        470.7632751464844
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원결정인자 / 에피토프 (Antigenic determinant / epitope)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        491.7632751464844,
        421.05230712890625,
        502.80328369140625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        513.7232666015625,
        488.35638427734375,
        524.7633056640625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결정하는 부위의 화학적 구조",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        535.80322265625,
        258.9596862792969,
        546.84326171875
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항체 (Antibody)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        567.7232666015625,
        192.91744995117188,
        578.7633056640625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        589.80322265625,
        473.3999938964844,
        600.84326171875
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        611.7632446289062,
        488.35638427734375,
        622.8032836914062
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역원(immunogen)과 결합한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        633.7232666015625,
        292.5328063964844,
        644.7633056640625
      ],
      "page_num": 16,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항혈청 (Antiserum)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        665.7632446289062,
        211.7572021484375,
        676.8032836914062
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항체를 포함하는 혈청",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        687.7232666015625,
        220.5599822998047,
        698.7633056640625
      ],
      "page_num": 16,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        120.31440734863281,
        414.9193115234375,
        129.3144073486328
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 12 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.2903442382812,
        314.625,
        731.2503051757812
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        155.76327514648438,
        488.2360534667969,
        166.8032684326172
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 항체가 혈청 중에 생긴다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        177.72328186035156,
        284.61279296875,
        188.76327514648438
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "핵산추출 (Nucleic acid extraction)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        209.76327514648438,
        295.0354919433594,
        220.8032684326172
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        231.72328186035156,
        484.44000244140625,
        242.76327514648438
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용 오차 (Allowable error)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        263.7632751464844,
        254.85137939453125,
        274.80328369140625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        285.7232666015625,
        484.67999267578125,
        296.7632751464844
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        307.80328369140625,
        488.3560485839844,
        318.8432922363281
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만족시킬 수 있는 변이의 정도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        329.7632751464844,
        264.47998046875,
        340.80328369140625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "혈청전환 (Seroconversion)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        361.80328369140625,
        253.87733459472656,
        372.8432922363281
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        383.7632751464844,
        488.2357482910156,
        394.80328369140625
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전환",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        405.7232666015625,
        132.59999084472656,
        416.7632751464844
      ],
      "page_num": 17,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ. 관련규정",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        434.5199890136719,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 13 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ  관련규정",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        115.55999755859375,
        157.32000732421875,
        235.44000244140625,
        183.6719970703125
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍「의료기기법」제6조 (제조업의 허가 등)",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        110.5199966430664,
        222.87515258789062,
        322.8652648925781,
        236.20799255371094
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍「의료기기법」제15조 (수입업허가 등)",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        110.5199966430664,
        246.275146484375,
        312.1852722167969,
        259.6080017089844
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍「의료기기법 시행규칙」제5조 (제조허가의 절차)",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        110.5199966430664,
        269.6751403808594,
        365.58526611328125,
        283.00799560546875
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍「의료기기법 시행규칙」제7조 (제조신고의 절차)",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        110.5199966430664,
        293.07513427734375,
        365.58526611328125,
        306.4079895019531
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        110.5199966430664,
        316.47515869140625,
        381.5452880859375,
        329.8080139160156
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        110.5199966430664,
        339.8751525878906,
        376.2652893066406,
        353.2080078125
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍「의료기기 허가․신고․심사 등에 관한 규정」",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        110.5199966430664,
        363.275146484375,
        358.79998779296875,
        376.6080017089844
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍「의료기기 품목 및 품목별 등급에 관한 규정」",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        110.5199966430664,
        386.6751403808594,
        358.67999267578125,
        400.00799560546875
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍「의료기기 안정성시험 기준」",
      "font_size": 11.039999961853027,
      "font_name": "T9",
      "bbox": [
        110.5199966430664,
        410.07513427734375,
        277.20001220703125,
        423.4079895019531
      ],
      "page_num": 18,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 14 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ",
      "font_size": 18.0,
      "font_name": "T6",
      "bbox": [
        119.5199966430664,
        159.83999633789062,
        441.7184753417969,
        181.44000244140625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신청서 기재 항목 및 기술문서 제출자료",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        119.5199966430664,
        159.83999633789062,
        441.7184753417969,
        181.44000244140625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        216.18807983398438,
        271.3235168457031,
        230.9480743408203
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조․수입허가신청서",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        216.18807983398438,
        271.3235168457031,
        230.9480743408203
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 명칭(제품명, 품목명, 모델명)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        253.08328247070312,
        285.556396484375,
        264.123291015625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 분류번호(등급)",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        116.04000091552734,
        273.47998046875,
        205.7452850341797,
        286.7169494628906
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 모양 및 구조",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        294.8432922363281,
        202.15640258789062,
        305.88330078125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 원재료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        316.80328369140625,
        165.4796600341797,
        327.8432922363281
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 제조방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        338.8832702636719,
        176.5196533203125,
        349.92327880859375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 성능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        116.04000091552734,
        360.84326171875,
        154.55999755859375,
        371.8832702636719
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 사용목적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        380.6432800292969,
        176.5196533203125,
        391.68328857421875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 사용방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        402.603271484375,
        176.5196533203125,
        413.6432800292969
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 사용 시 주의사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        424.68328857421875,
        220.4396514892578,
        435.7232971191406
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 포장단위",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        446.6432800292969,
        176.5196533203125,
        457.68328857421875
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 저장방법 및 사용기간",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        468.603271484375,
        242.5196533203125,
        479.6432800292969
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 시험규격",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        490.68328857421875,
        176.5196533203125,
        501.7232971191406
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        116.04000091552734,
        511.0799865722656,
        365.22528076171875,
        524.3169555664062
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 허가(인증)조건",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.04000091552734,
        530.8800048828125,
        205.79998779296875,
        544.116943359375
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 비고",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.04000091552734,
        552.2324829101562,
        154.55999755859375,
        563.876220703125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        597.1880493164062,
        282.36395263671875,
        611.9480590820312
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기술문서에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        597.1880493164062,
        282.36395263671875,
        611.9480590820312
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        634.083251953125,
        429.0,
        645.123291015625
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 원재료 및 제조방법에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        656.043212890625,
        297.4800109863281,
        667.083251953125
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 사용목적에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        678.0032348632812,
        242.51998901367188,
        689.0432739257812
      ],
      "page_num": 19,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ. 신청서 기재 항목 및 기술문서 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        315.6000061035156,
        114.7944107055664,
        481.44561767578125,
        123.7944107055664
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 15 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 저장방법과 사용기간 또는 유효기간에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        153.00328063964844,
        379.9200134277344,
        164.04327392578125
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 제품의 성능을 확인하기 위한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        174.96328735351562,
        308.3996887207031,
        186.00328063964844
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 체외진단용 의료기기의 취급자 안전에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        197.04327392578125,
        379.9200134277344,
        208.08326721191406
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 이미 허가·인증받은 제품과 비교한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        219.00328063964844,
        334.0796813964844,
        230.04327392578125
      ],
      "page_num": 20,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 16 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ",
      "font_size": 21.959999084472656,
      "font_name": "T6",
      "bbox": [
        117.5999984741211,
        157.32000732421875,
        431.5199890136719,
        183.6719970703125
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조․수입허가 신청서 기재 항목",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        117.5999984741211,
        157.32000732421875,
        431.5199890136719,
        183.6719970703125
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        226.14808654785156,
        175.80398559570312,
        241.028076171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명칭",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        226.14808654785156,
        175.80398559570312,
        241.028076171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.  제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        268.0832824707031,
        421.7727966308594,
        279.123291015625
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 제품명이 없는 경우, 생략 가능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        290.04327392578125,
        298.32000732421875,
        301.0832824707031
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        312.0032653808594,
        481.4402160644531,
        323.04327392578125
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        334.0832824707031,
        471.1199951171875,
        345.123291015625
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        366.0032653808594,
        484.6800842285156,
        377.04327392578125
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여서는 아니 된다. 다만, 다음의 어느 하나에 해당하는 경우에는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.75999450683594,
        388.0832824707031,
        488.3558349609375,
        399.123291015625
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그러하지 아니하다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.75999450683594,
        410.04327392578125,
        222.9328155517578,
        421.0832824707031
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        432.0032653808594,
        488.35614013671875,
        443.04327392578125
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동일한 의료기기로서 취소된 날로부터 1년이 지난 경우",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.55999755859375,
        454.0832824707031,
        426.9599914550781,
        465.123291015625
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        476.04327392578125,
        484.67999267578125,
        487.0832824707031
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 경우",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        144.47999572753906,
        498.0032653808594,
        180.59950256347656,
        509.04327392578125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        520.083251953125,
        488.35638427734375,
        531.123291015625
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수입업소명을 병기하여 구분하는 경우",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        144.47999572753906,
        542.043212890625,
        336.9596862792969,
        553.083251953125
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        586.083251953125,
        488.35565185546875,
        597.123291015625
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        608.043212890625,
        484.67999267578125,
        619.083251953125
      ],
      "page_num": 21,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일제조사 제품에 한하여 가능함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        630.0032348632812,
        305.5960693359375,
        641.0432739257812
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        347.1600036621094,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 17 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 별첨 기재시의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        153.00328063964844,
        222.3599853515625,
        164.04327392578125
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "㈜오송진단",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        156.239990234375,
        179.37034606933594,
        455.30987548828125,
        189.33035278320312
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고위험성감염체면역검사시약",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        156.239990234375,
        179.37034606933594,
        455.30987548828125,
        189.33035278320312
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CMV",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        156.239990234375,
        179.37034606933594,
        455.30987548828125,
        189.33035278320312
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(제조․수입업소명)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        138.59999084472656,
        205.6503448486328,
        462.3944396972656,
        215.6103515625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(품목명)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        138.59999084472656,
        205.6503448486328,
        462.3944396972656,
        215.6103515625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(모델명)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        138.59999084472656,
        205.6503448486328,
        462.3944396972656,
        215.6103515625
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "㈜오송진단",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        153.83999633789062,
        232.8903350830078,
        462.869873046875,
        242.850341796875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오송IVD",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        153.83999633789062,
        232.8903350830078,
        462.869873046875,
        242.850341796875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고위험성감염체면역검사시약",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        153.83999633789062,
        232.8903350830078,
        462.869873046875,
        242.850341796875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        153.83999633789062,
        232.8903350830078,
        462.869873046875,
        242.850341796875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제조․수입업소명)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        139.0800018310547,
        259.17034912109375,
        469.9544372558594,
        269.1303405761719
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(제품명)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        139.0800018310547,
        259.17034912109375,
        469.9544372558594,
        269.1303405761719
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(품목명)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        139.0800018310547,
        259.17034912109375,
        469.9544372558594,
        269.1303405761719
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(모델명)",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        139.0800018310547,
        259.17034912109375,
        469.9544372558594,
        269.1303405761719
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 별첨 기재시의 예",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        130.55999755859375,
        280.55999755859375,
        232.3199920654297,
        293.8080139160156
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명칭",
      "font_size": 12.0,
      "font_name": "Batang",
      "bbox": [
        130.9199981689453,
        306.25921630859375,
        159.95999145507812,
        318.25921630859375
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 품목명: 고위험성감염체면역검사시약",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.9199981689453,
        325.53033447265625,
        313.0780944824219,
        335.4903259277344
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 모델명: CMV",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.9199981689453,
        341.4903259277344,
        206.67042541503906,
        351.4503173828125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 품목분류번호: D04160.01",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.9199981689453,
        357.4503479003906,
        265.1331481933594,
        367.41033935546875
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 등급: 3등급",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        130.9199981689453,
        373.53033447265625,
        199.0800018310547,
        383.4903259277344
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        423.7880859375,
        229.083984375,
        438.548095703125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모양 및 구조",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        423.7880859375,
        229.083984375,
        438.548095703125
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 모양 및 구조 - 작용원리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        470.6432800292969,
        255.7196502685547,
        481.68328857421875
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        492.603271484375,
        488.3560485839844,
        503.6432800292969
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        514.6832275390625,
        488.35638427734375,
        525.7232666015625
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 포함하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        536.6432495117188,
        238.39663696289062,
        547.6832885742188
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        580.6832275390625,
        488.3568115234375,
        591.7232666015625
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        602.6432495117188,
        221.85281372070312,
        613.6832885742188
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        624.6032104492188,
        161.39999389648438,
        635.6432495117188
      ],
      "page_num": 22,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        646.6832275390625,
        484.67999267578125,
        657.7232666015625
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다. 전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        668.6432495117188,
        488.3553466796875,
        679.6832885742188
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가 감염자다. 태아 감염율이 매우 높고 저개발국가와 사회경제적 상황",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        690.6032104492188,
        484.67974853515625,
        701.6432495117188
      ],
      "page_num": 22,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 18 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 좋지 않은 지역에서의 감염율은 타지역보다 높다. 생후 감염된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        153.00328063964844,
        488.35650634765625,
        164.04327392578125
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        174.96328735351562,
        484.67999267578125,
        186.00328063964844
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "핵구증 유사 증세(mononucleosis)를 보이기도 한다. 한번 감염되면",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        197.04327392578125,
        488.3561706542969,
        208.08326721191406
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        219.00328063964844,
        484.6796875,
        230.04327392578125
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지면 질환이 재발한다. 그러므로 대부분의 정상인에서 CMV 감염은",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        240.96327209472656,
        488.35650634765625,
        252.00326538085938
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        263.04327392578125,
        484.6804504394531,
        274.0832824707031
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장비대증, 간질폐렴 등의 증상을 유발한다. (이하생략)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        285.0032653808594,
        415.5599670410156,
        296.04327392578125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        329.04327392578125,
        476.372802734375,
        340.0832824707031
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        351.0032653808594,
        161.39999389648438,
        362.04327392578125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        372.9632873535156,
        488.3578186035156,
        384.0032958984375
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        395.04327392578125,
        456.8127746582031,
        406.0832824707031
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.0032653808594,
        488.3560485839844,
        428.04327392578125
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결합한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        438.9632873535156,
        204.69281005859375,
        450.0032958984375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        461.04327392578125,
        484.67999267578125,
        472.0832824707031
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        483.0032653808594,
        488.35540771484375,
        494.04327392578125
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아직 free상태였던 β항원의 binding site에 붙게 된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        504.9632873535156,
        434.3562927246094,
        516.0032958984375
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        527.043212890625,
        488.35638427734375,
        538.083251953125
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "화합물이 형성된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        549.0032348632812,
        254.2528076171875,
        560.0432739257812
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        570.9632568359375,
        484.67999267578125,
        582.0032958984375
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "photomultiplier가 측정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        593.043212890625,
        297.6927795410156,
        604.083251953125
      ],
      "page_num": 23,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        615.0032348632812,
        484.05279541015625,
        626.0432739257812
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 모양 및 구조 - 외형",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        659.043212890625,
        233.75999450683594,
        670.083251953125
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        681.0032348632812,
        484.67999267578125,
        692.0432739257812
      ],
      "page_num": 23,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        347.1600036621094,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 19 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 시약을 확인할 수 있는 컬러사진을 첨부한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        204.1199951171875,
        153.00328063964844,
        460.17279052734375,
        164.04327392578125
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        174.96328735351562,
        488.3562927246094,
        186.00328063964844
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        208.67999267578125,
        197.04327392578125,
        484.67999267578125,
        208.08326721191406
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "새 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        208.67999267578125,
        219.00328063964844,
        299.852783203125,
        230.04327392578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        240.96327209472656,
        488.3557434082031,
        252.00326538085938
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.0399932861328,
        263.04327392578125,
        488.3560485839844,
        274.0832824707031
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.0399932861328,
        285.0032653808594,
        229.1728057861328,
        296.04327392578125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그림 1. 외관사진 작성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        226.79998779296875,
        513.4832153320312,
        368.3999938964844,
        524.5232543945312
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 1. 구성표의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        535.563232421875,
        208.07998657226562,
        546.603271484375
      ],
      "page_num": 24,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일련",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        562.0503540039062,
        137.52000427246094,
        572.0103149414062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        578.13037109375,
        137.52000427246094,
        588.09033203125
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.27999877929688,
        570.0903930664062,
        439.67999267578125,
        580.0503540039062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세부 구성",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.27999877929688,
        570.0903930664062,
        439.67999267578125,
        580.0503540039062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "외관상 특징",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        152.27999877929688,
        570.0903930664062,
        439.67999267578125,
        580.0503540039062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        604.1703491210938,
        173.5090789794922,
        614.1303100585938
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Strip",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        604.1703491210938,
        173.5090789794922,
        614.1303100585938
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "샘플웰, 희석웰, 전세척웰,",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        203.63999938964844,
        596.13037109375,
        325.7567443847656,
        606.09033203125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세척완중웰, 컨쥬게이트, 큐벳",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        195.1199951171875,
        612.0903930664062,
        330.8399963378906,
        622.0503540039062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10개의 웰(액상시약 함유)로",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.44000244140625,
        596.13037109375,
        481.3967590332031,
        606.09033203125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이루어진 플라스틱 스트립",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        352.32000732421875,
        612.0903930664062,
        472.1999816894531,
        622.0503540039062
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        630.2103881835938,
        336.3162841796875,
        648.09033203125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        630.2103881835938,
        336.3162841796875,
        648.09033203125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV 항원 (AD169)이 코팅된",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        630.2103881835938,
        336.3162841796875,
        648.09033203125
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에스피알",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        243.0,
        646.1703491210938,
        282.9595031738281,
        656.1303100585938
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무색 투명한 분말이 흡착된",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        349.79998779296875,
        630.2103881835938,
        478.0362854003906,
        640.1703491210938
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고형 팁",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        394.79998779296875,
        646.1703491210938,
        429.719970703125,
        656.1303100585938
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        662.7303466796875,
        454.67950439453125,
        672.6903076171875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        662.7303466796875,
        454.67950439453125,
        672.6903076171875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "칼리브레이터",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        662.7303466796875,
        454.67950439453125,
        672.6903076171875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "담황색의 액상시약",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        662.7303466796875,
        454.67950439453125,
        672.6903076171875
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        677.850341796875,
        454.67950439453125,
        687.810302734375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        677.850341796875,
        454.67950439453125,
        687.810302734375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성 대조액",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        677.850341796875,
        454.67950439453125,
        687.810302734375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "담황색의 액상시약",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        677.850341796875,
        454.67950439453125,
        687.810302734375
      ],
      "page_num": 24,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        693.0903930664062,
        454.67950439453125,
        703.0503540039062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "C2",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        693.0903930664062,
        454.67950439453125,
        703.0503540039062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "음성 대조액",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        693.0903930664062,
        454.67950439453125,
        703.0503540039062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "담황색의 액상시약",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        124.68000030517578,
        693.0903930664062,
        454.67950439453125,
        703.0503540039062
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 20 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        158.34808349609375,
        189.12388610839844,
        173.1080780029297
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원재료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        158.34808349609375,
        189.12388610839844,
        173.1080780029297
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 원재료는 다음 양식의 표를 사용하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        205.20327758789062,
        365.2527770996094,
        216.24327087402344
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        313.92327880859375,
        451.8927917480469,
        324.9632873535156
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        335.8832702636719,
        488.35662841796875,
        346.92327880859375
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        180.47999572753906,
        357.84326171875,
        488.3560485839844,
        368.8832702636719
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우에는 세트별로 구분하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        180.47999572753906,
        379.92327880859375,
        376.17279052734375,
        390.9632873535156
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        401.8832702636719,
        484.6796875,
        412.92327880859375
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        205.55999755859375,
        423.84326171875,
        280.17279052734375,
        434.8832702636719
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        445.92327880859375,
        488.2357482910156,
        456.9632873535156
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        275.5199890136719,
        467.8832702636719,
        322.7727966308594,
        478.92327880859375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 분량",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        489.84326171875,
        167.2799835205078,
        500.8832702636719
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        511.9232482910156,
        488.3560485839844,
        522.9632568359375
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "역가를 기재",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.0,
        533.8832397460938,
        219.59999084472656,
        544.9232788085938
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        555.84326171875,
        488.35662841796875,
        566.88330078125
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응정지제, 희석액 등) 성분은 적량으로 표시 가능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.0800018310547,
        577.9232177734375,
        421.67999267578125,
        588.9632568359375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        599.8832397460938,
        482.2796630859375,
        610.9232788085938
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        621.84326171875,
        488.3569030761719,
        632.88330078125
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.95999145507812,
        643.9232177734375,
        181.79998779296875,
        654.9632568359375
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        665.8832397460938,
        488.2360534667969,
        676.9232788085938
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재하고 규격이 없는 경우 자사규격 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        184.44000244140625,
        687.84326171875,
        451.53277587890625,
        698.88330078125
      ],
      "page_num": 25,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일련",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        234.33033752441406,
        137.27996826171875,
        244.29034423828125
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        242.37034606933594,
        241.5171356201172,
        260.2503356933594
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        242.37034606933594,
        241.5171356201172,
        260.2503356933594
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배합목적",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.5999984741211,
        242.37034606933594,
        241.5171356201172,
        260.2503356933594
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원재료명 또는",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        260.3999938964844,
        234.33033752441406,
        326.95672607421875,
        244.29034423828125
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성분명",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        277.32000732421875,
        242.37034606933594,
        473.2804260253906,
        260.2503356933594
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분량",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        277.32000732421875,
        242.37034606933594,
        473.2804260253906,
        260.2503356933594
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        277.32000732421875,
        242.37034606933594,
        473.2804260253906,
        260.2503356933594
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        277.32000732421875,
        242.37034606933594,
        473.2804260253906,
        260.2503356933594
      ],
      "page_num": 25,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        347.1600036621094,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 21 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바. 비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        153.00328063964844,
        470.852783203125,
        164.04327392578125
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 2. 원재료 작성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        197.04327392578125,
        235.5599822998047,
        208.08326721191406
      ],
      "page_num": 26,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일련",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        114.72000122070312,
        225.09034729003906,
        134.63999938964844,
        235.05035400390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "번호",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        114.72000122070312,
        243.09034729003906,
        134.63999938964844,
        253.05035400390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "명칭",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        141.59999084472656,
        234.09034729003906,
        426.4795227050781,
        244.05035400390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배합목적",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        141.59999084472656,
        234.09034729003906,
        426.4795227050781,
        244.05035400390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원재료명 또는 성분명",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        141.59999084472656,
        234.09034729003906,
        426.4795227050781,
        244.05035400390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분량",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        141.59999084472656,
        234.09034729003906,
        426.4795227050781,
        244.05035400390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        141.59999084472656,
        234.09034729003906,
        426.4795227050781,
        244.05035400390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고(용량",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        435.47998046875,
        225.09034729003906,
        483.7962951660156,
        235.05035400390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 수량)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        438.0,
        243.09034729003906,
        477.8999938964844,
        253.05035400390625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        393.2103271484375,
        127.60675048828125,
        403.1703186035156
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Strip",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.39999389648438,
        375.2103271484375,
        162.82907104492188,
        385.1703186035156
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "60개",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.75999450683594,
        393.2103271484375,
        162.47999572753906,
        403.1703186035156
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/kit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        144.0,
        411.2103271484375,
        159.37522888183594,
        421.1703186035156
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웰1 : 샘플웰",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        270.5703430175781,
        391.21673583984375,
        280.53033447265625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검체",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        270.5703430175781,
        391.21673583984375,
        280.53033447265625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        270.5703430175781,
        391.21673583984375,
        280.53033447265625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        261.5703430175781,
        426.4795227050781,
        271.53033447265625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        279.5703430175781,
        426.4795227050781,
        289.53033447265625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        453.8399963378906,
        270.5703430175781,
        462.1367492675781,
        280.53033447265625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웰2 : 희석웰",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        309.9303283691406,
        397.0799865722656,
        319.89031982421875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tween-60 phosphate  적량",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        309.9303283691406,
        397.0799865722656,
        319.89031982421875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        300.9303283691406,
        426.4795227050781,
        310.89031982421875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        318.9303283691406,
        426.4795227050781,
        328.89031982421875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100ul",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        445.0799865722656,
        309.9303283691406,
        470.8984680175781,
        319.89031982421875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웰3 : 전세척웰",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        349.17034912109375,
        397.0799865722656,
        359.1303405761719
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tris-Cl",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        349.17034912109375,
        397.0799865722656,
        359.1303405761719
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        349.17034912109375,
        397.0799865722656,
        359.1303405761719
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        340.17034912109375,
        426.4795227050781,
        350.1303405761719
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        358.17034912109375,
        426.4795227050781,
        368.1303405761719
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100ul",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        445.0799865722656,
        349.17034912109375,
        470.8984680175781,
        359.1303405761719
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웰4-5-7-8 :",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        379.53033447265625,
        237.1967315673828,
        389.4903259277344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세척완충웰",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        397.53033447265625,
        217.19952392578125,
        407.4903259277344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Tris base",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        287.5199890136719,
        388.53033447265625,
        397.0799865722656,
        398.4903259277344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        287.5199890136719,
        388.53033447265625,
        397.0799865722656,
        398.4903259277344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        379.53033447265625,
        426.4795227050781,
        389.4903259277344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        397.53033447265625,
        426.4795227050781,
        407.4903259277344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "150ul",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        445.0799865722656,
        388.53033447265625,
        470.8984680175781,
        398.4903259277344
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웰6 : 컨쥬게이트",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        435.4503479003906,
        246.35951232910156,
        445.41033935546875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "mAb anti-human IgG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        258.9599914550781,
        426.4503479003906,
        364.63671875,
        436.41033935546875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "conjugate-APS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        274.1999816894531,
        444.4503479003906,
        346.18695068359375,
        454.41033935546875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ">500",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        375.1199951171875,
        427.29034423828125,
        402.5569152832031,
        437.2503356933594
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㎍/L",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        377.03997802734375,
        443.3703308105469,
        397.20074462890625,
        453.330322265625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        426.4503479003906,
        426.4795227050781,
        436.41033935546875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        444.4503479003906,
        426.4795227050781,
        454.41033935546875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "100ul",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        445.0799865722656,
        435.4503479003906,
        470.8984680175781,
        445.41033935546875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웰9 : 엠티 웰",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        479.4903259277344,
        314.2967529296875,
        489.4503173828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        479.4903259277344,
        314.2967529296875,
        489.4503173828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        470.4903259277344,
        426.4795227050781,
        480.4503173828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        488.4903259277344,
        426.4795227050781,
        498.4503173828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        453.8399963378906,
        479.4903259277344,
        462.1367492675781,
        489.4503173828125
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웰10 : 큐벳",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        515.850341796875,
        397.0799865722656,
        525.9302978515625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2-Methylisothiazolone",
      "font_size": 9.960000038146973,
      "font_name": "Batang",
      "bbox": [
        167.27999877929688,
        515.850341796875,
        397.0799865722656,
        525.9302978515625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적량",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        515.850341796875,
        397.0799865722656,
        525.9302978515625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        506.9703063964844,
        426.4795227050781,
        516.9302978515625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        524.9703369140625,
        426.4795227050781,
        534.9302978515625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "150ul",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        445.0799865722656,
        515.9703369140625,
        470.8984680175781,
        525.9302978515625
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        562.890380859375,
        161.19338989257812,
        572.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        562.890380859375,
        161.19338989257812,
        572.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항원이 코팅된 팁",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.27999877929688,
        544.890380859375,
        247.1999969482422,
        554.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(30개의SPRx2개",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        168.83999633789062,
        562.890380859375,
        246.36000061035156,
        572.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의 파우치)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.63999938964844,
        580.890380859375,
        232.6199951171875,
        590.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV Ag(AD 169)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        266.1600036621094,
        562.890380859375,
        398.3890686035156,
        572.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30ug",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        266.1600036621094,
        562.890380859375,
        398.3890686035156,
        572.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        553.890380859375,
        426.4795227050781,
        563.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        571.890380859375,
        426.4795227050781,
        581.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동결건조",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        438.0,
        562.890380859375,
        477.9595031738281,
        572.850341796875
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        609.6903686523438,
        227.27903747558594,
        619.6503295898438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        609.6903686523438,
        227.27903747558594,
        619.6503295898438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "칼리브레이터",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        609.6903686523438,
        227.27903747558594,
        619.6503295898438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IgG positive",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        267.47998046875,
        600.6903686523438,
        356.1187438964844,
        610.6503295898438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "serum",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        296.0400085449219,
        618.6903686523438,
        324.3763122558594,
        628.6503295898438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5unit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        375.47998046875,
        609.6903686523438,
        398.77545166015625,
        619.6503295898438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        600.6903686523438,
        426.4795227050781,
        610.6503295898438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        618.6903686523438,
        426.4795227050781,
        628.6503295898438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2mlx1병",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        438.5999755859375,
        609.6903686523438,
        477.3599853515625,
        619.6503295898438
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        649.0503540039062,
        217.19952392578125,
        659.0103149414062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        649.0503540039062,
        217.19952392578125,
        659.0103149414062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성대조액",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        649.0503540039062,
        217.19952392578125,
        659.0103149414062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IgG positive",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        267.47998046875,
        640.0503540039062,
        356.1187438964844,
        650.0103149414062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "serum",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        296.0400085449219,
        658.0503540039062,
        324.3763122558594,
        668.0103149414062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8unit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        375.47998046875,
        649.0503540039062,
        398.77545166015625,
        659.0103149414062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        640.0503540039062,
        426.4795227050781,
        650.0103149414062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        658.0503540039062,
        426.4795227050781,
        668.0103149414062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5mlx1병",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.1600036621094,
        649.0503540039062,
        481.67999267578125,
        659.0103149414062
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        684.3303833007812,
        217.19952392578125,
        694.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C2",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        684.3303833007812,
        217.19952392578125,
        694.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "음성대조액",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.79999542236328,
        684.3303833007812,
        217.19952392578125,
        694.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IgG negative",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        266.2799987792969,
        675.3303833007812,
        357.43817138671875,
        685.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "serum",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        296.0400085449219,
        693.3303833007812,
        324.3763122558594,
        703.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.5uni",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        372.9599914550781,
        675.3303833007812,
        401.29937744140625,
        685.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "t",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        385.1999816894531,
        693.3303833007812,
        388.9349670410156,
        703.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        675.3303833007812,
        426.4795227050781,
        685.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        406.44000244140625,
        693.3303833007812,
        426.4795227050781,
        703.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5mlx1병",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        434.1600036621094,
        684.3303833007812,
        481.67999267578125,
        694.2903442382812
      ],
      "page_num": 26,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 22 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        158.34808349609375,
        202.4438018798828,
        173.1080780029297
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조방법",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        158.34808349609375,
        202.4438018798828,
        173.1080780029297
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. ‘제조원의 제조방법에 따른다.’라고 기재한다. 다만, 다음 각 호에 해당",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        202.92327880859375,
        484.6796875,
        213.96327209472656
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 경우에는 해당사항을 부가하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        225.00328063964844,
        361.6528015136719,
        236.04327392578125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        246.96328735351562,
        488.3560485839844,
        258.0032958984375
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        268.92327880859375,
        488.35662841796875,
        279.9632873535156
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        291.0032653808594,
        437.9727783203125,
        302.04327392578125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        362.34808349609375,
        202.4438018798828,
        377.10809326171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용목적",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        362.34808349609375,
        202.4438018798828,
        377.10809326171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 사용목적은 성능을 포함하여 다음에 따라 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        409.2032775878906,
        387.2127990722656,
        420.2432861328125
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        431.16326904296875,
        488.3560485839844,
        442.2032775878906
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        453.1232604980469,
        406.9966125488281,
        464.16326904296875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        475.2032775878906,
        484.6796875,
        486.2432861328125
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        162.36000061035156,
        497.16326904296875,
        488.35638427734375,
        508.2032775878906
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정량하는 체외진단용 의료기기이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        162.36000061035156,
        519.1232299804688,
        341.4927978515625,
        530.1632690429688
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        541.2032470703125,
        488.35638427734375,
        552.2432861328125
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.55999755859375,
        563.1632690429688,
        484.6363830566406,
        574.2033081054688
      ],
      "page_num": 27,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모세관, 타액 및 기타 체액 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.55999755859375,
        585.1232299804688,
        302.6399841308594,
        596.1632690429688
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        607.2032470703125,
        479.15997314453125,
        618.2432861328125
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 측정원리 : 측정에 사용된 검사원리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        629.1632690429688,
        324.8396911621094,
        640.2033081054688
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        347.1600036621094,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 23 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        153.00328063964844,
        488.357666015625,
        164.04327392578125
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CMIA),",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        162.47999572753906,
        174.96328735351562,
        488.35675048828125,
        186.00328063964844
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효소형광법(Enzyme",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        162.47999572753906,
        174.96328735351562,
        488.35675048828125,
        186.00328063964844
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Linked",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        162.47999572753906,
        174.96328735351562,
        488.35675048828125,
        186.00328063964844
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Fluorescent",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        162.47999572753906,
        174.96328735351562,
        488.35675048828125,
        186.00328063964844
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Assay,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        162.47999572753906,
        174.96328735351562,
        488.35675048828125,
        186.00328063964844
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        162.47999572753906,
        197.04327392578125,
        434.6399841308594,
        208.08326721191406
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 성능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        219.12327575683594,
        147.5996551513672,
        230.16326904296875
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        241.08328247070312,
        484.67999267578125,
        252.12327575683594
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치적으로 제시된 성능 기재",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.0399932861328,
        263.04327392578125,
        287.1160583496094,
        274.0832824707031
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        285.0032653808594,
        488.35638427734375,
        296.04327392578125
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성능 배제",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        306.9632873535156,
        206.99964904785156,
        318.0032958984375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        329.04327392578125,
        488.35662841796875,
        340.0832824707031
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 특성에 맞는 성능을 구체적 근거 자료로 제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.3199920654297,
        351.0032653808594,
        414.7200012207031,
        362.04327392578125
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 3. 성능 작성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        395.04327392578125,
        239.51998901367188,
        406.0832824707031
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "번호",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        133.1999969482422,
        425.6103515625,
        383.9999694824219,
        435.5703430175781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능항목",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        133.1999969482422,
        425.6103515625,
        383.9999694824219,
        435.5703430175781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        133.1999969482422,
        425.6103515625,
        383.9999694824219,
        435.5703430175781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        446.850341796875,
        464.0395202636719,
        456.8103332519531
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정밀도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        446.850341796875,
        464.0395202636719,
        456.8103332519531
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "농도별 측정횟수(일) 변이계수 등 제시",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        446.850341796875,
        464.0395202636719,
        456.8103332519531
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        481.29034423828125,
        236.63951110839844,
        491.2503356933594
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석적 특이도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        481.29034423828125,
        236.63951110839844,
        491.2503356933594
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        250.4399871826172,
        465.330322265625,
        500.9566955566406,
        475.2903137207031
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일으키지 않는다. 헤모글로빈 : 1000mg/dL, 인지질 :",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        253.0800018310547,
        481.29034423828125,
        498.3162841796875,
        491.2503356933594
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "300mg/dL, 빌리루빈 : 40 mg/dL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        297.6000061035156,
        497.3703308105469,
        450.3453369140625,
        507.330322265625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        515.850341796875,
        488.40350341796875,
        525.810302734375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 특이도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        515.850341796875,
        488.40350341796875,
        525.810302734375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        515.850341796875,
        488.40350341796875,
        525.810302734375
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        534.3303833007812,
        489.2434997558594,
        544.2903442382812
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 민감도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        534.3303833007812,
        489.2434997558594,
        544.2903442382812
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양성 환자 검체 OO 개 모두 양성 판정 100.00 %",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        534.3303833007812,
        489.2434997558594,
        544.2903442382812
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        552.8103637695312,
        490.9807434082031,
        562.7703247070312
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상관성",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        552.8103637695312,
        490.9807434082031,
        562.7703247070312
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "99.80%(Compare with Other company's product)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.27999877929688,
        552.8103637695312,
        490.9807434082031,
        562.7703247070312
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        608.1080322265625,
        202.4438018798828,
        622.8681030273438
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용방법",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        608.1080322265625,
        202.4438018798828,
        622.8681030273438
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        654.9632568359375,
        484.67999267578125,
        666.0032958984375
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        676.9232177734375,
        488.3560485839844,
        687.9632568359375
      ],
      "page_num": 28,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 24 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 의료기기를 중심으로 사용방법을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        153.00328063964844,
        405.6927795410156,
        164.04327392578125
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 검체준비 및 저장방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        174.96328735351562,
        255.23965454101562,
        186.00328063964844
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 검체대상 및 채취방법 등",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        197.04327392578125,
        288.0763854980469,
        208.08326721191406
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 검체 종류별 사용 가능한 항응고제",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        219.00328063964844,
        337.51605224609375,
        230.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 사용되는 검체의 종류별 필요 분량",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        240.96327209472656,
        333.8396911621094,
        252.00326538085938
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 검체 보관조건, 방법 및 사용기간 등",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        263.04327392578125,
        342.6000061035156,
        274.0832824707031
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 냉동 및 해동된 검체의 사용 가능성 및 제한점",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        285.0032653808594,
        397.9960632324219,
        296.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 원심분리 조건 등을 포함한 검체 전처리과정 등",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        306.9632873535156,
        399.8399963378906,
        318.0032958984375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 검사 전 준비사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        329.04327392578125,
        233.15965270996094,
        340.0832824707031
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        351.0032653808594,
        488.3560485839844,
        362.04327392578125
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기구 및 조건 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        372.9632873535156,
        276.6927795410156,
        384.0032958984375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        395.04327392578125,
        452.4927978515625,
        406.0832824707031
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.0032653808594,
        436.05279541015625,
        428.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        438.9632873535156,
        488.35638427734375,
        450.0032958984375
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소프트웨어의 회사명, 모델명 등을 기재",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        461.04327392578125,
        362.35638427734375,
        472.0832824707031
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        483.0032653808594,
        483.2127990722656,
        494.04327392578125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 검사과정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        504.9632873535156,
        189.23965454101562,
        516.0032958984375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        527.043212890625,
        484.6796875,
        538.083251953125
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        549.0032348632812,
        488.35662841796875,
        560.0432739257812
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판독시간, 방법 등)을 상세하게 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        570.9632568359375,
        350.372802734375,
        582.0032958984375
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 결과판정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        593.043212890625,
        189.23965454101562,
        604.083251953125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        615.0032348632812,
        488.3548583984375,
        626.0432739257812
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        636.9632568359375,
        488.3560485839844,
        648.0032958984375
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        659.043212890625,
        187.0528106689453,
        670.083251953125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        681.0032348632812,
        488.3571472167969,
        692.0432739257812
      ],
      "page_num": 29,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        347.1600036621094,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 25 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        161.39999389648438,
        153.00328063964844,
        450.5727844238281,
        164.04327392578125
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가) 그대로 보고하는지 재검사가 필요한지 여부",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        174.96328735351562,
        392.5199890136719,
        186.00328063964844
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        197.04327392578125,
        488.35662841796875,
        208.08326721191406
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재채취하는지 여부",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        219.00328063964844,
        263.0400085449219,
        230.04327392578125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        240.96327209472656,
        488.35638427734375,
        252.00326538085938
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "알고리즘을 제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        172.8000030517578,
        263.04327392578125,
        255.23965454101562,
        274.0832824707031
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        285.0032653808594,
        488.3560485839844,
        296.04327392578125
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 보정결과 확인 절차에 대해 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.1999969482422,
        306.9632873535156,
        370.39630126953125,
        318.0032958984375
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        329.04327392578125,
        488.35638427734375,
        340.0832824707031
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.0399932861328,
        351.0032653808594,
        481.05279541015625,
        362.04327392578125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 정도관리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        395.04327392578125,
        189.23965454101562,
        406.0832824707031
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.0032653808594,
        423.1966247558594,
        428.04327392578125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        438.9632873535156,
        488.35638427734375,
        450.0032958984375
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준값에 적합함을 확인하는 과정을 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        461.04327392578125,
        395.35662841796875,
        472.0832824707031
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        483.0032653808594,
        488.2362976074219,
        494.04327392578125
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        532.3880615234375,
        255.7238006591797,
        547.1480712890625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 시 주의사항",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        532.3880615234375,
        255.7238006591797,
        547.1480712890625
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 다음의 사항을 포함하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        579.1232299804688,
        299.2528076171875,
        590.1632690429688
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 체외진단용으로 사용해야 함을 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        601.2032470703125,
        355.5166320800781,
        612.2432861328125
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        623.1632690429688,
        488.35638427734375,
        634.2033081054688
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.75999450683594,
        645.1232299804688,
        457.7727966308594,
        656.1632690429688
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        667.2032470703125,
        484.67999267578125,
        678.2432861328125
      ],
      "page_num": 30,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.55999755859375,
        689.1632690429688,
        170.85281372070312,
        700.2033081054688
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 26 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        153.00328063964844,
        485.71661376953125,
        164.04327392578125
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마. 경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        174.96328735351562,
        484.679443359375,
        186.00328063964844
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(온도, 습도의 영향 등)을 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        197.04327392578125,
        325.29278564453125,
        208.08326721191406
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바. 임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        219.00328063964844,
        488.35638427734375,
        230.04327392578125
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과 판정상 주의사항을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.55999755859375,
        240.96327209472656,
        322.87628173828125,
        252.00326538085938
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사. 검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        263.04327392578125,
        488.35662841796875,
        274.0832824707031
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위양성도 및 위음성도) 등을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.16000366210938,
        285.0032653808594,
        342.0928039550781,
        296.04327392578125
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        488.35626220703125,
        318.0032958984375
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사의 결과에 영향을 미칠 수 있다. 또한 비정상적인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        202.55999755859375,
        329.04327392578125,
        488.3560485839844,
        340.0832824707031
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        202.55999755859375,
        351.0032653808594,
        484.6795654296875,
        362.04327392578125
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도는 결과를 방해할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        202.55999755859375,
        372.9632873535156,
        359.9727783203125,
        384.0032958984375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아. 다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        395.04327392578125,
        488.3562927246094,
        406.0832824707031
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정보를 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        417.0032653808594,
        232.41281127929688,
        428.04327392578125
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자. 일회용의 경우 재사용하지 않도록 주의사항을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        438.9632873535156,
        432.436279296875,
        450.0032958984375
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        510.3080749511719,
        202.4438018798828,
        525.1881103515625
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포장단위",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        510.3080749511719,
        202.4438018798828,
        525.1881103515625
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        557.1632690429688,
        488.35638427734375,
        568.2033081054688
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.63999938964844,
        579.1232299804688,
        488.35638427734375,
        590.1632690429688
      ],
      "page_num": 31,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.63999938964844,
        601.2032470703125,
        176.5966339111328,
        612.2432861328125
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        347.1600036621094,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 27 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 32,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "9",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        158.34808349609375,
        282.3638000488281,
        173.1080780029297
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "저장방법 및 사용기간",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        158.34808349609375,
        282.3638000488281,
        173.1080780029297
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        205.20327758789062,
        484.67999267578125,
        216.24327087402344
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장방법 및 사용기간 또는 유효기간을 설정하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        227.1632843017578,
        414.0766296386719,
        238.20327758789062
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        249.123291015625,
        488.35662841796875,
        260.1632995605469
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        271.2032775878906,
        486.1966247558594,
        282.2432861328125
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        293.16326904296875,
        484.6796875,
        304.2032775878906
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.9199981689453,
        315.123291015625,
        488.35638427734375,
        326.1632995605469
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등이 포함되도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.9199981689453,
        337.2032775878906,
        259.05279541015625,
        348.2432861328125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        359.16326904296875,
        484.6803283691406,
        370.2032775878906
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기간)을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        381.123291015625,
        233.97280883789062,
        392.1632995605469
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        403.2032775878906,
        488.3560485839844,
        414.2432861328125
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        425.16326904296875,
        476.0127868652344,
        436.2032775878906
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 4. 저장방법 및 사용기간(유효기간) 작성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        466.92327880859375,
        362.0400085449219,
        477.9632873535156
      ],
      "page_num": 32,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구성",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.91999816894531,
        491.1303405761719,
        138.83999633789062,
        501.09033203125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        118.91999816894531,
        509.1303405761719,
        138.83999633789062,
        519.09033203125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉여부",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        148.67999267578125,
        500.1303405761719,
        461.6395263671875,
        510.09033203125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보관조건",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        148.67999267578125,
        500.1303405761719,
        461.6395263671875,
        510.09033203125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용기간",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        148.67999267578125,
        500.1303405761719,
        461.6395263671875,
        510.09033203125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        148.67999267578125,
        500.1303405761719,
        461.6395263671875,
        510.09033203125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Strip",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.7199935913086,
        538.2903442382812,
        140.14907836914062,
        548.2503051757812
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        153.59999084472656,
        527.6103515625,
        183.59951782226562,
        537.5703125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2~8℃",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        209.1599884033203,
        538.2903442382812,
        238.8000030517578,
        548.2503051757812
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조일로부터 11개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        289.79998779296875,
        527.6103515625,
        386.3999938964844,
        537.5703125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "냉암소보관",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        426.5999755859375,
        538.2903442382812,
        476.6390380859375,
        548.2503051757812
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        548.9703369140625,
        383.5195007324219,
        558.9302978515625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉일로부터 7개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        548.9703369140625,
        383.5195007324219,
        558.9302978515625
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SPR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        119.39999389648438,
        580.890380859375,
        138.51339721679688,
        590.850341796875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        153.59999084472656,
        570.2103881835938,
        183.59951782226562,
        580.1703491210938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2~8℃",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        209.1599884033203,
        580.890380859375,
        238.8000030517578,
        590.850341796875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조일로부터 11개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        289.79998779296875,
        570.2103881835938,
        386.3999938964844,
        580.1703491210938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        591.5703735351562,
        383.5195007324219,
        601.5303344726562
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉일로부터 7개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        591.5703735351562,
        383.5195007324219,
        601.5303344726562
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "S1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        122.87999725341797,
        623.4903564453125,
        134.92669677734375,
        633.4503173828125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        153.59999084472656,
        612.9303588867188,
        183.59951782226562,
        622.8903198242188
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2~8℃",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        209.1599884033203,
        623.4903564453125,
        238.8000030517578,
        633.4503173828125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조일로부터 11개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        289.79998779296875,
        612.9303588867188,
        386.3999938964844,
        622.8903198242188
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        634.1703491210938,
        383.5195007324219,
        644.1303100585938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉일로부터 7개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        634.1703491210938,
        383.5195007324219,
        644.1303100585938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C1",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        122.63999938964844,
        666.2103881835938,
        135.16676330566406,
        676.1703491210938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        153.59999084472656,
        655.5303344726562,
        183.59951782226562,
        665.4902954101562
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2~8℃",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        209.1599884033203,
        666.2103881835938,
        238.8000030517578,
        676.1703491210938
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조일로부터 11개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        289.79998779296875,
        655.5303344726562,
        386.3999938964844,
        665.4902954101562
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        676.7703857421875,
        383.5195007324219,
        686.7303466796875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개봉일로부터 7개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        676.7703857421875,
        383.5195007324219,
        686.7303466796875
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 28 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 33,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        118.19999694824219,
        227.22808837890625,
        202.4438018798828,
        241.9880828857422
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험규격",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        118.19999694824219,
        227.22808837890625,
        202.4438018798828,
        241.9880828857422
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        274.0832824707031,
        488.35638427734375,
        285.123291015625
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        296.04327392578125,
        488.35638427734375,
        307.0832824707031
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적용할 수 있는 시험규격을 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        318.0032653808594,
        317.61279296875,
        329.04327392578125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        362.04327392578125,
        484.67999267578125,
        373.0832824707031
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "항목, 시험기준, 시험방법을 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        384.0032653808594,
        318.6927795410156,
        395.04327392578125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 시험항목",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        406.0832824707031,
        189.23965454101562,
        417.123291015625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        428.04327392578125,
        430.53277587890625,
        439.0832824707031
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        450.0032653808594,
        488.35638427734375,
        461.04327392578125
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        472.0832824707031,
        457.53277587890625,
        483.123291015625
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 시험기준",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        494.04327392578125,
        189.23965454101562,
        505.0832824707031
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        516.0032348632812,
        484.6796875,
        527.0432739257812
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        538.083251953125,
        488.3553771972656,
        549.123291015625
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영향을 받는 경우에는 그 조건을 명시하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        560.043212890625,
        413.852783203125,
        571.083251953125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        582.0032348632812,
        189.23965454101562,
        593.0432739257812
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        604.083251953125,
        488.3560485839844,
        615.123291015625
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구체적, 개조식으로 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.59999084472656,
        626.043212890625,
        308.9727783203125,
        637.083251953125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        648.0032348632812,
        488.35638427734375,
        659.0432739257812
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        670.083251953125,
        488.35736083984375,
        681.123291015625
      ],
      "page_num": 33,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        692.043212890625,
        204.81280517578125,
        703.083251953125
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C2",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        122.63999938964844,
        170.850341796875,
        135.16676330566406,
        180.8103485107422
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        153.59999084472656,
        160.17034912109375,
        183.59951782226562,
        170.13035583496094
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2~8℃",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        209.1599884033203,
        170.850341796875,
        238.8000030517578,
        180.8103485107422
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조일로부터 11개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        289.79998779296875,
        160.17034912109375,
        386.3999938964844,
        170.13035583496094
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개봉",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        181.5303497314453,
        383.5195007324219,
        191.4903564453125
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개봉일로부터 7개월",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.63999938964844,
        181.5303497314453,
        383.5195007324219,
        191.4903564453125
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅴ. 제조․수입허가 신청서 기재 항목",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        347.1600036621094,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 29 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        153.00328063964844,
        488.3554992675781,
        164.04327392578125
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 설정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.39999389648438,
        174.96328735351562,
        248.372802734375,
        186.00328063964844
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        197.04327392578125,
        488.3560485839844,
        208.08326721191406
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.0399932861328,
        219.00328063964844,
        220.29281616210938,
        230.04327392578125
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        240.96327209472656,
        483.5727844238281,
        252.00326538085938
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 5. 시험규격 작성의 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        285.0032653808594,
        246.59999084472656,
        296.04327392578125
      ],
      "page_num": 34,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험항목",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.7199935913086,
        315.5703430175781,
        430.9195251464844,
        325.53033447265625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험기준",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.7199935913086,
        315.5703430175781,
        430.9195251464844,
        325.53033447265625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.7199935913086,
        315.5703430175781,
        430.9195251464844,
        325.53033447265625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 외관검사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.47999572753906,
        357.9303283691406,
        171.23951721191406,
        367.89031982421875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "튜브 내 이물질 유무, 라벨 인쇄",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        342.9303283691406,
        339.4795227050781,
        352.89031982421875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상태, 구성품 누락여부를 확인한",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        357.9303283691406,
        339.4795227050781,
        367.89031982421875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        372.9303283691406,
        195.73851013183594,
        382.89031982421875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "육안으로 확인한다",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        357.9303283691406,
        429.239501953125,
        367.89031982421875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 검출한계",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.47999572753906,
        426.4503479003906,
        171.23951721191406,
        436.41033935546875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대조용 시약키트와 비교하여 O.D.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        403.8903503417969,
        339.49859619140625,
        413.850341796875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "값이 10% 이내",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        418.8903503417969,
        253.55999755859375,
        428.850341796875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(품질관리용 냉동보관된 환자혈청",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        433.8903503417969,
        342.7962951660156,
        443.850341796875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 표준혈청)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        448.8903503417969,
        252.7799835205078,
        458.850341796875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품질관리를 위해 냉동보관된",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        396.4503479003906,
        482.956298828125,
        406.41033935546875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "환자혈청을 2배씩 계단희석",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        411.4503479003906,
        479.6395263671875,
        421.41033935546875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하여 대조용 시약키트와 동시",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        426.4503479003906,
        479.6399841308594,
        436.41033935546875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 검사하여 검출한계를 비교",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        441.4503479003906,
        479.6399841308594,
        451.41033935546875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        456.4503479003906,
        367.218505859375,
        466.41033935546875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 정밀도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.47999572753906,
        500.9703369140625,
        161.27952575683594,
        510.9303283691406
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10번",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        470.9703369140625,
        339.4795227050781,
        480.9303283691406
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반복측정하여",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        470.9703369140625,
        339.4795227050781,
        480.9303283691406
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        470.9703369140625,
        339.4795227050781,
        480.9303283691406
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        470.9703369140625,
        339.4795227050781,
        480.9303283691406
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(O.D)값의 변이계수(CV)가 10%",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        485.9703369140625,
        342.79791259765625,
        495.9303283691406
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이내",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        500.9703369140625,
        202.7995147705078,
        510.9303283691406
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(품질관리용 냉동보관된 고, 중,",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        515.9703369140625,
        342.7972106933594,
        525.9302978515625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저 환자혈청)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        530.9703369140625,
        242.8199920654297,
        540.9302978515625
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품질관리용 고, 중, 저 환자",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        493.53033447265625,
        479.6399841308594,
        503.4903259277344
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈청을 10회씩 측정한다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        508.5303649902344,
        458.8985290527344,
        518.4903564453125
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 민감도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.47999572753906,
        562.0503540039062,
        161.27952575683594,
        572.0103149414062
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모두 양성",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        547.0503540039062,
        227.75999450683594,
        557.0103149414062
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(품질관리용 냉동보관된 양성환자",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        562.0503540039062,
        339.4795227050781,
        572.0103149414062
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검체 10개 이상)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        577.0503540039062,
        259.5,
        587.0103149414062
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품질관리용 혈청(LOD+2SD)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        554.6103515625,
        482.9554443359375,
        564.5703125
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10건을 검사한다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        569.6103515625,
        423.8585205078125,
        579.5703125
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 특이도",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        117.47999572753906,
        618.6903686523438,
        161.27952575683594,
        628.6503295898438
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모두 음성",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        603.6903686523438,
        227.75999450683594,
        613.6503295898438
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(품질관리용 냉동보관된 음성검체",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        618.6903686523438,
        342.7962951660156,
        628.6503295898438
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30개 이상)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        182.75999450683594,
        633.6903686523438,
        234.4199981689453,
        643.6503295898438
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "음성 대조물질 30건을 검사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        611.13037109375,
        479.6399841308594,
        621.09033203125
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        344.2799987792969,
        626.13037109375,
        367.218505859375,
        636.09033203125
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 30 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        118.19999694824219,
        158.34808349609375,
        189.12388610839844,
        173.1080780029297
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조원",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        118.19999694824219,
        158.34808349609375,
        189.12388610839844,
        173.1080780029297
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        205.20327758789062,
        434.372802734375,
        216.24327087402344
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        249.123291015625,
        488.3560485839844,
        260.1632995605469
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상호와 주소를 모두 기재한다. 다만, 제조자가 외국회사일 경우에는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        271.2032775878906,
        488.3560485839844,
        282.2432861328125
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조국을 추가로 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        293.16326904296875,
        262.6528015136719,
        304.2032775878906
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 설명",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        315.2432861328125,
        161.39999389648438,
        326.2832946777344
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        337.3232727050781,
        454.41278076171875,
        348.36328125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제조의뢰자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        381.2432861328125,
        195.5993194580078,
        392.2832946777344
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 상호 : 식약(주)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        403.3232727050781,
        238.55999755859375,
        414.36328125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        425.28326416015625,
        441.0,
        436.3232727050781
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 제조자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        469.3232727050781,
        173.6396484375,
        480.36328125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 상호 : FDAS",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        491.28326416015625,
        224.3390350341797,
        502.3232727050781
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 제조국 : 미국",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        513.2432250976562,
        227.63998413085938,
        524.2832641601562
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 주소 : 0000 U.S Highway 000, CA 0000, USA",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        535.3232421875,
        405.4803771972656,
        546.36328125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        328.0799865722656,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 31 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ",
      "font_size": 21.959999084472656,
      "font_name": "T6",
      "bbox": [
        117.36000061035156,
        157.32000732421875,
        414.4820861816406,
        183.6719970703125
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술문서 등의 심사를 위한 제출자료",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        117.36000061035156,
        157.32000732421875,
        414.4820861816406,
        183.6719970703125
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 원칙",
      "font_size": 12.0,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        222.8592071533203,
        150.0,
        234.8592071533203
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        246.84329223632812,
        488.3560485839844,
        257.88330078125
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        268.92327880859375,
        488.35638427734375,
        279.9632873535156
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        290.8832702636719,
        171.4528045654297,
        301.92327880859375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        312.8432922363281,
        488.35638427734375,
        323.88330078125
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전자적 기록매체(CD·디스켓 등)와 함께 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.9199981689453,
        334.92327880859375,
        398.852783203125,
        345.9632873535156
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        356.8832702636719,
        488.3560485839844,
        367.92327880859375
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구체적으로 기재하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.9199981689453,
        378.84326171875,
        292.05279541015625,
        389.8832702636719
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        400.92327880859375,
        484.6796875,
        411.9632873535156
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. 다만,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        422.8832702636719,
        488.2362976074219,
        433.92327880859375
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        444.84326171875,
        482.956298828125,
        455.8832702636719
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        466.92327880859375,
        488.3560485839844,
        477.9632873535156
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "첨부하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        488.8832702636719,
        228.2128143310547,
        499.92327880859375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 이미 허가받은 제품과의 동등비교",
      "font_size": 12.0,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        532.939208984375,
        308.2799987792969,
        544.939208984375
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        115.91999816894531,
        557.8800048828125,
        484.67999267578125,
        571.1279907226562
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        135.72000122070312,
        577.6799926757812,
        490.2002868652344,
        590.9169311523438
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허가받은 사항과 비교한다.",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        135.72000122070312,
        597.47998046875,
        269.0179138183594,
        610.7169189453125
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나.",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        115.91999816894531,
        617.280029296875,
        484.7380676269531,
        630.5280151367188
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        115.91999816894531,
        617.280029296875,
        484.7380676269531,
        630.5280151367188
      ],
      "page_num": 36,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판단 표에 따라 제출자료가 면제될 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        138.83999633789062,
        637.0800170898438,
        359.1379089355469,
        650.3169555664062
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 32 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        110.5199966430664,
        151.44000244140625,
        471.9597473144531,
        164.68798828125
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        110.5199966430664,
        592.0991821289062,
        404.852783203125,
        604.0991821289062
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 인정범위",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        125.5199966430664,
        616.083251953125,
        188.27964782714844,
        627.123291015625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        638.043212890625,
        447.5560607910156,
        649.083251953125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        660.0032348632812,
        488.3560485839844,
        671.0432739257812
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.55999755859375,
        682.083251953125,
        488.3560485839844,
        693.123291015625
      ],
      "page_num": 37,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        328.0799865722656,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 33 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.55999755859375,
        153.00328063964844,
        488.3557434082031,
        164.04327392578125
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인한 자료 또는 이를 공증한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.55999755859375,
        174.96328735351562,
        341.9996643066406,
        186.00328063964844
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        197.04327392578125,
        488.3560485839844,
        208.08326721191406
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.51998901367188,
        219.00328063964844,
        484.6796875,
        230.04327392578125
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.51998901367188,
        240.96327209472656,
        169.5599822998047,
        252.00326538085938
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        263.04327392578125,
        488.35638427734375,
        274.0832824707031
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        285.0032653808594,
        488.3560485839844,
        296.04327392578125
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        306.9632873535156,
        484.67999267578125,
        318.0032958984375
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 검토하여 타당하다고 인정할 수 있는 시험성적서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        329.04327392578125,
        421.4396667480469,
        340.0832824707031
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 기재내용",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        125.5199966430664,
        372.9632873535156,
        188.27964782714844,
        384.0032958984375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 업체명 및 주소",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        395.04327392578125,
        234.95999145507812,
        406.0832824707031
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.0032653808594,
        432.8396911621094,
        428.04327392578125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 시험검사품의 모델명, 상품명(해당 경우에 한함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        438.9632873535156,
        403.0799865722656,
        450.0032958984375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 시험일자 및 시험성적서 발급일자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        461.04327392578125,
        328.4396667480469,
        472.0832824707031
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 시험 책임자의 서명 또는 직인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        483.0032653808594,
        311.8800048828125,
        494.04327392578125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        504.9632873535156,
        483.9599914550781,
        516.0032958984375
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        527.043212890625,
        488.35638427734375,
        538.083251953125
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요한 경우에 한함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        549.0032348632812,
        261.9599914550781,
        560.0432739257812
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8) 시험환경요인(시험결과에 영향을 주는 경우에 한함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        570.9632568359375,
        421.91998291015625,
        582.0032958984375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        125.5199966430664,
        615.0032348632812,
        488.3545227050781,
        626.0432739257812
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험한 자료의 경우)",
      "font_size": 11.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        146.16000366210938,
        636.9632568359375,
        248.61280822753906,
        648.0032958984375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험시설개요",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        659.043212890625,
        223.9193115234375,
        670.083251953125
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        681.0032348632812,
        488.35662841796875,
        692.0432739257812
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 34 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주요설비 목록 등이 기재되어 있어야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        153.00328063964844,
        354.0,
        164.04327392578125
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 주요설비",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        174.96328735351562,
        201.95965576171875,
        186.00328063964844
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        197.04327392578125,
        488.35638427734375,
        208.08326721191406
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사항이 기재되고 관련 증빙자료를 함께 제출하여야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        219.00328063964844,
        425.3999938964844,
        230.04327392578125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 연구인력구성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        240.96327209472656,
        223.9193115234375,
        252.00326538085938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        263.04327392578125,
        488.3560485839844,
        274.0832824707031
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정보가 기재되어야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        285.0032653808594,
        260.5199890136719,
        296.04327392578125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 시험자의 연구경력",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        306.9632873535156,
        251.399658203125,
        318.0032958984375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        329.04327392578125,
        488.35662841796875,
        340.0832824707031
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        351.0032653808594,
        488.35736083984375,
        362.04327392578125
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        372.9632873535156,
        482.6396789550781,
        384.0032958984375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        444.3080749511719,
        472.07965087890625,
        458.6751403808594
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료",
      "font_size": 12.839439392089844,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        444.3080749511719,
        472.07965087890625,
        458.6751403808594
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 개발경위",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        491.28326416015625,
        169.67965698242188,
        502.3232727050781
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        513.1232299804688,
        488.3562927246094,
        524.1632690429688
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        147.0,
        535.2032470703125,
        481.29278564453125,
        546.2432861328125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        557.1632690429688,
        488.3560485839844,
        568.2033081054688
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근거를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        579.1232299804688,
        243.2128143310547,
        590.1632690429688
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 측정원리 ․ 방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        623.1632690429688,
        204.47964477539062,
        634.2033081054688
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        645.1232299804688,
        484.6796875,
        656.1632690429688
      ],
      "page_num": 39,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 방법 및 측정원리를 설명하는 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.8000030517578,
        667.2032470703125,
        401.852783203125,
        678.2432861328125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        689.1632690429688,
        445.29278564453125,
        700.2033081054688
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        328.0799865722656,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 35 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        153.00328063964844,
        485.1163024902344,
        164.04327392578125
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 국내․외에서 사용현황",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        219.00328063964844,
        232.07965087890625,
        230.04327392578125
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        240.96327209472656,
        483.3327941894531,
        252.00326538085938
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        263.04327392578125,
        484.67999267578125,
        274.0832824707031
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "된 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.75999450683594,
        285.0032653808594,
        197.27964782714844,
        296.04327392578125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        306.9632873535156,
        488.35662841796875,
        318.0032958984375
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품 안전성 및 성능과 관련된 유해사례보고 요약",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.36000061035156,
        329.04327392578125,
        412.44000244140625,
        340.0832824707031
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 제조국에서 사용되지 않는 경우는 그 사유",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        351.0032653808594,
        376.036376953125,
        362.04327392578125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        422.34808349609375,
        349.0839538574219,
        437.10809326171875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원재료 및 제조방법에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        422.34808349609375,
        349.0839538574219,
        437.10809326171875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 원재료의 성분 또는 분량을 확인할 수 있는 근거자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        469.2032775878906,
        395.0396728515625,
        480.2432861328125
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 해당시약의 성분과 분량을 확인할 수 있는 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        491.16326904296875,
        387.1199951171875,
        502.2032775878906
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        513.1232299804688,
        488.35638427734375,
        524.1632690429688
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 자료 포함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        535.2032470703125,
        222.5996551513672,
        546.2432861328125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        557.1632690429688,
        482.0396728515625,
        568.2033081054688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 원료물질의 품질 확인 근거자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        579.1232299804688,
        304.6796875,
        590.1632690429688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        601.2032470703125,
        488.35638427734375,
        612.2432861328125
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 활성도를 확인할 수 있는 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.16000366210938,
        623.1632690429688,
        316.55999755859375,
        634.2033081054688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        645.1232299804688,
        488.3560485839844,
        656.1632690429688
      ],
      "page_num": 40,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분자량 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.67999267578125,
        667.2032470703125,
        200.75999450683594,
        678.2432861328125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 36 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 제조공정의 흐름도를 포함한 제조공정에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        153.00328063964844,
        383.9996643066406,
        164.04327392578125
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.55999755859375,
        174.96328735351562,
        488.35638427734375,
        186.00328063964844
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        136.3199920654297,
        197.04327392578125,
        479.7599792480469,
        208.08326721191406
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.55999755859375,
        219.00328063964844,
        484.6796875,
        230.04327392578125
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.36000061035156,
        240.96327209472656,
        484.6796875,
        252.00326538085938
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.36000061035156,
        263.04327392578125,
        160.53280639648438,
        274.0832824707031
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.55999755859375,
        285.0032653808594,
        484.67999267578125,
        296.04327392578125
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "호와 주소)을 확인할 수 있는 자료도 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        138.83999633789062,
        306.9632873535156,
        378.4527893066406,
        318.0032958984375
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        378.3080749511719,
        282.36395263671875,
        393.1880798339844
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용목적에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        378.3080749511719,
        282.36395263671875,
        393.1880798339844
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        425.16326904296875,
        484.67999267578125,
        436.2032775878906
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        447.1232604980469,
        488.3557434082031,
        458.16326904296875
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        126.1199951171875,
        469.2032775878906,
        173.37281799316406,
        480.2432861328125
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 해당제품의 제품설명서(insert)를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        491.16326904296875,
        345.0928039550781,
        502.2032775878906
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        562.508056640625,
        418.56396484375,
        577.26806640625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "저장방법과 사용기간(유효기간)에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        562.508056640625,
        418.56396484375,
        577.26806640625
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        599.4032592773438,
        488.35638427734375,
        610.4432983398438
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        621.3632202148438,
        427.6528015136719,
        632.4032592773438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 구성 제품별로 구분하여 안정성 시험 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        643.3232421875,
        403.6528015136719,
        654.36328125
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        665.4032592773438,
        484.6796875,
        676.4432983398438
      ],
      "page_num": 41,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        687.3632202148438,
        141.69281005859375,
        698.4032592773438
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        328.0799865722656,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 37 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        153.00328063964844,
        484.67999267578125,
        164.04327392578125
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 참고한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        174.96328735351562,
        191.2528076171875,
        186.00328063964844
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. 저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        197.04327392578125,
        484.6363830566406,
        208.08326721191406
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로트 이상의 시험성적서를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.75999450683594,
        219.00328063964844,
        310.41278076171875,
        230.04327392578125
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        240.96327209472656,
        484.67999267578125,
        252.00326538085938
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        263.04327392578125,
        484.67999267578125,
        274.0832824707031
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "료를 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        285.0032653808594,
        202.1728057861328,
        296.04327392578125
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        306.9632873535156,
        484.67999267578125,
        318.0032958984375
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        329.04327392578125,
        163.77281188964844,
        340.0832824707031
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        351.0032653808594,
        488.355712890625,
        362.04327392578125
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인정범위내의 자료 이어야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        372.9632873535156,
        290.372802734375,
        384.0032958984375
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        444.3080749511719,
        362.4039611816406,
        459.1880798339844
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품의 성능을 확인하기 위한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        444.3080749511719,
        362.4039611816406,
        459.1880798339844
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        491.16326904296875,
        442.17279052734375,
        502.2032775878906
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 분석적 성능시험에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        513.1232299804688,
        293.6396789550781,
        524.1632690429688
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        535.2032470703125,
        484.6804504394531,
        546.2432861328125
      ],
      "page_num": 42,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "범위 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        557.1632690429688,
        200.52000427246094,
        568.2033081054688
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 분석적 특이도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        579.1232299804688,
        229.4396514892578,
        590.1632690429688
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 정밀도(반복, 재현성 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        601.2032470703125,
        282.1199951171875,
        612.2432861328125
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 정확도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        623.1632690429688,
        190.91964721679688,
        634.2033081054688
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 교차반응",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        645.1232299804688,
        201.95965576171875,
        656.1632690429688
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 임상적 성능시험에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        667.2032470703125,
        293.6396789550781,
        678.2432861328125
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 임상적 민감도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        689.1632690429688,
        229.4396514892578,
        700.2033081054688
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 38 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 임상적 특이도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        153.00328063964844,
        229.4396514892578,
        164.04327392578125
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        174.96328735351562,
        484.67999267578125,
        186.00328063964844
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상 또는 1배치 3회 이상)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.1999969482422,
        197.04327392578125,
        267.239990234375,
        208.08326721191406
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 표준물질 및 검체보관 등에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        219.00328063964844,
        327.36053466796875,
        230.04327392578125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        240.96327209472656,
        434.8800048828125,
        252.00326538085938
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        263.04327392578125,
        465.47967529296875,
        274.0832824707031
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 체외진단용 의료기기의 취급자 안전에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        285.0032653808594,
        392.6400146484375,
        296.04327392578125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 이미 허가·인증받은 제품과 비교한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        306.9632873535156,
        346.7996826171875,
        318.0032958984375
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        356.34808349609375,
        448.9239501953125,
        371.10809326171875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체외진단용 의료기기의 취급자 안전에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        356.34808349609375,
        448.9239501953125,
        371.10809326171875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        403.2032775878906,
        484.6793518066406,
        414.2432861328125
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        425.16326904296875,
        488.3560485839844,
        436.2032775878906
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        447.1232604980469,
        438.5727844238281,
        458.16326904296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        469.2032775878906,
        484.6796875,
        480.2432861328125
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        491.16326904296875,
        191.2528076171875,
        502.2032775878906
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        540.5480346679688,
        337.3200378417969,
        554.7951049804688
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이미 허가받은 제품과 비교한 자료",
      "font_size": 12.839439392089844,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        540.5480346679688,
        337.3200378417969,
        554.7951049804688
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        110.5199966430664,
        583.5599975585938,
        490.3199768066406,
        596.7969360351562
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지",
      "font_size": 11.039999961853027,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        123.47999572753906,
        603.3599853515625,
        484.67974853515625,
        616.596923828125
      ],
      "page_num": 43,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제5호서식’의 비교표를 기재하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "T8",
      "bbox": [
        123.47999572753906,
        623.1600341796875,
        321.3379211425781,
        636.39697265625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅵ. 기술문서 등의 심사를 위한 제출자료",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        328.0799865722656,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 39 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 40 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ",
      "font_size": 21.959999084472656,
      "font_name": "T6",
      "bbox": [
        115.91999816894531,
        157.32000732421875,
        379.1999816894531,
        183.6719970703125
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성능시험에 대한 상세사항",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        115.91999816894531,
        157.32000732421875,
        379.1999816894531,
        183.6719970703125
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        246.18807983398438,
        329.0439758300781,
        260.9480895996094
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석적 성능시험에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        246.18807983398438,
        329.0439758300781,
        260.9480895996094
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 분석적 성능시험자료의 작성 시 권장사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        283.0832824707031,
        333.35968017578125,
        294.123291015625
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        305.04327392578125,
        484.67999267578125,
        316.0832824707031
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        327.0032653808594,
        484.67999267578125,
        338.04327392578125
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장 간에 동등한 성능을 확인하도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        349.0832824707031,
        346.17279052734375,
        360.123291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        371.04327392578125,
        484.67999267578125,
        382.0832824707031
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        393.0032653808594,
        484.67999267578125,
        404.04327392578125
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성) 이상의 검체를 이용하여 성능을 확인하도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        415.0832824707031,
        412.17279052734375,
        426.123291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        463.0992126464844,
        443.91607666015625,
        475.0992126464844
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        487.0832824707031,
        488.3557434082031,
        498.123291015625
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        509.0432434082031,
        488.35638427734375,
        520.083251953125
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우는 적용범위가 제한될 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        123.83999633789062,
        531.0032348632812,
        302.9727783203125,
        542.0432739257812
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 최소검출한계",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        553.083251953125,
        211.19931030273438,
        564.123291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        575.043212890625,
        201.95965576171875,
        586.083251953125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        597.0032348632812,
        488.3560485839844,
        608.0432739257812
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보이는 최저 농도를 최소검출한계(limit of detection, LoD)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.59999084472656,
        619.083251953125,
        484.68035888671875,
        630.123291015625
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 설정하는 것이 보편적이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.59999084472656,
        641.043212890625,
        326.2527770996094,
        652.083251953125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        663.0032348632812,
        484.67999267578125,
        674.0432739257812
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.39999389648438,
        685.083251953125,
        488.3557434082031,
        696.123291015625
      ],
      "page_num": 45,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 41 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.39999389648438,
        153.00328063964844,
        220.53280639648438,
        164.04327392578125
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        174.96328735351562,
        201.95965576171875,
        186.00328063964844
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        197.04327392578125,
        484.67999267578125,
        208.08326721191406
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        219.00328063964844,
        488.3560485839844,
        230.04327392578125
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 양성검체를 희석한 검체 등을 사용한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        240.96327209472656,
        405.2127990722656,
        252.00326538085938
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        263.04327392578125,
        488.3559265136719,
        274.0832824707031
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상의 검체 사용을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.47999572753906,
        285.0032653808594,
        326.372802734375,
        296.04327392578125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        488.3560485839844,
        318.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "핵산추출시약이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        488.3560485839844,
        318.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함되지",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        488.3560485839844,
        318.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않은",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        488.3560485839844,
        318.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PCR검사",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        488.3560485839844,
        318.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "키트인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        488.3560485839844,
        318.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        488.3560485839844,
        318.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "plasmid 등을 이용가능하다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        179.75999450683594,
        329.04327392578125,
        320.372802734375,
        340.0832824707031
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        351.0032653808594,
        488.3560485839844,
        362.04327392578125
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.63999938964844,
        372.9632873535156,
        488.35662841796875,
        384.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전혈 등)의 종류별 시험 결과를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.63999938964844,
        395.04327392578125,
        385.8927917480469,
        406.0832824707031
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.1232604980469,
        201.95965576171875,
        428.16326904296875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        438.9632873535156,
        488.35662841796875,
        450.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.51998901367188,
        461.04327392578125,
        470.852783203125,
        472.0832824707031
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        483.0032653808594,
        484.67999267578125,
        494.04327392578125
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "험방법을 요약 제출할 수 있다. 사용가능한 것으로 제시된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        504.9632873535156,
        488.3560485839844,
        516.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        527.043212890625,
        484.67999267578125,
        538.083251953125
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "도를 산출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        549.0032348632812,
        248.49281311035156,
        560.0432739257812
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        148.8000030517578,
        570.9632568359375,
        488.3560485839844,
        582.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이중(duplicate)으로 측정한다. 컷오프 근처의 농도에서는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        170.87998962402344,
        593.043212890625,
        488.35498046875,
        604.083251953125
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정횟수를 증가시킨다(예 : 20회 이상 등).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        170.87998962402344,
        615.0032348632812,
        394.29278564453125,
        626.0432739257812
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        636.9632568359375,
        488.3560485839844,
        648.0032958984375
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최소 농도로 제시할 수 있다. 검출한계에 영향을 줄 수 있는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.0399932861328,
        659.043212890625,
        488.35638427734375,
        670.083251953125
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.0399932861328,
        681.0032348632812,
        488.35626220703125,
        692.0432739257812
      ],
      "page_num": 46,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 42 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.0399932861328,
        153.00328063964844,
        450.6927795410156,
        164.04327392578125
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        174.96328735351562,
        488.3569030761719,
        186.00328063964844
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "LOD (limit of detection), LOQ (limit of quantitation)를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        197.04327392578125,
        488.35638427734375,
        208.08326721191406
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        219.00328063964844,
        488.35638427734375,
        230.04327392578125
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법(classical approach, precision profile approach, probit",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        240.96327209472656,
        488.3569030761719,
        252.00326538085938
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "approach)이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        263.04327392578125,
        488.35675048828125,
        274.0832824707031
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는데",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        263.04327392578125,
        488.35675048828125,
        274.0832824707031
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        263.04327392578125,
        488.35675048828125,
        274.0832824707031
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        263.04327392578125,
        488.35675048828125,
        274.0832824707031
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전통적인",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        263.04327392578125,
        488.35675048828125,
        274.0832824707031
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법(classical",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        263.04327392578125,
        488.35675048828125,
        274.0832824707031
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "approach)은 blank 검체와 최소검출한계 근처의 low level",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        285.0032653808594,
        488.35723876953125,
        296.04327392578125
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        306.9632873535156,
        482.1327819824219,
        318.0032958984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        329.04327392578125,
        201.95965576171875,
        340.0832824707031
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        351.0032653808594,
        488.35662841796875,
        362.04327392578125
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체수, 반복횟수, 계산법을 함께 제시한다. 최소검출한계는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        372.9632873535156,
        488.3557434082031,
        384.0032958984375
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        395.04327392578125,
        484.67999267578125,
        406.0832824707031
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        417.0032653808594,
        246.55630493164062,
        428.04327392578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        438.9632873535156,
        488.3563232421875,
        450.0032958984375
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.16000366210938,
        461.04327392578125,
        426.6927795410156,
        472.0832824707031
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        483.0032653808594,
        488.3560485839844,
        494.04327392578125
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.0399932861328,
        504.9632873535156,
        484.653076171875,
        516.0032958984375
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 표시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.0399932861328,
        527.043212890625,
        236.73280334472656,
        538.083251953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 판정기준치(cut-off value)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        571.083251953125,
        282.360595703125,
        582.123291015625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        593.043212890625,
        201.95965576171875,
        604.083251953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        615.0032348632812,
        488.3559265136719,
        626.0432739257812
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.16000366210938,
        636.9632568359375,
        259.17279052734375,
        648.0032958984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        659.043212890625,
        488.35638427734375,
        670.083251953125
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.0399932861328,
        681.0032348632812,
        488.35638427734375,
        692.0432739257812
      ],
      "page_num": 47,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 43 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 48,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거칠 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.0399932861328,
        153.00328063964844,
        275.1327819824219,
        164.04327392578125
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        174.96328735351562,
        488.35638427734375,
        186.00328063964844
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        172.67999267578125,
        197.04327392578125,
        488.35638427734375,
        208.08326721191406
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        172.67999267578125,
        219.00328063964844,
        201.556640625,
        230.04327392578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        240.96327209472656,
        488.3560485839844,
        252.00326538085938
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근거로 설정된 경우, 해당 자료로 대신할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        175.1999969482422,
        263.04327392578125,
        428.9727783203125,
        274.0832824707031
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        285.0032653808594,
        484.67999267578125,
        296.04327392578125
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로 설정할 경우, 결과 분포 및 설정 방법을 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.87998962402344,
        306.9632873535156,
        444.0928039550781,
        318.0032958984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        329.04327392578125,
        488.3560485839844,
        340.0832824707031
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우에는 설정근거를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.83999633789062,
        351.0032653808594,
        332.0127868652344,
        362.04327392578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사) 판정기준치를 산정하는 방법을 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        372.9632873535156,
        379.17279052734375,
        384.0032958984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        395.04327392578125,
        488.3560485839844,
        406.0832824707031
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정한 근거를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        167.51998901367188,
        417.0032653808594,
        291.6927795410156,
        428.04327392578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.55999755859375,
        438.9632873535156,
        488.35638427734375,
        450.0032958984375
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        179.51998901367188,
        461.04327392578125,
        488.3560485839844,
        472.0832824707031
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성능시험자료의 작성 시 준수 사항 참고).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        179.51998901367188,
        483.0032653808594,
        391.6528015136719,
        494.04327392578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        505.0832824707031,
        201.95965576171875,
        516.123291015625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "판정기준치(농도)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        527.043212890625,
        238.55999755859375,
        538.083251953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 측정범위",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        570.9632568359375,
        189.23965454101562,
        582.0032958984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        593.043212890625,
        201.95965576171875,
        604.083251953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 측정범위는 정성검사는 생략할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        615.0032348632812,
        373.6528015136719,
        626.0432739257812
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        636.9632568359375,
        488.3560485839844,
        648.0032958984375
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재현해 낼 수 있는 농도 범위를 말한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.72000122070312,
        659.043212890625,
        375.81280517578125,
        670.083251953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        681.0032348632812,
        488.3563537597656,
        692.0432739257812
      ],
      "page_num": 48,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 44 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        153.00328063964844,
        488.3560485839844,
        164.04327392578125
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        174.96328735351562,
        488.35638427734375,
        186.00328063964844
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        197.04327392578125,
        244.1728057861328,
        208.08326721191406
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        219.00328063964844,
        484.67999267578125,
        230.04327392578125
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        240.96327209472656,
        488.3560485839844,
        252.00326538085938
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        263.04327392578125,
        194.73280334472656,
        274.0832824707031
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        285.0032653808594,
        488.3560485839844,
        296.04327392578125
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 포함해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.239990234375,
        306.9632873535156,
        287.372802734375,
        318.0032958984375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        329.04327392578125,
        201.95965576171875,
        340.0832824707031
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        351.0032653808594,
        484.67999267578125,
        362.04327392578125
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        372.9632873535156,
        488.3560485839844,
        384.0032958984375
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 양성검체를 희석한 검체 등을 사용한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.63999938964844,
        395.04327392578125,
        405.2127990722656,
        406.0832824707031
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        417.0032653808594,
        488.35638427734375,
        428.04327392578125
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "plasmid 등을 이용가능하다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        176.51998901367188,
        438.9632873535156,
        317.2527770996094,
        450.0032958984375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        461.04327392578125,
        488.3560485839844,
        472.0832824707031
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        483.0032653808594,
        488.3565368652344,
        494.04327392578125
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "없어야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        504.9632873535156,
        237.9328155517578,
        516.0032958984375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        527.043212890625,
        484.6795654296875,
        538.083251953125
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "순위는 다음과 같다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.0399932861328,
        549.0032348632812,
        275.372802734375,
        560.0432739257812
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        170.51998901367188,
        570.9632568359375,
        488.2360534667969,
        582.0032958984375
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        170.51998901367188,
        593.043212890625,
        488.3560485839844,
        604.083251953125
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        170.51998901367188,
        615.0032348632812,
        488.35638427734375,
        626.0432739257812
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        170.51998901367188,
        636.9632568359375,
        488.35638427734375,
        648.0032958984375
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        170.51998901367188,
        659.043212890625,
        488.35638427734375,
        670.083251953125
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        170.51998901367188,
        681.0032348632812,
        484.44000244140625,
        692.0432739257812
      ],
      "page_num": 49,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 45 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        174.96328735351562,
        201.95965576171875,
        186.00328063964844
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        197.04327392578125,
        488.35662841796875,
        208.08326721191406
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        219.00328063964844,
        472.7727966308594,
        230.04327392578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        240.96327209472656,
        488.3557434082031,
        252.00326538085938
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        263.04327392578125,
        484.67999267578125,
        274.0832824707031
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        285.0032653808594,
        488.3560485839844,
        296.04327392578125
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통해 농도가 확립된 검체를 이용한다. 희석은 고농도와 저농",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        306.9632873535156,
        484.6796875,
        318.0032958984375
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        329.04327392578125,
        488.3560485839844,
        340.0832824707031
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        351.0032653808594,
        488.35638427734375,
        362.04327392578125
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수도 있다. 측정은 각 농도별로 2-4회 반복 측정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        169.55999755859375,
        372.9632873535156,
        445.29278564453125,
        384.0032958984375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        395.04327392578125,
        201.95965576171875,
        406.0832824707031
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 직선성 범위의 농도 구간을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        417.0032653808594,
        362.61279296875,
        428.04327392578125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        438.9632873535156,
        484.6795654296875,
        450.0032958984375
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.1199951171875,
        461.04327392578125,
        260.1327819824219,
        472.0832824707031
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 분석적 특이도",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        504.97918701171875,
        204.95999145507812,
        516.9791870117188
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        528.9632568359375,
        189.23965454101562,
        540.0032958984375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        551.043212890625,
        488.35662841796875,
        562.083251953125
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        573.0032348632812,
        483.0927734375,
        584.0432739257812
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        594.9632568359375,
        484.67999267578125,
        606.0032958984375
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        617.043212890625,
        488.3558349609375,
        628.083251953125
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다음과 같은 물질에 대한 간섭 평가 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        639.0032348632812,
        430.29278564453125,
        650.0432739257812
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검체 처치에 첨가된 물질(보존제, 안정제 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        155.51998901367188,
        660.9632568359375,
        384.1199951171875,
        672.0032958984375
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        155.51998901367188,
        683.043212890625,
        442.3199768066406,
        694.083251953125
      ],
      "page_num": 50,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 46 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 51,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 6. 혈청을 이용한 항체검사에서 간섭물질 예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        153.00328063964844,
        361.0799865722656,
        164.04327392578125
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        418.3232727050781,
        484.6796875,
        429.36328125
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과 같은 4가지 형태의 세트를 준비한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.75999450683594,
        440.28326416015625,
        360.81280517578125,
        451.3232727050781
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 분석물질 음성검체(간섭물질 없음)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        462.36328125,
        348.47998046875,
        473.4032897949219
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 분석물질 음성검체 + 간섭물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        484.3232727050781,
        330.11968994140625,
        495.36328125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 분석물질 약양성검체(간섭물질 없음)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        506.4032897949219,
        359.5199890136719,
        517.4432983398438
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 분석물질 약양성검체 + 간섭물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        528.3632202148438,
        341.15966796875,
        539.4032592773438
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        572.2832641601562,
        192.9160614013672,
        583.3233032226562
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험할 간섭물질의 목록을 작성한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        594.2432250976562,
        342.5727844238281,
        605.2832641601562
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        616.3232421875,
        488.35662841796875,
        627.36328125
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        638.2832641601562,
        488.35638427734375,
        649.3233032226562
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        660.2432250976562,
        468.5727844238281,
        671.2832641601562
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        682.3232421875,
        488.35638427734375,
        693.36328125
      ],
      "page_num": 51,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간섭물질",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        180.47999572753906,
        182.13034057617188,
        396.1199951171875,
        192.09034729003906
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        180.47999572753906,
        182.13034057617188,
        396.1199951171875,
        192.09034729003906
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "외인성 물질",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        209.25033569335938,
        344.519287109375,
        219.21034240722656
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반의약품",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        209.25033569335938,
        344.519287109375,
        219.21034240722656
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체 처리 과정에 통상적으로 첨가될",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        232.0503387451172,
        290.956298828125,
        242.01034545898438
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물질",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        250.05035400390625,
        138.55674743652344,
        260.0103454589844
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보존제, 안정제 등",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        292.55999755859375,
        241.0503387451172,
        375.3599853515625,
        251.01034545898438
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "드물지 않게 볼 수 있는 특이 검체에",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        262.8903503417969,
        290.9567565917969,
        272.850341796875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포함된 물질",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        280.8903503417969,
        169.31951904296875,
        290.850341796875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "혈색소, 지질, 빌리루빈, 이상 단백질 등",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        292.55999755859375,
        271.8903503417969,
        472.67999267578125,
        281.850341796875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비정상적으로 백혈구가 매우 높은 검",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        293.6103515625,
        287.6399841308594,
        303.5703430175781
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "체",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        311.6103515625,
        125.27999877929688,
        321.5703430175781
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        383.03997802734375,
        302.6103515625,
        391.33673095703125,
        312.5703430175781
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Hematocrit이 매우 높은 검체",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        324.4503479003906,
        391.33673095703125,
        334.41033935546875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        324.4503479003906,
        391.33673095703125,
        334.41033935546875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Rheumatoid factor 양성인 검체",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        337.29034423828125,
        391.33673095703125,
        347.2503356933594
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        337.29034423828125,
        391.33673095703125,
        347.2503356933594
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "높은 자가면역항체를 가진 검체",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.31999969482422,
        377.1303405761719,
        260.2795104980469,
        387.09033203125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "systemic lupus erythematosus(SLE),",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        292.55999755859375,
        359.1303405761719,
        467.77716064453125,
        369.09033203125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "antinuclear antibodies(ANA),",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        292.55999755859375,
        377.1303405761719,
        429.97955322265625,
        387.09033203125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "human anti-mouse antibodies(HAMA) 등",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        292.55999755859375,
        395.1303405761719,
        477.239990234375,
        405.09033203125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 47 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상이 되도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        153.00328063964844,
        259.6528015136719,
        164.04327392578125
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        174.96328735351562,
        488.35638427734375,
        186.00328063964844
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용범위(dmax)를 결정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        197.04327392578125,
        303.3327941894531,
        208.08326721191406
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5) 각 검체를 3회 이상 반복 검사한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        219.00328063964844,
        337.8927917480469,
        230.04327392578125
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        240.96327209472656,
        488.356689453125,
        252.00326538085938
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과를 비교한다. 정량검사의 경우는 bias를 구한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        263.04327392578125,
        420.6927795410156,
        274.0832824707031
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        285.0032653808594,
        488.356689453125,
        296.04327392578125
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        306.9632873535156,
        488.3560485839844,
        318.0032958984375
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도에 따른 영향을 보기위해 용량-반응 검사(dose-response",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        329.04327392578125,
        488.3583679199219,
        340.0832824707031
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "test)를 실시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        351.0032653808594,
        246.4528045654297,
        362.04327392578125
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        395.04327392578125,
        189.23965454101562,
        406.0832824707031
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.0032653808594,
        488.356689453125,
        428.04327392578125
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        438.9632873535156,
        488.35638427734375,
        450.0032958984375
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        461.04327392578125,
        488.3560485839844,
        472.0832824707031
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판단한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        483.0032653808594,
        208.39663696289062,
        494.04327392578125
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        504.9632873535156,
        488.3560485839844,
        516.0032958984375
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차이를 기술한다. 대상측정물질을 함유하지 않고 간섭 가능한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        527.043212890625,
        488.3560485839844,
        538.083251953125
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        549.0032348632812,
        484.6796875,
        560.0432739257812
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        570.9632568359375,
        479.61279296875,
        582.0032958984375
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        593.043212890625,
        484.67999267578125,
        604.083251953125
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.239990234375,
        615.0032348632812,
        475.8927917480469,
        626.0432739257812
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 정밀도 (반복성, 재현성 등)",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        659.0592041015625,
        280.44000244140625,
        671.0592041015625
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        683.043212890625,
        189.23965454101562,
        694.083251953125
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 48 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 53,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        153.00328063964844,
        488.35638427734375,
        164.04327392578125
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.9199981689453,
        174.96328735351562,
        243.69281005859375,
        186.00328063964844
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        197.04327392578125,
        488.35638427734375,
        208.08326721191406
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "재현성으로 구분하여 평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.0,
        219.00328063964844,
        316.17279052734375,
        230.04327392578125
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        240.96327209472656,
        488.35638427734375,
        252.00326538085938
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시기를 거친 다음 평가를 수행하도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        263.04327392578125,
        375.0928039550781,
        274.0832824707031
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        306.9632873535156,
        189.23965454101562,
        318.0032958984375
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        329.04327392578125,
        484.6796875,
        340.0832824707031
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        351.0032653808594,
        488.3560485839844,
        362.04327392578125
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        372.9632873535156,
        488.35638427734375,
        384.0032958984375
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있어야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        395.04327392578125,
        221.2528076171875,
        406.0832824707031
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.0032653808594,
        488.3571472167969,
        428.04327392578125
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 이용가능하다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        438.9632873535156,
        254.2528076171875,
        450.0032958984375
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 최소 3가지 이상의 농도를 포함해야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        461.04327392578125,
        370.8927917480469,
        472.0832824707031
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        483.0032653808594,
        488.3560485839844,
        494.04327392578125
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        504.9632873535156,
        488.35638427734375,
        516.0032958984375
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체 등을 사용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        527.043212890625,
        292.6528015136719,
        538.083251953125
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        570.9632568359375,
        189.23965454101562,
        582.0032958984375
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 반복성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        593.043212890625,
        190.91964721679688,
        604.083251953125
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        615.0032348632812,
        484.6796875,
        626.0432739257812
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 계획을 수립하여 시행한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.16000366210938,
        636.9632568359375,
        335.7327880859375,
        648.0032958984375
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        659.043212890625,
        488.2360534667969,
        670.083251953125
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정하는 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.63999938964844,
        681.0032348632812,
        297.81280517578125,
        692.0432739257812
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 49 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 54,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 재현성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        153.00328063964844,
        190.91964721679688,
        164.04327392578125
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        174.96328735351562,
        484.67999267578125,
        186.00328063964844
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이나 칼리브레이터가 사용되어야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        172.9199981689453,
        197.04327392578125,
        368.4927978515625,
        208.08326721191406
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        219.00328063964844,
        488.35638427734375,
        230.04327392578125
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        174.36000061035156,
        240.96327209472656,
        221.49281311035156,
        252.00326538085938
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        263.04327392578125,
        488.2360534667969,
        274.0832824707031
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실시하는 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        172.55999755859375,
        285.0032653808594,
        296.7327880859375,
        296.04327392578125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        450.5727844238281,
        318.0032958984375
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        329.04327392578125,
        484.67999267578125,
        340.0832824707031
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되도록 계획을 수립한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        173.75999450683594,
        351.0032653808594,
        297.93280029296875,
        362.04327392578125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        395.04327392578125,
        189.23965454101562,
        406.0832824707031
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.0032653808594,
        484.6796875,
        428.04327392578125
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(between-run), 날짜 간 정밀도(between-day), 검사실 내 정",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        438.9632873535156,
        484.67999267578125,
        450.0032958984375
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "밀도(within-laboratory) 자료를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        461.04327392578125,
        373.7727966308594,
        472.0832824707031
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        483.0032653808594,
        488.3560485839844,
        494.04327392578125
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        504.9632873535156,
        488.3560485839844,
        516.0032958984375
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        527.043212890625,
        204.69281005859375,
        538.083251953125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        549.0032348632812,
        488.3559265136719,
        560.0432739257812
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "변이계수를 산출하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        570.9632568359375,
        314.9727783203125,
        582.0032958984375
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다. 정성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        593.043212890625,
        484.67999267578125,
        604.083251953125
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        615.0032348632812,
        488.35638427734375,
        626.0432739257812
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        636.9632568359375,
        484.6796875,
        648.0032958984375
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "를 산출하여 기재한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        659.043212890625,
        270.6927795410156,
        670.083251953125
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 해당하는 경우 다음의 사항들을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        681.0032348632812,
        370.05279541015625,
        692.0432739257812
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 50 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가) 검사를 시행한 검체의 농도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        153.00328063964844,
        309.9596862792969,
        164.04327392578125
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 각각의 농도에서의 반복정밀도 표준편차",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        174.96328735351562,
        375.9596862792969,
        186.00328063964844
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다) 각각의 농도에서의 검사실내 정밀도 표준편차",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        197.04327392578125,
        403.4396667480469,
        208.08326721191406
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        219.00328063964844,
        441.9596862792969,
        230.04327392578125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 실제 검사일수, 검사실의 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        240.96327209472656,
        313.20001220703125,
        252.00326538085938
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바) 총 run의 수(해당된다면 제시)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        263.04327392578125,
        326.5199890136719,
        274.0832824707031
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사) 총 관찰치의 수: optional",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        285.0032653808594,
        298.5340270996094,
        296.04327392578125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아) 시약 lot의 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        306.9632873535156,
        240.83998107910156,
        318.0032958984375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자) Calibration 시행 횟수와 calibrator lot의 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        150.47999572753906,
        329.04327392578125,
        392.8800048828125,
        340.0832824707031
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 정확도",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        372.9792175292969,
        162.95999145507812,
        384.9792175292969
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. WHO international reference standard 물질 등 국제표준품, 상용",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        396.9632873535156,
        484.67999267578125,
        408.0032958984375
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.44000244140625,
        419.04327392578125,
        484.67999267578125,
        430.0832824707031
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 권장하며 최소 2회 반복 측정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.44000244140625,
        441.0032653808594,
        340.1566162109375,
        452.04327392578125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        462.9632873535156,
        488.3560485839844,
        474.0032958984375
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "bias)경우를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        148.9199981689453,
        485.04327392578125,
        264.0766296386719,
        496.0832824707031
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        507.0032653808594,
        471.93280029296875,
        518.0432739257812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        528.9632568359375,
        488.3562927246094,
        540.0032958984375
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        147.36000061035156,
        551.043212890625,
        194.97280883789062,
        562.083251953125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        573.0032348632812,
        488.3560485839844,
        584.0432739257812
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        145.3199920654297,
        594.9632568359375,
        192.4528045654297,
        606.0032958984375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 교차반응",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        639.0192260742188,
        174.95999145507812,
        651.0192260742188
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        663.0032348632812,
        189.23965454101562,
        674.0432739257812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        684.9632568359375,
        488.3560485839844,
        696.0032958984375
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 51 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 56,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함된 검체를 이용한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        153.00328063964844,
        281.7327880859375,
        164.04327392578125
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        197.04327392578125,
        192.9160614013672,
        208.08326721191406
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 시험할 교차반응물질의 목록을 작성한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        219.00328063964844,
        364.53277587890625,
        230.04327392578125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        240.96327209472656,
        488.3560485839844,
        252.00326538085938
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        263.04327392578125,
        204.69281005859375,
        274.0832824707031
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        285.0032653808594,
        488.3560485839844,
        296.04327392578125
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        306.9632873535156,
        484.6796875,
        318.0032958984375
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "날 수 있는 고농도를 사용할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        329.04327392578125,
        380.61279296875,
        340.0832824707031
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        351.0032653808594,
        488.3560485839844,
        362.04327392578125
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        371.5625305175781,
        488.35638427734375,
        384.0032958984375
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다(CFU; colony forming unit, PFU; plaque forming unit).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        395.04327392578125,
        469.05279541015625,
        406.0832824707031
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시 : CMV 항체 검사시 교차반응물질의 종류",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        438.9632873535156,
        382.20001220703125,
        450.0032958984375
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        461.04327392578125,
        488.3565368652344,
        472.0832824707031
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        483.0032653808594,
        488.3565368652344,
        494.04327392578125
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        504.9632873535156,
        491.5130615234375,
        516.0032958984375
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.9994354248047,
        527.043212890625,
        488.35791015625,
        538.083251953125
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        549.0032348632812,
        488.3572998046875,
        560.0432739257812
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "vaccine recipients",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        570.9632568359375,
        233.63986206054688,
        582.0032958984375
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시 : CMV PCR 검사시 교차반응 시험 균주",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        615.0032348632812,
        376.20001220703125,
        626.0432739257812
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Adenovirus Type 1",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        641.2832641601562,
        427.5163879394531,
        652.3233032226562
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Adenovirus Type 3",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        641.2832641601562,
        427.5163879394531,
        652.3233032226562
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Adenovirus Type 5",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        655.80322265625,
        427.5163879394531,
        666.84326171875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Adenovirus Type 6",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        655.80322265625,
        427.5163879394531,
        666.84326171875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Adenovirus Type 7",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        670.2032470703125,
        427.5163879394531,
        681.2432861328125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Adenovirus Type 8",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        670.2032470703125,
        427.5163879394531,
        681.2432861328125
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Adenovirus Type 10",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        684.6032104492188,
        433.87652587890625,
        695.6432495117188
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Adenovirus Type 13",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        684.6032104492188,
        433.87652587890625,
        695.6432495117188
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 52 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 57,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Adenovirus Type 14",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        157.3232879638672,
        433.87652587890625,
        168.36328125
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Adenovirus Type 31",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        157.3232879638672,
        433.87652587890625,
        168.36328125
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Influenza A Aichi",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        171.72328186035156,
        425.2798767089844,
        182.76327514648438
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Influenza A Malaya",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        171.72328186035156,
        425.2798767089844,
        182.76327514648438
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Influenza A Hong Kong",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        186.12327575683594,
        425.31317138671875,
        197.16326904296875
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Influenza A Denver",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        186.12327575683594,
        425.31317138671875,
        197.16326904296875
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Influenza A Port Chalmers",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        200.64328002929688,
        428.87896728515625,
        211.6832733154297
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Influenza A Victoria",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        200.64328002929688,
        428.87896728515625,
        211.6832733154297
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Influenza A New Jersey",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        215.04327392578125,
        403.3524169921875,
        226.08326721191406
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Influenza A PR",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        215.04327392578125,
        403.3524169921875,
        226.08326721191406
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Influenza A WS",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        229.4432830810547,
        446.7329406738281,
        240.4832763671875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza B Hong Kong",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        229.4432830810547,
        446.7329406738281,
        240.4832763671875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza BMaryland",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        243.84327697753906,
        415.67950439453125,
        254.88327026367188
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza B Mass",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        243.84327697753906,
        415.67950439453125,
        254.88327026367188
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza BTaiwan",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        258.2432861328125,
        403.6205139160156,
        269.2832946777344
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza B GL",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        258.2432861328125,
        403.6205139160156,
        269.2832946777344
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza BRussia",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        272.6432800292969,
        403.3524169921875,
        283.68328857421875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza A PR",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        272.6432800292969,
        403.3524169921875,
        283.68328857421875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza A WS",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        287.16326904296875,
        446.7329406738281,
        298.2032775878906
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza B Hong Kong",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        287.16326904296875,
        446.7329406738281,
        298.2032775878906
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza BMaryland",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        301.5632629394531,
        415.67950439453125,
        312.603271484375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza B Mass",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        301.5632629394531,
        415.67950439453125,
        312.603271484375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza BTaiwan",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        315.9632873535156,
        403.6205139160156,
        327.0032958984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza B GL",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        315.9632873535156,
        403.6205139160156,
        327.0032958984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Influenza BRussia",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        330.2432861328125,
        376.2925720214844,
        341.4032897949219
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSV Long",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        330.2432861328125,
        376.2925720214844,
        341.4032897949219
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSV Wash",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        344.6432800292969,
        377.1171569824219,
        355.68328857421875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RSV 9320",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        344.6432800292969,
        377.1171569824219,
        355.68328857421875
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Parainfluenza 1 C-35",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        358.5632629394531,
        441.315673828125,
        369.603271484375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Parainfluenza 2 Greer",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        358.5632629394531,
        441.315673828125,
        369.603271484375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Parainfluenza 3 C 243",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        372.36328125,
        449.9566650390625,
        383.4032897949219
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Parainfluenza 4a M-25",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        372.36328125,
        449.9566650390625,
        383.4032897949219
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Parainfluenza 4b CH19503",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        386.16326904296875,
        382.6363830566406,
        397.2032775878906
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HSV-1 IF",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        386.16326904296875,
        382.6363830566406,
        397.2032775878906
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HSV-1 MacIntyre",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        399.9632873535156,
        388.6355285644531,
        411.0032958984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HSV-2 MS",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        399.9632873535156,
        388.6355285644531,
        411.0032958984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HSV-2 Strain G",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        413.7632751464844,
        398.2364501953125,
        424.80328369140625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VZV Webster",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        413.7632751464844,
        398.2364501953125,
        424.80328369140625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VZV Ellen",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        427.5632629394531,
        400.03704833984375,
        438.603271484375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VZV AV92-3",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        427.5632629394531,
        400.03704833984375,
        438.603271484375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Epstein-Barr",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        441.4832763671875,
        367.5164489746094,
        452.5232849121094
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Rubeola",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        441.4832763671875,
        367.5164489746094,
        452.5232849121094
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mumps",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        455.28326416015625,
        491.35723876953125,
        466.3232727050781
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Echovirus Types 4, 6, 9, 11,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        455.28326416015625,
        491.35723876953125,
        466.3232727050781
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30, 34",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        324.0,
        472.80328369140625,
        361.99700927734375,
        483.8432922363281
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Coxsackievirus Types B1, B2,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        486.7232666015625,
        309.7962951660156,
        497.7632751464844
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B3, B4, B5, B6",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        504.2432556152344,
        212.11715698242188,
        515.2832641601562
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Poliovirus Types 1, 2, 3",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        324.0,
        486.7232666015625,
        457.63653564453125,
        497.7632751464844
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Acholeplasma laidlawi",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        518.043212890625,
        470.3169860839844,
        529.083251953125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Acinetobacter calcoaceticus",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        518.043212890625,
        470.3169860839844,
        529.083251953125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bordetella bronchiseptica",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        531.9632568359375,
        430.7162780761719,
        543.0032958984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bordetella pertussis",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        531.9632568359375,
        430.7162780761719,
        543.0032958984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Chlamydophila pneumoniae",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        545.7632446289062,
        443.168701171875,
        556.8032836914062
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Chlamydophila psittaci",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        545.7632446289062,
        443.168701171875,
        556.8032836914062
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Chlamydia trachomatis",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        559.563232421875,
        475.0894775390625,
        570.603271484375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Corynebacterium diphtheriae",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        559.563232421875,
        475.0894775390625,
        570.603271484375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Escherichia coli",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        573.3632202148438,
        434.91650390625,
        584.4032592773438
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Gardnerella vaginalis",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        573.3632202148438,
        434.91650390625,
        584.4032592773438
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Haemophilis influenzae type A",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        587.1632690429688,
        442.209716796875,
        598.2033081054688
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Klebsiella pneumoniae",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        587.1632690429688,
        442.209716796875,
        598.2033081054688
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Legionella pneumophila",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        600.9632568359375,
        440.79510498046875,
        612.0032958984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Moraxella cartarrhalis",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        600.9632568359375,
        440.79510498046875,
        612.0032958984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mycoplasma hominis",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        614.8832397460938,
        420.7285461425781,
        625.9232788085938
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mycoplasma orale",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        614.8832397460938,
        420.7285461425781,
        625.9232788085938
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mycoplasma pneumoniae",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        628.6832275390625,
        447.2322082519531,
        639.7232666015625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mycoplasma salivarium",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        628.6832275390625,
        447.2322082519531,
        639.7232666015625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Neisseria gonorrhoeae",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        642.4832153320312,
        415.11627197265625,
        653.5232543945312
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Proteus mirabilis",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        642.4832153320312,
        415.11627197265625,
        653.5232543945312
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Pseudomonas aeruginosa",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        656.2832641601562,
        438.9973449707031,
        667.3233032226562
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Salmonella enteriditis",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        656.2832641601562,
        438.9973449707031,
        667.3233032226562
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Salmonella typhimurium",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        670.083251953125,
        444.1556396484375,
        681.123291015625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Staphylococcus aureus",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        670.083251953125,
        444.1556396484375,
        681.123291015625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Streptococcus agalactiae",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        683.8832397460938,
        463.8096923828125,
        694.9232788085938
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Streptococcus pneumoniae",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        683.8832397460938,
        463.8096923828125,
        694.9232788085938
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 53 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 58,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        208.32327270507812,
        189.23965454101562,
        219.36326599121094
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        230.2832794189453,
        488.35614013671875,
        241.32327270507812
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "data를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        160.55999755859375,
        252.2432861328125,
        245.372802734375,
        263.2832946777344
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        274.3232727050781,
        419.4927978515625,
        285.36328125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        345.6680908203125,
        329.0439758300781,
        360.4281005859375
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상적 성능시험에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        345.6680908203125,
        329.0439758300781,
        360.4281005859375
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 임상적 성능시험 자료의 작성 시 준수사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        387.4832763671875,
        338.7596740722656,
        398.5232849121094
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        409.4432678222656,
        488.35638427734375,
        420.4832763671875
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유래된 검체를 대상으로 시험한 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        431.5232849121094,
        388.17279052734375,
        442.56329345703125
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        453.4832763671875,
        488.35638427734375,
        464.5232849121094
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        475.4432678222656,
        488.3560485839844,
        486.4832763671875
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대상으로 한 자료를 제출하는 것을 원칙으로 한다. 이는 인종 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        497.5232849121094,
        488.2360534667969,
        508.56329345703125
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        519.4832153320312,
        484.67999267578125,
        530.5232543945312
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문이다. 민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        541.4432373046875,
        488.3560485839844,
        552.4832763671875
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        563.5232543945312,
        484.67999267578125,
        574.5632934570312
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        585.4832153320312,
        488.35638427734375,
        596.5232543945312
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요구 할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        607.4432373046875,
        223.1728057861328,
        618.4832763671875
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        629.5232543945312,
        488.3560485839844,
        640.5632934570312
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행기관에서 수행한 결과를 포함하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        651.4832153320312,
        371.61279296875,
        662.5232543945312
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        673.4432373046875,
        484.67999267578125,
        684.4832763671875
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        695.5232543945312,
        484.67999267578125,
        706.5632934570312
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Streptococcus pyogenes",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        157.20327758789062,
        451.43414306640625,
        168.24327087402344
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ureaplasma urealyticum",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        157.20327758789062,
        451.43414306640625,
        168.24327087402344
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Candida glabrata",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        171.00328063964844,
        442.23651123046875,
        182.04327392578125
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Trichomonas vaginalis",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.0394287109375,
        171.00328063964844,
        442.23651123046875,
        182.04327392578125
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 54 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 59,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 자세한 실험프로토콜을 제공해야한다. 질환이 있음을 규명한 참고",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        153.00328063964844,
        484.67999267578125,
        164.04327392578125
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        174.96328735351562,
        488.3560485839844,
        186.00328063964844
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        197.04327392578125,
        488.35662841796875,
        208.08326721191406
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        219.00328063964844,
        488.3558654785156,
        230.04327392578125
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법일 수도 있다. 종합한 방법일 경우 참값으로 규정한 알고리즘을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        240.96327209472656,
        488.3557434082031,
        252.00326538085938
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        263.04327392578125,
        184.77281188964844,
        274.0832824707031
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        285.0032653808594,
        488.35626220703125,
        296.04327392578125
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        306.9632873535156,
        488.3554382324219,
        318.0032958984375
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        329.04327392578125,
        484.6798095703125,
        340.0832824707031
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간을 제시할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        351.0032653808594,
        246.69281005859375,
        362.04327392578125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        372.9632873535156,
        488.2360534667969,
        384.0032958984375
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확보하기 어려울 경우, 냉동검체를 사용할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        395.04327392578125,
        396.81280517578125,
        406.0832824707031
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        417.0032653808594,
        484.67999267578125,
        428.04327392578125
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        438.9632873535156,
        484.67999267578125,
        450.0032958984375
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        137.52000427246094,
        461.04327392578125,
        151.77281188964844,
        472.0832824707031
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 4등급 체외진단용 의료기기 시험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        483.0032653808594,
        303.8399963378906,
        494.04327392578125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        504.9632873535156,
        484.67999267578125,
        516.0032958984375
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        527.043212890625,
        484.67999267578125,
        538.083251953125
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        549.0032348632812,
        484.67999267578125,
        560.0432739257812
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        570.9632568359375,
        488.3560485839844,
        582.0032958984375
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "침습적인 시험. 다만, 정맥채혈 등 피험자에게 중대한 위험을 미치",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        593.043212890625,
        484.67999267578125,
        604.083251953125
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지 않는 시험 및 잔여검체로 실시하는 시험은 제외)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        615.0032348632812,
        403.4399719238281,
        626.0432739257812
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        636.9632568359375,
        484.67999267578125,
        648.0032958984375
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기기로 임상적 성능시험의 결과를 확인할 수 없는 시험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        659.043212890625,
        419.8796691894531,
        670.083251953125
      ],
      "page_num": 59,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        681.0032348632812,
        484.6796875,
        692.0432739257812
      ],
      "page_num": 59,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 55 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 60,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        153.00328063964844,
        484.6796875,
        164.04327392578125
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용 의료기기의 시험에 한함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        174.96328735351562,
        282.47998046875,
        186.00328063964844
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        197.04327392578125,
        484.67999267578125,
        208.08326721191406
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험기관의 임상시험계획승인을 받고 실시해야함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        219.00328063964844,
        392.5199890136719,
        230.04327392578125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        245.1632843017578,
        488.3560485839844,
        256.2032775878906
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.87999725341797,
        267.2432861328125,
        484.67999267578125,
        278.2832946777344
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "료로 제출하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.87999725341797,
        289.2032775878906,
        239.1328125,
        300.2432861328125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되",
      "font_size": 10.797332763671875,
      "font_name": "Batang",
      "bbox": [
        125.87999725341797,
        311.16326904296875,
        484.5601501464844,
        322.2032775878906
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 15,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함)",
      "font_size": 10.797332763671875,
      "font_name": "Batang",
      "bbox": [
        125.87999725341797,
        333.2432861328125,
        474.140625,
        344.2832946777344
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        359.4032897949219,
        488.2357482910156,
        370.44329833984375
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리기준」(고시 별표 14)에 의하여 실시한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        381.36328125,
        388.7996826171875,
        392.4032897949219
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        403.4432678222656,
        484.6796875,
        414.4832763671875
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 기관",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        425.4032897949219,
        196.07998657226562,
        436.44329833984375
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        447.36328125,
        433.7996826171875,
        458.4032897949219
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        469.4432678222656,
        445.6796875,
        480.4832763671875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        491.40325927734375,
        488.3560485839844,
        502.4432678222656
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        513.3632202148438,
        484.67999267578125,
        524.4032592773438
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "험자료 또는 이에 준하는 것으로 인정되는 시험자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        535.4432373046875,
        403.4396667480469,
        546.4832763671875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        557.4032592773438,
        484.67999267578125,
        568.4432983398438
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에 해당하는 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        139.55999755859375,
        579.3632202148438,
        227.51998901367188,
        590.4032592773438
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        120.47999572753906,
        601.4432373046875,
        482.7327880859375,
        612.4832763671875
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 식약처장이 지정한 임상시험기관에서 시험한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        623.4032592773438,
        398.1600036621094,
        634.4432983398438
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        645.3632202148438,
        488.3560485839844,
        656.4032592773438
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.52000427246094,
        667.4432373046875,
        488.35638427734375,
        678.4832763671875
      ],
      "page_num": 60,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이에 준하는 것으로 인정되는 시험자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.52000427246094,
        689.4032592773438,
        344.5196838378906,
        700.4432983398438
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 56 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 61,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        153.00328063964844,
        488.3560485839844,
        164.04327392578125
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        174.96328735351562,
        488.35638427734375,
        186.00328063964844
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        197.04327392578125,
        488.35736083984375,
        208.08326721191406
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인한 자료 또는 이를 공증한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.27999877929688,
        219.00328063964844,
        327.8396911621094,
        230.04327392578125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 과학논문인용색인(Science citation index)에 등재된 전문학회지에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        240.96327209472656,
        488.3557434082031,
        252.00326538085938
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "게재된 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        146.0399932861328,
        263.04327392578125,
        206.63998413085938,
        274.0832824707031
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 임상적 민감도",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        329.0592041015625,
        204.95999145507812,
        341.0592041015625
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        353.04327392578125,
        189.23965454101562,
        364.0832824707031
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        375.0032653808594,
        488.3560485839844,
        386.04327392578125
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이용하여 평가한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        396.9632873535156,
        257.8363037109375,
        408.0032958984375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        419.04327392578125,
        488.35626220703125,
        430.0832824707031
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        441.0032653808594,
        247.15663146972656,
        452.04327392578125
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 예시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        138.83999633789062,
        462.9632873535156,
        174.71998596191406,
        474.0032958984375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        155.51998901367188,
        485.04327392578125,
        484.6796875,
        496.0832824707031
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 자료 또는 양성임을 증명하는 임상자료 등. 평가대상 제품의",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        155.51998901367188,
        507.0032653808594,
        488.3560485839844,
        518.0432739257812
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과와 관계없는 기준이여야 함",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        155.51998901367188,
        528.9632568359375,
        315.0,
        540.0032958984375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        551.043212890625,
        484.6796875,
        562.083251953125
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "도록 한다. 또한 다양한 아형(유전자형, 변이체, 혈청형 등)이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        573.0032348632812,
        488.35638427734375,
        584.0432739257812
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함되는 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        594.9632568359375,
        285.3162841796875,
        606.0032958984375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        617.043212890625,
        484.67999267578125,
        628.083251953125
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        639.0032348632812,
        488.3560485839844,
        650.0432739257812
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 통계적으로 의미 있는 검체수를 산정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        660.9632568359375,
        397.17279052734375,
        672.0032958984375
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        683.043212890625,
        488.35662841796875,
        694.083251953125
      ],
      "page_num": 61,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 57 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 62,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        153.00328063964844,
        488.3560485839844,
        164.04327392578125
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이용할 수도 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        174.96328735351562,
        252.31640625,
        186.00328063964844
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        219.00328063964844,
        189.23965454101562,
        230.04327392578125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        240.96327209472656,
        488.3560485839844,
        252.00326538085938
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.87998962402344,
        263.04327392578125,
        484.67999267578125,
        274.0832824707031
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 제공한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        158.87998962402344,
        285.0032653808594,
        226.27664184570312,
        296.04327392578125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        306.9632873535156,
        488.3563537597656,
        318.0032958984375
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        155.16000366210938,
        329.04327392578125,
        445.53277587890625,
        340.0832824707031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        351.0032653808594,
        469.8927917480469,
        362.04327392578125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        372.9632873535156,
        488.35638427734375,
        384.0032958984375
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.239990234375,
        395.04327392578125,
        459.3327941894531,
        406.0832824707031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.0032653808594,
        488.3560485839844,
        428.04327392578125
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시행할 집단에서의 유병률을 평가할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.59999084472656,
        438.9632873535156,
        421.17279052734375,
        450.0032958984375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        461.04327392578125,
        189.23965454101562,
        472.0832824707031
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        483.0032653808594,
        488.3560485839844,
        494.04327392578125
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        504.9632873535156,
        488.35662841796875,
        516.0032958984375
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        527.043212890625,
        484.67999267578125,
        538.083251953125
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        549.0032348632812,
        479.9727783203125,
        560.0432739257812
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        570.9632568359375,
        488.35638427734375,
        582.0032958984375
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 제시한다. 유병률을 구한 경우는 유병률도 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        593.043212890625,
        449.852783203125,
        604.083251953125
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        615.0032348632812,
        488.3560485839844,
        626.0432739257812
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        159.59999084472656,
        636.9632568359375,
        206.85281372070312,
        648.0032958984375
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        659.043212890625,
        484.67999267578125,
        670.083251953125
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        678.84326171875,
        488.35638427734375,
        689.88330078125
      ],
      "page_num": 62,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 58 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 63,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        153.00328063964844,
        484.6796875,
        164.04327392578125
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측도, 음성예측도 제시를 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        172.80328369140625,
        331.5328063964844,
        183.84327697753906
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 임상적 특이도",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        214.57920837402344,
        204.95999145507812,
        226.57920837402344
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        238.5632781982422,
        189.23965454101562,
        249.603271484375
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) CMV 감염이 없는 환자검체를 이용한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        260.6432800292969,
        362.2527770996094,
        271.68328857421875
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        282.603271484375,
        488.3565368652344,
        293.6432800292969
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        304.5632629394531,
        488.356201171875,
        315.603271484375
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        326.6432800292969,
        488.356689453125,
        337.68328857421875
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        348.603271484375,
        468.6927795410156,
        359.6432800292969
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        370.5632629394531,
        458.0127868652344,
        381.603271484375
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        414.603271484375,
        189.23965454101562,
        425.6432800292969
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        436.5632629394531,
        488.3557434082031,
        447.603271484375
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제공해야한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        458.6432800292969,
        226.77281188964844,
        469.68328857421875
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        480.603271484375,
        488.35638427734375,
        491.6432800292969
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과거에 확진된 보관검체로도 실험할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        502.5632629394531,
        386.1327819824219,
        513.603271484375
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        546.603271484375,
        189.23965454101562,
        557.643310546875
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 임상적 특이도 및 95% 신뢰구간을 제시한다. 임상적 특이도",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        568.563232421875,
        484.6801452636719,
        579.603271484375
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        590.6432495117188,
        484.67999267578125,
        601.6832885742188
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정기준치 미만)으로 나오는 환자의 비율이다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        612.6032104492188,
        386.1327819824219,
        623.6432495117188
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        634.563232421875,
        488.35638427734375,
        645.603271484375
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        656.6432495117188,
        232.1728057861328,
        667.6832885742188
      ],
      "page_num": 63,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        678.6032104492188,
        488.3560485839844,
        689.6432495117188
      ],
      "page_num": 63,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 59 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 64,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        153.00328063964844,
        208.39663696289062,
        164.04327392578125
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        224.34808349609375,
        483.60394287109375,
        256.6280822753906
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        224.34808349609375,
        483.60394287109375,
        256.6280822753906
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(3배치 1회이상 또는 1배치 3회 이상)",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        224.34808349609375,
        483.60394287109375,
        256.6280822753906
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        291.0032653808594,
        484.67999267578125,
        302.04327392578125
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        312.9632873535156,
        458.71630859375,
        324.0032958984375
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        357.0032653808594,
        488.35736083984375,
        368.04327392578125
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        378.9632873535156,
        488.3560485839844,
        390.0032958984375
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중복될 경우 이를 생략한다).",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        401.04327392578125,
        273.6927795410156,
        412.0832824707031
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        444.9632873535156,
        488.35662841796875,
        456.0032958984375
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정밀도 등)을 설정한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        127.55999755859375,
        467.04327392578125,
        246.3328094482422,
        478.0832824707031
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        558.3080444335938,
        382.323974609375,
        573.1881103515625
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표준물질 및 검체보관 등에 관한 자료",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        558.3080444335938,
        382.323974609375,
        573.1881103515625
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 완제품 품질관리 시험에 사용된 표준물질에 관한 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        605.1632690429688,
        400.55999755859375,
        616.2033081054688
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        627.2432250976562,
        484.67999267578125,
        638.2832641601562
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        649.2032470703125,
        217.1728057861328,
        660.2432861328125
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        671.1632690429688,
        449.8379821777344,
        682.2033081054688
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 출처 및 근거 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        693.2432250976562,
        255.07640075683594,
        704.2832641601562
      ],
      "page_num": 64,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 60 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        153.00328063964844,
        476.0127868652344,
        164.04327392578125
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        174.96328735351562,
        488.35638427734375,
        186.00328063964844
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과 분석 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        197.04327392578125,
        238.15606689453125,
        208.08326721191406
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 표준물질 관리방법 및 관리기록서(정도관리 포함)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        219.00328063964844,
        410.8799743652344,
        230.04327392578125
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        273.0032653808594,
        425.760009765625,
        284.04327392578125
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        294.9632873535156,
        488.35662841796875,
        306.0032958984375
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. 이는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        317.04327392578125,
        488.3560485839844,
        328.0832824707031
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        339.0032653808594,
        484.67999267578125,
        350.04327392578125
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "체의 사용 가능성 및 제한점 등을 포함한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        360.9632873535156,
        365.61279296875,
        372.0032958984375
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 검체 취급 및 보관조건에 대한 시험 결과를 제시한다. 이는 제시된",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        383.04327392578125,
        488.3560485839844,
        394.0832824707031
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        405.0032653808594,
        488.35638427734375,
        416.04327392578125
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단계에 대해 동일한 검사 결과를 보임을 입증해야 한다. 이 시험은",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        426.9632873535156,
        488.3560485839844,
        438.0032958984375
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        449.04327392578125,
        484.67999267578125,
        460.0832824707031
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        471.0032653808594,
        488.3560485839844,
        482.04327392578125
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함께 기록한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        492.9632873535156,
        217.1728057861328,
        504.0032958984375
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        515.043212890625,
        484.67999267578125,
        526.083251953125
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "처리법, 허용기준, 결과 등을 요약하여 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        537.0032348632812,
        388.53277587890625,
        548.0432739257812
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 13.799982070922852,
      "font_name": "H2hdrM",
      "bbox": [
        121.91999816894531,
        608.3480224609375,
        222.48397827148438,
        623.1080932617188
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상관성 평가",
      "font_size": 13.799982070922852,
      "font_name": "HYwulM",
      "bbox": [
        121.91999816894531,
        608.3480224609375,
        222.48397827148438,
        623.1080932617188
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 일반사항",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        655.2032470703125,
        169.67965698242188,
        666.2432861328125
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        677.1632690429688,
        488.35638427734375,
        688.2033081054688
      ],
      "page_num": 65,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅶ. 성능시험에 대한 상세사항",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        369.0,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 61 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 66,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비교시험성적서를 포함하여야 한다. 다만, 측정원리 및 측정항목이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        153.00328063964844,
        488.3557434082031,
        164.04327392578125
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        174.96328735351562,
        448.05279541015625,
        186.00328063964844
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        197.04327392578125,
        488.3560485839844,
        208.08326721191406
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        219.00328063964844,
        488.35638427734375,
        230.04327392578125
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. 분석적 성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        240.96327209472656,
        484.67999267578125,
        252.00326538085938
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        263.04327392578125,
        484.6805114746094,
        274.0832824707031
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 추가 자료로 제시할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        285.0032653808594,
        304.5328063964844,
        296.04327392578125
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        306.9632873535156,
        488.3560485839844,
        318.0032958984375
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        329.04327392578125,
        488.3569030761719,
        340.0832824707031
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특이도 자료 대신에 상관성 자료를 제출할 수 있다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        351.0032653808594,
        407.2362976074219,
        362.04327392578125
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 시험물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        395.04327392578125,
        169.67965698242188,
        406.0832824707031
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        417.0032653808594,
        488.3557434082031,
        428.04327392578125
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함하여 비교시험을 수행한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        438.9632873535156,
        303.3162841796875,
        450.0032958984375
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        461.04327392578125,
        488.3560485839844,
        472.0832824707031
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        483.0032653808594,
        426.0928039550781,
        494.04327392578125
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        504.9632873535156,
        484.67999267578125,
        516.0032958984375
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함하여 비교하도록 한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        527.043212890625,
        270.3162841796875,
        538.083251953125
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        549.0032348632812,
        488.3557434082031,
        560.0432739257812
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고, 최소 100개 이상의 검체를 시험하도록 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        570.9632568359375,
        424.63629150390625,
        582.0032958984375
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 시험방법",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        615.0032348632812,
        169.67965698242188,
        626.0432739257812
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        636.9632568359375,
        484.67999267578125,
        648.0032958984375
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        659.043212890625,
        484.6796875,
        670.083251953125
      ],
      "page_num": 66,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        681.0032348632812,
        167.73280334472656,
        692.0432739257812
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 62 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 67,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        153.00328063964844,
        455.35662841796875,
        164.04327392578125
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 비교 제품은 각 제품의 사용방법에 따라서 시험한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        174.96328735351562,
        412.29278564453125,
        186.00328063964844
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        197.04327392578125,
        449.83660888671875,
        208.08326721191406
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        219.00328063964844,
        484.67999267578125,
        230.04327392578125
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고 이에 대한 자료를 제공하여야 한다. 불일치의 원인을 분석할",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        240.96327209472656,
        488.3560485839844,
        252.00326538085938
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        263.04327392578125,
        472.8766174316406,
        274.0832824707031
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 결과제시",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        306.9632873535156,
        169.67965698242188,
        318.0032958984375
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        329.04327392578125,
        472.7727966308594,
        340.0832824707031
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        351.0032653808594,
        488.35638427734375,
        362.04327392578125
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의학적 결정치에서의 bias를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        372.9632873535156,
        340.0362854003906,
        384.0032958984375
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        395.04327392578125,
        484.6796875,
        406.0832824707031
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사와의 일치도(신뢰구간과 함께)를 제시한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        142.55999755859375,
        417.0032653808594,
        382.17279052734375,
        428.04327392578125
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        438.9632873535156,
        488.35662841796875,
        450.0032958984375
      ],
      "page_num": 67,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅷ. 참고문헌",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        434.6399841308594,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 63 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 68,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅷ",
      "font_size": 21.959999084472656,
      "font_name": "T6",
      "bbox": [
        115.91999816894531,
        157.32000732421875,
        235.3199920654297,
        183.6719970703125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고문헌",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        115.91999816894531,
        157.32000732421875,
        235.3199920654297,
        183.6719970703125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. CLSI. Evaluation of Stability of In Vitro Diagnostic Reagents;",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        244.92327880859375,
        488.3562927246094,
        255.96327209472656
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Approved Guideline. CLSI document EP25-A. Wayne, PA: Cinical",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        266.8832702636719,
        488.3565368652344,
        277.92327880859375
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and Laboratory Standard Institute; 2009",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        288.8432922363281,
        342.1971435546875,
        299.88330078125
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        333.0032653808594,
        488.3594665527344,
        344.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLSI.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        333.0032653808594,
        488.3594665527344,
        344.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Evaluation",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        333.0032653808594,
        488.3594665527344,
        344.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        333.0032653808594,
        488.3594665527344,
        344.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Precision",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        333.0032653808594,
        488.3594665527344,
        344.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Performance",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        333.0032653808594,
        488.3594665527344,
        344.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        333.0032653808594,
        488.3594665527344,
        344.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Quantitative",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        333.0032653808594,
        488.3594665527344,
        344.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Measurement Methods; Approved Guideline - Second Edition.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        354.9632873535156,
        488.3570556640625,
        366.0032958984375
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLSI document EP5-A2. Wayne, PA: Cinical and Laboratory",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        376.92327880859375,
        488.35595703125,
        387.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Standard Institute; 2004",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        399.0032653808594,
        258.31719970703125,
        410.04327392578125
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        442.92327880859375,
        488.3559265136719,
        453.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLSI.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        442.92327880859375,
        488.3559265136719,
        453.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "User",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        442.92327880859375,
        488.3559265136719,
        453.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Protocol",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        442.92327880859375,
        488.3559265136719,
        453.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        442.92327880859375,
        488.3559265136719,
        453.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Evaluation",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        442.92327880859375,
        488.3559265136719,
        453.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        442.92327880859375,
        488.3559265136719,
        453.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Qualitative",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        442.92327880859375,
        488.3559265136719,
        453.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Test",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        442.92327880859375,
        488.3559265136719,
        453.9632873535156
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Performance;",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        465.0032653808594,
        488.3562927246094,
        476.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Approved",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        465.0032653808594,
        488.3562927246094,
        476.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guideline",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        465.0032653808594,
        488.3562927246094,
        476.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        465.0032653808594,
        488.3562927246094,
        476.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Second",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        465.0032653808594,
        488.3562927246094,
        476.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Edition.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        465.0032653808594,
        488.3562927246094,
        476.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CLSI",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        465.0032653808594,
        488.3562927246094,
        476.04327392578125
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "document EP12-A2. Wayne, PA: Cinical and Laboratory Standard",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        486.9632873535156,
        488.3562927246094,
        498.0032958984375
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Institute; 2008",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        508.9232482910156,
        208.3971710205078,
        519.9632568359375
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. CLSI. Protocols for Determination of Limits of Detection and",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        552.9632568359375,
        488.3565368652344,
        564.0032958984375
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Limits of Quantitation; Approved Guideline. CLSI document",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        574.9232177734375,
        488.3566589355469,
        585.9632568359375
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "EP17-A2. Wayne, PA: Cinical and Laboratory Standard Institute;",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        597.0032348632812,
        488.35931396484375,
        608.0432739257812
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2012",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        618.9632568359375,
        156.19717407226562,
        630.0032958984375
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. CLSI. Evaluation of the Linearity of Quantitative Measurement",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        663.0032348632812,
        488.3557434082031,
        674.0432739257812
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Procedures: A Statistical Approach; Approved Guideline. CLSI",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        684.9632568359375,
        488.3562927246094,
        696.0032958984375
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 64 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "document EP6-A. Wayne, PA: Cinical and Laboratory Standard",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        153.12327575683594,
        488.3573913574219,
        164.16326904296875
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Institute; 2003",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        175.08328247070312,
        208.3971710205078,
        186.12327575683594
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6. CLSI. Method Comparison and Bias Estimation Using Patient",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        219.12327575683594,
        488.3560485839844,
        230.16326904296875
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Samples;",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        241.08328247070312,
        488.3575134277344,
        252.12327575683594
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Approved",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        241.08328247070312,
        488.3575134277344,
        252.12327575683594
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guideline",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        241.08328247070312,
        488.3575134277344,
        252.12327575683594
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        241.08328247070312,
        488.3575134277344,
        252.12327575683594
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Second",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        241.08328247070312,
        488.3575134277344,
        252.12327575683594
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Edition",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        241.08328247070312,
        488.3575134277344,
        252.12327575683594
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Interim",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        241.08328247070312,
        488.3575134277344,
        252.12327575683594
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Revision). CLSI document EP9-A2-IR. Wayne, PA: Cinical and",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        263.04327392578125,
        488.3565368652344,
        274.0832824707031
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Laboratory Standard Institute; 2010",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        285.123291015625,
        319.27716064453125,
        296.1632995605469
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. CLSI. Interference Testing in Clinical Chemistry; Approved",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        329.04327392578125,
        488.3577575683594,
        340.0832824707031
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Guideline - Second Edition. CLSI document EP7-A. Wayne, PA:",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        351.123291015625,
        488.35614013671875,
        362.1632995605469
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Cinical and Laboratory Standard Institute; 2005",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        373.0832824707031,
        381.5571594238281,
        384.123291015625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. CLSI. Molecular Diagnostic Methods for Infectious Diseases;",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        417.1232604980469,
        488.35699462890625,
        428.16326904296875
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Approved Guideline - Second Edition. CLSI document MM3-A2.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        439.0832824707031,
        488.3564453125,
        450.123291015625
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Wayne, PA: Cinical and Laboratory Standard Institute; 2006",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        461.04327392578125,
        448.8771667480469,
        472.0832824707031
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        505.0832824707031,
        488.3551940917969,
        516.123291015625
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Device Studies -Frequently Asked Questions, 2010",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        130.55999755859375,
        527.043212890625,
        408.1976013183594,
        538.083251953125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. Guidance for industry and FDA staff/ Format for traditional and",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        571.083251953125,
        488.3565368652344,
        582.123291015625
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "abbreviated 510(k)s, 2005",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        593.043212890625,
        275.7171630859375,
        604.083251953125
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11. Guidance for Industry and Food and Drug Administration Staff",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        637.083251953125,
        488.35638427734375,
        648.123291015625
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Class II Special Controls Guidance Document: Herpes Simplex",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        659.043212890625,
        488.3569030761719,
        670.083251953125
      ],
      "page_num": 69,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Virus Types 1 and 2 Serological Assays, 2011",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        681.1232299804688,
        384.6771545410156,
        692.1632690429688
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ⅷ. 참고문헌",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        434.6399841308594,
        115.2744140625,
        481.68560791015625,
        124.2744140625
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 65 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "12. Linnet, K and Kondratovich, M. A Partly Noparametric Approach",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        175.08328247070312,
        488.3565368652344,
        186.12327575683594
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "for Determination of the Llimit of Detection. Clinical Chemistry",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        197.04327392578125,
        488.3568115234375,
        208.08326721191406
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2004:50;732-740",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        135.47999572753906,
        219.12327575683594,
        228.92047119140625,
        230.16326904296875
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13. http://www.cdc.gov/cmv/congenital-infection.html",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        263.04327392578125,
        388.780517578125,
        274.0832824707031
      ],
      "page_num": 70,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 66 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅸ  부록",
      "font_size": 18.0,
      "font_name": "H2hdrM",
      "bbox": [
        114.36000061035156,
        157.32000732421875,
        195.36000061035156,
        183.6719970703125
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 3,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. CMV 표준물질 현황",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        244.939208984375,
        238.44000244140625,
        256.939208984375
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. WHO international reference preparation3)",
      "font_size": 8.279999732971191,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        268.8924560546875,
        366.179931640625,
        279.9632873535156
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        290.8832702636719,
        488.35675048828125,
        301.92327880859375
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1st",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        312.8432922363281,
        488.35791015625,
        323.88330078125
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "International Standard, 2010,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        312.8432922363281,
        488.35791015625,
        323.88330078125
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2008",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        312.8432922363281,
        488.35791015625,
        323.88330078125
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NIBSC",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        312.8432922363281,
        488.35791015625,
        323.88330078125
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "09/162",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        312.8432922363281,
        488.35791015625,
        323.88330078125
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10.2138",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        334.92327880859375,
        199.15769958496094,
        345.9632873535156
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. NIBSC의 관련 표준물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        356.8832702636719,
        267.1196594238281,
        367.92327880859375
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        378.84326171875,
        488.3565368652344,
        389.8832702636719
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "NIBSC code: 10/B5994)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        400.8924560546875,
        285.0763854980469,
        411.9632873535156
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) Human Cytomegalovirus for Nucleic Acid Amplification",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        422.8832702636719,
        488.3564453125,
        433.92327880859375
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Techniques NIBSC code: 08/314-XXX5)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        444.84326171875,
        372.6763916015625,
        455.8832702636719
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. SeraCare사의 관련 표준물질6)",
      "font_size": 8.279999732971191,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        466.8924560546875,
        299.3399353027344,
        477.9632873535156
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        488.8832702636719,
        488.2375183105469,
        499.92327880859375
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5100, 5600, 8100 Multi-Analyte Positive Control: for use",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        510.8432922363281,
        488.3568420410156,
        521.88330078125
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "with in vitro diagnostic test kits for the detection of",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        532.9232177734375,
        488.3559265136719,
        543.9632568359375
      ],
      "page_num": 71,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "antibodies",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        554.8832397460938,
        208.9202423095703,
        565.9232788085938
      ],
      "page_num": 71,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        593.8344116210938,
        365.63720703125,
        614.7144165039062
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4)",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        593.8344116210938,
        365.63720703125,
        614.7144165039062
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "http://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        123.5999984741211,
        617.3543701171875,
        483.9047546386719,
        638.1143798828125
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ge.aspx?catid=10/B599-02",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        123.5999984741211,
        617.3543701171875,
        483.9047546386719,
        638.1143798828125
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5)",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        640.994384765625,
        121.63932800292969,
        649.994384765625
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "http://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        123.5999984741211,
        652.6343994140625,
        483.9047546386719,
        673.3944091796875
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ge.aspx?catid=08/314-004",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        123.5999984741211,
        652.6343994140625,
        483.9047546386719,
        673.3944091796875
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6)",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        676.1544189453125,
        118.77392578125,
        685.1544189453125
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "http://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        123.5999984741211,
        687.9144287109375,
        483.8338623046875,
        708.6743774414062
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "=ProductName,ProductName",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        123.5999984741211,
        687.9144287109375,
        483.8338623046875,
        708.6743774414062
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IX. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        452.3999938964844,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 67 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) ACCURUN 145, 146 CMV IgG Positive Control",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        153.00328063964844,
        408.33184814453125,
        164.04327392578125
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) ACCURUN 146 CMV IgM Positive Control",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        174.96328735351562,
        382.6515197753906,
        186.00328063964844
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        197.04327392578125,
        476.0126037597656,
        208.08326721191406
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        219.00328063964844,
        456.8126220703125,
        230.04327392578125
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) ACCURUN 350 Series 300 CMV DNA Positive Control",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        240.96327209472656,
        449.01153564453125,
        252.00326538085938
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) ACCURUN 800 ToRCH Serology Negative Control",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        263.04327392578125,
        423.45184326171875,
        274.0832824707031
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8) ACCURUN 810 Multi-Analyte Serology Negative Control",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        285.0032653808594,
        461.4918518066406,
        296.04327392578125
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9) Anti-CMV Mixed Titer Performance Panel",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        306.9632873535156,
        388.75714111328125,
        318.0032958984375
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10) Anti-CMV Qualification Panel",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        329.04327392578125,
        322.05364990234375,
        340.0832824707031
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11) CMV DNA Linearity Panel",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        351.0032653808594,
        312.676025390625,
        362.04327392578125
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12) Anti-CMV Seroconversion Panel - PTC9017)",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        372.9632873535156,
        416.47637939453125,
        384.0032958984375
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. AcroMetrix Quality Control 관련 표준물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        395.04327392578125,
        365.0396728515625,
        406.0832824707031
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) AcroMetrix CMV Controls(negative, low positive, high",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        417.0032653808594,
        488.35699462890625,
        428.04327392578125
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "positive) : CMV DNA",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        438.9632873535156,
        276.1963806152344,
        450.0032958984375
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. ATCC 균주",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        461.04327392578125,
        203.87998962402344,
        472.0832824707031
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) VR-538, -807, -977, -1578, -1590, -1780, -2356,",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        483.0032653808594,
        488.3580017089844,
        494.04327392578125
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "-538D, -977D의 총 9종, 각 $360",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        504.9632873535156,
        340.15631103515625,
        516.0032958984375
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 국내 병원성바이러스은행 보유균주",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        527.043212890625,
        321.23968505859375,
        538.083251953125
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) Human Cytomegalovirus : KBPV-VR-7",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        549.0032348632812,
        367.7559814453125,
        560.0432739257812
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사. 그 외 표준물질",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.5199966430664,
        570.9632568359375,
        222.23965454101562,
        582.0032958984375
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        593.043212890625,
        488.3577575683594,
        604.083251953125
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Seroconversion Panel",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        615.0032348632812,
        272.1171569824219,
        626.0432739257812
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        140.52000427246094,
        636.9632568359375,
        488.3577575683594,
        648.0032958984375
      ],
      "page_num": 72,
      "block_type": "heading",
      "level": 14,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Seroconversion Panel",
      "font_size": 11.039999961853027,
      "font_name": "Haansoft Batang",
      "bbox": [
        157.55999755859375,
        659.043212890625,
        268.53363037109375,
        670.083251953125
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) http://www.seracarepanels.com/default.aspx",
      "font_size": 8.759956359863281,
      "font_name": "Batang",
      "bbox": [
        110.5199966430664,
        699.6743774414062,
        295.5656433105469,
        708.6743774414062
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 68 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. CMV 제품 국내 제조 및 수입 현황",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        110.5199966430664,
        179.05921936035156,
        322.44000244140625,
        191.05921936035156
      ],
      "page_num": 73,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사법",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.87999725341797,
        226.6503448486328,
        476.7599792480469,
        236.6103515625
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "품명",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.87999725341797,
        226.6503448486328,
        476.7599792480469,
        236.6103515625
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조사",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.87999725341797,
        226.6503448486328,
        476.7599792480469,
        236.6103515625
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제조국",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.87999725341797,
        226.6503448486328,
        476.7599792480469,
        236.6103515625
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        129.36000061035156,
        387.3303527832031,
        147.27005004882812,
        397.29034423828125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Vidas CMV IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        245.37034606933594,
        477.4679260253906,
        255.33035278320312
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMERIEUX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        245.37034606933594,
        477.4679260253906,
        255.33035278320312
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "France",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        245.37034606933594,
        477.4679260253906,
        255.33035278320312
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Elecsys CMV IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        261.09033203125,
        482.44659423828125,
        271.0503234863281
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Roche",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        261.09033203125,
        482.44659423828125,
        271.0503234863281
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Germany",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        261.09033203125,
        482.44659423828125,
        271.0503234863281
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Enzygnost Anti-CMV IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        276.6903381347656,
        482.44659423828125,
        286.65032958984375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        276.6903381347656,
        482.44659423828125,
        286.65032958984375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Germany",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        276.6903381347656,
        482.44659423828125,
        286.65032958984375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Architect CMV IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        292.41033935546875,
        477.8295593261719,
        302.3703308105469
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        292.41033935546875,
        477.8295593261719,
        302.3703308105469
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ireland",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        292.41033935546875,
        477.8295593261719,
        302.3703308105469
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Chorus cytomegalovirus IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        314.6103515625,
        326.5228576660156,
        324.5703430175781
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMEDICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        369.0,
        306.5703430175781,
        436.87652587890625,
        316.53033447265625
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSIS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        373.0799865722656,
        322.65032958984375,
        429.34503173828125,
        332.6103210449219
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Italy",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        451.1999816894531,
        314.6103515625,
        472.4866027832031,
        324.5703430175781
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Liaison CMV IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        336.8103332519531,
        472.4866027832031,
        346.77032470703125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LIAISON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        336.8103332519531,
        472.4866027832031,
        346.77032470703125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Italy",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        336.8103332519531,
        472.4866027832031,
        346.77032470703125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Radim cytomegalovirus IgG/IgM EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        351.09033203125,
        349.0369567871094,
        361.0503234863281
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "well",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        359.1303405761719,
        472.4866027832031,
        377.0103454589844
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RADIM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        359.1303405761719,
        472.4866027832031,
        377.0103454589844
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Italy",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        359.1303405761719,
        472.4866027832031,
        377.0103454589844
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bioelisa CMV IgM immuno capture",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        381.3303527832031,
        474.3489685058594,
        391.29034423828125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOKIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        381.3303527832031,
        474.3489685058594,
        391.29034423828125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Spain",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        381.3303527832031,
        474.3489685058594,
        391.29034423828125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bioelisa CMV IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        396.9303283691406,
        474.3489685058594,
        406.89031982421875
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOKIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        396.9303283691406,
        474.3489685058594,
        406.89031982421875
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Spain",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        396.9303283691406,
        474.3489685058594,
        406.89031982421875
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Axsym CMV IgG (AXM CMV IgG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        411.2103271484375,
        338.83721923828125,
        421.1703186035156
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RGT)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        419.2503356933594,
        472.4705810546875,
        437.1303405761719
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        419.2503356933594,
        472.4705810546875,
        437.1303405761719
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        419.2503356933594,
        472.4705810546875,
        437.1303405761719
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Axsym CMV IgM (AXM CMV IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        440.0103454589844,
        342.91754150390625,
        449.9703369140625
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.0)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        448.0503234863281,
        472.4705810546875,
        465.9303283691406
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        448.0503234863281,
        472.4705810546875,
        465.9303283691406
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        448.0503234863281,
        472.4705810546875,
        465.9303283691406
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Immulite 2500 CMV IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        470.2503356933594,
        472.4705810546875,
        480.2103271484375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SIEMENS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        470.2503356933594,
        472.4705810546875,
        480.2103271484375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        470.2503356933594,
        472.4705810546875,
        480.2103271484375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Immulite 1000 CMV IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        485.850341796875,
        472.4705810546875,
        495.8103332519531
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SIEMENS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        485.850341796875,
        472.4705810546875,
        495.8103332519531
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        485.850341796875,
        472.4705810546875,
        495.8103332519531
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Zeus CMV IgG/IgM ELISA test system",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        508.1703186035156,
        360.8560485839844,
        518.1303100585938
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ZEUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        387.9599914550781,
        500.1303405761719,
        417.9167785644531,
        510.09033203125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        371.8800048828125,
        508.1703186035156,
        472.4705810546875,
        526.0503540039062
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "USA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        371.8800048828125,
        508.1703186035156,
        472.4705810546875,
        526.0503540039062
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Platelia CMV IgG/IgM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        529.7703857421875,
        477.4679260253906,
        539.7303466796875
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIO-RAD",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        529.7703857421875,
        477.4679260253906,
        539.7303466796875
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "France",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        529.7703857421875,
        477.4679260253906,
        539.7303466796875
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Molecular",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        115.68000030517578,
        608.2503662109375,
        164.3585205078125,
        618.2103271484375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "method",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        121.55999755859375,
        624.3303833007812,
        155.1492462158203,
        634.2903442382812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QIAGEN artus CMV LC PCR kit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        544.2903442382812,
        482.44659423828125,
        554.2503051757812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QIAGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        544.2903442382812,
        482.44659423828125,
        554.2503051757812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Germany",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        544.2903442382812,
        482.44659423828125,
        554.2503051757812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QIAGEN artus CMV RG PCR kit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        558.8103637695312,
        482.44659423828125,
        568.7703247070312
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QIAGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        558.8103637695312,
        482.44659423828125,
        568.7703247070312
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Germany",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        558.8103637695312,
        482.44659423828125,
        568.7703247070312
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QIAGEN artus CMV TM PCR kit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        573.3303833007812,
        482.44659423828125,
        583.2903442382812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QIAGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        573.3303833007812,
        482.44659423828125,
        583.2903442382812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Germany",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        573.3303833007812,
        482.44659423828125,
        583.2903442382812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QIAGEN CMV PCR kit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        587.850341796875,
        482.44659423828125,
        597.810302734375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QIAGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        587.850341796875,
        482.44659423828125,
        597.810302734375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Germany",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        587.850341796875,
        482.44659423828125,
        597.810302734375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Seegene Anyplex CMV Real-time",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        601.5303344726562,
        338.2371520996094,
        611.4902954101562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Quantitation PCR kit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        617.6103515625,
        268.69573974609375,
        627.5703125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SEEGENE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        377.5199890136719,
        609.5703735351562,
        475.4999084472656,
        619.5303344726562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Korea",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        377.5199890136719,
        609.5703735351562,
        475.4999084472656,
        619.5303344726562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BioSewoom Real-Q CMV kit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        630.3303833007812,
        475.4999084472656,
        640.2903442382812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOSEWOOM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        630.3303833007812,
        475.4999084472656,
        640.2903442382812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Korea",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        630.3303833007812,
        475.4999084472656,
        640.2903442382812
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BioSewoom Real-Q CMV quantification",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        643.1703491210938,
        363.6777038574219,
        653.1303100585938
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "kit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        659.2503662109375,
        183.375244140625,
        669.2103271484375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOSEWOOM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        369.6000061035156,
        651.2103881835938,
        475.4999084472656,
        661.1703491210938
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Korea",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        369.6000061035156,
        651.2103881835938,
        475.4999084472656,
        661.1703491210938
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Bioneer AccuPower® CMV Quantitative",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        672.5703735351562,
        363.5577392578125,
        682.5303344726562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PCR Kit",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        680.6103515625,
        475.4999084472656,
        698.4902954101562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIONEER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        680.6103515625,
        475.4999084472656,
        698.4902954101562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Korea",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        171.239990234375,
        680.6103515625,
        475.4999084472656,
        698.4902954101562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IX. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        452.3999938964844,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 69 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 74,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)",
      "font_size": 12.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        111.47999572753906,
        153.0192108154297,
        420.47998046875,
        165.0192108154297
      ],
      "page_num": 74,
      "block_type": "heading",
      "level": 12,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Document No",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        114.95999908447266,
        200.49034118652344,
        411.4072570800781,
        210.45034790039062
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Device name",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        114.95999908447266,
        200.49034118652344,
        411.4072570800781,
        210.45034790039062
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Company",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        114.95999908447266,
        200.49034118652344,
        411.4072570800781,
        210.45034790039062
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Date",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        449.03997802734375,
        191.49034118652344,
        473.5964660644531,
        201.45034790039062
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Apprived",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        438.9599914550781,
        209.49034118652344,
        480.4704895019531,
        219.45034790039062
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K100433",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        270.09033203125,
        167.9273223876953,
        280.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMULITE 2000 CMV IGM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        225.09034729003906,
        321.3167724609375,
        235.05035400390625
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMULITE CMV IGM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        243.09034729003906,
        292.9972839355469,
        253.05035400390625
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONTROLS AND IMMULITE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        261.09033203125,
        327.1979064941406,
        271.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "200 CMV IGM ADJUSTOR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        279.09033203125,
        315.91595458984375,
        289.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODEL L2KCM2 L2KCM6",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        297.09033203125,
        315.0769958496094,
        307.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LCMC1 LCMC2",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        315.09033203125,
        257.2070617675781,
        325.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SIEMENS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        252.09033203125,
        396.197265625,
        262.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEALTHCARE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        270.09033203125,
        420.5574645996094,
        280.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        288.09033203125,
        417.10418701171875,
        298.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 13",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        261.09033203125,
        481.39752197265625,
        271.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2010",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        279.09033203125,
        471.4073791503906,
        289.0503234863281
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K093784",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        348.6903381347656,
        167.9273223876953,
        358.65032958984375
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ATHENA MULTI-LYTE TORCH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        339.6903381347656,
        345.6761474609375,
        349.65032958984375
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGG PLUS TEST SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        357.6903381347656,
        312.60455322265625,
        367.65032958984375
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ZEUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        339.6903381347656,
        376.63677978515625,
        349.65032958984375
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        357.6903381347656,
        431.2987365722656,
        367.65032958984375
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        339.6903381347656,
        477.7969970703125,
        349.65032958984375
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2010",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        357.6903381347656,
        471.4073791503906,
        367.65032958984375
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K081164",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        400.41033935546875,
        167.9273223876953,
        410.3703308105469
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D3 DFA CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        382.41033935546875,
        333.0758056640625,
        392.3703308105469
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMEDIATE EARLY ANTIGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        400.41033935546875,
        338.9559326171875,
        410.3703308105469
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IDENTIFICATION KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        418.41033935546875,
        293.0697021484375,
        428.3703308105469
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        391.41033935546875,
        414.1959533691406,
        401.3703308105469
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HYBRIDS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        409.41033935546875,
        417.13824462890625,
        419.3703308105469
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 13",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        391.41033935546875,
        479.1175231933594,
        401.3703308105469
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2008",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        409.41033935546875,
        471.4073791503906,
        419.3703308105469
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K040290",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        443.0103454589844,
        167.9273223876953,
        452.9703369140625
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIASORIN LIAISON CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        434.0103454589844,
        310.99774169921875,
        443.9703369140625
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGM/IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        452.0103454589844,
        224.1309051513672,
        461.9703369140625
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIASORIN S.P.A.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        443.0103454589844,
        429.97894287109375,
        452.9703369140625
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 01",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        434.0103454589844,
        479.1175231933594,
        443.9703369140625
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2005",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        452.0103454589844,
        471.4073791503906,
        461.9703369140625
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K001767",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        476.7303466796875,
        167.9273223876953,
        486.6903381347656
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAMEDIX IS-CMV IGM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        467.7303466796875,
        309.19677734375,
        477.6903381347656
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAPTURE TEST SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        485.7303466796875,
        312.2435607910156,
        495.6903381347656
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAMEDIX CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        476.7303466796875,
        432.8585510253906,
        486.6903381347656
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 07",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        467.7303466796875,
        480.5575256347656,
        477.6903381347656
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2000",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        485.7303466796875,
        471.4073791503906,
        495.6903381347656
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K993952",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        519.3303833007812,
        167.9273223876953,
        529.2903442382812
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMULITE 2000 CMV IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        510.3303527832031,
        319.27593994140625,
        520.2903442382812
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODEL L2KCV2 L2KCV6",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        528.3303833007812,
        307.6067810058594,
        538.2903442382812
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        501.330322265625,
        414.1959533691406,
        511.2903137207031
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        519.3303833007812,
        404.9570617675781,
        529.2903442382812
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        537.3303833007812,
        376.2185363769531,
        547.2903442382812
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        510.3303527832031,
        480.0769958496094,
        520.2903442382812
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        528.3303833007812,
        471.4073791503906,
        538.2903442382812
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K991650",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        570.9303588867188,
        306.38970947265625,
        580.8903198242188
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV BRITE TURBO KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        570.9303588867188,
        306.38970947265625,
        580.8903198242188
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOTEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        552.9303588867188,
        395.4771423339844,
        562.8903198242188
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        570.9303588867188,
        420.4358825683594,
        580.8903198242188
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        588.9303588867188,
        376.2185363769531,
        598.8903198242188
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 12",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        561.9303588867188,
        477.7969970703125,
        571.8903198242188
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        579.9303588867188,
        471.4073791503906,
        589.8903198242188
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K984139",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        649.0503540039062,
        167.9273223876953,
        659.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "THE APTUS (AUTOMATED)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        604.0503540039062,
        330.6750183105469,
        614.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "APPLICATION OF THE CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        622.0503540039062,
        329.35772705078125,
        632.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGG ELISA TEST SYSTEM. AN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        640.0503540039062,
        343.0365295410156,
        650.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYME LINKED",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        658.0503540039062,
        273.0756530761719,
        668.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOSORBENT ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        676.0503540039062,
        318.07745361328125,
        686.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(ELISA) FOR THE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        694.0503540039062,
        275.0732727050781,
        704.0103149414062
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ZEUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        640.0503540039062,
        376.63677978515625,
        650.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        658.0503540039062,
        431.2987365722656,
        668.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 11",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.8800048828125,
        640.0503540039062,
        478.8769836425781,
        650.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        658.0503540039062,
        471.4073791503906,
        668.0103149414062
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 70 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 75,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K983803",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        202.41033935546875,
        167.9273223876953,
        212.37034606933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "THE APTUS (AUTOMATED)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        157.41033935546875,
        330.6750183105469,
        167.37034606933594
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "APPLICATION OF THE CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        175.41033935546875,
        329.35772705078125,
        185.37034606933594
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IGM ELISA TEST SYSTEM. AN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        193.41033935546875,
        345.1960754394531,
        203.37034606933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYME LINKED",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        211.41033935546875,
        273.0756530761719,
        221.37034606933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOSORBENT ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        229.41033935546875,
        318.07745361328125,
        239.37034606933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(ELISA) FOR THE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        247.41033935546875,
        275.0732727050781,
        257.3703308105469
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ZEUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        193.41033935546875,
        376.63677978515625,
        203.37034606933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        211.41033935546875,
        431.2987365722656,
        221.37034606933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 14",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        193.41033935546875,
        480.0769958496094,
        203.37034606933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        211.41033935546875,
        471.4073791503906,
        221.37034606933594
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K983762",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        272.0103454589844,
        298.4870300292969,
        281.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NUCLISENS CMV PP67",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        272.0103454589844,
        298.4870300292969,
        281.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORGANON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        263.0103454589844,
        400.3963623046875,
        272.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEKNIKA CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        281.0103454589844,
        429.258544921875,
        290.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 15",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        263.0103454589844,
        479.8370056152344,
        272.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        281.0103454589844,
        471.4073791503906,
        290.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K982485",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        305.7303466796875,
        297.9631042480469,
        315.6903381347656
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SERAQUEST CMV IGM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        305.7303466796875,
        297.9631042480469,
        315.6903381347656
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QUEST INTL.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        296.7303466796875,
        417.91650390625,
        306.6903381347656
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        314.7303466796875,
        367.458740234375,
        324.6903381347656
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 13",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.8800048828125,
        296.7303466796875,
        478.8769836425781,
        306.6903381347656
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1999",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        314.7303466796875,
        471.4073791503906,
        324.6903381347656
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K982311",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        339.3303527832031,
        167.9273223876953,
        349.29034423828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BARTELS CINAKIT CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        330.3303527832031,
        310.9967346191406,
        340.29034423828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIGENEMIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        348.3303527832031,
        257.6690673828125,
        358.29034423828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INTRACEL CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        339.3303527832031,
        433.81854248046875,
        349.29034423828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 14",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        330.3303527832031,
        480.0769958496094,
        340.29034423828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        348.3303527832031,
        471.4073791503906,
        358.29034423828125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K982027",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        380.6103515625,
        167.9273223876953,
        390.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODIFICATION TO COPALIS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        362.6103515625,
        331.75634765625,
        372.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV TOTAL ANTIBODY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        380.6103515625,
        308.9554138183594,
        390.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        398.6103515625,
        217.11314392089844,
        408.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIASORIN INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        380.6103515625,
        422.1782531738281,
        390.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 25",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        371.6103515625,
        480.5575256347656,
        381.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        389.6103515625,
        471.4073791503906,
        399.5703430175781
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K981163",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        420.4503479003906,
        167.9273223876953,
        430.41033935546875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAMEDIX IS-CMV IGG TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        411.4503479003906,
        340.156494140625,
        421.41033935546875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        429.4503479003906,
        225.48451232910156,
        439.41033935546875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAMEDIX CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        420.4503479003906,
        432.8585510253906,
        430.41033935546875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 21",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        411.4503479003906,
        479.8370056152344,
        421.41033935546875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        429.4503479003906,
        471.4073791503906,
        439.41033935546875
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K974901",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        451.17034912109375,
        167.9273223876953,
        461.1303405761719
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HYBRID CAPTURE SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        442.17034912109375,
        325.9971923828125,
        452.1303405761719
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV DNA ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        460.17034912109375,
        272.19268798828125,
        470.1303405761719
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIGENE CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        451.17034912109375,
        420.0185546875,
        461.1303405761719
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 29",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        442.17034912109375,
        479.8370056152344,
        452.1303405761719
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        460.17034912109375,
        471.4073791503906,
        470.1303405761719
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K974456",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        500.0103454589844,
        227.0709991455078,
        509.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMVGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        500.0103454589844,
        227.0709991455078,
        509.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INSTRUMENTAT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        473.0103454589844,
        431.7902526855469,
        482.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        491.0103454589844,
        368.35601806640625,
        500.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        509.0103454589844,
        419.5962829589844,
        518.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CO.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        527.0103759765625,
        363.2585754394531,
        536.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 01",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        491.0103454589844,
        481.39752197265625,
        500.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1998",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        509.0103454589844,
        471.4073791503906,
        518.9703369140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K972884",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        548.850341796875,
        167.9273223876953,
        558.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ACCURUN 146 CMV IGM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        539.850341796875,
        311.8372802734375,
        549.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "POSITIVE CONTROL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        557.850341796875,
        285.1039123535156,
        567.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BOSTON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        539.850341796875,
        392.1156311035156,
        549.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMEDICA INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        557.850341796875,
        430.9382629394531,
        567.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 22",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        539.850341796875,
        480.5575256347656,
        549.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        557.850341796875,
        471.4073791503906,
        567.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K971335",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        588.6903686523438,
        343.1109619140625,
        598.6503295898438
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QUANTA LITE CMV IGG ELISA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        588.6903686523438,
        343.1109619140625,
        598.6503295898438
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INOVA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        570.6903686523438,
        382.876708984375,
        580.6503295898438
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        588.6903686523438,
        420.4358825683594,
        598.6503295898438
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        606.6903686523438,
        367.458740234375,
        616.6503295898438
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 01",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        579.6903686523438,
        480.0769958496094,
        589.6503295898438
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        597.6903686523438,
        471.4073791503906,
        607.6503295898438
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K964875",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        629.850341796875,
        167.9273223876953,
        639.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV ANTIGEN CONTROL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        620.850341796875,
        315.5561218261719,
        630.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SLIDES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        638.850341796875,
        219.22451782226562,
        648.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VIRAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        620.850341796875,
        381.19647216796875,
        630.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIGENS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        638.850341796875,
        426.3782653808594,
        648.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 18",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        620.850341796875,
        480.5575256347656,
        630.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        638.850341796875,
        471.4073791503906,
        648.810302734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K963084",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        672.5703735351562,
        167.9273223876953,
        682.5303344726562
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OPUS CMV TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        663.5703735351562,
        274.2764892578125,
        673.5303344726562
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEM-MODIFICATION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        681.5703735351562,
        310.9491271972656,
        691.5303344726562
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        654.5703735351562,
        395.8367004394531,
        664.5303344726562
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        672.5703735351562,
        420.4358825683594,
        682.5303344726562
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        690.5703735351562,
        367.458740234375,
        700.5303344726562
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 09",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.3999938964844,
        663.5703735351562,
        479.23699951171875,
        673.5303344726562
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        681.5703735351562,
        471.4073791503906,
        691.5303344726562
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IX. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        452.3999938964844,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 71 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 76,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K960434",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        185.850341796875,
        167.9273223876953,
        195.8103485107422
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCSTAR CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        167.850341796875,
        340.1553039550781,
        177.8103485107422
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IGM CAPTURE ELISA ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        185.850341796875,
        334.7574462890625,
        195.8103485107422
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODEL 8530",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        203.850341796875,
        247.48741149902344,
        213.8103485107422
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCSTAR CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        185.850341796875,
        427.09954833984375,
        195.8103485107422
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 17",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.3999938964844,
        176.850341796875,
        479.23699951171875,
        186.8103485107422
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        194.850341796875,
        471.4073791503906,
        204.8103485107422
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K955799",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        240.33033752441406,
        167.9273223876953,
        250.29034423828125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "COPALIS CMV TOTAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        231.33033752441406,
        298.8766784667969,
        241.29034423828125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIBODY ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        249.33035278320312,
        275.9141540527344,
        259.29034423828125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SIENNA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        231.33033752441406,
        389.2362060546875,
        241.29034423828125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOTECH INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        249.33035278320312,
        418.458251953125,
        259.29034423828125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 10",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        231.33033752441406,
        477.7969970703125,
        241.29034423828125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        249.33035278320312,
        471.4073791503906,
        259.29034423828125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K955361",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        284.3703308105469,
        167.9273223876953,
        294.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCSTAR CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        275.3703308105469,
        340.1553039550781,
        285.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGG ELISA ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        293.3703308105469,
        275.43414306640625,
        303.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCSTAR CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        284.3703308105469,
        427.09954833984375,
        294.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 22",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        275.3703308105469,
        477.7969970703125,
        285.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        293.3703308105469,
        471.4073791503906,
        303.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K955360",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        335.9703369140625,
        167.9273223876953,
        345.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCSTAR CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        326.9703369140625,
        340.1553039550781,
        336.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGG FAST ELISA ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        344.9703369140625,
        307.95416259765625,
        354.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCSTAR CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        335.9703369140625,
        427.09954833984375,
        345.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 22",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        326.9703369140625,
        477.7969970703125,
        336.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        344.9703369140625,
        471.4073791503906,
        354.9303283691406
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K954301",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        387.6903381347656,
        167.9273223876953,
        397.65032958984375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT CMV TOTAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        369.6903381347656,
        298.0356750488281,
        379.65032958984375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIBODY EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        387.6903381347656,
        263.11651611328125,
        397.65032958984375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(MODIFICATION)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        405.6903381347656,
        270.058349609375,
        415.65032958984375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        378.6903381347656,
        392.957275390625,
        388.65032958984375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        396.6903381347656,
        426.3441162109375,
        406.65032958984375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 24",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        378.6903381347656,
        480.5575256347656,
        388.65032958984375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        396.6903381347656,
        471.4073791503906,
        406.65032958984375
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K954191",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        430.29034423828125,
        295.891357421875,
        440.2503356933594
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SERAQUEST CMV IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        430.29034423828125,
        295.891357421875,
        440.2503356933594
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QUEST INTL.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        421.29034423828125,
        417.91650390625,
        431.2503356933594
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        439.29034423828125,
        367.458740234375,
        449.2503356933594
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 23",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        421.29034423828125,
        479.8370056152344,
        431.2503356933594
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        439.29034423828125,
        471.4073791503906,
        449.2503356933594
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K953943",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        463.8903503417969,
        167.9273223876953,
        473.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AXSYM CMV IGG ANTIBODY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        454.8903503417969,
        332.23541259765625,
        464.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        472.8903503417969,
        217.11314392089844,
        482.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        454.8903503417969,
        392.957275390625,
        464.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        472.8903503417969,
        426.3441162109375,
        482.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 20",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        454.8903503417969,
        479.8370056152344,
        464.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        472.8903503417969,
        471.4073791503906,
        482.850341796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K952254",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        506.6103210449219,
        167.9273223876953,
        516.5703125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYME LINKED",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        488.6103515625,
        273.0756530761719,
        498.5703430175781
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOABSORBENT ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        506.6103210449219,
        332.2364501953125,
        516.5703125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        524.6103515625,
        285.9445495605469,
        534.5703125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PYRAMID",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        488.6103515625,
        397.0368957519531,
        498.5703430175781
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOLOGICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        506.6103210449219,
        412.0356140136719,
        516.5703125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        524.6103515625,
        376.2185363769531,
        534.5703125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        497.6103515625,
        480.5575256347656,
        507.5703430175781
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1995",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        515.6103515625,
        471.4073791503906,
        525.5703125
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K951851",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        585.2103881835938,
        167.9273223876953,
        595.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ALLIANCE CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        549.2103881835938,
        346.39532470703125,
        559.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMEDIATE EARLY ANTIGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        567.2103881835938,
        338.9559326171875,
        577.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIRECT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        585.2103881835938,
        224.7165069580078,
        595.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOFLUORESCENCE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        603.2103881835938,
        311.357666015625,
        613.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        621.2103881835938,
        217.11314392089844,
        631.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "E.I. DUPONT DE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        567.2103881835938,
        432.91680908203125,
        577.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NEMOURS & CO.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        585.2103881835938,
        435.7967834472656,
        595.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        603.2103881835938,
        367.458740234375,
        613.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 24",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        576.2103881835938,
        477.7969970703125,
        586.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        594.2103881835938,
        471.4073791503906,
        604.1703491210938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K951821",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        665.370361328125,
        167.9273223876953,
        675.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS DIRECT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        647.370361328125,
        332.7165832519531,
        657.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOFLUORESCENCE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        665.370361328125,
        311.357666015625,
        675.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        683.370361328125,
        217.11314392089844,
        693.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LIGHT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        656.370361328125,
        382.0361022949219,
        666.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        674.370361328125,
        417.10418701171875,
        684.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 07",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        656.370361328125,
        479.1175231933594,
        666.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        674.370361328125,
        471.4073791503906,
        684.330322265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 72 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 77,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K951800",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        180.21034240722656,
        167.9273223876953,
        190.17034912109375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGG HUMAN SERUM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        171.21034240722656,
        317.5972595214844,
        181.17034912109375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONTROLS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        189.21034240722656,
        237.94432067871094,
        199.17034912109375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PYRAMID",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        162.21034240722656,
        397.0368957519531,
        172.17034912109375
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "BIOLOGICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        180.21034240722656,
        412.0356140136719,
        190.17034912109375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        198.21034240722656,
        376.2185363769531,
        208.17034912109375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        171.21034240722656,
        480.5575256347656,
        181.17034912109375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1995",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        189.21034240722656,
        471.4073791503906,
        199.17034912109375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K951550",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        236.61033630371094,
        167.9273223876953,
        246.57034301757812
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV BRITE ANTIGENEMIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        227.61033630371094,
        325.2756042480469,
        237.57034301757812
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        245.61033630371094,
        234.6296844482422,
        255.57034301757812
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOTEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        218.61033630371094,
        395.4771423339844,
        228.57034301757812
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        236.61033630371094,
        420.4358825683594,
        246.57034301757812
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        254.6103515625,
        376.2185363769531,
        264.5703430175781
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 30",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.8800048828125,
        227.61033630371094,
        478.8769836425781,
        237.57034301757812
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        245.61033630371094,
        471.4073791503906,
        255.57034301757812
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K950672",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        288.2103271484375,
        287.4913635253906,
        298.1703186035156
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMULITE CMV IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        288.2103271484375,
        287.4913635253906,
        298.1703186035156
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        270.2103271484375,
        414.1959533691406,
        280.1703186035156
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        288.2103271484375,
        404.9570617675781,
        298.1703186035156
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        306.2103271484375,
        376.2185363769531,
        316.1703186035156
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 17",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        279.2103271484375,
        479.1175231933594,
        289.1703186035156
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1996",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        297.2103271484375,
        471.4073791503906,
        307.1703186035156
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K944438",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        339.9303283691406,
        309.74969482421875,
        349.89031982421875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEMAGEN CMV IGG KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        339.9303283691406,
        309.74969482421875,
        349.89031982421875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEMAGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        321.9303283691406,
        402.07666015625,
        331.89031982421875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        339.9303283691406,
        420.4358825683594,
        349.89031982421875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        357.9303283691406,
        367.458740234375,
        367.89031982421875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 20",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        330.9303283691406,
        479.8370056152344,
        340.89031982421875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1997",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        348.9303283691406,
        471.4073791503906,
        358.89031982421875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K942171",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        382.53033447265625,
        402.512939453125,
        392.4903259277344
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV EARLY ANTIGEN TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        382.53033447265625,
        402.512939453125,
        392.4903259277344
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NEOGENEX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        382.53033447265625,
        402.512939453125,
        392.4903259277344
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 30",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        373.53033447265625,
        479.1175231933594,
        383.4903259277344
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1994",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        391.53033447265625,
        471.4073791503906,
        401.4903259277344
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K935809",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        434.2503356933594,
        167.9273223876953,
        444.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS INDIRECT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        416.2503356933594,
        343.9972839355469,
        426.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNOFLUORESCENCE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        434.2503356933594,
        311.357666015625,
        444.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        452.2503356933594,
        217.11314392089844,
        462.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LIGHT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        425.2503356933594,
        382.0361022949219,
        435.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        443.2503356933594,
        417.10418701171875,
        453.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 05",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        425.2503356933594,
        481.39752197265625,
        435.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1994",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        443.2503356933594,
        471.4073791503906,
        453.2103271484375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K934798",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        494.850341796875,
        340.5435791015625,
        504.8103332519531
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PATHODX CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        494.850341796875,
        340.5435791015625,
        504.8103332519531
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        476.850341796875,
        414.1959533691406,
        486.8103332519531
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        494.850341796875,
        404.9570617675781,
        504.8103332519531
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        512.850341796875,
        376.2185363769531,
        522.810302734375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 25",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        485.850341796875,
        480.5575256347656,
        495.8103332519531
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1994",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        503.8503112792969,
        471.4073791503906,
        513.810302734375
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K933549",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        537.4503784179688,
        306.752685546875,
        547.4103393554688
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VIDAS CMV IGM ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        537.4503784179688,
        306.752685546875,
        547.4103393554688
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOMERIEUX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        528.4503784179688,
        414.6770935058594,
        538.4103393554688
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VITEK INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        546.4503784179688,
        405.01873779296875,
        556.4103393554688
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 02",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        528.4503784179688,
        480.5575256347656,
        538.4103393554688
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1994",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        546.4503784179688,
        471.4073791503906,
        556.4103393554688
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K933389",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        571.1703491210938,
        253.2914276123047,
        581.1303100585938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OPUS CMV-G",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        571.1703491210938,
        253.2914276123047,
        581.1303100585938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PB DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        562.1703491210938,
        432.074951171875,
        572.1303100585938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEMS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        580.1703491210938,
        421.2187194824219,
        590.1303100585938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 28",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        562.1703491210938,
        479.1175231933594,
        572.1303100585938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1994",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        580.1703491210938,
        471.4073791503906,
        590.1303100585938
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K924096",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        613.7703857421875,
        321.72454833984375,
        623.7303466796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV ELISA TEST SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        613.7703857421875,
        321.72454833984375,
        623.7303466796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ZEUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        604.7703857421875,
        376.63677978515625,
        614.7303466796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        622.7703857421875,
        431.2987365722656,
        632.7303466796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 02",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        604.7703857421875,
        479.95751953125,
        614.7303466796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1993",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        622.7703857421875,
        471.4073791503906,
        632.7303466796875
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K922582",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        665.4903564453125,
        167.9273223876953,
        675.4503173828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BARTELS CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        656.4903564453125,
        341.8363037109375,
        666.4503173828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGG EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        674.4903564453125,
        223.83004760742188,
        684.4503173828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAXTER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        647.4903564453125,
        391.7571105957031,
        657.4503173828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        665.4903564453125,
        420.4358825683594,
        675.4503173828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        683.4903564453125,
        367.458740234375,
        693.4503173828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 08",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        656.4903564453125,
        479.95751953125,
        666.4503173828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1993",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        674.4903564453125,
        471.4073791503906,
        684.4503173828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IX. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        452.3999938964844,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 73 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 78,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K922580",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        177.9303436279297,
        167.9273223876953,
        187.89035034179688
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BARTELS CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        168.9303436279297,
        341.8363037109375,
        178.89035034179688
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGM EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        186.9303436279297,
        225.87005615234375,
        196.89035034179688
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAXTER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        159.9303436279297,
        391.7571105957031,
        169.89035034179688
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        177.9303436279297,
        420.4358825683594,
        187.89035034179688
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        195.9303436279297,
        367.458740234375,
        205.89035034179688
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 08",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        168.9303436279297,
        479.95751953125,
        178.89035034179688
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1993",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        186.9303436279297,
        471.4073791503906,
        196.89035034179688
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K921616",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        223.17034912109375,
        167.9273223876953,
        233.13035583496094
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV-VUE(TM) CMV ANTIGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        214.17034912109375,
        346.03546142578125,
        224.13035583496094
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DETECTION KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        232.17034912109375,
        267.26971435546875,
        242.13035583496094
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INCSTAR CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        223.17034912109375,
        427.09954833984375,
        233.13035583496094
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 11",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        214.17034912109375,
        480.5575256347656,
        224.13035583496094
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1992",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        232.17034912109375,
        471.4073791503906,
        242.13035583496094
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K921011",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        265.8903503417969,
        333.8699645996094,
        275.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PHARMACIA CMV IGM ELISA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        265.8903503417969,
        333.8699645996094,
        275.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PHARMACIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        247.89035034179688,
        412.5167236328125,
        257.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        265.8903503417969,
        420.4358825683594,
        275.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        283.8903503417969,
        367.458740234375,
        293.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        256.8903503417969,
        477.7969970703125,
        266.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1992",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        274.8903503417969,
        471.4073791503906,
        284.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K920661",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        307.05035400390625,
        304.5941467285156,
        317.0103454589844
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VIDAS CMV IGG ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        307.05035400390625,
        304.5941467285156,
        317.0103454589844
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VITEK SYSTEMS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        298.05035400390625,
        436.27813720703125,
        308.0103454589844
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        316.05035400390625,
        367.458740234375,
        326.0103454589844
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 12",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        298.05035400390625,
        479.8370056152344,
        308.0103454589844
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1993",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        316.05035400390625,
        471.4073791503906,
        326.0103454589844
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K920222",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        346.8903503417969,
        167.9273223876953,
        356.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEALTHTEST ASSAY FOR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        328.8903503417969,
        321.4372863769531,
        338.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIBODY TO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        346.8903503417969,
        259.7569580078125,
        356.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        364.8903503417969,
        285.9445495605469,
        374.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AKERS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        328.8903503417969,
        384.5570068359375,
        338.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "RESEARCH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        346.8903503417969,
        404.5975646972656,
        356.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        364.8903503417969,
        376.2185363769531,
        374.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        337.8903503417969,
        477.7969970703125,
        347.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1992",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        355.8903503417969,
        471.4073791503906,
        365.850341796875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K915892",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        395.7303466796875,
        297.15008544921875,
        405.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGG ELISA TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        395.7303466796875,
        297.15008544921875,
        405.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GULL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        377.7303466796875,
        376.996337890625,
        387.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        395.7303466796875,
        429.6758117675781,
        405.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        413.7303466796875,
        367.458740234375,
        423.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 14",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        386.7303466796875,
        479.8370056152344,
        396.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1992",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        404.7303466796875,
        471.4073791503906,
        414.6903381347656
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K915479",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        444.5703430175781,
        273.39031982421875,
        454.53033447265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAPTIA CMV-TA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        444.5703430175781,
        273.39031982421875,
        454.53033447265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MERCIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        426.5703430175781,
        390.4374084472656,
        436.53033447265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        444.5703430175781,
        420.4358825683594,
        454.53033447265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LTD.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        462.5703430175781,
        370.338134765625,
        472.53033447265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 04",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        435.5703430175781,
        481.39752197265625,
        445.53033447265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1992",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        453.5703430175781,
        471.4073791503906,
        463.53033447265625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K914789",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        484.41033935546875,
        413.2987365722656,
        494.3703308105469
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELISA CMV IGM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        484.41033935546875,
        413.2987365722656,
        494.3703308105469
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCLAVO INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        484.41033935546875,
        413.2987365722656,
        494.3703308105469
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 04",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        475.41033935546875,
        480.5575256347656,
        485.3703308105469
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1992",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        493.41033935546875,
        471.4073791503906,
        503.3703308105469
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K913910",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        524.2503662109375,
        167.9273223876953,
        534.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYGNOST(R) ANTI-CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        515.2503662109375,
        328.03594970703125,
        525.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        533.2503662109375,
        200.8513946533203,
        543.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        506.2503356933594,
        395.8367004394531,
        516.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        524.2503662109375,
        420.4358825683594,
        534.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        542.2503662109375,
        367.458740234375,
        552.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 28",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        515.2503662109375,
        479.95751953125,
        525.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1992",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        533.2503662109375,
        471.4073791503906,
        543.2103271484375
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K913693",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        572.9703369140625,
        167.9273223876953,
        582.9302978515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYGNOST(R)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        563.9703369140625,
        265.5176696777344,
        573.9302978515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTI-CMV/IGM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        581.9703369140625,
        263.76177978515625,
        591.9302978515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        554.9703369140625,
        395.8367004394531,
        564.9302978515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        572.9703369140625,
        420.4358825683594,
        582.9302978515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        590.9703369140625,
        367.458740234375,
        600.9302978515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        563.9703369140625,
        479.8370056152344,
        573.9302978515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1992",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        581.9703369140625,
        471.4073791503906,
        591.9302978515625
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K913080",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        621.8103637695312,
        303.36322021484375,
        631.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OPUS(R) ANTI CMV-M",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        621.8103637695312,
        303.36322021484375,
        631.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PB",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        603.8103637695312,
        362.8371887207031,
        613.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        621.8103637695312,
        420.4358825683594,
        631.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        639.8103637695312,
        367.458740234375,
        649.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 28",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.3999938964844,
        612.8103637695312,
        479.23699951171875,
        622.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1991",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        630.8103637695312,
        471.4073791503906,
        640.7703247070312
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K912592",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        672.0903930664062,
        289.7106018066406,
        682.0503540039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV-EA MAB TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        672.0903930664062,
        289.7106018066406,
        682.0503540039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GULL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        654.0903930664062,
        376.996337890625,
        664.0503540039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        672.0903930664062,
        429.6758117675781,
        682.0503540039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        690.0903930664062,
        367.458740234375,
        700.0503540039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 04",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        663.0903930664062,
        480.0769958496094,
        673.0503540039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1991",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        681.0903930664062,
        471.4073791503906,
        691.0503540039062
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 74 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 79,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K910003",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        164.9703369140625,
        167.9273223876953,
        174.9303436279297
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        155.9703369140625,
        289.2762756347656,
        165.9303436279297
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIBODY SCREEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        173.9703369140625,
        282.2705078125,
        183.9303436279297
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUCOR INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        164.9703369140625,
        422.53826904296875,
        174.9303436279297
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 20",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        155.9703369140625,
        480.5575256347656,
        165.9303436279297
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1991",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        173.9703369140625,
        471.4073791503906,
        183.9303436279297
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K905257",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        195.8103485107422,
        318.36456298828125,
        205.77035522460938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OPUS CMV TEST SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        195.8103485107422,
        318.36456298828125,
        205.77035522460938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PB DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        186.8103485107422,
        432.074951171875,
        196.77035522460938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEMS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        204.8103485107422,
        421.2187194824219,
        214.77035522460938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 17",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        186.8103485107422,
        479.95751953125,
        196.77035522460938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1991",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        204.8103485107422,
        471.4073791503906,
        214.77035522460938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K905078",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        235.6503448486328,
        167.9273223876953,
        245.6103515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO CMV-G ANTIBODY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        226.6503448486328,
        324.3154296875,
        236.6103515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELISA TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        244.6503448486328,
        246.27005004882812,
        254.6103515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        217.6503448486328,
        385.87567138671875,
        227.6103515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        235.6503448486328,
        414.1959533691406,
        245.6103515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEMS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        253.65032958984375,
        421.2187194824219,
        263.6103210449219
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 17",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        226.6503448486328,
        480.0769958496094,
        236.6103515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        244.6503448486328,
        471.4073791503906,
        254.6103515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K905077",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        284.4903564453125,
        167.9273223876953,
        294.4503479003906
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO CMV-M ANTIBODY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        275.4903564453125,
        326.35687255859375,
        285.4503479003906
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELISA TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        293.4903259277344,
        246.27005004882812,
        303.4503173828125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        266.4903564453125,
        385.87567138671875,
        276.4503479003906
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        284.4903564453125,
        414.1959533691406,
        294.4503479003906
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEMS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        302.4903259277344,
        421.2187194824219,
        312.4503173828125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 17",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        275.4903564453125,
        480.0769958496094,
        285.4503479003906
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        293.4903259277344,
        471.4073791503906,
        303.4503173828125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K904456",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        324.2103271484375,
        167.9273223876953,
        334.1703186035156
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS (CMV)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        315.2103271484375,
        327.1967468261719,
        325.1703186035156
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELISA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        333.2103271484375,
        213.39093017578125,
        343.1703186035156
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VIROTECH INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        324.2103271484375,
        425.53826904296875,
        334.1703186035156
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 03",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        315.2103271484375,
        479.95751953125,
        325.1703186035156
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1991",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        333.2103271484375,
        471.4073791503906,
        343.1703186035156
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K904036",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        364.05035400390625,
        167.9273223876953,
        374.0103454589844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BARTELS CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        355.05035400390625,
        341.8363037109375,
        365.0103454589844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMED. EARLY ANTIGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        373.05035400390625,
        313.10906982421875,
        383.0103454589844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAXTER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        346.05035400390625,
        391.7571105957031,
        356.0103454589844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEALTHCARE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        364.05035400390625,
        420.5574645996094,
        374.0103454589844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        382.05035400390625,
        376.2185363769531,
        392.0103454589844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.3999938964844,
        355.05035400390625,
        479.23699951171875,
        365.0103454589844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        373.05035400390625,
        471.4073791503906,
        383.0103454589844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K903807",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        412.8903503417969,
        299.1900939941406,
        422.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGM ELISA TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        412.8903503417969,
        299.1900939941406,
        422.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GULL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        394.8903503417969,
        376.996337890625,
        404.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        412.8903503417969,
        429.6758117675781,
        422.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        430.8903503417969,
        367.458740234375,
        440.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 17",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        403.8903503417969,
        480.0769958496094,
        413.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        421.8903503417969,
        471.4073791503906,
        431.850341796875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K901485",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        461.7303466796875,
        167.9273223876953,
        471.6903381347656
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYGNOST ANTI-CMV/IGG +",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        452.7303466796875,
        345.91650390625,
        462.6903381347656
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        470.7303466796875,
        202.92315673828125,
        480.6903381347656
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        443.7303466796875,
        395.8367004394531,
        453.6903381347656
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        461.7303466796875,
        420.4358825683594,
        471.6903381347656
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        479.7303466796875,
        367.458740234375,
        489.6903381347656
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 20",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        452.7303466796875,
        481.39752197265625,
        462.6903381347656
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1991",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        470.7303466796875,
        471.4073791503906,
        480.6903381347656
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K900796",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        510.5703430175781,
        297.15008544921875,
        520.5303344726562
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGG ELISA TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        510.5703430175781,
        297.15008544921875,
        520.5303344726562
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GULL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        492.5703430175781,
        376.996337890625,
        502.53033447265625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        510.5703430175781,
        429.6758117675781,
        520.5303344726562
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        528.5703735351562,
        367.458740234375,
        538.5303344726562
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 02",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        501.5703430175781,
        481.39752197265625,
        511.53033447265625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        519.5703735351562,
        471.4073791503906,
        529.5303344726562
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K900743",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        559.4103393554688,
        337.2045593261719,
        569.3703002929688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV-IGM IFA TEST SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        559.4103393554688,
        337.2045593261719,
        569.3703002929688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ZEUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        550.4103393554688,
        376.63677978515625,
        560.3703002929688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        568.4103393554688,
        431.2987365722656,
        578.3703002929688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 26",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        550.4103393554688,
        479.95751953125,
        560.3703002929688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        568.4103393554688,
        471.4073791503906,
        578.3703002929688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K900474",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        599.13037109375,
        167.9273223876953,
        609.09033203125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMX CMV IGG ANTIBODY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        590.13037109375,
        315.555419921875,
        600.09033203125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        608.13037109375,
        217.11314392089844,
        618.09033203125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        590.13037109375,
        392.957275390625,
        600.09033203125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        608.13037109375,
        426.3441162109375,
        618.09033203125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        590.13037109375,
        477.7969970703125,
        600.09033203125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        608.13037109375,
        471.4073791503906,
        618.09033203125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K900473",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        629.9703369140625,
        167.9273223876953,
        639.9302978515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMX CMV IGM ANTIBODY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        620.9703369140625,
        317.5968933105469,
        630.9302978515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        638.9703369140625,
        217.11314392089844,
        648.9302978515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        620.9703369140625,
        392.957275390625,
        630.9302978515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        638.9703369140625,
        426.3441162109375,
        648.9302978515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        620.9703369140625,
        477.7969970703125,
        630.9302978515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        638.9703369140625,
        471.4073791503906,
        648.9302978515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K896355",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        669.8103637695312,
        167.9273223876953,
        679.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGM ELISA TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        660.8103637695312,
        302.59649658203125,
        670.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        678.8103637695312,
        225.48451232910156,
        688.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ZEUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        660.8103637695312,
        376.63677978515625,
        670.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        678.8103637695312,
        431.2987365722656,
        688.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        660.8103637695312,
        479.8370056152344,
        670.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        678.8103637695312,
        471.4073791503906,
        688.7703247070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IX. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        452.3999938964844,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 80,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 75 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 80,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K896295",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        173.9703369140625,
        284.1632080078125,
        183.9303436279297
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAPTIA(R) CMV-M",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        173.9703369140625,
        284.1632080078125,
        183.9303436279297
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MERCIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        155.9703369140625,
        390.4374084472656,
        165.9303436279297
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        173.9703369140625,
        420.4358825683594,
        183.9303436279297
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LTD.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        191.9703369140625,
        370.338134765625,
        201.9303436279297
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 06",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        164.9703369140625,
        480.5575256347656,
        174.9303436279297
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        182.9703369140625,
        471.4073791503906,
        192.9303436279297
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K896194",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        222.8103485107422,
        282.0914611816406,
        232.77035522460938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CAPTIA(R) CMV-G",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        222.8103485107422,
        282.0914611816406,
        232.77035522460938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MERCIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        204.8103485107422,
        390.4374084472656,
        214.77035522460938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        222.8103485107422,
        420.4358825683594,
        232.77035522460938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LTD.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        240.8103485107422,
        370.338134765625,
        250.77035522460938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 06",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        213.8103485107422,
        480.5575256347656,
        223.77035522460938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1990",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        231.8103485107422,
        471.4073791503906,
        241.77035522460938
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K894002",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        271.65032958984375,
        167.9273223876953,
        281.6103210449219
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        253.65032958984375,
        289.2762756347656,
        263.6103210449219
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FLUORESCENT MONOCLONAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        271.65032958984375,
        338.47613525390625,
        281.6103210449219
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIBODY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        289.65032958984375,
        236.79310607910156,
        299.6103210449219
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAXTER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        253.65032958984375,
        391.7571105957031,
        263.6103210449219
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HEALTHCARE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        271.65032958984375,
        420.5574645996094,
        281.6103210449219
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        289.65032958984375,
        376.2185363769531,
        299.6103210449219
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 10",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        262.65032958984375,
        480.5575256347656,
        272.6103210449219
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        280.65032958984375,
        471.4073791503906,
        290.6103210449219
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K893468",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        320.4903259277344,
        167.9273223876953,
        330.4503173828125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGG ANTIBODY TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        302.4903259277344,
        323.9565124511719,
        312.4503173828125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(INDIRECT FLUORESCENT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        320.4903259277344,
        321.0761413574219,
        330.4503173828125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        338.4903259277344,
        215.82015991210938,
        348.4503173828125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        311.4903259277344,
        394.15643310546875,
        321.4503173828125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONCEPTS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        329.4903259277344,
        427.0987243652344,
        339.4503173828125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 14",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        311.4903259277344,
        477.7969970703125,
        321.4503173828125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        329.4903259277344,
        471.4073791503906,
        339.4503173828125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K893467",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        360.2103271484375,
        167.9273223876953,
        370.1703186035156
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGG ANTIBODY TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        351.2103271484375,
        323.9565124511719,
        361.1703186035156
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(INDIRECT ENZYME TEST)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        369.2103271484375,
        323.460205078125,
        379.1703186035156
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        351.2103271484375,
        394.15643310546875,
        361.1703186035156
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONCEPTS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        369.2103271484375,
        427.0987243652344,
        379.1703186035156
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 14",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        351.2103271484375,
        477.7969970703125,
        361.1703186035156
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        369.2103271484375,
        471.4073791503906,
        379.1703186035156
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K893466",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        391.05035400390625,
        167.9273223876953,
        401.0103454589844
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGM ANTIBODY TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        382.05035400390625,
        325.9964904785156,
        392.0103454589844
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(INDIRECT ENZYME TEST)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        400.05035400390625,
        323.460205078125,
        410.0103454589844
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        382.05035400390625,
        394.15643310546875,
        392.0103454589844
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONCEPTS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        400.05035400390625,
        427.0987243652344,
        410.0103454589844
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 14",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        382.05035400390625,
        477.7969970703125,
        392.0103454589844
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        400.05035400390625,
        471.4073791503906,
        410.0103454589844
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K893465",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        430.8903503417969,
        167.9273223876953,
        440.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGM ANTIBODY TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        412.8903503417969,
        325.9964904785156,
        422.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(INDIRECT FLUORESCENT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        430.8903503417969,
        321.0761413574219,
        440.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        448.8903503417969,
        215.82015991210938,
        458.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        421.8903503417969,
        394.15643310546875,
        431.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONCEPTS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        439.8903503417969,
        427.0987243652344,
        449.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 25",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        421.8903503417969,
        477.7969970703125,
        431.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        439.8903503417969,
        471.4073791503906,
        449.850341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K893230",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        479.7303466796875,
        167.9273223876953,
        489.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DETECTADOT TM SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        470.7303466796875,
        326.83819580078125,
        480.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2000 CMV IGM TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        488.7303466796875,
        292.1100769042969,
        498.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GULL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        461.7303466796875,
        376.996337890625,
        471.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        479.7303466796875,
        429.6758117675781,
        489.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        497.7303466796875,
        367.458740234375,
        507.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 18",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        470.7303466796875,
        480.0769958496094,
        480.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        488.7303466796875,
        471.4073791503906,
        498.6903381347656
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K891393",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        528.5703735351562,
        167.9273223876953,
        538.5303344726562
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORGENICS IMMUNOCOMB(TM)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        510.5703430175781,
        343.5169677734375,
        520.5303344726562
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGG ANTIBODY TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        528.5703735351562,
        323.9565124511719,
        538.5303344726562
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        546.5703735351562,
        201.74969482421875,
        556.5303344726562
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORGENICS LTD.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        528.5703735351562,
        427.0986633300781,
        538.5303344726562
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 23",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        519.5703735351562,
        479.1175231933594,
        529.5303344726562
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        537.5703735351562,
        471.4073791503906,
        547.5303344726562
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K891081",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        577.4103393554688,
        321.72454833984375,
        587.3703002929688
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV ELISA TEST SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        577.4103393554688,
        321.72454833984375,
        587.3703002929688
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ZEUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        568.4103393554688,
        376.63677978515625,
        578.3703002929688
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        586.4103393554688,
        431.2987365722656,
        596.3703002929688
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 02",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        568.4103393554688,
        479.1175231933594,
        578.3703002929688
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        586.4103393554688,
        471.4073791503906,
        596.3703002929688
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K890610",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        626.13037109375,
        167.9273223876953,
        636.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VIRONOSTIKA(TM)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        608.13037109375,
        284.7165832519531,
        618.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTI-CMV IGM MICROELISA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        626.13037109375,
        337.6364440917969,
        636.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        644.13037109375,
        225.48451232910156,
        654.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORGANON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        617.13037109375,
        400.3963623046875,
        627.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEKNIKA CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        635.13037109375,
        429.258544921875,
        645.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 23",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        617.13037109375,
        479.1175231933594,
        627.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        635.13037109375,
        471.4073791503906,
        645.09033203125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K884842",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        674.9703369140625,
        268.381103515625,
        684.9302978515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV-CUBE(TM)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        674.9703369140625,
        268.381103515625,
        684.9302978515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIFCO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        656.9703369140625,
        380.8359069824219,
        666.9302978515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        674.9703369140625,
        429.6758117675781,
        684.9302978515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        692.9703369140625,
        367.458740234375,
        702.9302978515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 11",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        665.9703369140625,
        479.95751953125,
        675.9302978515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        683.9703369140625,
        471.4073791503906,
        693.9302978515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 76 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 81,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K884248",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        182.9703369140625,
        167.9273223876953,
        192.9303436279297
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MODIFIED DDI SEROCARD",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        173.9703369140625,
        319.63751220703125,
        183.9303436279297
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGG TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        191.9703369140625,
        285.50970458984375,
        201.9303436279297
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DISEASE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        155.9703369140625,
        394.1574401855469,
        165.9303436279297
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DETECTION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        173.9703369140625,
        410.4768981933594,
        183.9303436279297
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INTERNATIONAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        191.9703369140625,
        436.75537109375,
        201.9303436279297
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        209.9703369140625,
        367.458740234375,
        219.9303436279297
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 10",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        173.9703369140625,
        479.95751953125,
        183.9303436279297
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        191.9703369140625,
        471.4073791503906,
        201.9303436279297
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K883399",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        231.8103485107422,
        167.9273223876953,
        241.77035522460938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "UBI MAGIWEL CMV IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        222.8103485107422,
        310.1564636230469,
        232.77035522460938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QUANTITATIVE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        240.8103485107422,
        263.91119384765625,
        250.77035522460938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "UNITED",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        222.8103485107422,
        390.0768127441406,
        232.77035522460938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOTECH INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        240.8103485107422,
        418.458251953125,
        250.77035522460938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        222.8103485107422,
        480.5575256347656,
        232.77035522460938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        240.8103485107422,
        471.4073791503906,
        250.77035522460938
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K883102",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        262.65032958984375,
        325.8299560546875,
        272.6103210449219
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VIRGO (R) CMV-IGG ELISA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        262.65032958984375,
        325.8299560546875,
        272.6103210449219
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELECTRO-NUCL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        253.65032958984375,
        430.42474365234375,
        263.6103210449219
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "EONICS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        271.65032958984375,
        410.4187316894531,
        281.6103210449219
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 08",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        253.65032958984375,
        479.8370056152344,
        263.6103210449219
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        271.65032958984375,
        471.4073791503906,
        281.6103210449219
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K882835",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        293.4903259277344,
        167.9273223876953,
        303.4503173828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INDIRECT FLUORESCENT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        284.4903564453125,
        316.03814697265625,
        294.4503479003906
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ASSAY FOR (HCMV)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        302.4903259277344,
        287.5798645019531,
        312.4503173828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STELLAR BIO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        284.4903564453125,
        419.5964050292969,
        294.4503479003906
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEMS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        302.4903259277344,
        421.2187194824219,
        312.4503173828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 05",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        284.4903564453125,
        480.0769958496094,
        294.4503479003906
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1988",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        302.4903259277344,
        471.4073791503906,
        312.4503173828125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K882024",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        333.2103271484375,
        167.9273223876953,
        343.1703186035156
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FITC MURINE MONOCLONAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        324.2103271484375,
        333.9161376953125,
        334.1703186035156
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTI-CMV IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        342.2103271484375,
        263.3713684082031,
        352.1703186035156
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WHITTAKER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        315.2103271484375,
        414.3164978027344,
        325.1703186035156
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOPRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        333.2103271484375,
        422.4767150878906,
        343.1703186035156
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        351.2103271484375,
        367.458740234375,
        361.1703186035156
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 03",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        324.2103271484375,
        480.5575256347656,
        334.1703186035156
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1988",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        342.2103271484375,
        471.4073791503906,
        352.1703186035156
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K881932",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        382.05035400390625,
        167.9273223876953,
        392.0103454589844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO* CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        373.05035400390625,
        335.11529541015625,
        383.0103454589844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IDENTIFICATION REAGENT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        391.05035400390625,
        324.0294189453125,
        401.0103454589844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORTHO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        364.05035400390625,
        385.87567138671875,
        374.0103454589844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        382.05035400390625,
        414.1959533691406,
        392.0103454589844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEMS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        400.05035400390625,
        421.2187194824219,
        410.0103454589844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 01",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        373.05035400390625,
        480.5575256347656,
        383.0103454589844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1988",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        391.05035400390625,
        471.4073791503906,
        401.0103454589844
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K880679",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        421.8903503417969,
        430.09765625,
        431.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BION CMV-G TEST SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        421.8903503417969,
        430.09765625,
        431.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BION ENT. LTD.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        421.8903503417969,
        430.09765625,
        431.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 03",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        412.8903503417969,
        479.1175231933594,
        422.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1988",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        430.8903503417969,
        471.4073791503906,
        440.850341796875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K880433",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        461.7303466796875,
        167.9273223876953,
        471.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS IGG EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        452.7303466796875,
        335.1169738769531,
        462.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        470.7303466796875,
        201.74969482421875,
        480.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DE FERRIS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        443.7303466796875,
        404.957275390625,
        453.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        461.7303466796875,
        429.6758117675781,
        471.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        479.7303466796875,
        367.458740234375,
        489.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Mar 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        452.7303466796875,
        480.5575256347656,
        462.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        470.7303466796875,
        471.4073791503906,
        480.6903381347656
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K880290",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        501.5703430175781,
        167.9273223876953,
        511.53033447265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MICROTRAK CMV CULTURE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        492.5703430175781,
        330.6766662597656,
        502.53033447265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONFIRMATION TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        510.5703430175781,
        296.43060302734375,
        520.5303344726562
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYVA CO.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        501.5703430175781,
        395.778564453125,
        511.53033447265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 19",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        492.5703430175781,
        479.95751953125,
        502.53033447265625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1988",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        510.5703430175781,
        471.4073791503906,
        520.5303344726562
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K875361",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        550.4103393554688,
        167.9273223876953,
        560.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SERODOT CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        532.4103393554688,
        262.5166931152344,
        542.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(CYTOMEGALOVIRUS) IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        550.4103393554688,
        322.15594482421875,
        560.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        568.4103393554688,
        234.6296844482422,
        578.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DISEASE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        523.4103393554688,
        394.1574401855469,
        533.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DETECTION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        541.4103393554688,
        410.4768981933594,
        551.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INTERNATIONAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        559.4103393554688,
        436.75537109375,
        569.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        577.4103393554688,
        367.458740234375,
        587.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 13",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        541.4103393554688,
        481.39752197265625,
        551.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1988",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        559.4103393554688,
        471.4073791503906,
        569.3703002929688
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K875159",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        608.13037109375,
        167.9273223876953,
        618.09033203125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DETECTADOT SYSTEM 2000",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        599.13037109375,
        333.5577697753906,
        609.09033203125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGG TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        617.13037109375,
        261.7505798339844,
        627.09033203125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GULL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        590.13037109375,
        376.996337890625,
        600.09033203125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        608.13037109375,
        429.6758117675781,
        618.09033203125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        626.13037109375,
        367.458740234375,
        636.09033203125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 06",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        599.13037109375,
        481.39752197265625,
        609.09033203125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1988",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        617.13037109375,
        471.4073791503906,
        627.09033203125
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K873114",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        665.9703369140625,
        167.9273223876953,
        675.9302978515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS CONTROL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        656.9703369140625,
        343.0361328125,
        666.9302978515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SLIDES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        674.9703369140625,
        219.22451782226562,
        684.9302978515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MEDICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        638.9703369140625,
        397.0378723144531,
        648.9302978515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        656.9703369140625,
        414.1959533691406,
        666.9302978515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TECHNOLOGIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        674.9703369140625,
        430.0353698730469,
        684.9302978515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        692.9703369140625,
        367.458740234375,
        702.9302978515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 25",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        656.9703369140625,
        479.8370056152344,
        666.9302978515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1987",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        674.9703369140625,
        471.4073791503906,
        684.9302978515625
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IX. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        452.3999938964844,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 82,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 77 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 82,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K872942",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        173.9703369140625,
        167.9273223876953,
        183.9303436279297
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGM CMV CLIN-ELISA(TM)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        164.9703369140625,
        328.8787536621094,
        174.9303436279297
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST SYSTEM NUMBER: 5530",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        182.9703369140625,
        339.2873840332031,
        192.9303436279297
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CLINICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        164.9703369140625,
        398.3565979003906,
        174.9303436279297
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENCES INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        182.9703369140625,
        423.01824951171875,
        192.9303436279297
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 11",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.8800048828125,
        164.9703369140625,
        478.8769836425781,
        174.9303436279297
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1988",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        182.9703369140625,
        471.4073791503906,
        192.9303436279297
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K872881",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        213.8103485107422,
        318.0296936035156,
        223.77035522460938
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT CMV-M EIA KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        213.8103485107422,
        318.0296936035156,
        223.77035522460938
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        204.8103485107422,
        392.957275390625,
        214.77035522460938
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        222.8103485107422,
        426.3441162109375,
        232.77035522460938
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 13",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        204.8103485107422,
        481.39752197265625,
        214.77035522460938
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1988",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        222.8103485107422,
        471.4073791503906,
        232.77035522460938
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K872576",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        253.65032958984375,
        167.9273223876953,
        263.6103210449219
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "COLORGENE DNA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        235.6503448486328,
        275.1160888671875,
        245.6103515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HYBRIDIZATION TEST CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        253.65032958984375,
        328.99774169921875,
        263.6103210449219
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONFIRMATION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        271.65032958984375,
        263.428955078125,
        281.6103210449219
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZO BIOCHEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        244.6503448486328,
        430.0379638671875,
        254.6103515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        262.65032958984375,
        367.458740234375,
        272.6103210449219
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 04",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        244.6503448486328,
        480.0769958496094,
        254.6103515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1987",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        262.65032958984375,
        471.4073791503906,
        272.6103210449219
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K871832",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        293.4903259277344,
        432.8585510253906,
        303.4503173828125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGM MICROASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        293.4903259277344,
        432.8585510253906,
        303.4503173828125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAMEDIX CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        293.4903259277344,
        432.8585510253906,
        303.4503173828125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 07",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        284.4903564453125,
        480.5575256347656,
        294.4503479003906
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1987",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        302.4903259277344,
        471.4073791503906,
        312.4503173828125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K864565",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        333.2103271484375,
        167.9273223876953,
        343.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MONABRITE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        315.2103271484375,
        248.8366241455078,
        325.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS (CMV)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        333.2103271484375,
        327.1967468261719,
        343.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IFA KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        351.2103271484375,
        224.18968200683594,
        361.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SERONO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        315.2103271484375,
        391.2760009765625,
        325.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        333.2103271484375,
        420.4358825683594,
        343.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        351.2103271484375,
        367.458740234375,
        361.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 19",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        324.2103271484375,
        479.8370056152344,
        334.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1987",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        342.2103271484375,
        471.4073791503906,
        352.1703186035156
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K864420",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        373.05035400390625,
        432.8585510253906,
        383.0103454589844
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV MICROASSAY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        373.05035400390625,
        432.8585510253906,
        383.0103454589844
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAMEDIX CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        373.05035400390625,
        432.8585510253906,
        383.0103454589844
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 02",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        364.05035400390625,
        479.8370056152344,
        374.0103454589844
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1987",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        382.05035400390625,
        471.4073791503906,
        392.0103454589844
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K863798",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        412.8903503417969,
        167.9273223876953,
        422.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FIAX(R) TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        394.8903503417969,
        283.8765869140625,
        404.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS M",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        412.8903503417969,
        303.4371337890625,
        422.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIBODIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        430.8903503417969,
        246.70413208007812,
        440.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WHITTAKER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        394.8903503417969,
        414.3164978027344,
        404.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOPRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        412.8903503417969,
        422.4767150878906,
        422.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        430.8903503417969,
        367.458740234375,
        440.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 14",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        403.8903503417969,
        479.95751953125,
        413.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1987",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        421.8903503417969,
        471.4073791503906,
        431.850341796875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K863488",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        461.7303466796875,
        167.9273223876953,
        471.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYGNOST ANTI-CMV IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        452.7303466796875,
        334.27593994140625,
        462.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        470.7303466796875,
        210.87005615234375,
        480.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        443.7303466796875,
        395.8367004394531,
        453.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        461.7303466796875,
        420.4358825683594,
        471.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        479.7303466796875,
        367.458740234375,
        489.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 20",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        452.7303466796875,
        477.7969970703125,
        462.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1987",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        470.7303466796875,
        471.4073791503906,
        480.6903381347656
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K862705",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        501.5703430175781,
        167.9273223876953,
        511.53033447265625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS IGG EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        492.5703430175781,
        335.1169738769531,
        502.53033447265625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        510.5703430175781,
        234.6296844482422,
        520.5303344726562
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABSYSTEMS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        492.5703430175781,
        419.1172180175781,
        502.53033447265625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        510.5703430175781,
        367.458740234375,
        520.5303344726562
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 01",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.3999938964844,
        492.5703430175781,
        479.23699951171875,
        502.53033447265625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        510.5703430175781,
        471.4073791503906,
        520.5303344726562
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K861363",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        541.4103393554688,
        167.9273223876953,
        551.3703002929688
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYGNOST ANTI-CMV IGM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        532.4103393554688,
        336.4363098144531,
        542.3703002929688
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        550.4103393554688,
        210.87005615234375,
        560.3703002929688
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        523.4103393554688,
        395.8367004394531,
        533.3703002929688
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        541.4103393554688,
        420.4358825683594,
        551.3703002929688
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        559.4103393554688,
        367.458740234375,
        569.3703002929688
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jul 21",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        444.9599914550781,
        532.4103393554688,
        477.7969970703125,
        542.3703002929688
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        550.4103393554688,
        471.4073791503906,
        560.3703002929688
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K861123",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        590.13037109375,
        167.9273223876953,
        600.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "THE GOLDEN QUAD TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        581.13037109375,
        321.7974853515625,
        591.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(CMV)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        599.13037109375,
        215.82017517089844,
        609.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MICROBIOLOGIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        572.13037109375,
        428.3143310546875,
        582.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AL RESEARCH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        590.13037109375,
        423.43707275390625,
        600.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        608.13037109375,
        376.2185363769531,
        618.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 02",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        581.13037109375,
        479.8370056152344,
        591.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1987",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        599.13037109375,
        471.4073791503906,
        609.09033203125
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K860493",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        629.9703369140625,
        428.89825439453125,
        639.9302978515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOTECH CMV IGG EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        629.9703369140625,
        428.89825439453125,
        639.9302978515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOTECH INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        629.9703369140625,
        428.89825439453125,
        639.9302978515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 20",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        620.9703369140625,
        481.39752197265625,
        630.9302978515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        638.9703369140625,
        471.4073791503906,
        648.9302978515625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K860450",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        669.8103637695312,
        293.7900695800781,
        679.7703247070312
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "THE CMV-IGM TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        669.8103637695312,
        293.7900695800781,
        679.7703247070312
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MICROBIOLOGIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        651.8103637695312,
        428.3143310546875,
        661.7703247070312
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AL RESEARCH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        669.8103637695312,
        423.43707275390625,
        679.7703247070312
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        687.8103637695312,
        376.2185363769531,
        697.7703247070312
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 13",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        660.8103637695312,
        481.39752197265625,
        670.7703247070312
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        678.8103637695312,
        471.4073791503906,
        688.7703247070312
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 78 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 83,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K860279",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        182.9703369140625,
        167.9273223876953,
        192.9303436279297
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS DIRECT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        173.9703369140625,
        332.7165832519531,
        183.9303436279297
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FLUORESCENT ANTIBODY KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        191.9703369140625,
        340.5896911621094,
        201.9303436279297
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BARTELS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        155.9703369140625,
        397.5169677734375,
        165.9303436279297
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNODIAGNO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        173.9703369140625,
        430.7703857421875,
        183.9303436279297
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STIC SUPPLIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        191.9703369140625,
        428.356201171875,
        201.9303436279297
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        209.9703369140625,
        367.458740234375,
        219.9303436279297
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 13",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        173.9703369140625,
        481.39752197265625,
        183.9303436279297
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        191.9703369140625,
        471.4073791503906,
        201.9303436279297
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K854839",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        240.8103485107422,
        335.189697265625,
        250.77035522460938
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGELISA M TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        240.8103485107422,
        335.189697265625,
        250.77035522460938
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WHITTAKER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        222.8103485107422,
        414.3164978027344,
        232.77035522460938
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOPRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        240.8103485107422,
        422.4767150878906,
        250.77035522460938
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        258.8103332519531,
        367.458740234375,
        268.77032470703125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 04",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        231.8103485107422,
        479.8370056152344,
        241.77035522460938
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        249.81033325195312,
        471.4073791503906,
        259.77032470703125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K854666",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        289.65032958984375,
        167.9273223876953,
        299.6103210449219
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS (CMV)",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        271.65032958984375,
        327.1967468261719,
        281.6103210449219
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ELISA TEST SYS. CAT.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        289.65032958984375,
        306.4365234375,
        299.6103210449219
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "NO:4530",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        307.65032958984375,
        224.2066192626953,
        317.6103210449219
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CLINICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        280.65032958984375,
        398.3565979003906,
        290.6103210449219
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENCES INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        298.65032958984375,
        423.01824951171875,
        308.6103210449219
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 05",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        280.65032958984375,
        479.8370056152344,
        290.6103210449219
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        298.65032958984375,
        471.4073791503906,
        308.6103210449219
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K853989",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        329.4903259277344,
        418.6995544433594,
        339.4503173828125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "COR DOT CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        329.4903259277344,
        418.6995544433594,
        339.4503173828125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORDIS CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        329.4903259277344,
        418.6995544433594,
        339.4503173828125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jun 13",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.6399841308594,
        320.4903259277344,
        479.1175231933594,
        330.4503173828125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        338.4903259277344,
        471.4073791503906,
        348.4503173828125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K853889",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        360.2103271484375,
        418.6995544433594,
        370.1703186035156
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORDIA CMV-M",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        360.2103271484375,
        418.6995544433594,
        370.1703186035156
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORDIS CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        360.2103271484375,
        418.6995544433594,
        370.1703186035156
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Apr 21",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        351.2103271484375,
        479.95751953125,
        361.1703186035156
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        369.2103271484375,
        471.4073791503906,
        379.1703186035156
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K853277",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        391.05035400390625,
        276.3890686035156,
        401.0103454589844
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV CF ANTIGEN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        391.05035400390625,
        276.3890686035156,
        401.0103454589844
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HILLCREST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        382.05035400390625,
        407.4789733886719,
        392.0103454589844
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOLOGICALS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        400.05035400390625,
        414.94384765625,
        410.0103454589844
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 07",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        382.05035400390625,
        480.5575256347656,
        392.0103454589844
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1985",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        400.05035400390625,
        471.4073791503906,
        410.0103454589844
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K853137",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        430.8903503417969,
        238.83056640625,
        440.850341796875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        430.8903503417969,
        238.83056640625,
        440.850341796875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GULL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        412.8903503417969,
        376.996337890625,
        422.850341796875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        430.8903503417969,
        429.6758117675781,
        440.850341796875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        448.8903503417969,
        367.458740234375,
        458.850341796875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 14",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        421.8903503417969,
        480.5575256347656,
        431.850341796875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1985",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        439.8903503417969,
        471.4073791503906,
        449.850341796875
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K852929",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        479.7303466796875,
        167.9273223876953,
        489.6903381347656
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV-COMPLEMENT FIXATION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        461.7303466796875,
        345.55682373046875,
        471.6903381347656
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIGEN AND NEGATIVE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        479.7303466796875,
        319.87542724609375,
        489.6903381347656
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONTR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        497.7303466796875,
        218.43283081054688,
        507.6903381347656
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MICROBIX",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        461.7303466796875,
        400.3984069824219,
        471.6903381347656
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOSYSTEMS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        479.7303466796875,
        416.23779296875,
        489.6903381347656
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        497.7303466796875,
        367.458740234375,
        507.6903381347656
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 12",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        470.7303466796875,
        480.5575256347656,
        480.6903381347656
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1985",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        488.7303466796875,
        471.4073791503906,
        498.6903381347656
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K852494",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        519.5703735351562,
        232.95037841796875,
        529.5303344726562
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV-IHA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        519.5703735351562,
        232.95037841796875,
        529.5303344726562
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HILLCREST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        510.5703430175781,
        407.4789733886719,
        520.5303344726562
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOLOGICALS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        528.5703735351562,
        414.94384765625,
        538.5303344726562
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        510.5703430175781,
        479.8370056152344,
        520.5303344726562
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1985",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        528.5703735351562,
        471.4073791503906,
        538.5303344726562
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K852478",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        559.4103393554688,
        167.9273223876953,
        569.3703002929688
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ENZYGNOST + ANTI-CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        550.4103393554688,
        324.6759338378906,
        560.3703002929688
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IGG TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        568.4103393554688,
        233.79005432128906,
        578.3703002929688
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BEHRING",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        541.4103393554688,
        395.8367004394531,
        551.3703002929688
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        559.4103393554688,
        420.4358825683594,
        569.3703002929688
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        577.4103393554688,
        367.458740234375,
        587.3703002929688
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        550.4103393554688,
        479.8370056152344,
        560.3703002929688
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1985",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        568.4103393554688,
        471.4073791503906,
        578.3703002929688
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K843657",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        599.13037109375,
        285.9445495605469,
        609.09033203125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        599.13037109375,
        285.9445495605469,
        609.09033203125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INSTITUTE",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        590.13037109375,
        407.95703125,
        600.09033203125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VIRION LTD.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        608.13037109375,
        411.2586669921875,
        618.09033203125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 26",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        590.13037109375,
        479.8370056152344,
        600.09033203125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1985",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        608.13037109375,
        471.4073791503906,
        618.09033203125
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K843189",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        629.9703369140625,
        167.9273223876953,
        639.9302978515625
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS IGG EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        620.9703369140625,
        335.1169738769531,
        630.9302978515625
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        638.9703369140625,
        234.6296844482422,
        648.9302978515625
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABSYSTEMS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        620.9703369140625,
        419.1172180175781,
        630.9302978515625
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        638.9703369140625,
        367.458740234375,
        648.9302978515625
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 08",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.8800048828125,
        620.9703369140625,
        478.8769836425781,
        630.9302978515625
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1986",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        638.9703369140625,
        471.4073791503906,
        648.9302978515625
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K843138",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        669.8103637695312,
        238.83056640625,
        679.7703247070312
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        669.8103637695312,
        238.83056640625,
        679.7703247070312
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "MICROBIOLOGIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        651.8103637695312,
        428.3143310546875,
        661.7703247070312
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AL RESEARCH",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        669.8103637695312,
        423.43707275390625,
        679.7703247070312
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        687.8103637695312,
        376.2185363769531,
        697.7703247070312
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 29",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.8800048828125,
        660.8103637695312,
        478.8769836425781,
        670.7703247070312
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1985",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        678.8103637695312,
        471.4073791503906,
        688.7703247070312
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IX. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        452.3999938964844,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 79 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 84,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K842661",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        166.41033935546875,
        167.9273223876953,
        176.37034606933594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTI-CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        157.41033935546875,
        323.95501708984375,
        167.37034606933594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        175.41033935546875,
        201.74969482421875,
        185.37034606933594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AMICO LAB INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        166.41033935546875,
        432.13824462890625,
        176.37034606933594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 06",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        157.41033935546875,
        480.0769958496094,
        167.37034606933594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1985",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        175.41033935546875,
        471.4073791503906,
        185.37034606933594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K842529",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        200.01034545898438,
        432.13824462890625,
        209.97035217285156
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AMIZYME-CMV KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        200.01034545898438,
        432.13824462890625,
        209.97035217285156
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AMICO LAB INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        200.01034545898438,
        432.13824462890625,
        209.97035217285156
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 06",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        191.01034545898438,
        480.0769958496094,
        200.97035217285156
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1985",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        209.01034545898438,
        471.4073791503906,
        218.97035217285156
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K841520",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        260.7303466796875,
        167.9273223876953,
        270.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV LATEX AGGLUTINATION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        251.7303466796875,
        341.4739685058594,
        261.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        269.7303466796875,
        234.6296844482422,
        279.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BD BECTON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        224.7303466796875,
        410.837646484375,
        234.6903533935547
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DICKINSON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        242.7303466796875,
        407.11639404296875,
        252.6903533935547
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "VACUTAINER",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        260.7303466796875,
        418.3961181640625,
        270.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SYSTEMS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        278.7303466796875,
        398.7181396484375,
        288.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PREANALYTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        296.7303466796875,
        419.6730651855469,
        306.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 07",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        251.7303466796875,
        479.8370056152344,
        261.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1984",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        269.7303466796875,
        471.4073791503906,
        279.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K833089",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        319.8903503417969,
        167.9273223876953,
        329.850341796875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        310.8903503417969,
        289.2762756347656,
        320.850341796875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIBODY FLUORO-KIT II",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        328.8903503417969,
        322.21502685546875,
        338.850341796875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CLINICAL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        310.8903503417969,
        398.3565979003906,
        320.850341796875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENCES INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        328.8903503417969,
        423.01824951171875,
        338.850341796875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 02",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        310.8903503417969,
        481.39752197265625,
        320.850341796875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1984",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        328.8903503417969,
        471.4073791503906,
        338.850341796875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K832221",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        350.7303466796875,
        336.03009033203125,
        360.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "YBBOTT CMV TOTAL AB EIA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        350.7303466796875,
        336.03009033203125,
        360.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ABBOTT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        341.7303466796875,
        392.957275390625,
        351.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        359.7303466796875,
        426.3441162109375,
        369.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.3999938964844,
        341.7303466796875,
        479.23699951171875,
        351.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1983",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        359.7303466796875,
        471.4073791503906,
        369.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K831711",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        390.5703430175781,
        263.7900695800781,
        400.53033447265625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV IGM TEST",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        390.5703430175781,
        263.7900695800781,
        400.53033447265625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "GULL",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        372.5703430175781,
        376.996337890625,
        382.53033447265625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LABORATORIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        390.5703430175781,
        429.6758117675781,
        400.53033447265625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        408.5703430175781,
        367.458740234375,
        418.53033447265625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 27",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.3999938964844,
        381.5703430175781,
        479.23699951171875,
        391.53033447265625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1983",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        399.5703430175781,
        471.4073791503906,
        409.53033447265625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K831343",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        431.850341796875,
        335.189697265625,
        441.8103332519531
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV RQ BIO-ENZABEAD KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        431.850341796875,
        335.189697265625,
        441.8103332519531
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LITTON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        422.850341796875,
        389.59674072265625,
        432.8103332519531
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIONETICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        440.850341796875,
        402.46600341796875,
        450.8103332519531
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Aug 08",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        422.850341796875,
        480.5575256347656,
        432.8103332519531
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1983",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        440.850341796875,
        471.4073791503906,
        450.8103332519531
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K830615",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        465.4503479003906,
        298.1092224121094,
        475.41033935546875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGELISA STAT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        465.4503479003906,
        298.1092224121094,
        475.41033935546875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "M.A.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        456.4503479003906,
        372.43768310546875,
        466.41033935546875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIOPRODUCTS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        474.4503479003906,
        419.1449890136719,
        484.41033935546875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 09",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        456.4503479003906,
        481.39752197265625,
        466.41033935546875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1983",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        474.4503479003906,
        471.4073791503906,
        484.41033935546875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K823123",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        497.7303466796875,
        418.6995544433594,
        507.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORDIA CMV",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        497.7303466796875,
        418.6995544433594,
        507.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CORDIS CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        497.7303466796875,
        418.6995544433594,
        507.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Dec 28",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.67999267578125,
        488.7303466796875,
        480.0769958496094,
        498.6903381347656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1982",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        506.7303161621094,
        471.4073791503906,
        516.6903076171875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K822965",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        528.4503784179688,
        415.8195495605469,
        538.4103393554688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CETUS CMV IHA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        528.4503784179688,
        415.8195495605469,
        538.4103393554688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CETUS CORP.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        528.4503784179688,
        415.8195495605469,
        538.4103393554688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Feb 15",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        519.4503784179688,
        479.8370056152344,
        529.4103393554688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1983",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        537.4503784179688,
        471.4073791503906,
        547.4103393554688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K822606",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        559.2903442382812,
        167.9273223876953,
        569.2503051757812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        550.2903442382812,
        289.2762756347656,
        560.2503051757812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTOBODY IGG",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        568.2903442382812,
        263.0113525390625,
        578.2503051757812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMULOK INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        559.2903442382812,
        422.8987121582031,
        569.2503051757812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 01",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        550.2903442382812,
        480.5575256347656,
        560.2503051757812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1982",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        568.2903442382812,
        471.4073791503906,
        578.2503051757812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K820895",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        608.13037109375,
        167.9273223876953,
        618.09033203125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYLOMEGALOVIRUS DIRECT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        599.13037109375,
        331.3965759277344,
        609.09033203125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FLUORESCENT ANTI",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        617.13037109375,
        289.3343811035156,
        627.09033203125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BARTELS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        581.13037109375,
        397.5169677734375,
        591.09033203125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNODIAGNO",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        599.13037109375,
        430.7703857421875,
        609.09033203125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "STIC SUPPLIES",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        617.13037109375,
        428.356201171875,
        627.09033203125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        635.13037109375,
        367.458740234375,
        645.09033203125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "May 03",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        441.3599853515625,
        599.13037109375,
        481.39752197265625,
        609.09033203125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1982",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        617.13037109375,
        471.4073791503906,
        627.09033203125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K811671",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        667.4103393554688,
        167.9273223876953,
        677.3703002929688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALOVIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        658.4103393554688,
        289.2762756347656,
        668.3703002929688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTIBODY TEST SYSTEM",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        676.4103393554688,
        317.2845458984375,
        686.3703002929688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ZEUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        658.4103393554688,
        376.63677978515625,
        668.3703002929688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SCIENTIFIC INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        676.4103393554688,
        431.2987365722656,
        686.3703002929688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        658.4103393554688,
        479.8370056152344,
        668.3703002929688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1981",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        676.4103393554688,
        471.4073791503906,
        686.3703002929688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        110.15999603271484,
        117.55441284179688,
        414.9193115234375,
        126.55441284179688
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 80 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        721.4103393554688,
        314.625,
        731.3703002929688
      ],
      "page_num": 85,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "K802930",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        173.9703369140625,
        167.9273223876953,
        183.9303436279297
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CYTOMEGALO VIRUS &",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        164.9703369140625,
        307.63702392578125,
        174.9303436279297
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CONTROLS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        182.9703369140625,
        237.94432067871094,
        192.9303436279297
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ORION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        155.9703369140625,
        382.0361022949219,
        165.9303436279297
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTICA",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        173.9703369140625,
        421.7555847167969,
        183.9303436279297
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        191.9703369140625,
        367.458740234375,
        201.9303436279297
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Jan 09",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.8800048828125,
        164.9703369140625,
        478.8769836425781,
        174.9303436279297
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1981",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        182.9703369140625,
        471.4073791503906,
        192.9303436279297
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K801963",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        222.8103485107422,
        262.5896911621094,
        232.77035522460938
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV TEST KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        222.8103485107422,
        262.5896911621094,
        232.77035522460938
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IMMUNO-DIAGN",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        204.8103485107422,
        432.0282287597656,
        214.77035522460938
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        222.8103485107422,
        381.19647216796875,
        232.77035522460938
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PRODUCTS INC.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        240.8103485107422,
        427.5782470703125,
        250.77035522460938
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Oct 23",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        443.3999938964844,
        213.8103485107422,
        479.23699951171875,
        223.77035522460938
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1980",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        231.8103485107422,
        471.4073791503906,
        241.77035522460938
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K801722",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        262.65032958984375,
        167.9273223876953,
        272.6103210449219
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV BIO-BEAD TITRATION",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        253.65032958984375,
        331.87518310546875,
        263.6103210449219
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        271.65032958984375,
        201.74969482421875,
        281.6103210449219
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LITTON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        253.65032958984375,
        389.59674072265625,
        263.6103210449219
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIONETICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        271.65032958984375,
        402.46600341796875,
        281.6103210449219
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sep 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.79998779296875,
        253.65032958984375,
        479.8370056152344,
        263.6103210449219
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1980",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        271.65032958984375,
        471.4073791503906,
        281.6103210449219
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K791948",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        302.4903259277344,
        167.9273223876953,
        312.4503173828125
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "FIAX TEST KIT FOR",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        293.4903259277344,
        292.27630615234375,
        303.4503173828125
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ANTI-CYTOMEGALORIRUS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        183.0,
        311.4903259277344,
        320.14324951171875,
        321.4503173828125
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "INTL.",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        284.4903564453125,
        377.9565124511719,
        294.4503479003906
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DIAGNOSTIC",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        302.4903259277344,
        414.1959533691406,
        312.4503173828125
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TECHNOLOGY",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        320.4903259277344,
        416.67205810546875,
        330.4503173828125
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 16",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        293.4903259277344,
        480.5575256347656,
        303.4503173828125
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1979",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        311.4903259277344,
        471.4073791503906,
        321.4503173828125
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "K791612",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        342.2103271484375,
        333.86968994140625,
        352.1703186035156
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CMV BIO-BEAD SCREEN KIT",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        125.39999389648438,
        342.2103271484375,
        333.86968994140625,
        352.1703186035156
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "LITTON",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        333.2103271484375,
        389.59674072265625,
        343.1703186035156
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BIONETICS",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        346.67999267578125,
        351.2103271484375,
        402.46600341796875,
        361.1703186035156
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Nov 13",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        442.1999816894531,
        333.2103271484375,
        480.5575256347656,
        343.1703186035156
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1979",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        448.0799865722656,
        351.2103271484375,
        471.4073791503906,
        361.1703186035156
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IX. 부록",
      "font_size": 8.759956359863281,
      "font_name": "H2hdrM",
      "bbox": [
        452.3999938964844,
        115.2744140625,
        481.6860046386719,
        124.2744140625
      ],
      "page_num": 86,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        170.51998901367188,
        480.43975830078125,
        451.2854309082031,
        493.68731689453125
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오송보건의료행정타운",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        247.55999755859375,
        496.5197448730469,
        347.5185852050781,
        509.7673034667969
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전평가원 의료기기심사부 체외진단기기과",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        172.55999755859375,
        512.479736328125,
        422.51904296875,
        525.7273559570312
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEL : 043-719-4652~65  FAX : 043-719-4650",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        191.51998901367188,
        528.439697265625,
        403.6434326171875,
        541.6873168945312
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "http://www.mfds.go.kr",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        247.4399871826172,
        544.5197143554688,
        347.8001403808594,
        557.767333984375
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“내가 지킨 청렴실천 모아지면 청렴사회”",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        217.3199920654297,
        567.3197021484375,
        405.8579406738281,
        580.5673217773438
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    }
  ],
  "markdown_content": "<!-- PAGE_1 -->\n# 산전검사 중\n\n<!-- PAGE_1 -->\n# 거대세포바이러스(CMV)\n\n<!-- PAGE_1 -->\n# 체외진단용 의료기기\n\n<!-- PAGE_1 -->\n# 허가심사 가이드라인\n\n<!-- PAGE_1 -->\n# (민원인 안내서]\n\n- 2018. 7.\n발간등록번호\n\n안내서-0649-02\n\n<!-- PAGE_2 -->\n###### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사\n\n가이드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n**[표 시작]**\n\n| 제․개정 | 라. 표준물질 및 검체보관 등에 관한 자료 | 나. 시험방법 | 로트 이상의 시험성적서를 제출한다. | 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다. | 1) 시험할 교차반응물질의 목록을 작성한다. | 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다. | 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다. | 있다. | 설정한다. | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다. | BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다. | 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다. | IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP. | DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까? | SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ. 개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가. 시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다. | 마) 실제 검사일수, 검사실의 수 | 1. 개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다. | 또는 양성검체를 희석한 검체 등을 사용한다. | QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD. | BIOTECH INC. | BIOPRODUCTS | PRODUCTS INC. | 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다. | IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다. | ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC. | PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP. | SYSTEMS INC. | BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다. | 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28. | 산전검사 중 CMV 검사시약 | INC. | VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다. | 기술한다. | 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다. | 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ. 용어의 정의 | 3 | 결과를 비교한다. 정량검사의 경우는 bias를 구한다. | 시기를 거친 다음 평가를 수행하도록 한다. | 기술한다. | 한다. | 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다. | ORGANON | DIAGNOSTICS | ORTHO | INC. | 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC. | BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다. | INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP. | CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마. 체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다. | Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다. (이하생략) | 의 추가 자료로 제시할 수 있다. | 위양성도 및 위음성도) 등을 기재한다. | 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2. 원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다. | 실시하는 것을 권장한다. | (사유 :                                                      ) | 이상의 검체 사용을 권장한다. | 제시한다. | INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP. | INC. | DIAGNOSTIC | STELLAR BIO | INTL. |\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다. | and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다. | 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다. | 한다. | ANTIBODY | ELISA TEST SYS. CAT. | DIAGNOSTICS | PRODUCTS | CORP. |\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP. | 제조국을 추가로 기재한다. | Ⅲ. 관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL. | PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC. | SYSTEMS INC. | SCIENCES INC. | DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바. 이미 허가·인증받은 제품과 비교한 자료 | 나. 시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다. | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다. | 아) 시약 lot의 수 | 3. 사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다. | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다. | 자료를 포함해야 한다. | ｢ | 의료기기법 시행규칙｣ | CORP. | BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다. | Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까? | INC. | INC. | WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다. | 적용할 수 있는 시험규격을 명시한다. | (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1. 품목명: 고위험성감염체면역검사시약 | Ⅳ. 신청서 기재 항목 및 기술문서 제출자료 | 14 | 4. 저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2. | 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC. | DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP. | 나. 검사 전 준비사항 | 가. 전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다. | 요인이다. | 해 결정되는)의 유병률에 맞추어 해석해야 한다. | 장한다. | Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다. | 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다. | 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다. | BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC. | SCIENCES INC. | 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다. | 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다. | 전자적 기록매체(CD·디스켓 등)와 함께 제출한다. | 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP. | BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2. 모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? | □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP. | DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다. | 장 간에 동등한 성능을 확인하도록 한다. | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. | 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다. | 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1. 제조․수입허가신청서 | 14 | 5. 제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다. | 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등). | 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다. | 경우에는 설정근거를 제시한다. | ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC. | INC. | BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가. 시험물질 | 나. NIBSC의 관련 표준물질 | 3. 품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP. | Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다. | well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC. | INC. | LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP. | HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다. | 2. 기술문서에 관한 자료 | 14 | 6. 시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC. | 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP. | 나. 기재내용 | 인정범위내의 자료 이어야 한다. | 기구 및 조건 등을 기재한다. | Cinical and Laboratory Standard Institute; 2005 | 4. 등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다. | 의학적 결정치에서의 bias를 제시한다. | 사) 판정기준치를 산정하는 방법을 명시한다. | 수도 있다. 측정은 각 농도별로 2-4회 반복 측정한다. | 다. | IMMED. EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다. | antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1. 제조의뢰자 | 다른 원인에 기인하기도 한다. | 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다. | 구체적으로 기재하여야 한다. | 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다. | D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까? | 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC. | ABBOTT | GULL | CORP. | IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다. | Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7. 이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까? | □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3. 성능 작성의 예 | 마. 정도관리 | 다. 결과제시 | 라. 결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다. | immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다. | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다. | 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ. 제조․수입허가 신청서 기재항목 | 16 | 있어야 한다. | 한다(CFU; colony forming unit, PFU; plaque forming unit). | 이용하여 평가한다. | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다. | Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다. | 또는 양성검체를 희석한 검체 등을 사용한다. | FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다). | Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC. | SYSTEMS INC. | BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가. 시험항목 | 보간법(Interpolation)2)을 통해 이루어진다. | 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D. | (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다. | /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC. | INC. | 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나. 시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다. | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다. | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다. | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다. | 정보를 제공한다. | 가) 직선성 범위의 농도 구간을 제시한다. | 설정한 근거를 제시한다. | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다. | CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC. | LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT. LTD. | Ⅶ. 성능시험에 대한 상세사항 | 40 | 1. 명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP. | QUEST INTL. | IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까? | 적을 기재한다. | 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다. | 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다. | SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC. | INC. | LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5. | 100ul |\n| 자. 일회용의 경우 재사용하지 않도록 주의사항을 기재한다. | Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다. | 을 권장하며 최소 2회 반복 측정한다. | 2. 모양 및 구조 | 17 | 1. 분석적 성능시험에 관한 자료 | 40 | 결합한다. | 등을 이용가능하다. | 자료를 제출한다. | positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다. | 시행할 집단에서의 유병률을 평가할 것을 권장한다. | Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다. | HYBRID CAPTURE SYSTEM | INC. | CONCEPTS INC. | BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다. | 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. | conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A. | DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP. | INC. | 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다. | 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다. | ABBOTT | M.A. | 1992 |\n| K901485 | K880433 | K863488 | 다. 결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다. | 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다. | 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다. | 밀도(within-laboratory) 자료를 제시한다. | 제공해야한다. | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다. | 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다. | 자료를 제시한다. | CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다. | ※ 예시 | 3. 원재료 | 20 | 2. 임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD. |\n| 2. 제조자 | 제출한다. | ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다. | Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다. | 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP. | INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다. | 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC. | LABORATORIES | INC. | INC. | BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC. | Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다. | bias)경우를 제시한다. | 나) 분석물질 음성검체 + 간섭물질 | 4. 제조방법 | 22 | 3. 완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다. | Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고). | (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라. 분량 | 가. 해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다. | 1) 상호 : FDAS | 첨부하여야 한다. | ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나. 시험기준 | 함께 기록한다. | MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까? (공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP. | 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC. | SYVA CO. | INC. | ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다. 검사과정 | 다. 시약의 표준화(standardization)를 위해 사용된 방법을 기술한다. | 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5. 사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다. | 과거에 확진된 보관검체로도 실험할 수 있다. | -538D, -977D의 총 9종, 각 $360 | 없어야 한다. | 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.] | 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다. | LABORATORY | LABORATORIES | INC. | HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가. 분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다. | 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1. 외관사진 작성의 예 | 위음성 | CORP. | 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다. | 2018.7. | ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바. 국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다. | 판정기준치(농도) | 검체 등을 사용할 수 있다. | 제시한다. | 로 표시한다. | CYTOMEGALOVIRUS | CO. | CORP. | DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다. | K891393 | K822965 | CETUS CMV IHA | CETUS CORP. | 가. 시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6. 사용방법 | 23 | 4. 표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까? (민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC. | ORGENICS LTD. | BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다. | 있는 자료 포함 | 역가를 기재 | IGG | CORP. | 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC. | DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다. 결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다. | 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC. | 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다. | 7. 사용시 주의사항 | 25 | 5. 상관성 평가 | 60 | 화합물이 형성된다. | 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다. | 도를 산출한다. | ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가. 최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다. | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC. | PB DIAGNOSTIC | INTERNATIONAL | INC. | DIAGNOSTICS | IMMULOK INC. | □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I. DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나. 판정기준치(cut-off value) | 다. 측정범위 | 나. 시험방법 | 다. 시험방법 | 사. 그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다. | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다. | 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8. 포장단위 | 26 | 변이계수를 산출하여 기재한다. | TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까? | 제조일로부터 11개월 | 10건을 검사한다. | DIAGNOSTICS | INOVA | SCIENTIFIC INC. | ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC. | INC. |\n| SPR | 다. 시험방법 | 라. 원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ. 참고문헌 | 63 | 근거를 제시한다. | 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC. | BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO. | SCIENTIFIC INC. | 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP. | DIAGNOSTICS | INC. | ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라. 결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다. | 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다. | 1) 반복성 | 기술한다. | 9. 저장방법 및 사용기간 | 27 | photomultiplier가 측정한다. | 포함되는 것을 권장한다. | 등을 제시한다. 유병률을 구한 경우는 유병률도 제시한다. | 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가. 체외진단용으로 사용해야 함을 명시한다. | 기재한다. | Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다. | 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다. | 기재할 수 있다. | Ⅸ. 부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC. | INC. | ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP. | VIRION LTD. | 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가. 인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다. | 미개봉 | 10. 시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다. | Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등). | CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음. | 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다. | 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다. | K890610 | ※ 예시 | 가. 식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다. | ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다. | SCIENTIFIC INC. | INC. | 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC. | K843189 | 다. 측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다. | 판단 표에 따라 제출자료가 면제될 수 있다. | 시험한 자료의 경우) | 11. 제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다. | 자료를 제시한다. | 하는 계획을 수립하여 시행한다. | 30개 이상) | TEKNIKA CORP. | INC. | 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다. | 로 설정하는 것이 보편적이다. | IGG ELISA TEST SYSTEM. AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC. | INC. | LABORATORIES | MEDICAL | INC. | 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다. | 의해 구해진다. | 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다. | 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다. | 료를 제출한다. | MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다. | BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다. | 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다. | 를 산출하여 기재한다. | 따라 통계적으로 의미 있는 검체수를 산정한다. | Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다. | ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC. | ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나. 임상적 성능시험에 관한 자료 | 가. 시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다. | OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다. | 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC. | 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다. | 한다. | 측정하는 것을 권장한다. | SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC. | 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ. 기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n<!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다. 또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n<!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\nⅠ. 개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1. 목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2. 적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다. 과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다. 임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다. 선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1). 산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다. 선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.**\n\n**[표 끝]**\n\nⅡ. 용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n<!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ. 용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n<!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n<!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n<!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n<!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n<!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n<!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ. 용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n<!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n<!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ. 용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n<!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ. 용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다. 정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n<!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n<!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n<!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ. 관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ. 신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.  제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n<!-- PAGE_21 -->\n###### 가. 제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나. 제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다. 동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2. 제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다. 다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가. 허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나. 동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다. 서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1. 모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n<!-- PAGE_22 -->\n###### 가. 임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다. 전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다. 태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다. 생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다. 한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다. 그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나. 작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n<!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n<!-- PAGE_23 -->\n###### 2. 모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가. 외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n<!-- PAGE_24 -->\n###### 나. 외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다. 구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1. 구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나. 검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴). | Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1. 원재료는 다음 양식의 표를 사용하여 기재한다.\n\n<!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n<!-- PAGE_25 -->\n###### 가. 명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n<!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나. 배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다. 원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마. 규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바. 비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n<!-- PAGE_26 -->\n###### 표 2. 원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가. 국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다. | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다. |\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다.**\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다. | Apr 21 | Jul 14 |\n**Oct 16**\n**1. 외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2. 검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.**\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다. | Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3. 정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다.**\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다. | Nov 01 | Apr 26 | Sep 16 |\n| 다. 원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4. 민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다. | Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다. | QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다. | May 06 | May 03 |\n**Molecular**\n| 5. 특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가. 일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다. | Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC. | 1.5mlx1병 | 1989 |\n| 나. 제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다. | 1) 임상적 민감도 | 한다. | 이에 준하는 것으로 인정되는 시험자료 | 기재한다. | INC. | INC. | CORP. | CORP. |\n| serum | INC. | INC. | t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1. ‘제조원의 제조방법에 따른다.’라고 기재한다. 다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가. 멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1. 사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n<!-- PAGE_27 -->\n###### 2. 사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가. 검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3. 성능\n\n<!-- PAGE_28 -->\n###### 가. 근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나. 사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다. 헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1. 검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n<!-- PAGE_29 -->\n###### 가. 검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n<!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n<!-- PAGE_30 -->\n###### 1. 다음의 사항을 포함하여 기재한다.\n\n<!-- PAGE_30 -->\n###### 나. 일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다. 구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라. 사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n<!-- PAGE_31 -->\n###### 마. 경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n<!-- PAGE_31 -->\n###### 바. 임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사. 검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다. 또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아. 다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1. 체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1. 저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가. 키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n<!-- PAGE_32 -->\n###### 나. 일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다. 시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라. 전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4. 저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1. 시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2. 시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ. 제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n<!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5. 시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1. 수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n<!-- PAGE_35 -->\n###### 2. 모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다. 다만, 제조자가 외국회사일 경우에는\n\nⅥ. 기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1. 원칙\n\n<!-- PAGE_36 -->\n###### 가. 기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나. 첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다. 해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라. 외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. 다만,\n\n<!-- PAGE_36 -->\n###### 마. 이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2. 이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가. 제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n<!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3. 시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ. 기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다. 추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1. 개발경위\n\n<!-- PAGE_39 -->\n###### 가. 거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2. 측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가. 거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ. 기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다. 제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n<!-- PAGE_40 -->\n###### 3. 국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1. 원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나. 원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마. 분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바. 프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2. 제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가. 제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나. 원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다. 일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1. 허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2. 해당제품의 제품설명서(insert)를 제출한다.\n\n<!-- PAGE_41 -->\n###### 1. 완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2. 구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n<!-- PAGE_41 -->\n###### 3. 시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ. 기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4. 안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n<!-- PAGE_42 -->\n###### 5. 저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6. 일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7. 수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8. 저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1. 제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n<!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다. 완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1. 구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2. 유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1. 이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ. 기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1. 분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n<!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다. 사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다. 컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다. 검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n<!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다. 최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n<!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n<!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다. 희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2. 분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n<!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6. 혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n<!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n<!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다. 대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3. 정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n<!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n<!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다. 정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4. 정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나. 표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라. 보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마. 양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5. 교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n<!-- PAGE_56 -->\n###### 나. 시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다. 결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다. 이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다. 민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다. 질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다. 종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험. 다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나. 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다. 해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라. 과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1. 임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등. 평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다. 또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n<!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n<!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n<!-- PAGE_63 -->\n###### 2. 임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다. 임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n<!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1. 연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2. 시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3. 시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1. 완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가. 표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나. 자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n<!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가. 시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. 이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나. 검체 취급 및 보관조건에 대한 시험 결과를 제시한다. 이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다. 이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다. 시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1. 일반사항\n\n<!-- PAGE_65 -->\n###### 가. 국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ. 성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다. 다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n<!-- PAGE_66 -->\n###### 나. 임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. 분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다. 거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2. 시험물질\n\n<!-- PAGE_66 -->\n###### 가. 다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나. 임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다. 정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라. 정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3. 시험방법\n\n<!-- PAGE_66 -->\n###### 가. 해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나. 가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n<!-- PAGE_67 -->\n###### 다. 비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n<!-- PAGE_67 -->\n###### 라. 정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n<!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다. 불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4. 결과제시\n\n<!-- PAGE_67 -->\n###### 나. 정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다. 정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라. 결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\nⅧ. 참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1. CLSI. Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline. CLSI document EP25-A. Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n<!-- PAGE_68 -->\n###### CLSI.\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n<!-- PAGE_68 -->\n###### CLSI document EP5-A2. Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n<!-- PAGE_68 -->\n###### CLSI.\n\n<!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n<!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2. Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4. CLSI. Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline. CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2. Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5. CLSI. Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline. CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A. Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6. CLSI. Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision). CLSI document EP9-A2-IR. Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7. CLSI. Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition. CLSI document EP7-A. Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8. CLSI. Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition. CLSI document MM3-A2.\n\n<!-- PAGE_69 -->\n###### 9. Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10. Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11. Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ. 참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12. Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection. Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1. CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n<!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX. 부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2. CMV 제품 국내 제조 및 수입 현황\n\nIX. 부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3. 미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM. AN | ZEUS | INC. | Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC. | CORP. |\n| MODEL 8530 | SYSTEMS INC. | MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC. | INC. | INC. | 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX. 부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP. | PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD. | INTERNATIONAL | STIC SUPPLIES | INC. | Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC. | 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX. 부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC. | CLINICAL | AMICO LAB INC. | Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX. 부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX. 부록\n\n- - 77 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 78 -\nIX. 부록\n\n- - 79 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 80 -\nIX. 부록\n",
  "chunks": [
    {
      "chunk_id": "chunk_001",
      "text": "<!-- PAGE_1 -->\n# 산전검사 중\n\n<!-- PAGE_1 -->\n# 거대세포바이러스(CMV)\n\n<!-- PAGE_1 -->\n# 체외진단용 의료기기\n\n<!-- PAGE_1 -->\n# 허가심사 가이드라인\n\n<!-- PAGE_1 -->\n# (민원인 안내서]\n\n- 2018. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 0,
        "window_size": 3,
        "char_count": 156,
        "word_count": 31,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n# 산전검사 중\n\n<!-- PAGE_1 -->\n# 거대세포바이러스(CMV)\n\n<!-- PAGE_1 -->\n# 체외진단용 의료기기\n\n<!-- PAGE_1 -->\n# 허가심사 가이드라인\n\n<!-- PAGE_1 -->\n# (민원인 안내서]\n\n- 2018.  7.\n 발간등록번호\n\n안내서-0649-02\n\n<!-- PAGE_2 -->\n###### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사\n\n가이드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제․개정 | 라. ",
        "original_sentence": "<!-- PAGE_1 -->\n# 산전검사 중\n\n<!-- PAGE_1 -->\n# 거대세포바이러스(CMV)\n\n<!-- PAGE_1 -->\n# 체외진단용 의료기기\n\n<!-- PAGE_1 -->\n# 허가심사 가이드라인\n\n<!-- PAGE_1 -->\n# (민원인 안내서]\n\n- 2018. "
      }
    },
    {
      "chunk_id": "chunk_002",
      "text": "7.\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 1,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n# 산전검사 중\n\n<!-- PAGE_1 -->\n# 거대세포바이러스(CMV)\n\n<!-- PAGE_1 -->\n# 체외진단용 의료기기\n\n<!-- PAGE_1 -->\n# 허가심사 가이드라인\n\n<!-- PAGE_1 -->\n# (민원인 안내서]\n\n- 2018.  7.\n 발간등록번호\n\n안내서-0649-02\n\n<!-- PAGE_2 -->\n###### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사\n\n가이드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제․개정 | 라.  표준물질 및 검체보관 등에 관한 자료 | 나. ",
        "original_sentence": "7.\n"
      }
    },
    {
      "chunk_id": "chunk_003",
      "text": "발간등록번호\n\n안내서-0649-02\n\n<!-- PAGE_2 -->\n###### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사\n\n가이드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 2,
        "window_size": 3,
        "char_count": 150,
        "word_count": 24,
        "page_number": 2,
        "window_text": "<!-- PAGE_1 -->\n# 산전검사 중\n\n<!-- PAGE_1 -->\n# 거대세포바이러스(CMV)\n\n<!-- PAGE_1 -->\n# 체외진단용 의료기기\n\n<!-- PAGE_1 -->\n# 허가심사 가이드라인\n\n<!-- PAGE_1 -->\n# (민원인 안내서]\n\n- 2018.  7.\n 발간등록번호\n\n안내서-0649-02\n\n<!-- PAGE_2 -->\n###### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사\n\n가이드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제․개정 | 라.  표준물질 및 검체보관 등에 관한 자료 | 나.  시험방법 | 로트 이상의 시험성적서를 제출한다. ",
        "original_sentence": "발간등록번호\n\n안내서-0649-02\n\n<!-- PAGE_2 -->\n###### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사\n\n가이드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_004",
      "text": "**[표 시작]**\n\n| 제․개정 | 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 3,
        "window_size": 3,
        "char_count": 24,
        "word_count": 6,
        "page_number": 7,
        "window_text": "<!-- PAGE_1 -->\n# 산전검사 중\n\n<!-- PAGE_1 -->\n# 거대세포바이러스(CMV)\n\n<!-- PAGE_1 -->\n# 체외진단용 의료기기\n\n<!-- PAGE_1 -->\n# 허가심사 가이드라인\n\n<!-- PAGE_1 -->\n# (민원인 안내서]\n\n- 2018.  7.\n 발간등록번호\n\n안내서-0649-02\n\n<!-- PAGE_2 -->\n###### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사\n\n가이드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제․개정 | 라.  표준물질 및 검체보관 등에 관한 자료 | 나.  시험방법 | 로트 이상의 시험성적서를 제출한다.  | 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다. ",
        "original_sentence": "**[표 시작]**\n\n| 제․개정 | 라. "
      }
    },
    {
      "chunk_id": "chunk_005",
      "text": "표준물질 및 검체보관 등에 관한 자료 | 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 4,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 4,
        "window_text": "7.\n 발간등록번호\n\n안내서-0649-02\n\n<!-- PAGE_2 -->\n###### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사\n\n가이드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제․개정 | 라.  표준물질 및 검체보관 등에 관한 자료 | 나.  시험방법 | 로트 이상의 시험성적서를 제출한다.  | 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다.  | 1) 시험할 교차반응물질의 목록을 작성한다. ",
        "original_sentence": "표준물질 및 검체보관 등에 관한 자료 | 나. "
      }
    },
    {
      "chunk_id": "chunk_006",
      "text": "시험방법 | 로트 이상의 시험성적서를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 5,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 30,
        "window_text": "발간등록번호\n\n안내서-0649-02\n\n<!-- PAGE_2 -->\n###### 지침서ᆞ안내서 제ᆞ개정 점검표\n\n명칭\n\n산전검사 중 거대세포바이러스(CMV) 체외진단용 의료기기 허가·심사\n\n가이드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 제․개정 | 라.  표준물질 및 검체보관 등에 관한 자료 | 나.  시험방법 | 로트 이상의 시험성적서를 제출한다.  | 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다.  | 1) 시험할 교차반응물질의 목록을 작성한다.  | 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다. ",
        "original_sentence": "시험방법 | 로트 이상의 시험성적서를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_007",
      "text": "| 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 6,
        "window_size": 3,
        "char_count": 96,
        "word_count": 22,
        "page_number": 3,
        "window_text": "**[표 시작]**\n\n| 제․개정 | 라.  표준물질 및 검체보관 등에 관한 자료 | 나.  시험방법 | 로트 이상의 시험성적서를 제출한다.  | 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다.  | 1) 시험할 교차반응물질의 목록을 작성한다.  | 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다.  | 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다. ",
        "original_sentence": "| 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다. "
      }
    },
    {
      "chunk_id": "chunk_008",
      "text": "| 1) 시험할 교차반응물질의 목록을 작성한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 7,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 3,
        "window_text": "표준물질 및 검체보관 등에 관한 자료 | 나.  시험방법 | 로트 이상의 시험성적서를 제출한다.  | 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다.  | 1) 시험할 교차반응물질의 목록을 작성한다.  | 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다.  | 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 있다. ",
        "original_sentence": "| 1) 시험할 교차반응물질의 목록을 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_009",
      "text": "| 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 8,
        "window_size": 3,
        "char_count": 192,
        "word_count": 44,
        "page_number": 3,
        "window_text": "시험방법 | 로트 이상의 시험성적서를 제출한다.  | 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다.  | 1) 시험할 교차반응물질의 목록을 작성한다.  | 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다.  | 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 있다.  | 설정한다. ",
        "original_sentence": "| 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_010",
      "text": "| 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 9,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 2,
        "window_text": "| 2004:50;732-740 | 시험기관의 임상시험계획승인을 받고 실시해야함) | 2) 검체 종류별 사용 가능한 항응고제 | 5) 각 검체를 3회 이상 반복 검사한다.  | 1) 시험할 교차반응물질의 목록을 작성한다.  | 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다.  | 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 있다.  | 설정한다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다. ",
        "original_sentence": "| 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_011",
      "text": "| 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 10,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 34,
        "window_text": "| 1) 시험할 교차반응물질의 목록을 작성한다.  | 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다.  | 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 있다.  | 설정한다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다.  | BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다. ",
        "original_sentence": "| 있다. "
      }
    },
    {
      "chunk_id": "chunk_012",
      "text": "| 설정한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 11,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 30,
        "window_text": "| 2) 표준물질 관리방법 및 관리기록서(정도관리 포함) | 5) ACCURUN 26 Series 5000 ToRCH IgM Positive Control | 확인한 자료 또는 이를 공증한 자료 | 사항이 기재되고 관련 증빙자료를 함께 제출하여야 함 | 라) 반복정밀도 및 검사실내 정밀도 표준편차의 신뢰구간 | 재현성으로 구분하여 평가한다.  | 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 있다.  | 설정한다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다.  | BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다.  | 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다. ",
        "original_sentence": "| 설정한다. "
      }
    },
    {
      "chunk_id": "chunk_013",
      "text": "| □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 12,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 2,
        "window_text": "| 재채취하는지 여부 | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 있다.  | 설정한다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다.  | BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다.  | 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다.  | IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP. ",
        "original_sentence": "| □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_014",
      "text": "| BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 13,
        "window_size": 3,
        "char_count": 297,
        "word_count": 88,
        "page_number": 2,
        "window_text": "| 있다.  | 설정한다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다.  | BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다.  | 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다.  | IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP.  | DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까? ",
        "original_sentence": "| BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_015",
      "text": "| 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 14,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 25,
        "window_text": "| 설정한다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다.  | BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다.  | 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다.  | IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP.  | DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까?  | SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ. ",
        "original_sentence": "| 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_016",
      "text": "| IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 15,
        "window_size": 3,
        "char_count": 85,
        "word_count": 17,
        "page_number": 3,
        "window_text": "| □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | 새 등을 기재한다.  | BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다.  | 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다.  | IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP.  | DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까?  | SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ.  개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가. ",
        "original_sentence": "| IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP. "
      }
    },
    {
      "chunk_id": "chunk_017",
      "text": "| DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까? ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 16,
        "window_size": 3,
        "char_count": 249,
        "word_count": 51,
        "page_number": 12,
        "window_text": "| BIOTEST | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1 | 명칭 | K921616 | K896194 | CAPTIA(R) CMV-G | K801963 | CMV TEST KIT | 돕기 위해 사용되는 것이므로 단순 참고용임 | 하는 경우에는 해당사항을 부가하여 기재한다.  | 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다.  | IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP.  | DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까?  | SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ.  개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가.  시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다. ",
        "original_sentence": "| DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_018",
      "text": "| SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 17,
        "window_size": 3,
        "char_count": 93,
        "word_count": 27,
        "page_number": 3,
        "window_text": "| 장방법 및 사용기간 또는 유효기간을 설정하여 기재한다.  | IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP.  | DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까?  | SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ.  개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가.  시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다.  | 마) 실제 검사일수, 검사실의 수 | 1. ",
        "original_sentence": "| SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ. "
      }
    },
    {
      "chunk_id": "chunk_019",
      "text": "개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 18,
        "window_size": 3,
        "char_count": 151,
        "word_count": 33,
        "page_number": 3,
        "window_text": "| IMMULITE 2000 CMV IGM | ORTHO CMV-G ANTIBODY | UBI MAGIWEL CMV IGG | INCSTAR CORP.  | DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까?  | SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ.  개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가.  시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다.  | 마) 실제 검사일수, 검사실의 수 | 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다. ",
        "original_sentence": "개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가. "
      }
    },
    {
      "chunk_id": "chunk_020",
      "text": "시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 19,
        "window_size": 3,
        "char_count": 149,
        "word_count": 35,
        "page_number": 3,
        "window_text": "| DIAGNOSTICS | UNITED | LABORATORIES | WHITTAKER | BD BECTON | OSTIC | 1988 |\n| K883399 | Influenza A WS | Influenza B Hong Kong | 번호 | 승인일자 | 주요 내용 | IMMUNOSORBENT ASSAY | COPALIS CMV TOTAL | CMV BRITE ANTIGENEMIA | DETECTION KIT | 지침서ㆍ안내서가 있습니까?  | SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ.  개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가.  시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다.  | 마) 실제 검사일수, 검사실의 수 | 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다.  | 또는 양성검체를 희석한 검체 등을 사용한다. ",
        "original_sentence": "시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_021",
      "text": "| 마) 실제 검사일수, 검사실의 수 | 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 20,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| SIENNA | 1992 | 1990 | 1980 |\n| K951550 | K905078 | 명칭 | 배합목적 | 원재료명 또는 성분명 | 분량 | 규격 | Ⅰ.  개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가.  시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다.  | 마) 실제 검사일수, 검사실의 수 | 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD. ",
        "original_sentence": "| 마) 실제 검사일수, 검사실의 수 | 1. "
      }
    },
    {
      "chunk_id": "chunk_022",
      "text": "개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 21,
        "window_size": 3,
        "char_count": 39,
        "word_count": 9,
        "page_number": 30,
        "window_text": "개요 | 1 | ㈜오송진단 | 오송IVD | 고위험성감염체면역검사시약 | CMV | COLORGENE DNA | 원재료명 또는 | DIAGNOSTICS | DIAGNOSTIC |\n| K955799 | K854839 | CYTOMEGELISA M TEST KIT | 가.  시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다.  | 마) 실제 검사일수, 검사실의 수 | 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD.  | BIOTECH INC. ",
        "original_sentence": "개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_023",
      "text": "| 또는 양성검체를 희석한 검체 등을 사용한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 22,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 12,
        "window_text": "시험물질 | 3) 사용되는 검체의 종류별 필요 분량 | 3) 연구인력구성 | 6) ACCURUN 350 Series 300 CMV DNA Positive Control | 1) 완제품 품질관리 시험에 사용된 표준물질에 관한 자료 | 결과 판정상 주의사항을 기재한다.  | 마) 실제 검사일수, 검사실의 수 | 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD.  | BIOTECH INC.  | BIOPRODUCTS | PRODUCTS INC. ",
        "original_sentence": "| 또는 양성검체를 희석한 검체 등을 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_024",
      "text": "| QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 23,
        "window_size": 3,
        "char_count": 56,
        "word_count": 16,
        "page_number": 12,
        "window_text": "| 마) 실제 검사일수, 검사실의 수 | 1.  개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD.  | BIOTECH INC.  | BIOPRODUCTS | PRODUCTS INC.  | 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다. ",
        "original_sentence": "| QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD. "
      }
    },
    {
      "chunk_id": "chunk_025",
      "text": "| BIOTECH INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 24,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 12,
        "window_text": "개발경위, 측정원리·방법 및 국내․외 사용현황에 | 서 | 평가한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD.  | BIOTECH INC.  | BIOPRODUCTS | PRODUCTS INC.  | 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다.  | IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다. ",
        "original_sentence": "| BIOTECH INC. "
      }
    },
    {
      "chunk_id": "chunk_026",
      "text": "| BIOPRODUCTS | PRODUCTS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 25,
        "window_size": 3,
        "char_count": 30,
        "word_count": 5,
        "page_number": 12,
        "window_text": "| 또는 양성검체를 희석한 검체 등을 사용한다.  | QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD.  | BIOTECH INC.  | BIOPRODUCTS | PRODUCTS INC.  | 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다.  | IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다.  | ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC. ",
        "original_sentence": "| BIOPRODUCTS | PRODUCTS INC. "
      }
    },
    {
      "chunk_id": "chunk_027",
      "text": "| 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 26,
        "window_size": 3,
        "char_count": 84,
        "word_count": 21,
        "page_number": 3,
        "window_text": "| QUANTITATIVE | 성분명 | 분량 | 규격 | 비고 | 보존제, 안정제 등 | LTD.  | BIOTECH INC.  | BIOPRODUCTS | PRODUCTS INC.  | 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다.  | IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다.  | ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC.  | PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP. ",
        "original_sentence": "| 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_028",
      "text": "| IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 27,
        "window_size": 3,
        "char_count": 118,
        "word_count": 27,
        "page_number": 22,
        "window_text": "| BIOTECH INC.  | BIOPRODUCTS | PRODUCTS INC.  | 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다.  | IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다.  | ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC.  | PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP.  | SYSTEMS INC. ",
        "original_sentence": "| IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_029",
      "text": "| ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 28,
        "window_size": 3,
        "char_count": 68,
        "word_count": 12,
        "page_number": 12,
        "window_text": "| BIOPRODUCTS | PRODUCTS INC.  | 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다.  | IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다.  | ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC.  | PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP.  | SYSTEMS INC.  | BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다. ",
        "original_sentence": "| ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC. "
      }
    },
    {
      "chunk_id": "chunk_030",
      "text": "| PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 29,
        "window_size": 3,
        "char_count": 141,
        "word_count": 25,
        "page_number": 3,
        "window_text": "| 1989 |\n| 1 | 분석적 성능시험에 관한 자료 | Influenza BMaryland | Influenza B Mass | 사용될 수 있다.  | IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다.  | ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC.  | PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP.  | SYSTEMS INC.  | BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다.  | 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28. ",
        "original_sentence": "| PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP. "
      }
    },
    {
      "chunk_id": "chunk_031",
      "text": "| SYSTEMS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 30,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 12,
        "window_text": "| IMMULITE CMV IGM | (ELISA) FOR THE | TEST KIT | ELISA TEST | ENZO BIOCHEM | DICKINSON | 1996 | 1990 |\n| data를 제시한다.  | ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC.  | PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP.  | SYSTEMS INC.  | BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다.  | 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28.  | 산전검사 중 CMV 검사시약 | INC. ",
        "original_sentence": "| SYSTEMS INC. "
      }
    },
    {
      "chunk_id": "chunk_032",
      "text": "| BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 31,
        "window_size": 3,
        "char_count": 159,
        "word_count": 33,
        "page_number": 3,
        "window_text": "| ANTIBODY ASSAY | CMV LATEX AGGLUTINATION | SIEMENS | BIOTECH INC.  | PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP.  | SYSTEMS INC.  | BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다.  | 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28.  | 산전검사 중 CMV 검사시약 | INC.  | VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다. ",
        "original_sentence": "| BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다. "
      }
    },
    {
      "chunk_id": "chunk_033",
      "text": "| 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 32,
        "window_size": 3,
        "char_count": 50,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| PHARMACIA | 1996 | 1986 |\n| K872576 | (closeness of agreement) | CYTOMEGALOVIRUS | HYBRIDIZATION TEST CMV | CMV BIO-BEAD TITRATION | CORP.  | SYSTEMS INC.  | BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다.  | 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28.  | 산전검사 중 CMV 검사시약 | INC.  | VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다.  | 기술한다. ",
        "original_sentence": "| 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28. "
      }
    },
    {
      "chunk_id": "chunk_034",
      "text": "| 산전검사 중 CMV 검사시약 | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 33,
        "window_size": 3,
        "char_count": 25,
        "word_count": 7,
        "page_number": 1,
        "window_text": "| SYSTEMS INC.  | BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다.  | 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28.  | 산전검사 중 CMV 검사시약 | INC.  | VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다.  | 기술한다.  | 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다. ",
        "original_sentence": "| 산전검사 중 CMV 검사시약 | INC. "
      }
    },
    {
      "chunk_id": "chunk_035",
      "text": "| VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 34,
        "window_size": 3,
        "char_count": 108,
        "word_count": 23,
        "page_number": 3,
        "window_text": "| BAXTER | ELECTRO-NUCL | LITTON |\n| B1-2013-5 | K841520 | Influenza BTaiwan | Influenza B GL | (제조․수입업소명) | (제품명) | (품목명) | (모델명) | 1) CMV 감염이 없는 환자검체를 이용한다.  | 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28.  | 산전검사 중 CMV 검사시약 | INC.  | VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다.  | 기술한다.  | 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다.  | 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ. ",
        "original_sentence": "| VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_036",
      "text": "| 기술한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 35,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 30,
        "window_text": "| 관한 자료 | 34 | CONTROLS AND IMMULITE | 2013.5.28.  | 산전검사 중 CMV 검사시약 | INC.  | VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다.  | 기술한다.  | 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다.  | 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ.  용어의 정의 | 3 | 결과를 비교한다. ",
        "original_sentence": "| 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_037",
      "text": "| 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 36,
        "window_size": 3,
        "char_count": 158,
        "word_count": 35,
        "page_number": 12,
        "window_text": "| 산전검사 중 CMV 검사시약 | INC.  | VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다.  | 기술한다.  | 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다.  | 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ.  용어의 정의 | 3 | 결과를 비교한다.  정량검사의 경우는 bias를 구한다. ",
        "original_sentence": "| 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다. "
      }
    },
    {
      "chunk_id": "chunk_038",
      "text": "| 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 37,
        "window_size": 3,
        "char_count": 55,
        "word_count": 16,
        "page_number": 4,
        "window_text": "| VACUTAINER | 자사 |\n| K921011 | PHARMACIA CMV IGM ELISA | K883102 | VIRGO (R) CMV-IGG ELISA | K801722 | 한다.  | 기술한다.  | 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다.  | 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ.  용어의 정의 | 3 | 결과를 비교한다.  정량검사의 경우는 bias를 구한다.  | 시기를 거친 다음 평가를 수행하도록 한다. ",
        "original_sentence": "| 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ. "
      }
    },
    {
      "chunk_id": "chunk_039",
      "text": "용어의 정의 | 3 | 결과를 비교한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 38,
        "window_size": 3,
        "char_count": 23,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| 기술한다.  | 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다.  | 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ.  용어의 정의 | 3 | 결과를 비교한다.  정량검사의 경우는 bias를 구한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 기술한다. ",
        "original_sentence": "용어의 정의 | 3 | 결과를 비교한다. "
      }
    },
    {
      "chunk_id": "chunk_040",
      "text": "정량검사의 경우는 bias를 구한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 39,
        "window_size": 3,
        "char_count": 21,
        "word_count": 4,
        "page_number": 12,
        "window_text": "| 4) 검체 보관조건, 방법 및 사용기간 등 | 7) ACCURUN 800 ToRCH Serology Negative Control | 2) 검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료 | 때는 가능한 확진방법(Western blot, 염기순서검사)과 비교한다.  | 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ.  용어의 정의 | 3 | 결과를 비교한다.  정량검사의 경우는 bias를 구한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 기술한다.  | 한다. ",
        "original_sentence": "정량검사의 경우는 bias를 구한다. "
      }
    },
    {
      "chunk_id": "chunk_041",
      "text": "| 시기를 거친 다음 평가를 수행하도록 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 40,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 30,
        "window_text": "| 치적으로 제시된 성능 기재 | 게재된 자료 | 바) 총 run의 수(해당된다면 제시) | Ⅱ.  용어의 정의 | 3 | 결과를 비교한다.  정량검사의 경우는 bias를 구한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 기술한다.  | 한다.  | 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다. ",
        "original_sentence": "| 시기를 거친 다음 평가를 수행하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_042",
      "text": "| 기술한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 41,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 30,
        "window_text": "용어의 정의 | 3 | 결과를 비교한다.  정량검사의 경우는 bias를 구한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 기술한다.  | 한다.  | 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다.  | ORGANON | DIAGNOSTICS | ORTHO | INC. ",
        "original_sentence": "| 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_043",
      "text": "| 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 42,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 30,
        "window_text": "정량검사의 경우는 bias를 구한다.  | 시기를 거친 다음 평가를 수행하도록 한다.  | 기술한다.  | 한다.  | 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다.  | ORGANON | DIAGNOSTICS | ORTHO | INC.  | 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC. ",
        "original_sentence": "| 한다. "
      }
    },
    {
      "chunk_id": "chunk_044",
      "text": "| 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 43,
        "window_size": 3,
        "char_count": 42,
        "word_count": 12,
        "page_number": 4,
        "window_text": "| 시기를 거친 다음 평가를 수행하도록 한다.  | 기술한다.  | 한다.  | 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다.  | ORGANON | DIAGNOSTICS | ORTHO | INC.  | 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC.  | BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다. ",
        "original_sentence": "| 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_045",
      "text": "| ORGANON | DIAGNOSTICS | ORTHO | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 44,
        "window_size": 3,
        "char_count": 39,
        "word_count": 8,
        "page_number": 12,
        "window_text": "| 기술한다.  | 한다.  | 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다.  | ORGANON | DIAGNOSTICS | ORTHO | INC.  | 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC.  | BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP. ",
        "original_sentence": "| ORGANON | DIAGNOSTICS | ORTHO | INC. "
      }
    },
    {
      "chunk_id": "chunk_046",
      "text": "| 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 45,
        "window_size": 3,
        "char_count": 287,
        "word_count": 56,
        "page_number": 3,
        "window_text": "| 한다.  | 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다.  | ORGANON | DIAGNOSTICS | ORTHO | INC.  | 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC.  | BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP.  | CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마. ",
        "original_sentence": "| 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC. "
      }
    },
    {
      "chunk_id": "chunk_047",
      "text": "| BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 46,
        "window_size": 3,
        "char_count": 109,
        "word_count": 26,
        "page_number": 3,
        "window_text": "| 알고리즘을 제시 | 근거로 설정된 경우, 해당 자료로 대신할 수 있다.  | ORGANON | DIAGNOSTICS | ORTHO | INC.  | 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC.  | BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP.  | CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다. ",
        "original_sentence": "| BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_048",
      "text": "| INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 47,
        "window_size": 3,
        "char_count": 111,
        "word_count": 23,
        "page_number": 12,
        "window_text": "| ORGANON | DIAGNOSTICS | ORTHO | INC.  | 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC.  | BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP.  | CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다.  | Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다. ",
        "original_sentence": "| INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP. "
      }
    },
    {
      "chunk_id": "chunk_049",
      "text": "| CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 48,
        "window_size": 3,
        "char_count": 74,
        "word_count": 19,
        "page_number": 3,
        "window_text": "| 1987 |\n| K100433 | K983762 | NUCLISENS CMV PP67 | K894002 | 가. WHO international reference preparation3) | 웰1 : 샘플웰 | 검체 | - | FLUORESCENT MONOCLONAL | CONFIRMATION | CYTOMEGALOVIRUS (CMV) | TEST KIT | KIT | 혈색소, 지질, 빌리루빈, 이상 단백질 등 | HEALTHCARE | DIAGNOSTIC | HEALTHCARE | EONICS INC.  | BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP.  | CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다.  | Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다.  (이하생략) | 의 추가 자료로 제시할 수 있다. ",
        "original_sentence": "| CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마. "
      }
    },
    {
      "chunk_id": "chunk_050",
      "text": "체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 49,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 1,
        "window_text": "| BIONETICS | 1989 | 1984 | 1980 | - |\n| Influenza BRussia | Influenza A PR | 2) 교차반응을 보이는 물질의 종류와 빈도를 제시한다.  | INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP.  | CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다.  | Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다.  (이하생략) | 의 추가 자료로 제시할 수 있다.  | 위양성도 및 위음성도) 등을 기재한다. ",
        "original_sentence": "체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_051",
      "text": "| Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 50,
        "window_size": 3,
        "char_count": 200,
        "word_count": 40,
        "page_number": 12,
        "window_text": "| INCSTAR CYTOMEGALOVIRUS | ORTHO CMV-M ANTIBODY | 1992 |\n| ※ 별첨 기재시의 예 | 200 CMV IGM ADJUSTOR | TEKNIKA CORP.  | CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다.  | Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다.  (이하생략) | 의 추가 자료로 제시할 수 있다.  | 위양성도 및 위음성도) 등을 기재한다.  | 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2. ",
        "original_sentence": "| Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다. "
      }
    },
    {
      "chunk_id": "chunk_052",
      "text": "(이하생략) | 의 추가 자료로 제시할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 51,
        "window_size": 3,
        "char_count": 28,
        "word_count": 8,
        "page_number": 4,
        "window_text": "| CLINICAL | SYSTEMS | 규격 | 2010 | 1999 | 1989 |\n| K955361 | K905077 | 마.  체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다.  | Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다.  (이하생략) | 의 추가 자료로 제시할 수 있다.  | 위양성도 및 위음성도) 등을 기재한다.  | 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2.  원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다. ",
        "original_sentence": "(이하생략) | 의 추가 자료로 제시할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_053",
      "text": "| 위양성도 및 위음성도) 등을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 52,
        "window_size": 3,
        "char_count": 24,
        "word_count": 6,
        "page_number": 12,
        "window_text": "체외진단용 의료기기의 취급자 안전에 관한 자료 | 료를 포함한다.  | Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다.  (이하생략) | 의 추가 자료로 제시할 수 있다.  | 위양성도 및 위음성도) 등을 기재한다.  | 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2.  원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다.  | 실시하는 것을 권장한다. ",
        "original_sentence": "| 위양성도 및 위음성도) 등을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_054",
      "text": "| 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 53,
        "window_size": 3,
        "char_count": 43,
        "word_count": 12,
        "page_number": 12,
        "window_text": "| Influenza A WS | Influenza B Hong Kong | Laboratory Standard Institute; 2010 | -005 | 5) 냉동 및 해동된 검체의 사용 가능성 및 제한점 | 8) ACCURUN 810 Multi-Analyte Serology Negative Control | 장비대증, 간질폐렴 등의 증상을 유발한다.  (이하생략) | 의 추가 자료로 제시할 수 있다.  | 위양성도 및 위음성도) 등을 기재한다.  | 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2.  원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다.  | 실시하는 것을 권장한다.  | (사유 :                                                      ) | 이상의 검체 사용을 권장한다. ",
        "original_sentence": "| 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2. "
      }
    },
    {
      "chunk_id": "chunk_055",
      "text": "원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 54,
        "window_size": 3,
        "char_count": 40,
        "word_count": 13,
        "page_number": 3,
        "window_text": "(이하생략) | 의 추가 자료로 제시할 수 있다.  | 위양성도 및 위음성도) 등을 기재한다.  | 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2.  원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다.  | 실시하는 것을 권장한다.  | (사유 :                                                      ) | 이상의 검체 사용을 권장한다.  | 제시한다. ",
        "original_sentence": "원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_056",
      "text": "| 실시하는 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 55,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 30,
        "window_text": "| 위양성도 및 위음성도) 등을 기재한다.  | 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2.  원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다.  | 실시하는 것을 권장한다.  | (사유 :                                                      ) | 이상의 검체 사용을 권장한다.  | 제시한다.  | INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP. ",
        "original_sentence": "| 실시하는 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_057",
      "text": "| (사유 :                                                      ) | 이상의 검체 사용을 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 56,
        "window_size": 3,
        "char_count": 82,
        "word_count": 9,
        "page_number": 1,
        "window_text": "| 정보가 기재되어야 함 | 사) 총 관찰치의 수: optional | 2.  원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다.  | 실시하는 것을 권장한다.  | (사유 :                                                      ) | 이상의 검체 사용을 권장한다.  | 제시한다.  | INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP.  | INC. ",
        "original_sentence": "| (사유 :                                                      ) | 이상의 검체 사용을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_058",
      "text": "| 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 57,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 24,
        "window_text": "원재료 및 제조방법에 관한 자료 | 35 | 된 자료 | 을 제공한다.  | 실시하는 것을 권장한다.  | (사유 :                                                      ) | 이상의 검체 사용을 권장한다.  | 제시한다.  | INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP.  | INC.  | DIAGNOSTIC | STELLAR BIO | INTL. ",
        "original_sentence": "| 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_059",
      "text": "| INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 58,
        "window_size": 3,
        "char_count": 55,
        "word_count": 11,
        "page_number": 7,
        "window_text": "| 실시하는 것을 권장한다.  | (사유 :                                                      ) | 이상의 검체 사용을 권장한다.  | 제시한다.  | INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP.  | INC.  | DIAGNOSTIC | STELLAR BIO | INTL.  |\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다. ",
        "original_sentence": "| INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP. "
      }
    },
    {
      "chunk_id": "chunk_060",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 59,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| (사유 :                                                      ) | 이상의 검체 사용을 권장한다.  | 제시한다.  | INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP.  | INC.  | DIAGNOSTIC | STELLAR BIO | INTL.  |\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다.  | and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_061",
      "text": "| DIAGNOSTIC | STELLAR BIO | INTL. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 60,
        "window_size": 3,
        "char_count": 35,
        "word_count": 7,
        "page_number": 12,
        "window_text": "| 제시한다.  | INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP.  | INC.  | DIAGNOSTIC | STELLAR BIO | INTL.  |\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다.  | and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다.  | 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다. ",
        "original_sentence": "| DIAGNOSTIC | STELLAR BIO | INTL. "
      }
    },
    {
      "chunk_id": "chunk_062",
      "text": "|\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 61,
        "window_size": 3,
        "char_count": 56,
        "word_count": 13,
        "page_number": 4,
        "window_text": "| INDIRECT FLUORESCENT | 제정 | 허가심가 가이드 | INCSTAR CORP.  | INC.  | DIAGNOSTIC | STELLAR BIO | INTL.  |\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다.  | and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다.  | 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.  | 한다. ",
        "original_sentence": "|\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_063",
      "text": "| and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 62,
        "window_size": 3,
        "char_count": 61,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| INC.  | DIAGNOSTIC | STELLAR BIO | INTL.  |\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다.  | and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다.  | 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.  | 한다.  | ANTIBODY | ELISA TEST SYS. ",
        "original_sentence": "| and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다. "
      }
    },
    {
      "chunk_id": "chunk_064",
      "text": "| 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 63,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 19,
        "window_text": "| DIAGNOSTIC | STELLAR BIO | INTL.  |\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다.  | and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다.  | 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.  | 한다.  | ANTIBODY | ELISA TEST SYS.  CAT. ",
        "original_sentence": "| 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_065",
      "text": "| 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 64,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 30,
        "window_text": "|\n| K950672 | IMMULITE CMV IGG | K854666 | 료로 제출하여야 한다.  | and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다.  | 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.  | 한다.  | ANTIBODY | ELISA TEST SYS.  CAT.  | DIAGNOSTICS | PRODUCTS | CORP. ",
        "original_sentence": "| 한다. "
      }
    },
    {
      "chunk_id": "chunk_066",
      "text": "| ANTIBODY | ELISA TEST SYS. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 65,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 12,
        "window_text": "| and Laboratory Standard Institute; 2009 | 와 ISO에서 사용되고 있다.  | 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.  | 한다.  | ANTIBODY | ELISA TEST SYS.  CAT.  | DIAGNOSTICS | PRODUCTS | CORP.  |\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP. ",
        "original_sentence": "| ANTIBODY | ELISA TEST SYS. "
      }
    },
    {
      "chunk_id": "chunk_067",
      "text": "CAT. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 66,
        "window_size": 3,
        "char_count": 5,
        "word_count": 1,
        "page_number": 83,
        "window_text": "| 별표 2] 또는 이와 동등이상 규격의 멸균방법을 기재한다.  | 한다.  | ANTIBODY | ELISA TEST SYS.  CAT.  | DIAGNOSTICS | PRODUCTS | CORP.  |\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP.  | 제조국을 추가로 기재한다. ",
        "original_sentence": "CAT. "
      }
    },
    {
      "chunk_id": "chunk_068",
      "text": "| DIAGNOSTICS | PRODUCTS | CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 67,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 12,
        "window_text": "| 한다.  | ANTIBODY | ELISA TEST SYS.  CAT.  | DIAGNOSTICS | PRODUCTS | CORP.  |\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP.  | 제조국을 추가로 기재한다.  | Ⅲ. ",
        "original_sentence": "| DIAGNOSTICS | PRODUCTS | CORP. "
      }
    },
    {
      "chunk_id": "chunk_069",
      "text": "|\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 68,
        "window_size": 3,
        "char_count": 60,
        "word_count": 12,
        "page_number": 3,
        "window_text": "| ANTIBODY | ELISA TEST SYS.  CAT.  | DIAGNOSTICS | PRODUCTS | CORP.  |\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP.  | 제조국을 추가로 기재한다.  | Ⅲ.  관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL. ",
        "original_sentence": "|\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP. "
      }
    },
    {
      "chunk_id": "chunk_070",
      "text": "| 제조국을 추가로 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 69,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 25,
        "window_text": "CAT.  | DIAGNOSTICS | PRODUCTS | CORP.  |\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP.  | 제조국을 추가로 기재한다.  | Ⅲ.  관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL.  | PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC. ",
        "original_sentence": "| 제조국을 추가로 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_071",
      "text": "| Ⅲ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 70,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| DIAGNOSTICS | PRODUCTS | CORP.  |\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP.  | 제조국을 추가로 기재한다.  | Ⅲ.  관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL.  | PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC.  | SYSTEMS INC. ",
        "original_sentence": "| Ⅲ. "
      }
    },
    {
      "chunk_id": "chunk_072",
      "text": "관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 71,
        "window_size": 3,
        "char_count": 98,
        "word_count": 23,
        "page_number": 3,
        "window_text": "|\n| K882835 | K871832 | CMV IGM MICROASSAY | DIAMEDIX CORP.  | 제조국을 추가로 기재한다.  | Ⅲ.  관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL.  | PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC.  | SYSTEMS INC.  | SCIENCES INC. ",
        "original_sentence": "관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL. "
      }
    },
    {
      "chunk_id": "chunk_073",
      "text": "| PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 72,
        "window_size": 3,
        "char_count": 162,
        "word_count": 33,
        "page_number": 3,
        "window_text": "| 제조국을 추가로 기재한다.  | Ⅲ.  관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL.  | PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC.  | SYSTEMS INC.  | SCIENCES INC.  | DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바. ",
        "original_sentence": "| PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC. "
      }
    },
    {
      "chunk_id": "chunk_074",
      "text": "| SYSTEMS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 73,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 12,
        "window_text": "| Ⅲ.  관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL.  | PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC.  | SYSTEMS INC.  | SCIENCES INC.  | DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바.  이미 허가·인증받은 제품과 비교한 자료 | 나. ",
        "original_sentence": "| SYSTEMS INC. "
      }
    },
    {
      "chunk_id": "chunk_075",
      "text": "| SCIENCES INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 74,
        "window_size": 3,
        "char_count": 16,
        "word_count": 3,
        "page_number": 12,
        "window_text": "관련 규정 | 13 | MODEL L2KCM2 L2KCM6 | IGG ELISA ASSAY | ELISA TEST | FIAX TEST KIT FOR | QUEST INTL.  | PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC.  | SYSTEMS INC.  | SCIENCES INC.  | DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바.  이미 허가·인증받은 제품과 비교한 자료 | 나.  시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다. ",
        "original_sentence": "| SCIENCES INC. "
      }
    },
    {
      "chunk_id": "chunk_076",
      "text": "| DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 75,
        "window_size": 3,
        "char_count": 108,
        "word_count": 26,
        "page_number": 3,
        "window_text": "| PREANALYTIC | 1996 | 1996 | 1990 |\n| K791948 | Influenza BMaryland | Influenza B Mass | CMV IGG ANTIBODY TEST | ASSAY FOR (HCMV) | VITEK SYSTEMS | SYSTEMS INC.  | SYSTEMS INC.  | SCIENCES INC.  | DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바.  이미 허가·인증받은 제품과 비교한 자료 | 나.  시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다.  | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다. ",
        "original_sentence": "| DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바. "
      }
    },
    {
      "chunk_id": "chunk_077",
      "text": "이미 허가·인증받은 제품과 비교한 자료 | 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 76,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 4,
        "window_text": "| SYSTEMS INC.  | SCIENCES INC.  | DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바.  이미 허가·인증받은 제품과 비교한 자료 | 나.  시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다.  | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다.  | 아) 시약 lot의 수 | 3. ",
        "original_sentence": "이미 허가·인증받은 제품과 비교한 자료 | 나. "
      }
    },
    {
      "chunk_id": "chunk_078",
      "text": "시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 77,
        "window_size": 3,
        "char_count": 39,
        "word_count": 11,
        "page_number": 2,
        "window_text": "| SCIENCES INC.  | DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바.  이미 허가·인증받은 제품과 비교한 자료 | 나.  시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다.  | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다.  | 아) 시약 lot의 수 | 3.  사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다. ",
        "original_sentence": "시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_079",
      "text": "| 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 78,
        "window_size": 3,
        "char_count": 125,
        "word_count": 29,
        "page_number": 24,
        "window_text": "| DIAGNOSTIC | 자사 | 1988 | 1987 | 1986 |\n| K982485 | SERAQUEST CMV IGM | K920661 | VIDAS CMV IGG ASSAY | 바.  이미 허가·인증받은 제품과 비교한 자료 | 나.  시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다.  | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다.  | 아) 시약 lot의 수 | 3.  사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다. ",
        "original_sentence": "| 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_080",
      "text": "| 아) 시약 lot의 수 | 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 79,
        "window_size": 3,
        "char_count": 20,
        "word_count": 7,
        "page_number": 3,
        "window_text": "이미 허가·인증받은 제품과 비교한 자료 | 나.  시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다.  | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다.  | 아) 시약 lot의 수 | 3.  사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다.  | 자료를 포함해야 한다. ",
        "original_sentence": "| 아) 시약 lot의 수 | 3. "
      }
    },
    {
      "chunk_id": "chunk_081",
      "text": "사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 80,
        "window_size": 3,
        "char_count": 50,
        "word_count": 15,
        "page_number": 3,
        "window_text": "시험물질 | 명칭 | 호와 주소)을 확인할 수 있는 자료도 포함한다.  | 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다.  | 아) 시약 lot의 수 | 3.  사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다.  | 자료를 포함해야 한다.  | ｢ | 의료기기법 시행규칙｣ | CORP. ",
        "original_sentence": "사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_082",
      "text": "| □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 81,
        "window_size": 3,
        "char_count": 55,
        "word_count": 14,
        "page_number": 2,
        "window_text": "| 6) 원심분리 조건 등을 포함한 검체 전처리과정 등 | 4) 시험자의 연구경력 | 9) Anti-CMV Mixed Titer Performance Panel | 라) 각 장소마다 다수의 검사자가 평가에 참여하도록 한다.  | 아) 시약 lot의 수 | 3.  사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다.  | 자료를 포함해야 한다.  | ｢ | 의료기기법 시행규칙｣ | CORP.  | BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다. ",
        "original_sentence": "| □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다. "
      }
    },
    {
      "chunk_id": "chunk_083",
      "text": "| 자료를 포함해야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 82,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 4,
        "window_text": "| 아) 시약 lot의 수 | 3.  사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다.  | 자료를 포함해야 한다.  | ｢ | 의료기기법 시행규칙｣ | CORP.  | BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다.  | Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까? ",
        "original_sentence": "| 자료를 포함해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_084",
      "text": "| ｢ | 의료기기법 시행규칙｣ | CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 83,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 7,
        "window_text": "사용목적에 관한 자료 | 36 | 성능 배제 | 및 보정결과 확인 절차에 대해 제시한다.  | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다.  | 자료를 포함해야 한다.  | ｢ | 의료기기법 시행규칙｣ | CORP.  | BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다.  | Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까?  | INC. ",
        "original_sentence": "| ｢ | 의료기기법 시행규칙｣ | CORP. "
      }
    },
    {
      "chunk_id": "chunk_085",
      "text": "| BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 84,
        "window_size": 3,
        "char_count": 277,
        "word_count": 64,
        "page_number": 4,
        "window_text": "| □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 | 로 설정할 경우, 결과 분포 및 설정 방법을 명시한다.  | 자료를 포함해야 한다.  | ｢ | 의료기기법 시행규칙｣ | CORP.  | BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다.  | Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까?  | INC.  | INC. ",
        "original_sentence": "| BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_086",
      "text": "| Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까? ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 85,
        "window_size": 3,
        "char_count": 126,
        "word_count": 21,
        "page_number": 3,
        "window_text": "| 자료를 포함해야 한다.  | ｢ | 의료기기법 시행규칙｣ | CORP.  | BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다.  | Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까?  | INC.  | INC.  | WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다. ",
        "original_sentence": "| Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_087",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 86,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| ｢ | 의료기기법 시행규칙｣ | CORP.  | BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다.  | Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까?  | INC.  | INC.  | WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다.  | 적용할 수 있는 시험규격을 명시한다. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_088",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 87,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| BIOMEDICAL | - | 및 ｢ |\n| 웰2 : 희석웰 | Tween-60 phosphate  적량 | NO:4530 | CYTOMEGALOVIRUS | ANTI-CYTOMEGALORIRUS | IMMUNO | CLINICAL | □ 예 | ■ 아니오 | 100ul | 1979 |\n| B1-2015-5 | ※ 설명 | 시험항목 | 시험기준 | 시험방법 | Influenza BTaiwan | Influenza B GL | 규격에 따른 시험 성적서를 제출하여 제품의 균일성을 제시한다.  | Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까?  | INC.  | INC.  | WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다.  | 적용할 수 있는 시험규격을 명시한다.  | (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_089",
      "text": "| WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 88,
        "window_size": 3,
        "char_count": 79,
        "word_count": 19,
        "page_number": 3,
        "window_text": "| Chorus cytomegalovirus IgG/IgM | LCMC1 LCMC2 | CYTOMEGALOVIRUS (CMV) | MONABRITE | 행정규칙(고시ㆍ훈령ㆍ예규)의 내용을 단순 편집 또는 나열한 | 것입니까?  | INC.  | INC.  | WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다.  | 적용할 수 있는 시험규격을 명시한다.  | (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1.  품목명: 고위험성감염체면역검사시약 | Ⅳ. ",
        "original_sentence": "| WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다. "
      }
    },
    {
      "chunk_id": "chunk_090",
      "text": "| 적용할 수 있는 시험규격을 명시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 89,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 25,
        "window_text": "| INC.  | INC.  | WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다.  | 적용할 수 있는 시험규격을 명시한다.  | (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1.  품목명: 고위험성감염체면역검사시약 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 14 | 4. ",
        "original_sentence": "| 적용할 수 있는 시험규격을 명시한다. "
      }
    },
    {
      "chunk_id": "chunk_091",
      "text": "| (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 90,
        "window_size": 3,
        "char_count": 69,
        "word_count": 14,
        "page_number": 12,
        "window_text": "| INC.  | WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다.  | 적용할 수 있는 시험규격을 명시한다.  | (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1.  품목명: 고위험성감염체면역검사시약 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 14 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2. ",
        "original_sentence": "| (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1. "
      }
    },
    {
      "chunk_id": "chunk_092",
      "text": "품목명: 고위험성감염체면역검사시약 | Ⅳ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 91,
        "window_size": 3,
        "char_count": 24,
        "word_count": 4,
        "page_number": 19,
        "window_text": "| WHITTAKER | SERONO | 1999 | 1993 | Italy |\n| K893468 | K833089 | 것을 목적으로 한다.  | 적용할 수 있는 시험규격을 명시한다.  | (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1.  품목명: 고위험성감염체면역검사시약 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 14 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2.  | 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC. ",
        "original_sentence": "품목명: 고위험성감염체면역검사시약 | Ⅳ. "
      }
    },
    {
      "chunk_id": "chunk_093",
      "text": "신청서 기재 항목 및 기술문서 제출자료 | 14 | 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 92,
        "window_size": 3,
        "char_count": 32,
        "word_count": 10,
        "page_number": 2,
        "window_text": "| 적용할 수 있는 시험규격을 명시한다.  | (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1.  품목명: 고위험성감염체면역검사시약 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 14 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2.  | 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC.  | DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP. ",
        "original_sentence": "신청서 기재 항목 및 기술문서 제출자료 | 14 | 4. "
      }
    },
    {
      "chunk_id": "chunk_094",
      "text": "저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 93,
        "window_size": 3,
        "char_count": 91,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| (INDIRECT FLUORESCENT | HEMAGEN | TECHNOLOGY | 규격 |\n| K904456 | 1.  품목명: 고위험성감염체면역검사시약 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 14 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2.  | 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC.  | DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP.  | 나. ",
        "original_sentence": "저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2. "
      }
    },
    {
      "chunk_id": "chunk_095",
      "text": "| 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 94,
        "window_size": 3,
        "char_count": 37,
        "word_count": 8,
        "page_number": 7,
        "window_text": "품목명: 고위험성감염체면역검사시약 | Ⅳ.  신청서 기재 항목 및 기술문서 제출자료 | 14 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2.  | 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC.  | DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP.  | 나.  검사 전 준비사항 | 가. ",
        "original_sentence": "| 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC. "
      }
    },
    {
      "chunk_id": "chunk_096",
      "text": "| DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 95,
        "window_size": 3,
        "char_count": 53,
        "word_count": 12,
        "page_number": 3,
        "window_text": "신청서 기재 항목 및 기술문서 제출자료 | 14 | 4.  저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2.  | 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC.  | DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP.  | 나.  검사 전 준비사항 | 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다. ",
        "original_sentence": "| DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP. "
      }
    },
    {
      "chunk_id": "chunk_097",
      "text": "| 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 96,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 36,
        "window_text": "저장방법 및 사용기간(유효기간)에 관한 자료 | 36 | INCSTAR CYTOMEGALOVIRUS | FITC MURINE MONOCLONAL | 2015.2.  | 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC.  | DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP.  | 나.  검사 전 준비사항 | 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 요인이다. ",
        "original_sentence": "| 나. "
      }
    },
    {
      "chunk_id": "chunk_098",
      "text": "검사 전 준비사항 | 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 97,
        "window_size": 3,
        "char_count": 15,
        "word_count": 5,
        "page_number": 2,
        "window_text": "| 허가․신고․심사 등에 관한 규정｣ | VIROTECH INC.  | DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP.  | 나.  검사 전 준비사항 | 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 요인이다.  | 해 결정되는)의 유병률에 맞추어 해석해야 한다. ",
        "original_sentence": "검사 전 준비사항 | 가. "
      }
    },
    {
      "chunk_id": "chunk_099",
      "text": "전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 98,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 12,
        "window_text": "| DIAGNOSIS |\n| K853989 | COR DOT CMV | CORDIS CORP.  | 나.  검사 전 준비사항 | 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 요인이다.  | 해 결정되는)의 유병률에 맞추어 해석해야 한다.  | 장한다. ",
        "original_sentence": "전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_100",
      "text": "| 요인이다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 99,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 9,
        "window_text": "| 나.  검사 전 준비사항 | 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 요인이다.  | 해 결정되는)의 유병률에 맞추어 해석해야 한다.  | 장한다.  | Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다. ",
        "original_sentence": "| 요인이다. "
      }
    },
    {
      "chunk_id": "chunk_101",
      "text": "| 해 결정되는)의 유병률에 맞추어 해석해야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 100,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 12,
        "window_text": "검사 전 준비사항 | 가.  전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 요인이다.  | 해 결정되는)의 유병률에 맞추어 해석해야 한다.  | 장한다.  | Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다. ",
        "original_sentence": "| 해 결정되는)의 유병률에 맞추어 해석해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_102",
      "text": "| 장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 101,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 30,
        "window_text": "전체 결과 및 특이 환자 그룹이 있다면 그룹별 결과를 제시한다.  | 요인이다.  | 해 결정되는)의 유병률에 맞추어 해석해야 한다.  | 장한다.  | Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다.  | 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다. ",
        "original_sentence": "| 장한다. "
      }
    },
    {
      "chunk_id": "chunk_103",
      "text": "| Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 102,
        "window_size": 3,
        "char_count": 162,
        "word_count": 34,
        "page_number": 12,
        "window_text": "| 요인이다.  | 해 결정되는)의 유병률에 맞추어 해석해야 한다.  | 장한다.  | Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다.  | 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다.  | BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC. ",
        "original_sentence": "| Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다. "
      }
    },
    {
      "chunk_id": "chunk_104",
      "text": "| 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 103,
        "window_size": 3,
        "char_count": 57,
        "word_count": 16,
        "page_number": 38,
        "window_text": "| 해 결정되는)의 유병률에 맞추어 해석해야 한다.  | 장한다.  | Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다.  | 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다.  | BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC.  | SCIENCES INC. ",
        "original_sentence": "| 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_105",
      "text": "| 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 104,
        "window_size": 3,
        "char_count": 50,
        "word_count": 12,
        "page_number": 12,
        "window_text": "| 장한다.  | Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다.  | 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다.  | BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC.  | SCIENCES INC.  | 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다. ",
        "original_sentence": "| 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다. "
      }
    },
    {
      "chunk_id": "chunk_106",
      "text": "| BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 105,
        "window_size": 3,
        "char_count": 94,
        "word_count": 17,
        "page_number": 12,
        "window_text": "| Influenza BRussia | RSV Long | 4) 결과제시 | 2) 시험물질 | 10) Anti-CMV Qualification Panel | 자) Calibration 시행 횟수와 calibrator lot의 수 | 검사할 경우도 최소 5일 이상 검체를 나누어서 검사한다.  | 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다.  | 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다.  | BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC.  | SCIENCES INC.  | 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다.  | 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다. ",
        "original_sentence": "| BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC. "
      }
    },
    {
      "chunk_id": "chunk_107",
      "text": "| SCIENCES INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 106,
        "window_size": 3,
        "char_count": 16,
        "word_count": 3,
        "page_number": 12,
        "window_text": "| 을 검토하여 타당하다고 인정할 수 있는 시험성적서 | 날 수 있는 고농도를 사용할 것을 권장한다.  | 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다.  | BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC.  | SCIENCES INC.  | 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다.  | 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다.  | 전자적 기록매체(CD·디스켓 등)와 함께 제출한다. ",
        "original_sentence": "| SCIENCES INC. "
      }
    },
    {
      "chunk_id": "chunk_108",
      "text": "| 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 107,
        "window_size": 3,
        "char_count": 91,
        "word_count": 22,
        "page_number": 2,
        "window_text": "| 제품 안전성 및 성능과 관련된 유해사례보고 요약 | plasmid 등을 이용가능하다.  | BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC.  | SCIENCES INC.  | 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다.  | 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다.  | 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP. ",
        "original_sentence": "| 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_109",
      "text": "| 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 108,
        "window_size": 3,
        "char_count": 62,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| BARTELS CINAKIT CMV | HEALTHTEST ASSAY FOR | ANTIBODY FLUORO-KIT II | AKERS | CONCEPTS INC.  | SCIENCES INC.  | 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다.  | 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다.  | 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP.  | BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2. ",
        "original_sentence": "| 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_110",
      "text": "| 전자적 기록매체(CD·디스켓 등)와 함께 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 109,
        "window_size": 3,
        "char_count": 31,
        "word_count": 6,
        "page_number": 30,
        "window_text": "| SCIENCES INC.  | 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다.  | 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다.  | 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP.  | BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2.  모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
        "original_sentence": "| 전자적 기록매체(CD·디스켓 등)와 함께 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_111",
      "text": "| 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 110,
        "window_size": 3,
        "char_count": 98,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| 1989 | 1984 |\n| 등록대상 | K955360 | K882024 | K864565 | - 제조자와 제조의뢰자가 다른 경우, 구분하여 기재하여야 한다.  | 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다.  | 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP.  | BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2.  모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP. ",
        "original_sentence": "| 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP. "
      }
    },
    {
      "chunk_id": "chunk_112",
      "text": "| BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 111,
        "window_size": 3,
        "char_count": 129,
        "word_count": 27,
        "page_number": 3,
        "window_text": "| 고, 임상적 성능시험 실시기관의 임상시험계획승인을 받고 실시해야함) | -186 | 등이 포함되도록 한다.  | 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP.  | BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2.  모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP.  | DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다. ",
        "original_sentence": "| BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2. "
      }
    },
    {
      "chunk_id": "chunk_113",
      "text": "모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 112,
        "window_size": 3,
        "char_count": 42,
        "word_count": 10,
        "page_number": 2,
        "window_text": "| 전자적 기록매체(CD·디스켓 등)와 함께 제출한다.  | 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP.  | BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2.  모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP.  | DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다.  | 장 간에 동등한 성능을 확인하도록 한다. ",
        "original_sentence": "모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_114",
      "text": "| □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 113,
        "window_size": 3,
        "char_count": 87,
        "word_count": 20,
        "page_number": 2,
        "window_text": "| 10.2138 | Liaison CMV IgG/IgM | LIAISON | Italy | ELISA | CYTOMEGALOVIRUS (CMV) | INCSTAR CORP.  | BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2.  모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP.  | DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다.  | 장 간에 동등한 성능을 확인하도록 한다.  | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP. "
      }
    },
    {
      "chunk_id": "chunk_115",
      "text": "| DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 114,
        "window_size": 3,
        "char_count": 275,
        "word_count": 73,
        "page_number": 3,
        "window_text": "| BIOPRODUCTS | DIAGNOSTICS | LITTON | 1991 |\n| K982311 | K944438 | HEMAGEN CMV IGG KIT | K791612 | CMV BIO-BEAD SCREEN KIT | 2.  모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP.  | DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다.  | 장 간에 동등한 성능을 확인하도록 한다.  | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다. ",
        "original_sentence": "| DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_116",
      "text": "| 장 간에 동등한 성능을 확인하도록 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 115,
        "window_size": 3,
        "char_count": 25,
        "word_count": 7,
        "page_number": 28,
        "window_text": "모델명: CMV | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP.  | DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다.  | 장 간에 동등한 성능을 확인하도록 한다.  | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다.  | 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1. ",
        "original_sentence": "| 장 간에 동등한 성능을 확인하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_117",
      "text": "| 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 116,
        "window_size": 3,
        "char_count": 67,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| □ 예 | ■ 아니오 | ATHENA MULTI-LYTE TORCH | TEST) | ANTI-CMV IGG | ZEUS | INTRACEL CORP.  | DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다.  | 장 간에 동등한 성능을 확인하도록 한다.  | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다.  | 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1.  제조․수입허가신청서 | 14 | 5. ",
        "original_sentence": "| 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_118",
      "text": "| 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 117,
        "window_size": 3,
        "char_count": 61,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| DIAGNOSTICS | ABBOTT | 자사 | 1988 | 1987 | 1986 |\n| 2 | 임상적 성능시험에 관한 자료 | K920222 | RSV Wash | RSV 9320 | 튜브 내 이물질 유무, 라벨 인쇄 | IGG FAST ELISA ASSAY | ANTIBODY TO | 개정사항 반영 | RESEARCH | BAXTER | 1996 |\n| K093784 | K832221 | YBBOTT CMV TOTAL AB EIA | ※ 예시 | 여부 | 간을 제시할 수 있다.  | 장 간에 동등한 성능을 확인하도록 한다.  | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다.  | 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1.  제조․수입허가신청서 | 14 | 5.  제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다. ",
        "original_sentence": "| 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_119",
      "text": "| 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 118,
        "window_size": 3,
        "char_count": 36,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| 장 간에 동등한 성능을 확인하도록 한다.  | 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다.  | 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1.  제조․수입허가신청서 | 14 | 5.  제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다.  | 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등). ",
        "original_sentence": "| 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1. "
      }
    },
    {
      "chunk_id": "chunk_120",
      "text": "제조․수입허가신청서 | 14 | 5. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 119,
        "window_size": 3,
        "char_count": 21,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| 3) 제조국에서 사용되지 않는 경우는 그 사유 | 3) 2개 이상의 독립된 검사실에서 검사를 시행할 것을 권장한다.  | 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다.  | 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1.  제조․수입허가신청서 | 14 | 5.  제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다.  | 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등).  | 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다. ",
        "original_sentence": "제조․수입허가신청서 | 14 | 5. "
      }
    },
    {
      "chunk_id": "chunk_121",
      "text": "제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 120,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 11) CMV DNA Linearity Panel | 특이도 자료 대신에 상관성 자료를 제출할 수 있다.  | 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1.  제조․수입허가신청서 | 14 | 5.  제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다.  | 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등).  | 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다.  | 경우에는 설정근거를 제시한다. ",
        "original_sentence": "제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다. "
      }
    },
    {
      "chunk_id": "chunk_122",
      "text": "| 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등). ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 121,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 4,
        "window_text": "| 제품의 특성에 맞는 성능을 구체적 근거 자료로 제시 | 1.  제조․수입허가신청서 | 14 | 5.  제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다.  | 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등).  | 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다.  | 경우에는 설정근거를 제시한다.  | ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC. ",
        "original_sentence": "| 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등). "
      }
    },
    {
      "chunk_id": "chunk_123",
      "text": "| 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 122,
        "window_size": 3,
        "char_count": 79,
        "word_count": 17,
        "page_number": 3,
        "window_text": "제조․수입허가신청서 | 14 | 5.  제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다.  | 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등).  | 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다.  | 경우에는 설정근거를 제시한다.  | ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC.  | INC. ",
        "original_sentence": "| 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다. "
      }
    },
    {
      "chunk_id": "chunk_124",
      "text": "| 경우에는 설정근거를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 123,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 24,
        "window_text": "제품의 성능을 확인하기 위한 자료 | 37 | test)를 실시한다.  | 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등).  | 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다.  | 경우에는 설정근거를 제시한다.  | ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC.  | INC.  | BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가. ",
        "original_sentence": "| 경우에는 설정근거를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_125",
      "text": "| ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 124,
        "window_size": 3,
        "char_count": 64,
        "word_count": 14,
        "page_number": 12,
        "window_text": "| 확인하였음을 기술한 자료나 음성임을 확인 가능한 서류 등).  | 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다.  | 경우에는 설정근거를 제시한다.  | ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC.  | INC.  | BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가.  시험물질 | 나. NIBSC의 관련 표준물질 | 3. ",
        "original_sentence": "| ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC. "
      }
    },
    {
      "chunk_id": "chunk_126",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 125,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 웰3 : 전세척웰 | Tris-Cl | 적량 | Radim cytomegalovirus IgG/IgM EIA | 되도록 계획을 수립한다.  | 경우에는 설정근거를 제시한다.  | ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC.  | INC.  | BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가.  시험물질 | 나. NIBSC의 관련 표준물질 | 3.  품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_127",
      "text": "| BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 126,
        "window_size": 3,
        "char_count": 80,
        "word_count": 22,
        "page_number": 3,
        "window_text": "| 경우에는 설정근거를 제시한다.  | ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC.  | INC.  | BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가.  시험물질 | 나. NIBSC의 관련 표준물질 | 3.  품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP.  | Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다. ",
        "original_sentence": "| BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가. "
      }
    },
    {
      "chunk_id": "chunk_128",
      "text": "시험물질 | 나. NIBSC의 관련 표준물질 | 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 127,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| ANTIGENEMIA | CMV IGG ANTIBODY TEST | IFA KIT | IMMUNO | INC.  | INC.  | BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가.  시험물질 | 나. NIBSC의 관련 표준물질 | 3.  품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP.  | Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다.  | well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC. ",
        "original_sentence": "시험물질 | 나. NIBSC의 관련 표준물질 | 3. "
      }
    },
    {
      "chunk_id": "chunk_129",
      "text": "품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 128,
        "window_size": 3,
        "char_count": 114,
        "word_count": 22,
        "page_number": 3,
        "window_text": "| INC.  | BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가.  시험물질 | 나. NIBSC의 관련 표준물질 | 3.  품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP.  | Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다.  | well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC.  | INC. ",
        "original_sentence": "품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP. "
      }
    },
    {
      "chunk_id": "chunk_130",
      "text": "| Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 129,
        "window_size": 3,
        "char_count": 74,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| BIONETICS | 100ul | 1998 | 1997 | 1979 |\n| 6 | 체외진단용 의료기기의 취급자 안전에 관한 자료 | 가.  시험물질 | 나. NIBSC의 관련 표준물질 | 3.  품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP.  | Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다.  | well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC.  | INC.  | LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP. ",
        "original_sentence": "| Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_131",
      "text": "| well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 130,
        "window_size": 3,
        "char_count": 143,
        "word_count": 29,
        "page_number": 2,
        "window_text": "시험물질 | 나. NIBSC의 관련 표준물질 | 3.  품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP.  | Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다.  | well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC.  | INC.  | LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP.  | HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다. ",
        "original_sentence": "| well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC. "
      }
    },
    {
      "chunk_id": "chunk_132",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 131,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "품목분류번호: D04160.01 | BARTELS CYTOMEGALOVIRUS | 1992 |\n| 5 | 사용목적 | K893467 | K853889 | CORDIA CMV-M | CORDIS CORP.  | Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다.  | well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC.  | INC.  | LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP.  | HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다.  | 2. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_133",
      "text": "| LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 132,
        "window_size": 3,
        "char_count": 134,
        "word_count": 29,
        "page_number": 3,
        "window_text": "| Parainfluenza 1 C-35 | Parainfluenza 2 Greer | 체의 사용 가능성 및 제한점 등을 포함한다.  | well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC.  | INC.  | LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP.  | HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다.  | 2.  기술문서에 관한 자료 | 14 | 6. ",
        "original_sentence": "| LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP. "
      }
    },
    {
      "chunk_id": "chunk_134",
      "text": "| HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 133,
        "window_size": 3,
        "char_count": 122,
        "word_count": 29,
        "page_number": 2,
        "window_text": "| well | RADIM | Italy | 상태, 구성품 누락여부를 확인한 | IGG PLUS TEST SYSTEM | systemic lupus erythematosus(SLE), | 「산전검사 중 | 육안으로 확인한다 | SCIENTIFIC INC.  | INC.  | LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP.  | HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다.  | 2.  기술문서에 관한 자료 | 14 | 6.  시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC. ",
        "original_sentence": "| HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_135",
      "text": "| 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 134,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 19,
        "window_text": "| INC.  | LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP.  | HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다.  | 2.  기술문서에 관한 자료 | 14 | 6.  시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC.  | 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP. ",
        "original_sentence": "| 2. "
      }
    },
    {
      "chunk_id": "chunk_136",
      "text": "기술문서에 관한 자료 | 14 | 6. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 135,
        "window_size": 3,
        "char_count": 22,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| LABORATORIES | 규격 | 2010 | 1983 |\n| K904036 | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | MODIFICATION TO COPALIS | CYTOMEGALOVIRUS | CORP.  | HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다.  | 2.  기술문서에 관한 자료 | 14 | 6.  시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC.  | 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP.  | 나. ",
        "original_sentence": "기술문서에 관한 자료 | 14 | 6. "
      }
    },
    {
      "chunk_id": "chunk_137",
      "text": "시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 136,
        "window_size": 3,
        "char_count": 83,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| HEALTHCARE | ORTHO | □ 예 | ■ 아니오 |\n| Parainfluenza 3 C 243 | Parainfluenza 4a M-25 | 3) 검체는 적용하고자 하는 대상 인구집단을 반영하여야 한다.  | 2.  기술문서에 관한 자료 | 14 | 6.  시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC.  | 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP.  | 나.  기재내용 | 인정범위내의 자료 이어야 한다. ",
        "original_sentence": "시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC. "
      }
    },
    {
      "chunk_id": "chunk_138",
      "text": "| 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 137,
        "window_size": 3,
        "char_count": 60,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| 2.  기술문서에 관한 자료 | 14 | 6.  시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC.  | 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP.  | 나.  기재내용 | 인정범위내의 자료 이어야 한다.  | 기구 및 조건 등을 기재한다. ",
        "original_sentence": "| 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP. "
      }
    },
    {
      "chunk_id": "chunk_139",
      "text": "| 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 138,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 36,
        "window_text": "기술문서에 관한 자료 | 14 | 6.  시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC.  | 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP.  | 나.  기재내용 | 인정범위내의 자료 이어야 한다.  | 기구 및 조건 등을 기재한다.  | Cinical and Laboratory Standard Institute; 2005 | 4. ",
        "original_sentence": "| 나. "
      }
    },
    {
      "chunk_id": "chunk_140",
      "text": "기재내용 | 인정범위내의 자료 이어야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 139,
        "window_size": 3,
        "char_count": 25,
        "word_count": 6,
        "page_number": 4,
        "window_text": "시약의 취급자 안전에 관한 자료 | 38 | ABBOTT CMV TOTAL | (INDIRECT ENZYME TEST) | CONCEPTS INC.  | 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP.  | 나.  기재내용 | 인정범위내의 자료 이어야 한다.  | 기구 및 조건 등을 기재한다.  | Cinical and Laboratory Standard Institute; 2005 | 4.  등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다. ",
        "original_sentence": "기재내용 | 인정범위내의 자료 이어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_141",
      "text": "| 기구 및 조건 등을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 140,
        "window_size": 3,
        "char_count": 19,
        "word_count": 6,
        "page_number": 25,
        "window_text": "| 1989 | 1986 |\n| K864420 | CMV MICROASSAY | DIAMEDIX CORP.  | 나.  기재내용 | 인정범위내의 자료 이어야 한다.  | 기구 및 조건 등을 기재한다.  | Cinical and Laboratory Standard Institute; 2005 | 4.  등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다.  | 의학적 결정치에서의 bias를 제시한다. ",
        "original_sentence": "| 기구 및 조건 등을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_142",
      "text": "| Cinical and Laboratory Standard Institute; 2005 | 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 141,
        "window_size": 3,
        "char_count": 55,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 나.  기재내용 | 인정범위내의 자료 이어야 한다.  | 기구 및 조건 등을 기재한다.  | Cinical and Laboratory Standard Institute; 2005 | 4.  등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다.  | 의학적 결정치에서의 bias를 제시한다.  | 사) 판정기준치를 산정하는 방법을 명시한다. ",
        "original_sentence": "| Cinical and Laboratory Standard Institute; 2005 | 4. "
      }
    },
    {
      "chunk_id": "chunk_143",
      "text": "등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 142,
        "window_size": 3,
        "char_count": 89,
        "word_count": 15,
        "page_number": 3,
        "window_text": "기재내용 | 인정범위내의 자료 이어야 한다.  | 기구 및 조건 등을 기재한다.  | Cinical and Laboratory Standard Institute; 2005 | 4.  등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다.  | 의학적 결정치에서의 bias를 제시한다.  | 사) 판정기준치를 산정하는 방법을 명시한다.  | 수도 있다. ",
        "original_sentence": "등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다. "
      }
    },
    {
      "chunk_id": "chunk_144",
      "text": "| 의학적 결정치에서의 bias를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 143,
        "window_size": 3,
        "char_count": 25,
        "word_count": 5,
        "page_number": 12,
        "window_text": "| 기구 및 조건 등을 기재한다.  | Cinical and Laboratory Standard Institute; 2005 | 4.  등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다.  | 의학적 결정치에서의 bias를 제시한다.  | 사) 판정기준치를 산정하는 방법을 명시한다.  | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다. ",
        "original_sentence": "| 의학적 결정치에서의 bias를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_145",
      "text": "| 사) 판정기준치를 산정하는 방법을 명시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 144,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 30,
        "window_text": "| Cinical and Laboratory Standard Institute; 2005 | 4.  등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다.  | 의학적 결정치에서의 bias를 제시한다.  | 사) 판정기준치를 산정하는 방법을 명시한다.  | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 다. ",
        "original_sentence": "| 사) 판정기준치를 산정하는 방법을 명시한다. "
      }
    },
    {
      "chunk_id": "chunk_146",
      "text": "| 수도 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 145,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 34,
        "window_text": "등급: 3등급 | Strip | 12) Anti-CMV Seroconversion Panel - PTC9017) | 은 100XTP/(TP+FP)로 계산된다.  | 의학적 결정치에서의 bias를 제시한다.  | 사) 판정기준치를 산정하는 방법을 명시한다.  | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 다.  | IMMED. ",
        "original_sentence": "| 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_147",
      "text": "측정은 각 농도별로 2-4회 반복 측정한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 146,
        "window_size": 3,
        "char_count": 25,
        "word_count": 6,
        "page_number": 19,
        "window_text": "| 의학적 결정치에서의 bias를 제시한다.  | 사) 판정기준치를 산정하는 방법을 명시한다.  | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 다.  | IMMED.  EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다. ",
        "original_sentence": "측정은 각 농도별로 2-4회 반복 측정한다. "
      }
    },
    {
      "chunk_id": "chunk_148",
      "text": "| 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 147,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 34,
        "window_text": "| 사) 판정기준치를 산정하는 방법을 명시한다.  | 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 다.  | IMMED.  EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다.  | antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1. ",
        "original_sentence": "| 다. "
      }
    },
    {
      "chunk_id": "chunk_149",
      "text": "| IMMED. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 148,
        "window_size": 3,
        "char_count": 9,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| 수도 있다.  측정은 각 농도별로 2-4회 반복 측정한다.  | 다.  | IMMED.  EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다.  | antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1.  제조의뢰자 | 다른 원인에 기인하기도 한다. ",
        "original_sentence": "| IMMED. "
      }
    },
    {
      "chunk_id": "chunk_150",
      "text": "EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 149,
        "window_size": 3,
        "char_count": 59,
        "word_count": 11,
        "page_number": 12,
        "window_text": "측정은 각 농도별로 2-4회 반복 측정한다.  | 다.  | IMMED.  EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다.  | antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1.  제조의뢰자 | 다른 원인에 기인하기도 한다.  | 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다. ",
        "original_sentence": "EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_151",
      "text": "| antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 150,
        "window_size": 3,
        "char_count": 90,
        "word_count": 20,
        "page_number": 3,
        "window_text": "| 다.  | IMMED.  EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다.  | antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1.  제조의뢰자 | 다른 원인에 기인하기도 한다.  | 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다.  | 구체적으로 기재하여야 한다. ",
        "original_sentence": "| antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1. "
      }
    },
    {
      "chunk_id": "chunk_152",
      "text": "제조의뢰자 | 다른 원인에 기인하기도 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 151,
        "window_size": 3,
        "char_count": 25,
        "word_count": 6,
        "page_number": 8,
        "window_text": "| IMMED.  EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다.  | antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1.  제조의뢰자 | 다른 원인에 기인하기도 한다.  | 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다.  | 구체적으로 기재하여야 한다.  | 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다. ",
        "original_sentence": "제조의뢰자 | 다른 원인에 기인하기도 한다. "
      }
    },
    {
      "chunk_id": "chunk_153",
      "text": "| 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 152,
        "window_size": 3,
        "char_count": 43,
        "word_count": 10,
        "page_number": 3,
        "window_text": "EARLY ANTIGEN | ORTHO* CYTOMEGALOVIRUS | 농도는 결과를 방해할 수 있다.  | antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1.  제조의뢰자 | 다른 원인에 기인하기도 한다.  | 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다.  | 구체적으로 기재하여야 한다.  | 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다.  | D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까? ",
        "original_sentence": "| 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_154",
      "text": "| 구체적으로 기재하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 153,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 30,
        "window_text": "| antinuclear antibodies(ANA), | GULL | 1990 |\n| 3 | 사용목적에 관한 자료 | K982027 | K881932 | 1.  제조의뢰자 | 다른 원인에 기인하기도 한다.  | 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다.  | 구체적으로 기재하여야 한다.  | 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다.  | D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까?  | 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC. ",
        "original_sentence": "| 구체적으로 기재하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_155",
      "text": "| 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 154,
        "window_size": 3,
        "char_count": 87,
        "word_count": 18,
        "page_number": 12,
        "window_text": "제조의뢰자 | 다른 원인에 기인하기도 한다.  | 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다.  | 구체적으로 기재하여야 한다.  | 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다.  | D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까?  | 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC.  | ABBOTT | GULL | CORP. ",
        "original_sentence": "| 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_156",
      "text": "| D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까? ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 155,
        "window_size": 3,
        "char_count": 79,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 관리기준」(고시 별표 14)에 의하여 실시한 자료 | 기간)을 기재한다.  | 구체적으로 기재하여야 한다.  | 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다.  | D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까?  | 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC.  | ABBOTT | GULL | CORP.  | IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다. ",
        "original_sentence": "| D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_157",
      "text": "| 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 156,
        "window_size": 3,
        "char_count": 38,
        "word_count": 6,
        "page_number": 1,
        "window_text": "| 구체적으로 기재하여야 한다.  | 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다.  | D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까?  | 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC.  | ABBOTT | GULL | CORP.  | IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다.  | Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7. ",
        "original_sentence": "| 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC. "
      }
    },
    {
      "chunk_id": "chunk_158",
      "text": "| ABBOTT | GULL | CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 157,
        "window_size": 3,
        "char_count": 24,
        "word_count": 6,
        "page_number": 73,
        "window_text": "| 웰4-5-7-8 : | Bioelisa CMV IgM immuno capture | BIOKIT | Spain | 경우에는 세트별로 구분하여 기재한다.  | D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까?  | 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC.  | ABBOTT | GULL | CORP.  | IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다.  | Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7.  이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
        "original_sentence": "| ABBOTT | GULL | CORP. "
      }
    },
    {
      "chunk_id": "chunk_159",
      "text": "| IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 158,
        "window_size": 3,
        "char_count": 118,
        "word_count": 25,
        "page_number": 3,
        "window_text": "| D3 DFA CYTOMEGALOVIRUS | CMV TOTAL ANTIBODY | CMV IGM ANTIBODY TEST | 내용입니까?  | 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC.  | ABBOTT | GULL | CORP.  | IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다.  | Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7.  이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3. ",
        "original_sentence": "| IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_160",
      "text": "| Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 159,
        "window_size": 3,
        "char_count": 123,
        "word_count": 28,
        "page_number": 3,
        "window_text": "| 거대세포바이러스(CMV) 체외진단용 | DIASORIN INC.  | ABBOTT | GULL | CORP.  | IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다.  | Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7.  이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3.  성능 작성의 예 | 마. ",
        "original_sentence": "| Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7. "
      }
    },
    {
      "chunk_id": "chunk_161",
      "text": "이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 160,
        "window_size": 3,
        "char_count": 53,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| ABBOTT | GULL | CORP.  | IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다.  | Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7.  이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3.  성능 작성의 예 | 마.  정도관리 | 다. ",
        "original_sentence": "이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_162",
      "text": "| □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 161,
        "window_size": 3,
        "char_count": 172,
        "word_count": 42,
        "page_number": 2,
        "window_text": "| IMMUNO | DIAGNOSTIC | HILLCREST | 자사 | 1987 |\n| K942171 | CMV EARLY ANTIGEN TEST | NEOGENEX | 항목, 시험기준, 시험방법을 기재한다.  | Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7.  이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3.  성능 작성의 예 | 마.  정도관리 | 다.  결과제시 | 라. ",
        "original_sentence": "| □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3. "
      }
    },
    {
      "chunk_id": "chunk_163",
      "text": "성능 작성의 예 | 마. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 162,
        "window_size": 3,
        "char_count": 14,
        "word_count": 5,
        "page_number": 28,
        "window_text": "| Parainfluenza 4b CH19503 | HSV-1 IF | EIA |\n| K954301 | K893466 | K853277 | CMV CF ANTIGEN | K831711 | CMV IGM TEST | 7.  이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3.  성능 작성의 예 | 마.  정도관리 | 다.  결과제시 | 라.  결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다. ",
        "original_sentence": "성능 작성의 예 | 마. "
      }
    },
    {
      "chunk_id": "chunk_164",
      "text": "정도관리 | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 163,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 34,
        "window_text": "이미 허가받은 제품과 비교한 자료 | 38 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3.  성능 작성의 예 | 마.  정도관리 | 다.  결과제시 | 라.  결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.  | immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다. ",
        "original_sentence": "정도관리 | 다. "
      }
    },
    {
      "chunk_id": "chunk_165",
      "text": "결과제시 | 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 164,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 25,
        "window_text": "| □ 예 | ■ 아니오 | ANTIBODY EIA | IDENTIFICATION REAGENT | Tris base | 적량 | DIAGNOSTIC | LABORATORIES | 150ul | 1998 | 1994 | 1988 |\n| 1 | K915892 | CMV IGG ELISA TEST | 표 3.  성능 작성의 예 | 마.  정도관리 | 다.  결과제시 | 라.  결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.  | immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다.  | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다. ",
        "original_sentence": "결과제시 | 라. "
      }
    },
    {
      "chunk_id": "chunk_166",
      "text": "결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 165,
        "window_size": 3,
        "char_count": 76,
        "word_count": 16,
        "page_number": 12,
        "window_text": "성능 작성의 예 | 마.  정도관리 | 다.  결과제시 | 라.  결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.  | immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다.  | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ. ",
        "original_sentence": "결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_167",
      "text": "| immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 166,
        "window_size": 3,
        "char_count": 41,
        "word_count": 7,
        "page_number": 8,
        "window_text": "정도관리 | 다.  결과제시 | 라.  결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.  | immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다.  | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ.  제조․수입허가 신청서 기재항목 | 16 | 있어야 한다. ",
        "original_sentence": "| immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다. "
      }
    },
    {
      "chunk_id": "chunk_168",
      "text": "| 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 167,
        "window_size": 3,
        "char_count": 36,
        "word_count": 8,
        "page_number": 3,
        "window_text": "결과제시 | 라.  결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.  | immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다.  | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ.  제조․수입허가 신청서 기재항목 | 16 | 있어야 한다.  | 한다(CFU; colony forming unit, PFU; plaque forming unit). ",
        "original_sentence": "| 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_169",
      "text": "| 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 168,
        "window_size": 3,
        "char_count": 35,
        "word_count": 12,
        "page_number": 3,
        "window_text": "결과제시 | 라. AcroMetrix Quality Control 관련 표준물질 | 확보하기 어려울 경우, 냉동검체를 사용할 수 있다.  | immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다.  | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ.  제조․수입허가 신청서 기재항목 | 16 | 있어야 한다.  | 한다(CFU; colony forming unit, PFU; plaque forming unit).  | 이용하여 평가한다. ",
        "original_sentence": "| 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ. "
      }
    },
    {
      "chunk_id": "chunk_170",
      "text": "제조․수입허가 신청서 기재항목 | 16 | 있어야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 169,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 2,
        "window_text": "| immunoassay)이 사용되며, 다음과 같은 반응으로 이루어진다.  | 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ.  제조․수입허가 신청서 기재항목 | 16 | 있어야 한다.  | 한다(CFU; colony forming unit, PFU; plaque forming unit).  | 이용하여 평가한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다. ",
        "original_sentence": "제조․수입허가 신청서 기재항목 | 16 | 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_171",
      "text": "| 한다(CFU; colony forming unit, PFU; plaque forming unit). ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 170,
        "window_size": 3,
        "char_count": 58,
        "word_count": 9,
        "page_number": 12,
        "window_text": "| 1) 적용되는 체외진단분석기의 제조사 및 모델명을 기재한다.  | 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ.  제조․수입허가 신청서 기재항목 | 16 | 있어야 한다.  | 한다(CFU; colony forming unit, PFU; plaque forming unit).  | 이용하여 평가한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다. ",
        "original_sentence": "| 한다(CFU; colony forming unit, PFU; plaque forming unit). "
      }
    },
    {
      "chunk_id": "chunk_172",
      "text": "| 이용하여 평가한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 171,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 30,
        "window_text": "| 1) 업체명 및 주소 | 4) 결과제시 | 60개 | Ⅴ.  제조․수입허가 신청서 기재항목 | 16 | 있어야 한다.  | 한다(CFU; colony forming unit, PFU; plaque forming unit).  | 이용하여 평가한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다.  | 또는 양성검체를 희석한 검체 등을 사용한다. ",
        "original_sentence": "| 이용하여 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_173",
      "text": "| 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 172,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 30,
        "window_text": "제조․수입허가 신청서 기재항목 | 16 | 있어야 한다.  | 한다(CFU; colony forming unit, PFU; plaque forming unit).  | 이용하여 평가한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다). ",
        "original_sentence": "| 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다. "
      }
    },
    {
      "chunk_id": "chunk_174",
      "text": "| Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 173,
        "window_size": 3,
        "char_count": 66,
        "word_count": 15,
        "page_number": 12,
        "window_text": "| 한다(CFU; colony forming unit, PFU; plaque forming unit).  | 이용하여 평가한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다).  | Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC. ",
        "original_sentence": "| Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_175",
      "text": "| 또는 양성검체를 희석한 검체 등을 사용한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 174,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 12,
        "window_text": "| 이용하여 평가한다.  | 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다).  | Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC.  | SYSTEMS INC. ",
        "original_sentence": "| 또는 양성검체를 희석한 검체 등을 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_176",
      "text": "| FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다). ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 175,
        "window_size": 3,
        "char_count": 135,
        "word_count": 28,
        "page_number": 76,
        "window_text": "| 검사 등의 원인 분석 방법을 미리 확립하고 이를 명시한다.  | Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다).  | Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC.  | SYSTEMS INC.  | BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가. ",
        "original_sentence": "| FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다). "
      }
    },
    {
      "chunk_id": "chunk_177",
      "text": "| Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 176,
        "window_size": 3,
        "char_count": 147,
        "word_count": 26,
        "page_number": 3,
        "window_text": "| Bioelisa CMV IgG/IgM | BIOKIT | Spain | 전혈 등)의 종류별 시험 결과를 제시한다.  | 또는 양성검체를 희석한 검체 등을 사용한다.  | FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다).  | Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC.  | SYSTEMS INC.  | BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가.  시험항목 | 보간법(Interpolation)2)을 통해 이루어진다. ",
        "original_sentence": "| Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC. "
      }
    },
    {
      "chunk_id": "chunk_178",
      "text": "| SYSTEMS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 177,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 12,
        "window_text": "| 또는 양성검체를 희석한 검체 등을 사용한다.  | FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다).  | Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC.  | SYSTEMS INC.  | BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가.  시험항목 | 보간법(Interpolation)2)을 통해 이루어진다.  | 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D. ",
        "original_sentence": "| SYSTEMS INC. "
      }
    },
    {
      "chunk_id": "chunk_179",
      "text": "| BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 178,
        "window_size": 3,
        "char_count": 47,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| FIAX(R) TEST KIT | LABORATORIES | LABORATORIES | GULL | WHITTAKER | 1997 |\n| K081164 | HSV-1 MacIntyre | HSV-2 MS | 중복될 경우 이를 생략한다).  | Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC.  | SYSTEMS INC.  | BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가.  시험항목 | 보간법(Interpolation)2)을 통해 이루어진다.  | 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D.  | (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다. ",
        "original_sentence": "| BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가. "
      }
    },
    {
      "chunk_id": "chunk_180",
      "text": "시험항목 | 보간법(Interpolation)2)을 통해 이루어진다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 179,
        "window_size": 3,
        "char_count": 39,
        "word_count": 5,
        "page_number": 2,
        "window_text": "| Standard Institute; 2004 | NIBSC code: 10/B5994) | 세척완충웰 | IMMEDIATE EARLY ANTIGEN | ASSAY | (INDIRECT ENZYME TEST) | 의료기기 허가·심사 | CONCEPTS INC.  | SYSTEMS INC.  | BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가.  시험항목 | 보간법(Interpolation)2)을 통해 이루어진다.  | 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D.  | (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다.  | /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC. ",
        "original_sentence": "시험항목 | 보간법(Interpolation)2)을 통해 이루어진다. "
      }
    },
    {
      "chunk_id": "chunk_181",
      "text": "| 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 180,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| SYSTEMS INC.  | BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가.  시험항목 | 보간법(Interpolation)2)을 통해 이루어진다.  | 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D.  | (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다.  | /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC.  | INC. ",
        "original_sentence": "| 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D. "
      }
    },
    {
      "chunk_id": "chunk_182",
      "text": "| (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 181,
        "window_size": 3,
        "char_count": 49,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| BIOLOGICALS | 규격 | 1989 | 1985 | 1983 |\n| 가.  시험항목 | 보간법(Interpolation)2)을 통해 이루어진다.  | 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D.  | (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다.  | /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC.  | INC.  | 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나. ",
        "original_sentence": "| (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다. "
      }
    },
    {
      "chunk_id": "chunk_183",
      "text": "| /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 182,
        "window_size": 3,
        "char_count": 78,
        "word_count": 17,
        "page_number": 22,
        "window_text": "시험항목 | 보간법(Interpolation)2)을 통해 이루어진다.  | 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D.  | (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다.  | /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC.  | INC.  | 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나.  시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다. ",
        "original_sentence": "| /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC. "
      }
    },
    {
      "chunk_id": "chunk_184",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 183,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 1) 상호 : 식약(주) | 대조용 시약키트와 비교하여 O.D.  | (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다.  | /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC.  | INC.  | 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나.  시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다.  | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_185",
      "text": "| 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 184,
        "window_size": 3,
        "char_count": 55,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| (MODIFICATION) | 진단정확도기준 | 1992 |\n| 그러하지 아니하다.  | /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC.  | INC.  | 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나.  시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다.  | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다. ",
        "original_sentence": "| 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나. "
      }
    },
    {
      "chunk_id": "chunk_186",
      "text": "시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 185,
        "window_size": 3,
        "char_count": 68,
        "word_count": 16,
        "page_number": 12,
        "window_text": "| /kit | Axsym CMV IgG (AXM CMV IgG | DIAMEDIX IS-CMV IGG TEST | HYBRIDS INC.  | INC.  | 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나.  시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다.  | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다. ",
        "original_sentence": "시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_187",
      "text": "| 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 186,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 19,
        "window_text": "| INC.  | 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나.  시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다.  | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다.  | 정보를 제공한다. ",
        "original_sentence": "| 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_188",
      "text": "| 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 187,
        "window_size": 3,
        "char_count": 34,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 2008 |\n| K903807 | CMV IGM ELISA TEST | K863798 | 나.  시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다.  | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다.  | 정보를 제공한다.  | 가) 직선성 범위의 농도 구간을 제시한다. ",
        "original_sentence": "| 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_189",
      "text": "| 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 188,
        "window_size": 3,
        "char_count": 72,
        "word_count": 17,
        "page_number": 3,
        "window_text": "시험방법 | HSV-2 Strain G | VZV Webster | 성) 이상의 검체를 이용하여 성능을 확인하도록 한다.  | 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다.  | 정보를 제공한다.  | 가) 직선성 범위의 농도 구간을 제시한다.  | 설정한 근거를 제시한다. ",
        "original_sentence": "| 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_190",
      "text": "| 정보를 제공한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 189,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 30,
        "window_text": "| 2) 검사 키트의 사용조건(온도 또는 습도 등)을 기재한다.  | 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다.  | 정보를 제공한다.  | 가) 직선성 범위의 농도 구간을 제시한다.  | 설정한 근거를 제시한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다. ",
        "original_sentence": "| 정보를 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_191",
      "text": "| 가) 직선성 범위의 농도 구간을 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 190,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 24,
        "window_text": "| 1) 사용자가 정도 관리를 할 수 있는 방법을 제시한다.  | 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다.  | 정보를 제공한다.  | 가) 직선성 범위의 농도 구간을 제시한다.  | 설정한 근거를 제시한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다.  | CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC. ",
        "original_sentence": "| 가) 직선성 범위의 농도 구간을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_192",
      "text": "| 설정한 근거를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 191,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 24,
        "window_text": "| 2) 시험성적서 일련번호 및 각 페이지와 전체 페이지번호 | 3) 시험방법 | 검사와의 일치도(신뢰구간과 함께)를 제시한다.  | 정보를 제공한다.  | 가) 직선성 범위의 농도 구간을 제시한다.  | 설정한 근거를 제시한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다.  | CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC.  | LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT. ",
        "original_sentence": "| 설정한 근거를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_193",
      "text": "| □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 192,
        "window_size": 3,
        "char_count": 46,
        "word_count": 15,
        "page_number": 2,
        "window_text": "| 정보를 제공한다.  | 가) 직선성 범위의 농도 구간을 제시한다.  | 설정한 근거를 제시한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다.  | CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC.  | LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT.  LTD. ",
        "original_sentence": "| □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_194",
      "text": "| CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 193,
        "window_size": 3,
        "char_count": 78,
        "word_count": 13,
        "page_number": 12,
        "window_text": "| 가) 직선성 범위의 농도 구간을 제시한다.  | 설정한 근거를 제시한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다.  | CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC.  | LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT.  LTD.  | Ⅶ. ",
        "original_sentence": "| CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC. "
      }
    },
    {
      "chunk_id": "chunk_195",
      "text": "| LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 194,
        "window_size": 3,
        "char_count": 133,
        "word_count": 33,
        "page_number": 2,
        "window_text": "| 설정한 근거를 제시한다.  | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다.  | CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC.  | LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT.  LTD.  | Ⅶ.  성능시험에 대한 상세사항 | 40 | 1. ",
        "original_sentence": "| LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT. "
      }
    },
    {
      "chunk_id": "chunk_196",
      "text": "LTD. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 195,
        "window_size": 3,
        "char_count": 5,
        "word_count": 1,
        "page_number": 78,
        "window_text": "| □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 시할 수 있다.  | CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC.  | LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT.  LTD.  | Ⅶ.  성능시험에 대한 상세사항 | 40 | 1.  명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP. ",
        "original_sentence": "LTD. "
      }
    },
    {
      "chunk_id": "chunk_197",
      "text": "| Ⅶ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 196,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 45,
        "window_text": "| CYTOMEGALOVIRUS INDIRECT | CMV IGM ANTIBODY TEST | CYTOMEGALOVIRUS M | INC.  | LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT.  LTD.  | Ⅶ.  성능시험에 대한 상세사항 | 40 | 1.  명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP.  | QUEST INTL. ",
        "original_sentence": "| Ⅶ. "
      }
    },
    {
      "chunk_id": "chunk_198",
      "text": "성능시험에 대한 상세사항 | 40 | 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 197,
        "window_size": 3,
        "char_count": 24,
        "word_count": 7,
        "page_number": 2,
        "window_text": "| LABORATORIES | BIOPRODUCTS | GULL | □ 예 | ■ 아니오 |\n| 2 | 원재료 및 제조방법에 관한 자료 | K981163 | K880679 | BION CMV-G TEST SYSTEM | BION ENT.  LTD.  | Ⅶ.  성능시험에 대한 상세사항 | 40 | 1.  명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP.  | QUEST INTL.  | IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까? ",
        "original_sentence": "성능시험에 대한 상세사항 | 40 | 1. "
      }
    },
    {
      "chunk_id": "chunk_199",
      "text": "명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 198,
        "window_size": 3,
        "char_count": 80,
        "word_count": 19,
        "page_number": 2,
        "window_text": "LTD.  | Ⅶ.  성능시험에 대한 상세사항 | 40 | 1.  명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP.  | QUEST INTL.  | IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까?  | 적을 기재한다. ",
        "original_sentence": "명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP. "
      }
    },
    {
      "chunk_id": "chunk_200",
      "text": "| QUEST INTL. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 199,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 12,
        "window_text": "| Ⅶ.  성능시험에 대한 상세사항 | 40 | 1.  명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP.  | QUEST INTL.  | IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까?  | 적을 기재한다.  | 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다. ",
        "original_sentence": "| QUEST INTL. "
      }
    },
    {
      "chunk_id": "chunk_201",
      "text": "| IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까? ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 200,
        "window_size": 3,
        "char_count": 121,
        "word_count": 37,
        "page_number": 3,
        "window_text": "성능시험에 대한 상세사항 | 40 | 1.  명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP.  | QUEST INTL.  | IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까?  | 적을 기재한다.  | 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다. ",
        "original_sentence": "| IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까? "
      }
    },
    {
      "chunk_id": "chunk_202",
      "text": "| 적을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 201,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 25,
        "window_text": "명칭 | 16 | RGT) | ABBOTT | USA | 값이 10% 이내 | IDENTIFICATION KIT | DIAMEDIX CORP.  | QUEST INTL.  | IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까?  | 적을 기재한다.  | 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.  | SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC. ",
        "original_sentence": "| 적을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_203",
      "text": "| 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 202,
        "window_size": 3,
        "char_count": 248,
        "word_count": 58,
        "page_number": 12,
        "window_text": "| QUEST INTL.  | IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까?  | 적을 기재한다.  | 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.  | SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC.  | INC. ",
        "original_sentence": "| 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_204",
      "text": "| 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 203,
        "window_size": 3,
        "char_count": 34,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| IMMUNO | 1990 | 1987 |\n| 2 | 모양 및 구조 | 안내서- | 번호 | 성능항목 | 성능 | 2) 주소 : 서울특별시 은평구 녹번동 191가 식약타워 00층 | 는 기관 | 정리한 자료입니까?  | 적을 기재한다.  | 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.  | SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC.  | INC.  | LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5. ",
        "original_sentence": "| 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_205",
      "text": "| SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 204,
        "window_size": 3,
        "char_count": 53,
        "word_count": 9,
        "page_number": 12,
        "window_text": "| 적을 기재한다.  | 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.  | SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC.  | INC.  | LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5.  | 100ul |\n| 자. ",
        "original_sentence": "| SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC. "
      }
    },
    {
      "chunk_id": "chunk_206",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 205,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 양성 | 음성 | 전체 | mAb anti-human IgG | 가이드라인(민원인 안내서)」 명칭 | LIGHT | MERCIA | LITTON | >500 | 자사 |\n| K954191 | SERAQUEST CMV IGG | K893465 | K853137 | CMV TEST | K831343 | CMV RQ BIO-ENZABEAD KIT | VZV Ellen | VZV AV92-3 | 유래된 검체를 대상으로 시험한 자료를 제출한다.  | 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.  | SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC.  | INC.  | LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5.  | 100ul |\n| 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_207",
      "text": "| LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 206,
        "window_size": 3,
        "char_count": 128,
        "word_count": 25,
        "page_number": 3,
        "window_text": "| 1) 완제품의 최종 품질관리에 따른 성능시험을 포함한다.  | SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC.  | INC.  | LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5.  | 100ul |\n| 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다. ",
        "original_sentence": "| LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5. "
      }
    },
    {
      "chunk_id": "chunk_208",
      "text": "| 100ul |\n| 자. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 207,
        "window_size": 3,
        "char_count": 15,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| SYSTEM | (INDIRECT FLUORESCENT | ANTIBODIES | INC.  | INC.  | LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5.  | 100ul |\n| 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다.  | 을 권장하며 최소 2회 반복 측정한다. ",
        "original_sentence": "| 100ul |\n| 자. "
      }
    },
    {
      "chunk_id": "chunk_209",
      "text": "일회용의 경우 재사용하지 않도록 주의사항을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 208,
        "window_size": 3,
        "char_count": 30,
        "word_count": 6,
        "page_number": 2,
        "window_text": "| INC.  | LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5.  | 100ul |\n| 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다.  | 을 권장하며 최소 2회 반복 측정한다.  | 2. ",
        "original_sentence": "일회용의 경우 재사용하지 않도록 주의사항을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_210",
      "text": "| Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 209,
        "window_size": 3,
        "char_count": 107,
        "word_count": 24,
        "page_number": 2,
        "window_text": "| LABORATORIES | 1998 | 1988 |\n| K935809 | 웰6 : 컨쥬게이트 | (품질관리용 냉동보관된 환자혈청 | DIASORIN LIAISON CMV | IMMUNOFLUORESCENCE | 2017.5.  | 100ul |\n| 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다.  | 을 권장하며 최소 2회 반복 측정한다.  | 2.  모양 및 구조 | 17 | 1. ",
        "original_sentence": "| Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_211",
      "text": "| 을 권장하며 최소 2회 반복 측정한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 210,
        "window_size": 3,
        "char_count": 24,
        "word_count": 7,
        "page_number": 19,
        "window_text": "| 100ul |\n| 자.  일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다.  | 을 권장하며 최소 2회 반복 측정한다.  | 2.  모양 및 구조 | 17 | 1.  분석적 성능시험에 관한 자료 | 40 | 결합한다. ",
        "original_sentence": "| 을 권장하며 최소 2회 반복 측정한다. "
      }
    },
    {
      "chunk_id": "chunk_212",
      "text": "| 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 211,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 19,
        "window_text": "일회용의 경우 재사용하지 않도록 주의사항을 기재한다.  | Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다.  | 을 권장하며 최소 2회 반복 측정한다.  | 2.  모양 및 구조 | 17 | 1.  분석적 성능시험에 관한 자료 | 40 | 결합한다.  | 등을 이용가능하다. ",
        "original_sentence": "| 2. "
      }
    },
    {
      "chunk_id": "chunk_213",
      "text": "모양 및 구조 | 17 | 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 212,
        "window_size": 3,
        "char_count": 18,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| Epstein-Barr | Rubeola | ※ 예시 : CMV 항체 검사시 교차반응물질의 종류 | 3) 시험검사품의 모델명, 상품명(해당 경우에 한함) | 포함하여 비교시험을 수행한다.  | 을 권장하며 최소 2회 반복 측정한다.  | 2.  모양 및 구조 | 17 | 1.  분석적 성능시험에 관한 자료 | 40 | 결합한다.  | 등을 이용가능하다.  | 자료를 제출한다. ",
        "original_sentence": "모양 및 구조 | 17 | 1. "
      }
    },
    {
      "chunk_id": "chunk_214",
      "text": "분석적 성능시험에 관한 자료 | 40 | 결합한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 213,
        "window_size": 3,
        "char_count": 29,
        "word_count": 8,
        "page_number": 4,
        "window_text": "| 을 권장하며 최소 2회 반복 측정한다.  | 2.  모양 및 구조 | 17 | 1.  분석적 성능시험에 관한 자료 | 40 | 결합한다.  | 등을 이용가능하다.  | 자료를 제출한다.  | positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다. ",
        "original_sentence": "분석적 성능시험에 관한 자료 | 40 | 결합한다. "
      }
    },
    {
      "chunk_id": "chunk_215",
      "text": "| 등을 이용가능하다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 214,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 34,
        "window_text": "| 2.  모양 및 구조 | 17 | 1.  분석적 성능시험에 관한 자료 | 40 | 결합한다.  | 등을 이용가능하다.  | 자료를 제출한다.  | positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다.  | 시행할 집단에서의 유병률을 평가할 것을 권장한다. ",
        "original_sentence": "| 등을 이용가능하다. "
      }
    },
    {
      "chunk_id": "chunk_216",
      "text": "| 자료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 215,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 4,
        "window_text": "모양 및 구조 | 17 | 1.  분석적 성능시험에 관한 자료 | 40 | 결합한다.  | 등을 이용가능하다.  | 자료를 제출한다.  | positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다.  | 시행할 집단에서의 유병률을 평가할 것을 권장한다.  | Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다. ",
        "original_sentence": "| 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_217",
      "text": "| positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 216,
        "window_size": 3,
        "char_count": 47,
        "word_count": 12,
        "page_number": 12,
        "window_text": "분석적 성능시험에 관한 자료 | 40 | 결합한다.  | 등을 이용가능하다.  | 자료를 제출한다.  | positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다.  | 시행할 집단에서의 유병률을 평가할 것을 권장한다.  | Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다.  | HYBRID CAPTURE SYSTEM | INC. ",
        "original_sentence": "| positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다. "
      }
    },
    {
      "chunk_id": "chunk_218",
      "text": "| 시행할 집단에서의 유병률을 평가할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 217,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 30,
        "window_text": "| 등을 이용가능하다.  | 자료를 제출한다.  | positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다.  | 시행할 집단에서의 유병률을 평가할 것을 권장한다.  | Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다.  | HYBRID CAPTURE SYSTEM | INC.  | CONCEPTS INC. ",
        "original_sentence": "| 시행할 집단에서의 유병률을 평가할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_219",
      "text": "| Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 218,
        "window_size": 3,
        "char_count": 50,
        "word_count": 11,
        "page_number": 12,
        "window_text": "| 자료를 제출한다.  | positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다.  | 시행할 집단에서의 유병률을 평가할 것을 권장한다.  | Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다.  | HYBRID CAPTURE SYSTEM | INC.  | CONCEPTS INC.  | BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다. ",
        "original_sentence": "| Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다. "
      }
    },
    {
      "chunk_id": "chunk_220",
      "text": "| HYBRID CAPTURE SYSTEM | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 219,
        "window_size": 3,
        "char_count": 31,
        "word_count": 6,
        "page_number": 12,
        "window_text": "| positive) : CMV DNA | 과 같은 4가지 형태의 세트를 준비한다.  | 시행할 집단에서의 유병률을 평가할 것을 권장한다.  | Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다.  | HYBRID CAPTURE SYSTEM | INC.  | CONCEPTS INC.  | BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다.  | 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. ",
        "original_sentence": "| HYBRID CAPTURE SYSTEM | INC. "
      }
    },
    {
      "chunk_id": "chunk_221",
      "text": "| CONCEPTS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 220,
        "window_size": 3,
        "char_count": 16,
        "word_count": 3,
        "page_number": 12,
        "window_text": "| 시행할 집단에서의 유병률을 평가할 것을 권장한다.  | Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다.  | HYBRID CAPTURE SYSTEM | INC.  | CONCEPTS INC.  | BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다.  | 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
        "original_sentence": "| CONCEPTS INC. "
      }
    },
    {
      "chunk_id": "chunk_222",
      "text": "| BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 221,
        "window_size": 3,
        "char_count": 187,
        "word_count": 46,
        "page_number": 3,
        "window_text": "| Axsym CMV IgM (AXM CMV IgM | plasmid 등을 이용가능하다.  | HYBRID CAPTURE SYSTEM | INC.  | CONCEPTS INC.  | BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다.  | 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A. ",
        "original_sentence": "| BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_223",
      "text": "| 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 222,
        "window_size": 3,
        "char_count": 159,
        "word_count": 34,
        "page_number": 2,
        "window_text": "| HYBRID CAPTURE SYSTEM | INC.  | CONCEPTS INC.  | BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다.  | 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP. ",
        "original_sentence": "| 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. "
      }
    },
    {
      "chunk_id": "chunk_224",
      "text": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 223,
        "window_size": 3,
        "char_count": 34,
        "word_count": 7,
        "page_number": 2,
        "window_text": "| CONCEPTS INC.  | BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다.  | 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP.  | INC. ",
        "original_sentence": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. "
      }
    },
    {
      "chunk_id": "chunk_225",
      "text": "| conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 224,
        "window_size": 3,
        "char_count": 55,
        "word_count": 12,
        "page_number": 7,
        "window_text": "| BIONETICS | 1996 | 1989 | 1985 | 1983 |\n| 1 | 개발경위, 측정원리·방법 및 국내․외 사용현황에 관한 자료 | 5 | 제품의 성능을 확인하기 위한 자료 | K040290 | K915479 | CAPTIA CMV-TA | 0649-01 | 또는 불활화하여 감염력이 없음을 입증하는 자료를 제출한다.  | 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP.  | INC.  | 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다. ",
        "original_sentence": "| conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A. "
      }
    },
    {
      "chunk_id": "chunk_226",
      "text": "| DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 225,
        "window_size": 3,
        "char_count": 202,
        "word_count": 51,
        "page_number": 12,
        "window_text": "| 1 | 정밀도 | 농도별 측정횟수(일) 변이계수 등 제시 | ②「혈액관리법」제6조제3항에 따라 허가받은 공급혈액원 | Techniques NIBSC code: 08/314-XXX5) | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP.  | INC.  | 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다. ",
        "original_sentence": "| DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP. "
      }
    },
    {
      "chunk_id": "chunk_227",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 226,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP.  | INC.  | 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다.  | ABBOTT | M.A. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_228",
      "text": "| 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 227,
        "window_size": 3,
        "char_count": 42,
        "word_count": 12,
        "page_number": 3,
        "window_text": "| conjugate-APS | 변경 및 제·개정 점검표 등 추가 | DIASORIN S.P.A.  | DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP.  | INC.  | 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다.  | ABBOTT | M.A.  | 1992 |\n| K901485 | K880433 | K863488 | 다. ",
        "original_sentence": "| 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_229",
      "text": "| 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 228,
        "window_size": 3,
        "char_count": 141,
        "word_count": 27,
        "page_number": 3,
        "window_text": "| DIAGNOSTICS | DIAGNOSTICS | BEHRING | DE FERRIS | BEHRING | ㎍/L | 규격 | 1994 |\n| K974901 | 2.0) | ABBOTT | USA | 또는 표준혈청) | IGM/IGG | ASSAY | TEST) | 양성 | # 진양성 TP | # 위양성 FP | 진양성+ 위양성 | DIGENE CORP.  | INC.  | 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다.  | ABBOTT | M.A.  | 1992 |\n| K901485 | K880433 | K863488 | 다.  결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다. ",
        "original_sentence": "| 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다. "
      }
    },
    {
      "chunk_id": "chunk_230",
      "text": "| ABBOTT | M.A. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 229,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 73,
        "window_text": "| INC.  | 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다.  | ABBOTT | M.A.  | 1992 |\n| K901485 | K880433 | K863488 | 다.  결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다.  | 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다. ",
        "original_sentence": "| ABBOTT | M.A. "
      }
    },
    {
      "chunk_id": "chunk_231",
      "text": "| 1992 |\n| K901485 | K880433 | K863488 | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 230,
        "window_size": 3,
        "char_count": 44,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| 2005 |\n| 및 정성, 반정량 또는 정량 등을 구체적으로 기재한다.  | 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다.  | ABBOTT | M.A.  | 1992 |\n| K901485 | K880433 | K863488 | 다.  결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다.  | 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다.  | 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다. ",
        "original_sentence": "| 1992 |\n| K901485 | K880433 | K863488 | 다. "
      }
    },
    {
      "chunk_id": "chunk_232",
      "text": "결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 231,
        "window_size": 3,
        "char_count": 84,
        "word_count": 16,
        "page_number": 12,
        "window_text": "| 동일한 의료기기로서 취소된 날로부터 1년이 지난 경우 | AXSYM CMV IGG ANTIBODY | ENZYGNOST ANTI-CMV/IGG + | CYTOMEGALOVIRUS IGG EIA | ENZYGNOST ANTI-CMV IGG | 한다.  | ABBOTT | M.A.  | 1992 |\n| K901485 | K880433 | K863488 | 다.  결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다.  | 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다.  | 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다.  | 밀도(within-laboratory) 자료를 제시한다. ",
        "original_sentence": "결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다. "
      }
    },
    {
      "chunk_id": "chunk_233",
      "text": "| 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 232,
        "window_size": 3,
        "char_count": 52,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| ABBOTT | M.A.  | 1992 |\n| K901485 | K880433 | K863488 | 다.  결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다.  | 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다.  | 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다.  | 밀도(within-laboratory) 자료를 제시한다.  | 제공해야한다. ",
        "original_sentence": "| 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_234",
      "text": "| 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 233,
        "window_size": 3,
        "char_count": 75,
        "word_count": 17,
        "page_number": 12,
        "window_text": "| 1992 |\n| K901485 | K880433 | K863488 | 다.  결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다.  | 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다.  | 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다.  | 밀도(within-laboratory) 자료를 제시한다.  | 제공해야한다.  | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다. ",
        "original_sentence": "| 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_235",
      "text": "| 밀도(within-laboratory) 자료를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 234,
        "window_size": 3,
        "char_count": 34,
        "word_count": 4,
        "page_number": 4,
        "window_text": "결과제시 | 마. ATCC 균주 | Wayne, PA: Cinical and Laboratory Standard Institute; 2006 | 다.  | 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다.  | 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다.  | 밀도(within-laboratory) 자료를 제시한다.  | 제공해야한다.  | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다. ",
        "original_sentence": "| 밀도(within-laboratory) 자료를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_236",
      "text": "| 제공해야한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 235,
        "window_size": 3,
        "char_count": 10,
        "word_count": 2,
        "page_number": 30,
        "window_text": "| 4) 시험일자 및 시험성적서 발급일자 | 3) 최소 3가지 이상의 농도를 포함해야 한다.  | 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다.  | 밀도(within-laboratory) 자료를 제시한다.  | 제공해야한다.  | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다.  | 자료를 제시한다. ",
        "original_sentence": "| 제공해야한다. "
      }
    },
    {
      "chunk_id": "chunk_237",
      "text": "| 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 236,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 30,
        "window_text": "| 가) 분석물질 음성검체(간섭물질 없음) | 소프트웨어의 회사명, 모델명 등을 기재 | 기준값에 적합함을 확인하는 과정을 제공한다.  | 밀도(within-laboratory) 자료를 제시한다.  | 제공해야한다.  | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다.  | 자료를 제시한다.  | CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다. ",
        "original_sentence": "| 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_238",
      "text": "| 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 237,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 30,
        "window_text": "| 밀도(within-laboratory) 자료를 제시한다.  | 제공해야한다.  | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다.  | 자료를 제시한다.  | CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다.  | ※ 예시 | 3. ",
        "original_sentence": "| 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_239",
      "text": "| 자료를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 238,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 4,
        "window_text": "| 제공해야한다.  | 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다.  | 자료를 제시한다.  | CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다.  | ※ 예시 | 3.  원재료 | 20 | 2. ",
        "original_sentence": "| 자료를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_240",
      "text": "| CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 239,
        "window_size": 3,
        "char_count": 201,
        "word_count": 39,
        "page_number": 12,
        "window_text": "| 분석물질의 농도, 농도를 확인한 방법 등)을 기술해야 한다.  | 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다.  | 자료를 제시한다.  | CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다.  | ※ 예시 | 3.  원재료 | 20 | 2.  임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD. ",
        "original_sentence": "| CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다. "
      }
    },
    {
      "chunk_id": "chunk_241",
      "text": "| ※ 예시 | 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 240,
        "window_size": 3,
        "char_count": 12,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| 또는 l’당 ‘IU, U’의 단위로 표기할 것을 권장한다.  | 자료를 제시한다.  | CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다.  | ※ 예시 | 3.  원재료 | 20 | 2.  임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD.  |\n| 2. ",
        "original_sentence": "| ※ 예시 | 3. "
      }
    },
    {
      "chunk_id": "chunk_242",
      "text": "원재료 | 20 | 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 241,
        "window_size": 3,
        "char_count": 14,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| 자료를 제시한다.  | CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다.  | ※ 예시 | 3.  원재료 | 20 | 2.  임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD.  |\n| 2.  제조자 | 제출한다. ",
        "original_sentence": "원재료 | 20 | 2. "
      }
    },
    {
      "chunk_id": "chunk_243",
      "text": "임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 242,
        "window_size": 3,
        "char_count": 45,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| CMV DNA ASSAY | CMV-COMPLEMENT FIXATION | DIAGNOSTICS | GULL | LABORATORIES | DIAGNOSTICS | MICROBIX | 1998 |\n| 방법 X | K953943 | K830615 | CYTOMEGELISA STAT | 다. SeraCare사의 관련 표준물질6) | 정밀도 등)을 설정한다.  | ※ 예시 | 3.  원재료 | 20 | 2.  임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD.  |\n| 2.  제조자 | 제출한다.  | ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다. ",
        "original_sentence": "임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD. "
      }
    },
    {
      "chunk_id": "chunk_244",
      "text": "|\n| 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 243,
        "window_size": 3,
        "char_count": 7,
        "word_count": 3,
        "page_number": 19,
        "window_text": "| ※ 예시 | 3.  원재료 | 20 | 2.  임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD.  |\n| 2.  제조자 | 제출한다.  | ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다.  | Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다. ",
        "original_sentence": "|\n| 2. "
      }
    },
    {
      "chunk_id": "chunk_245",
      "text": "제조자 | 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 244,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 30,
        "window_text": "원재료 | 20 | 2.  임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD.  |\n| 2.  제조자 | 제출한다.  | ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다.  | Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다.  | 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP. ",
        "original_sentence": "제조자 | 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_246",
      "text": "| ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 245,
        "window_size": 3,
        "char_count": 70,
        "word_count": 18,
        "page_number": 2,
        "window_text": "임상적 성능시험에 관한 자료 | 53 | [근거: 「식품의약품안전처 | LTD.  |\n| 2.  제조자 | 제출한다.  | ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다.  | Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다.  | 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP.  | INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다. ",
        "original_sentence": "| ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_247",
      "text": "| Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 246,
        "window_size": 3,
        "char_count": 141,
        "word_count": 33,
        "page_number": 3,
        "window_text": "|\n| 2.  제조자 | 제출한다.  | ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다.  | Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다.  | 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP.  | INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다.  | 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC. ",
        "original_sentence": "| Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_248",
      "text": "| 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 247,
        "window_size": 3,
        "char_count": 80,
        "word_count": 22,
        "page_number": 3,
        "window_text": "제조자 | 제출한다.  | ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다.  | Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다.  | 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP.  | INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다.  | 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC.  | LABORATORIES | INC. ",
        "original_sentence": "| 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP. "
      }
    },
    {
      "chunk_id": "chunk_249",
      "text": "| INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 248,
        "window_size": 3,
        "char_count": 104,
        "word_count": 20,
        "page_number": 12,
        "window_text": "| ③ 법 제10조제3항에 따라 식약처장이 지정한 임상시험기관 | 권장하고 그 외 자사가 설정한 시험항목을 설정할 수 있다.  | Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다.  | 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP.  | INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다.  | 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC.  | LABORATORIES | INC.  | INC. ",
        "original_sentence": "| INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다. "
      }
    },
    {
      "chunk_id": "chunk_250",
      "text": "| 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 249,
        "window_size": 3,
        "char_count": 127,
        "word_count": 37,
        "page_number": 3,
        "window_text": "| Immulite 2500 CMV IgG/IgM | SIEMENS | USA | 10번 | 반복측정하여 | 검사 | 결과 | DIAMEDIX IS-CMV IGM | IGM | DETECTADOT TM SYSTEM | KIT | TEST | 기재한다.  | 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP.  | INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다.  | 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC.  | LABORATORIES | INC.  | INC.  | BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC. ",
        "original_sentence": "| 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC. "
      }
    },
    {
      "chunk_id": "chunk_251",
      "text": "| LABORATORIES | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 250,
        "window_size": 3,
        "char_count": 22,
        "word_count": 4,
        "page_number": 12,
        "window_text": "| 자사 | 위음성 + | 1991 | 1989 | 1987 |\n| K001767 | ASSAY | 30, 34 | DIAMEDIX CORP.  | INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다.  | 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC.  | LABORATORIES | INC.  | INC.  | BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC.  | Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다. ",
        "original_sentence": "| LABORATORIES | INC. "
      }
    },
    {
      "chunk_id": "chunk_252",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 251,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| INSTRUMENTAT | LABORATORIES | DIAGNOSTIC | BIOPRODUCTS | 1996 | 1983 |\n| K893230 | K852929 | 로 이루어진다.  | 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC.  | LABORATORIES | INC.  | INC.  | BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC.  | Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | bias)경우를 제시한다. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_253",
      "text": "| BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 252,
        "window_size": 3,
        "char_count": 82,
        "word_count": 20,
        "page_number": 1,
        "window_text": "| 2 | 분석적 특이도 | 웰9 : 엠티 웰 | - | (우 28159) 충청북도 청주시 흥덕구 오송읍 오송생명2로 187 | ANTIGEN AND NEGATIVE | 음성 | # 위음성 FN | # 진음성 TN | INC.  | LABORATORIES | INC.  | INC.  | BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC.  | Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | bias)경우를 제시한다.  | 나) 분석물질 음성검체 + 간섭물질 | 4. ",
        "original_sentence": "| BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC. "
      }
    },
    {
      "chunk_id": "chunk_254",
      "text": "| Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 253,
        "window_size": 3,
        "char_count": 86,
        "word_count": 21,
        "page_number": 3,
        "window_text": "| LABORATORIES | INC.  | INC.  | BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC.  | Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | bias)경우를 제시한다.  | 나) 분석물질 음성검체 + 간섭물질 | 4.  제조방법 | 22 | 3. ",
        "original_sentence": "| Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_255",
      "text": "| bias)경우를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 254,
        "window_size": 3,
        "char_count": 17,
        "word_count": 3,
        "page_number": 12,
        "window_text": "| INC.  | BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC.  | Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | bias)경우를 제시한다.  | 나) 분석물질 음성검체 + 간섭물질 | 4.  제조방법 | 22 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다. ",
        "original_sentence": "| bias)경우를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_256",
      "text": "| 나) 분석물질 음성검체 + 간섭물질 | 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 255,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 12,
        "window_text": "| BIOSYSTEMS | - |\n| 1) 4등급 체외진단용 의료기기 시험 | K914789 | ELISA CMV IGM | SCLAVO INC.  | Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | bias)경우를 제시한다.  | 나) 분석물질 음성검체 + 간섭물질 | 4.  제조방법 | 22 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다.  | Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고). ",
        "original_sentence": "| 나) 분석물질 음성검체 + 간섭물질 | 4. "
      }
    },
    {
      "chunk_id": "chunk_257",
      "text": "제조방법 | 22 | 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 256,
        "window_size": 3,
        "char_count": 15,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| Coxsackievirus Types B1, B2, | 5) 시험 책임자의 서명 또는 직인 | 검체의 이력 등이 밝혀진 검체를 사용할 것을 권장한다.  | bias)경우를 제시한다.  | 나) 분석물질 음성검체 + 간섭물질 | 4.  제조방법 | 22 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다.  | Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고).  | (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라. ",
        "original_sentence": "제조방법 | 22 | 3. "
      }
    },
    {
      "chunk_id": "chunk_258",
      "text": "완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 257,
        "window_size": 3,
        "char_count": 34,
        "word_count": 8,
        "page_number": 30,
        "window_text": "| bias)경우를 제시한다.  | 나) 분석물질 음성검체 + 간섭물질 | 4.  제조방법 | 22 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다.  | Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고).  | (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라.  분량 | 가. ",
        "original_sentence": "완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다. "
      }
    },
    {
      "chunk_id": "chunk_259",
      "text": "| Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고). ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 258,
        "window_size": 3,
        "char_count": 108,
        "word_count": 25,
        "page_number": 3,
        "window_text": "| 나) 분석물질 음성검체 + 간섭물질 | 4.  제조방법 | 22 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다.  | Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고).  | (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라.  분량 | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다. ",
        "original_sentence": "| Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고). "
      }
    },
    {
      "chunk_id": "chunk_260",
      "text": "| (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 259,
        "window_size": 3,
        "char_count": 137,
        "word_count": 34,
        "page_number": 3,
        "window_text": "제조방법 | 22 | 3.  완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다.  | Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고).  | (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라.  분량 | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다.  | 1) 상호 : FDAS | 첨부하여야 한다. ",
        "original_sentence": "| (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라. "
      }
    },
    {
      "chunk_id": "chunk_261",
      "text": "분량 | 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 260,
        "window_size": 3,
        "char_count": 8,
        "word_count": 3,
        "page_number": 25,
        "window_text": "완제품의 품질관리 시험성적서 또는 시험에 관한 | 판단한다.  | Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고).  | (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라.  분량 | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다.  | 1) 상호 : FDAS | 첨부하여야 한다.  | ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나. ",
        "original_sentence": "분량 | 가. "
      }
    },
    {
      "chunk_id": "chunk_262",
      "text": "해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 261,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 4,
        "window_text": "| Immulite 1000 CMV IgG/IgM | SIEMENS | USA | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정사 | 성능시험자료의 작성 시 준수 사항 참고).  | (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라.  분량 | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다.  | 1) 상호 : FDAS | 첨부하여야 한다.  | ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나.  시험기준 | 함께 기록한다. ",
        "original_sentence": "해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_263",
      "text": "| 1) 상호 : FDAS | 첨부하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 262,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| (O.D)값의 변이계수(CV)가 10% | CAPTURE TEST SYSTEM | 지침서등의 관리에 관한 규정」 | Poliovirus Types 1, 2, 3 | □ 예(☞지침서) | ■ 아니오 | 진음성 | 2000 |\n| 구성 | 라.  분량 | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다.  | 1) 상호 : FDAS | 첨부하여야 한다.  | ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나.  시험기준 | 함께 기록한다.  | MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까? ",
        "original_sentence": "| 1) 상호 : FDAS | 첨부하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_264",
      "text": "| ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 263,
        "window_size": 3,
        "char_count": 114,
        "word_count": 26,
        "page_number": 3,
        "window_text": "분량 | 가.  해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다.  | 1) 상호 : FDAS | 첨부하여야 한다.  | ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나.  시험기준 | 함께 기록한다.  | MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP. ",
        "original_sentence": "| ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나. "
      }
    },
    {
      "chunk_id": "chunk_265",
      "text": "시험기준 | 함께 기록한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 264,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 30,
        "window_text": "해당시약의 성분과 분량을 확인할 수 있는 자료 | 를 제출한다.  | 1) 상호 : FDAS | 첨부하여야 한다.  | ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나.  시험기준 | 함께 기록한다.  | MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP.  | 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC. ",
        "original_sentence": "시험기준 | 함께 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_266",
      "text": "| MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까? ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 265,
        "window_size": 3,
        "char_count": 77,
        "word_count": 14,
        "page_number": 22,
        "window_text": "| 1) 상호 : FDAS | 첨부하여야 한다.  | ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나.  시험기준 | 함께 기록한다.  | MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP.  | 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC.  | SYVA CO. ",
        "original_sentence": "| MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_267",
      "text": "(공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 266,
        "window_size": 3,
        "char_count": 165,
        "word_count": 34,
        "page_number": 3,
        "window_text": "| ENZYME LINKED | 2000 CMV IGM TEST | ION | PYRAMID | 규격 | 1989 | 1985 |\n| K934798 | PATHODX CYTOMEGALOVIRUS | 나.  시험기준 | 함께 기록한다.  | MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP.  | 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC.  | SYVA CO.  | INC. ",
        "original_sentence": "(공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP. "
      }
    },
    {
      "chunk_id": "chunk_268",
      "text": "| 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 267,
        "window_size": 3,
        "char_count": 74,
        "word_count": 22,
        "page_number": 2,
        "window_text": "시험기준 | 함께 기록한다.  | MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP.  | 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC.  | SYVA CO.  | INC.  | ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다. ",
        "original_sentence": "| 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC. "
      }
    },
    {
      "chunk_id": "chunk_269",
      "text": "| SYVA CO. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 268,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 75,
        "window_text": "| MICROTRAK CMV CULTURE | CYTOMEGALOVIRUS IGG EIA | 무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP.  | 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC.  | SYVA CO.  | INC.  | ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다.  검사과정 | 다. ",
        "original_sentence": "| SYVA CO. "
      }
    },
    {
      "chunk_id": "chunk_270",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 269,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "(공무원용) | 오송보건의료행정타운 | 300mg/dL, 빌리루빈 : 40 mg/dL | PRODUCTS | GULL | LABSYSTEMS | 1992 |\n| K974456 | CMVGEN | K880290 | K862705 | K823123 | CORDIA CMV | CORDIS CORP.  | 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC.  | SYVA CO.  | INC.  | ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다.  검사과정 | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_271",
      "text": "| ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 270,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 2,
        "window_text": "| 는 경우 | 개봉여부 | 보관조건 | 사용기간 | 비고 | 이내 | CONTR | 진양성 + | DIAGNOSTIC | INC.  | SYVA CO.  | INC.  | ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다.  검사과정 | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5. ",
        "original_sentence": "| ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다. "
      }
    },
    {
      "chunk_id": "chunk_272",
      "text": "검사과정 | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 271,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 34,
        "window_text": "| SYVA CO.  | INC.  | ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다.  검사과정 | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5.  사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다. ",
        "original_sentence": "검사과정 | 다. "
      }
    },
    {
      "chunk_id": "chunk_273",
      "text": "시약의 표준화(standardization)를 위해 사용된 방법을 기술한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 272,
        "window_size": 3,
        "char_count": 43,
        "word_count": 6,
        "page_number": 12,
        "window_text": "| INC.  | ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다.  검사과정 | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5.  사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다.  | 과거에 확진된 보관검체로도 실험할 수 있다. ",
        "original_sentence": "시약의 표준화(standardization)를 위해 사용된 방법을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_274",
      "text": "| 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 273,
        "window_size": 3,
        "char_count": 96,
        "word_count": 23,
        "page_number": 3,
        "window_text": "| ZEUS |\n| 지침서ㆍ안내서 | K952254 | 다.  검사과정 | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5.  사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다.  | 과거에 확진된 보관검체로도 실험할 수 있다.  | -538D, -977D의 총 9종, 각 $360 | 없어야 한다. ",
        "original_sentence": "| 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5. "
      }
    },
    {
      "chunk_id": "chunk_275",
      "text": "사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 274,
        "window_size": 3,
        "char_count": 50,
        "word_count": 11,
        "page_number": 2,
        "window_text": "검사과정 | 다.  시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5.  사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다.  | 과거에 확진된 보관검체로도 실험할 수 있다.  | -538D, -977D의 총 9종, 각 $360 | 없어야 한다.  | 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.] ",
        "original_sentence": "사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다. "
      }
    },
    {
      "chunk_id": "chunk_276",
      "text": "| 과거에 확진된 보관검체로도 실험할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 275,
        "window_size": 3,
        "char_count": 27,
        "word_count": 7,
        "page_number": 26,
        "window_text": "시약의 표준화(standardization)를 위해 사용된 방법을 기술한다.  | 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5.  사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다.  | 과거에 확진된 보관검체로도 실험할 수 있다.  | -538D, -977D의 총 9종, 각 $360 | 없어야 한다.  | 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.]  | 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다. ",
        "original_sentence": "| 과거에 확진된 보관검체로도 실험할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_277",
      "text": "| -538D, -977D의 총 9종, 각 $360 | 없어야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 276,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 결과들의 ‘표준편차’ 또는 ‘변이계수’라는 용어로 정량적으로 표현 | B3, B4, B5, B6 | 2) 결과제시 | 다) 분석물질 약양성검체(간섭물질 없음) | 5.  사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다.  | 과거에 확진된 보관검체로도 실험할 수 있다.  | -538D, -977D의 총 9종, 각 $360 | 없어야 한다.  | 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.]  | 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다.  | LABORATORY | LABORATORIES | INC. ",
        "original_sentence": "| -538D, -977D의 총 9종, 각 $360 | 없어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_278",
      "text": "| 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.] ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 277,
        "window_size": 3,
        "char_count": 73,
        "word_count": 14,
        "page_number": 4,
        "window_text": "사용목적 | 22 | 아직 free상태였던 β항원의 binding site에 붙게 된다.  | 과거에 확진된 보관검체로도 실험할 수 있다.  | -538D, -977D의 총 9종, 각 $360 | 없어야 한다.  | 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.]  | 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다.  | LABORATORY | LABORATORIES | INC.  | HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가. ",
        "original_sentence": "| 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.] "
      }
    },
    {
      "chunk_id": "chunk_279",
      "text": "| 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 278,
        "window_size": 3,
        "char_count": 271,
        "word_count": 60,
        "page_number": 3,
        "window_text": "| 과거에 확진된 보관검체로도 실험할 수 있다.  | -538D, -977D의 총 9종, 각 $360 | 없어야 한다.  | 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.]  | 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다.  | LABORATORY | LABORATORIES | INC.  | HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가.  분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다. ",
        "original_sentence": "| 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다. "
      }
    },
    {
      "chunk_id": "chunk_280",
      "text": "| LABORATORY | LABORATORIES | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 279,
        "window_size": 3,
        "char_count": 35,
        "word_count": 6,
        "page_number": 12,
        "window_text": "| -538D, -977D의 총 9종, 각 $360 | 없어야 한다.  | 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.]  | 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다.  | LABORATORY | LABORATORIES | INC.  | HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가.  분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다.  | 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1. ",
        "original_sentence": "| LABORATORY | LABORATORIES | INC. "
      }
    },
    {
      "chunk_id": "chunk_281",
      "text": "| HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 280,
        "window_size": 3,
        "char_count": 59,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 자료 | 59 | IMMUNOABSORBENT ASSAY | BIOLOGICAL | BEHRING | 개정, ‘17.5.1.]  | 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다.  | LABORATORY | LABORATORIES | INC.  | HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가.  분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다.  | 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1.  외관사진 작성의 예 | 위음성 | CORP. ",
        "original_sentence": "| HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가. "
      }
    },
    {
      "chunk_id": "chunk_282",
      "text": "분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 281,
        "window_size": 3,
        "char_count": 46,
        "word_count": 10,
        "page_number": 4,
        "window_text": "| 자사 | 1994 | 1982 |\n| 제품 | 8 | 포장단위 | K900796 | CMV IGG ELISA TEST | Institute; 2008 | 전체 | Zeus CMV IgG/IgM ELISA test system | 식품의약품안전평가원 의료기기심사부 체외진단기기과 | IMMULITE 2000 CMV IGG | ORGENICS IMMUNOCOMB(TM) | CONFIRMATION TEST | TEST KIT | 위양성 + 진음성 | N | 혈청을 10회씩 측정한다.  | LABORATORY | LABORATORIES | INC.  | HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가.  분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다.  | 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1.  외관사진 작성의 예 | 위음성 | CORP.  | 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다. ",
        "original_sentence": "분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다. "
      }
    },
    {
      "chunk_id": "chunk_283",
      "text": "| 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 282,
        "window_size": 3,
        "char_count": 153,
        "word_count": 37,
        "page_number": 2,
        "window_text": "| LABORATORY | LABORATORIES | INC.  | HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가.  분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다.  | 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1.  외관사진 작성의 예 | 위음성 | CORP.  | 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다.  | 2018.7. ",
        "original_sentence": "| 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1. "
      }
    },
    {
      "chunk_id": "chunk_284",
      "text": "외관사진 작성의 예 | 위음성 | CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 283,
        "window_size": 3,
        "char_count": 25,
        "word_count": 7,
        "page_number": 12,
        "window_text": "| HILLCREST | SCIENTIFIC | USA | 1998 | 1988 | 1986 |\n| 가.  분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다.  | 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1.  외관사진 작성의 예 | 위음성 | CORP.  | 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다.  | 2018.7.  | ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바. ",
        "original_sentence": "외관사진 작성의 예 | 위음성 | CORP. "
      }
    },
    {
      "chunk_id": "chunk_285",
      "text": "| 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 284,
        "window_size": 3,
        "char_count": 129,
        "word_count": 23,
        "page_number": 3,
        "window_text": "분석적 성능시험에 관한 자료 | 효소, ionophore, 시약에 의해 발생한다.  | 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1.  외관사진 작성의 예 | 위음성 | CORP.  | 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다.  | 2018.7.  | ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바.  국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다. ",
        "original_sentence": "| 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다. "
      }
    },
    {
      "chunk_id": "chunk_286",
      "text": "| 2018.7. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 285,
        "window_size": 3,
        "char_count": 10,
        "word_count": 2,
        "page_number": 3,
        "window_text": "| 구분 | 2) 제조국 : 미국 | 웰10 : 큐벳 | 2-Methylisothiazolone | 적량 | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설 | (품질관리용 냉동보관된 고, 중, | ENZYGNOST(R) ANTI-CMV | 그림 1.  외관사진 작성의 예 | 위음성 | CORP.  | 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다.  | 2018.7.  | ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바.  국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다.  | 판정기준치(농도) | 검체 등을 사용할 수 있다. ",
        "original_sentence": "| 2018.7. "
      }
    },
    {
      "chunk_id": "chunk_287",
      "text": "| ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 286,
        "window_size": 3,
        "char_count": 58,
        "word_count": 15,
        "page_number": 3,
        "window_text": "외관사진 작성의 예 | 위음성 | CORP.  | 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다.  | 2018.7.  | ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바.  국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다.  | 판정기준치(농도) | 검체 등을 사용할 수 있다.  | 제시한다. ",
        "original_sentence": "| ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바. "
      }
    },
    {
      "chunk_id": "chunk_288",
      "text": "국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 287,
        "window_size": 3,
        "char_count": 85,
        "word_count": 14,
        "page_number": 12,
        "window_text": "| 150ul | 1995 |\n| K993952 | K852494 | CMV-IHA | 안내서- | Acholeplasma laidlawi | Acinetobacter calcoaceticus | 정량하는 체외진단용 의료기기이다.  | 2018.7.  | ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바.  국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다.  | 판정기준치(농도) | 검체 등을 사용할 수 있다.  | 제시한다.  | 로 표시한다. ",
        "original_sentence": "국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_289",
      "text": "| 판정기준치(농도) | 검체 등을 사용할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 288,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 26,
        "window_text": "| 2018.7.  | ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바.  국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다.  | 판정기준치(농도) | 검체 등을 사용할 수 있다.  | 제시한다.  | 로 표시한다.  | CYTOMEGALOVIRUS | CO. ",
        "original_sentence": "| 판정기준치(농도) | 검체 등을 사용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_290",
      "text": "| 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 289,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 24,
        "window_text": "| ｢ | 의료기기 허가․신고․심사 등에 | PRODUCTS | 1990 |\n| K913910 | 바.  국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다.  | 판정기준치(농도) | 검체 등을 사용할 수 있다.  | 제시한다.  | 로 표시한다.  | CYTOMEGALOVIRUS | CO.  | CORP. ",
        "original_sentence": "| 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_291",
      "text": "| 로 표시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 290,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 30,
        "window_text": "국내 병원성바이러스은행 보유균주 | Device Studies -Frequently Asked Questions, 2010 | 함하여 비교하도록 한다.  | 판정기준치(농도) | 검체 등을 사용할 수 있다.  | 제시한다.  | 로 표시한다.  | CYTOMEGALOVIRUS | CO.  | CORP.  | DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다. ",
        "original_sentence": "| 로 표시한다. "
      }
    },
    {
      "chunk_id": "chunk_292",
      "text": "| CYTOMEGALOVIRUS | CO. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 291,
        "window_size": 3,
        "char_count": 24,
        "word_count": 4,
        "page_number": 75,
        "window_text": "| 판정기준치(농도) | 검체 등을 사용할 수 있다.  | 제시한다.  | 로 표시한다.  | CYTOMEGALOVIRUS | CO.  | CORP.  | DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다.  | K891393 | K822965 | CETUS CMV IHA | CETUS CORP. ",
        "original_sentence": "| CYTOMEGALOVIRUS | CO. "
      }
    },
    {
      "chunk_id": "chunk_293",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 292,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 74,
        "window_text": "| 제시한다.  | 로 표시한다.  | CYTOMEGALOVIRUS | CO.  | CORP.  | DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다.  | K891393 | K822965 | CETUS CMV IHA | CETUS CORP.  | 가. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_294",
      "text": "| DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 293,
        "window_size": 3,
        "char_count": 79,
        "word_count": 21,
        "page_number": 12,
        "window_text": "| 로 표시한다.  | CYTOMEGALOVIRUS | CO.  | CORP.  | DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다.  | K891393 | K822965 | CETUS CMV IHA | CETUS CORP.  | 가.  시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6. ",
        "original_sentence": "| DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_295",
      "text": "| K891393 | K822965 | CETUS CMV IHA | CETUS CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 294,
        "window_size": 3,
        "char_count": 50,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| CYTOMEGALOVIRUS | CO.  | CORP.  | DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다.  | K891393 | K822965 | CETUS CMV IHA | CETUS CORP.  | 가.  시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6.  사용방법 | 23 | 4. ",
        "original_sentence": "| K891393 | K822965 | CETUS CMV IHA | CETUS CORP. "
      }
    },
    {
      "chunk_id": "chunk_296",
      "text": "| 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 295,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| CORP.  | DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다.  | K891393 | K822965 | CETUS CMV IHA | CETUS CORP.  | 가.  시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6.  사용방법 | 23 | 4.  표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까? ",
        "original_sentence": "| 가. "
      }
    },
    {
      "chunk_id": "chunk_297",
      "text": "시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 296,
        "window_size": 3,
        "char_count": 109,
        "word_count": 22,
        "page_number": 12,
        "window_text": "| DIAGNOSTICS | DISEASE | BEHRING | 규격 |\n| 7 | 사용 시 주의사항 | 경우는 적용범위가 제한될 수 있다.  | K891393 | K822965 | CETUS CMV IHA | CETUS CORP.  | 가.  시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6.  사용방법 | 23 | 4.  표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC. ",
        "original_sentence": "시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6. "
      }
    },
    {
      "chunk_id": "chunk_298",
      "text": "사용방법 | 23 | 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 297,
        "window_size": 3,
        "char_count": 15,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| K891393 | K822965 | CETUS CMV IHA | CETUS CORP.  | 가.  시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6.  사용방법 | 23 | 4.  표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC.  | ORGENICS LTD. ",
        "original_sentence": "사용방법 | 23 | 4. "
      }
    },
    {
      "chunk_id": "chunk_299",
      "text": "표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까? ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 298,
        "window_size": 3,
        "char_count": 167,
        "word_count": 37,
        "page_number": 4,
        "window_text": "| 가.  시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6.  사용방법 | 23 | 4.  표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC.  | ORGENICS LTD.  | BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다. ",
        "original_sentence": "표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_300",
      "text": "(민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 299,
        "window_size": 3,
        "char_count": 85,
        "word_count": 15,
        "page_number": 3,
        "window_text": "시험물질 | Bordetella bronchiseptica | Bordetella pertussis | 라) 분석물질 약양성검체 + 간섭물질 | 미개봉 | 결과와 관계없는 기준이여야 함 | 6.  사용방법 | 23 | 4.  표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC.  | ORGENICS LTD.  | BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다.  | 있는 자료 포함 | 역가를 기재 | IGG | CORP. ",
        "original_sentence": "(민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC. "
      }
    },
    {
      "chunk_id": "chunk_301",
      "text": "| ORGENICS LTD. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 300,
        "window_size": 3,
        "char_count": 16,
        "word_count": 3,
        "page_number": 12,
        "window_text": "사용방법 | 23 | 4.  표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC.  | ORGENICS LTD.  | BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다.  | 있는 자료 포함 | 역가를 기재 | IGG | CORP.  | 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC. ",
        "original_sentence": "| ORGENICS LTD. "
      }
    },
    {
      "chunk_id": "chunk_302",
      "text": "| BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 301,
        "window_size": 3,
        "char_count": 167,
        "word_count": 40,
        "page_number": 3,
        "window_text": "표준품질 및 검체보관 등에 관한 자료 | 59 | 저 환자혈청) | MODEL L2KCV2 L2KCV6 | CMV IGG ANTIBODY TEST | SERODOT CMV | ENZYGNOST ANTI-CMV IGM | 명하거나 특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 | 것입니까?  (민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC.  | ORGENICS LTD.  | BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다.  | 있는 자료 포함 | 역가를 기재 | IGG | CORP.  | 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC.  | DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다. ",
        "original_sentence": "| BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_303",
      "text": "| 있는 자료 포함 | 역가를 기재 | IGG | CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 302,
        "window_size": 3,
        "char_count": 34,
        "word_count": 11,
        "page_number": 4,
        "window_text": "(민원인용) | TEL : 043-719-4652~65  FAX : 043-719-4650 | 제조일로부터 11개월 | BIOMERIEUX | INC.  | ORGENICS LTD.  | BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다.  | 있는 자료 포함 | 역가를 기재 | IGG | CORP.  | 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC.  | DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다.  결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다. ",
        "original_sentence": "| 있는 자료 포함 | 역가를 기재 | IGG | CORP. "
      }
    },
    {
      "chunk_id": "chunk_304",
      "text": "| 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 303,
        "window_size": 3,
        "char_count": 148,
        "word_count": 37,
        "page_number": 3,
        "window_text": "| ORGENICS LTD.  | BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다.  | 있는 자료 포함 | 역가를 기재 | IGG | CORP.  | 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC.  | DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다.  결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다.  | 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC. ",
        "original_sentence": "| 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC. "
      }
    },
    {
      "chunk_id": "chunk_305",
      "text": "| DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 304,
        "window_size": 3,
        "char_count": 60,
        "word_count": 14,
        "page_number": 2,
        "window_text": "| BIOLOGICALS | 1999 | 1985 |\n| K933549 | VIDAS CMV IGM ASSAY | 험자료 또는 이에 준하는 것으로 인정되는 시험자료 | 3) 주소 : 0000 U.S Highway 000, CA 0000, USA | 처리법, 허용기준, 결과 등을 요약하여 제시한다.  | 있는 자료 포함 | 역가를 기재 | IGG | CORP.  | 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC.  | DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다.  결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다.  | 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC.  | 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다. ",
        "original_sentence": "| DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다. "
      }
    },
    {
      "chunk_id": "chunk_306",
      "text": "결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 305,
        "window_size": 3,
        "char_count": 66,
        "word_count": 10,
        "page_number": 12,
        "window_text": "| 있는 자료 포함 | 역가를 기재 | IGG | CORP.  | 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC.  | DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다.  결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다.  | 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC.  | 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다.  | 7. ",
        "original_sentence": "결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다. "
      }
    },
    {
      "chunk_id": "chunk_307",
      "text": "| 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 306,
        "window_size": 3,
        "char_count": 63,
        "word_count": 14,
        "page_number": 2,
        "window_text": "| 1992 | 1983 |\n| 7 | 이미 허가받은 제품과 비교한 자료 | K861363 | 0649-02 | 수입업소명을 병기하여 구분하는 경우 | ACCURUN 146 CMV IGM | 2~8℃ | 관한 규정, ‘18.6.28.｣ | BOSTON | INC.  | DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다.  결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다.  | 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC.  | 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다.  | 7.  사용시 주의사항 | 25 | 5. ",
        "original_sentence": "| 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC. "
      }
    },
    {
      "chunk_id": "chunk_308",
      "text": "| 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 307,
        "window_size": 3,
        "char_count": 76,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| DETECTION | DIAGNOSTICS | BEHRING | 개정사항 반영 | 1989 |\n| 다.  결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다.  | 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC.  | 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다.  | 7.  사용시 주의사항 | 25 | 5.  상관성 평가 | 60 | 화합물이 형성된다. ",
        "original_sentence": "| 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_309",
      "text": "| 7. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 308,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 30,
        "window_text": "결과제시 | Chlamydophila pneumoniae | Chlamydophila psittaci | 지고 있다.  | 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC.  | 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다.  | 7.  사용시 주의사항 | 25 | 5.  상관성 평가 | 60 | 화합물이 형성된다.  | 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다. ",
        "original_sentence": "| 7. "
      }
    },
    {
      "chunk_id": "chunk_310",
      "text": "사용시 주의사항 | 25 | 5. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 309,
        "window_size": 3,
        "char_count": 19,
        "word_count": 6,
        "page_number": 2,
        "window_text": "| 항원이 코팅된 팁 | 모두 양성 | KIT | http://www.mfds.go.kr | VITEK INC.  | 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다.  | 7.  사용시 주의사항 | 25 | 5.  상관성 평가 | 60 | 화합물이 형성된다.  | 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다.  | 도를 산출한다. ",
        "original_sentence": "사용시 주의사항 | 25 | 5. "
      }
    },
    {
      "chunk_id": "chunk_311",
      "text": "상관성 평가 | 60 | 화합물이 형성된다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 310,
        "window_size": 3,
        "char_count": 25,
        "word_count": 7,
        "page_number": 4,
        "window_text": "| 1994 |\n| K972884 | K875361 | 1) Human Cytomegalovirus : KBPV-VR-7 | 기술한다.  | 7.  사용시 주의사항 | 25 | 5.  상관성 평가 | 60 | 화합물이 형성된다.  | 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다.  | 도를 산출한다.  | ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가. ",
        "original_sentence": "상관성 평가 | 60 | 화합물이 형성된다. "
      }
    },
    {
      "chunk_id": "chunk_312",
      "text": "| 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 311,
        "window_size": 3,
        "char_count": 46,
        "word_count": 13,
        "page_number": 30,
        "window_text": "| 7.  사용시 주의사항 | 25 | 5.  상관성 평가 | 60 | 화합물이 형성된다.  | 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다.  | 도를 산출한다.  | ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가.  최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다. ",
        "original_sentence": "| 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다. "
      }
    },
    {
      "chunk_id": "chunk_313",
      "text": "| 도를 산출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 312,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 30,
        "window_text": "사용시 주의사항 | 25 | 5.  상관성 평가 | 60 | 화합물이 형성된다.  | 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다.  | 도를 산출한다.  | ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가.  최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC. ",
        "original_sentence": "| 도를 산출한다. "
      }
    },
    {
      "chunk_id": "chunk_314",
      "text": "| ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 313,
        "window_size": 3,
        "char_count": 127,
        "word_count": 23,
        "page_number": 12,
        "window_text": "상관성 평가 | 60 | 화합물이 형성된다.  | 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다.  | 도를 산출한다.  | ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가.  최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC.  | PB DIAGNOSTIC | INTERNATIONAL | INC. ",
        "original_sentence": "| ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가. "
      }
    },
    {
      "chunk_id": "chunk_315",
      "text": "최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 314,
        "window_size": 3,
        "char_count": 222,
        "word_count": 47,
        "page_number": 12,
        "window_text": "| 필요한 경우에 한함) | 개봉 | 개봉일로부터 7개월 | 순위는 다음과 같다.  | 도를 산출한다.  | ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가.  최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC.  | PB DIAGNOSTIC | INTERNATIONAL | INC.  | DIAGNOSTICS | IMMULOK INC. ",
        "original_sentence": "최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_316",
      "text": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 315,
        "window_size": 3,
        "char_count": 89,
        "word_count": 18,
        "page_number": 2,
        "window_text": "| 도를 산출한다.  | ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가.  최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC.  | PB DIAGNOSTIC | INTERNATIONAL | INC.  | DIAGNOSTICS | IMMULOK INC.  | □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I. ",
        "original_sentence": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC. "
      }
    },
    {
      "chunk_id": "chunk_317",
      "text": "| PB DIAGNOSTIC | INTERNATIONAL | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 316,
        "window_size": 3,
        "char_count": 39,
        "word_count": 7,
        "page_number": 12,
        "window_text": "| ALLIANCE CYTOMEGALOVIRUS | (CYTOMEGALOVIRUS) IGG | TEST | ENZYGNOST + ANTI-CMV | CYTOMEGALOVIRUS | 비교방법 | ZEUS | 1986 |\n| 가.  최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC.  | PB DIAGNOSTIC | INTERNATIONAL | INC.  | DIAGNOSTICS | IMMULOK INC.  | □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I.  DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나. ",
        "original_sentence": "| PB DIAGNOSTIC | INTERNATIONAL | INC. "
      }
    },
    {
      "chunk_id": "chunk_318",
      "text": "| DIAGNOSTICS | IMMULOK INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 317,
        "window_size": 3,
        "char_count": 29,
        "word_count": 5,
        "page_number": 12,
        "window_text": "최소검출한계 | 범위 등) | antibodies | BIOTEST | BEHRING | 자사 |\n| 4 | 표준물질 및 검체보관 등에 관한 자료 | K900743 | CMV-IGM IFA TEST SYSTEM | K852478 | K822606 | Chlamydia trachomatis | Corynebacterium diphtheriae | 영향을 받는 경우에는 그 조건을 명시하여야 한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC.  | PB DIAGNOSTIC | INTERNATIONAL | INC.  | DIAGNOSTICS | IMMULOK INC.  | □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I.  DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나.  판정기준치(cut-off value) | 다. ",
        "original_sentence": "| DIAGNOSTICS | IMMULOK INC. "
      }
    },
    {
      "chunk_id": "chunk_319",
      "text": "| □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 318,
        "window_size": 3,
        "char_count": 181,
        "word_count": 44,
        "page_number": 2,
        "window_text": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | (품질관리용 냉동보관된 양성환자 | POSITIVE CONTROL | BIOMEDICA INC.  | PB DIAGNOSTIC | INTERNATIONAL | INC.  | DIAGNOSTICS | IMMULOK INC.  | □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I.  DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나.  판정기준치(cut-off value) | 다.  측정범위 | 나. ",
        "original_sentence": "| □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I. "
      }
    },
    {
      "chunk_id": "chunk_320",
      "text": "DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 319,
        "window_size": 3,
        "char_count": 81,
        "word_count": 20,
        "page_number": 2,
        "window_text": "| PB DIAGNOSTIC | INTERNATIONAL | INC.  | DIAGNOSTICS | IMMULOK INC.  | □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I.  DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나.  판정기준치(cut-off value) | 다.  측정범위 | 나.  시험방법 | 다. ",
        "original_sentence": "DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나. "
      }
    },
    {
      "chunk_id": "chunk_321",
      "text": "판정기준치(cut-off value) | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 320,
        "window_size": 3,
        "char_count": 26,
        "word_count": 4,
        "page_number": 12,
        "window_text": "| DIAGNOSTICS | IMMULOK INC.  | □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I.  DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나.  판정기준치(cut-off value) | 다.  측정범위 | 나.  시험방법 | 다.  시험방법 | 사. ",
        "original_sentence": "판정기준치(cut-off value) | 다. "
      }
    },
    {
      "chunk_id": "chunk_322",
      "text": "측정범위 | 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 321,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 36,
        "window_text": "| □ 예 | ■ 아니오 | 1997 | 1988 |\n| 2 | SPR | 4 | 저장방법과 사용기간(유효기간)에 관한 자료 | (30개의SPRx2개 | IMMEDIATE EARLY ANTIGEN | ENZYGNOST(R) | “내가 지킨 청렴실천 모아지면 청렴사회” | CMV Ag(AD 169) | 30ug | E.I.  DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나.  판정기준치(cut-off value) | 다.  측정범위 | 나.  시험방법 | 다.  시험방법 | 사.  그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다. ",
        "original_sentence": "측정범위 | 나. "
      }
    },
    {
      "chunk_id": "chunk_323",
      "text": "시험방법 | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 322,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 34,
        "window_text": "DUPONT DE |\n| 기타 확인사 | K991650 | CMV BRITE TURBO KIT | K933389 | OPUS CMV-G | 나.  판정기준치(cut-off value) | 다.  측정범위 | 나.  시험방법 | 다.  시험방법 | 사.  그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다.  | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다. ",
        "original_sentence": "시험방법 | 다. "
      }
    },
    {
      "chunk_id": "chunk_324",
      "text": "시험방법 | 사. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 323,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 34,
        "window_text": "판정기준치(cut-off value) | 다.  측정범위 | 나.  시험방법 | 다.  시험방법 | 사.  그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다.  | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다.  | 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8. ",
        "original_sentence": "시험방법 | 사. "
      }
    },
    {
      "chunk_id": "chunk_325",
      "text": "그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 324,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 25,
        "window_text": "측정범위 | 나.  시험방법 | 다.  시험방법 | 사.  그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다.  | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다.  | 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8.  포장단위 | 26 | 변이계수를 산출하여 기재한다. ",
        "original_sentence": "그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_326",
      "text": "| 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 325,
        "window_size": 3,
        "char_count": 88,
        "word_count": 18,
        "page_number": 12,
        "window_text": "시험방법 | 다.  시험방법 | 사.  그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다.  | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다.  | 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8.  포장단위 | 26 | 변이계수를 산출하여 기재한다.  | TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까? ",
        "original_sentence": "| 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_327",
      "text": "| 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 326,
        "window_size": 3,
        "char_count": 33,
        "word_count": 12,
        "page_number": 2,
        "window_text": "시험방법 | 사.  그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다.  | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다.  | 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8.  포장단위 | 26 | 변이계수를 산출하여 기재한다.  | TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까?  | 제조일로부터 11개월 | 10건을 검사한다. ",
        "original_sentence": "| 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8. "
      }
    },
    {
      "chunk_id": "chunk_328",
      "text": "포장단위 | 26 | 변이계수를 산출하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 327,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 3,
        "window_text": "그 외 표준물질 | 판독시간, 방법 등)을 상세하게 기재한다.  | 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다.  | 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8.  포장단위 | 26 | 변이계수를 산출하여 기재한다.  | TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까?  | 제조일로부터 11개월 | 10건을 검사한다.  | DIAGNOSTICS | INOVA | SCIENTIFIC INC. ",
        "original_sentence": "포장단위 | 26 | 변이계수를 산출하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_329",
      "text": "| TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까? ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 328,
        "window_size": 3,
        "char_count": 59,
        "word_count": 14,
        "page_number": 12,
        "window_text": "| 8) 시험환경요인(시험결과에 영향을 주는 경우에 한함) | vaccine recipients | 하고, 최소 100개 이상의 검체를 시험하도록 권장한다.  | 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8.  포장단위 | 26 | 변이계수를 산출하여 기재한다.  | TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까?  | 제조일로부터 11개월 | 10건을 검사한다.  | DIAGNOSTICS | INOVA | SCIENTIFIC INC.  | ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC. ",
        "original_sentence": "| TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_330",
      "text": "| 제조일로부터 11개월 | 10건을 검사한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 329,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 3,
        "window_text": "| 명칭 | 세부 구성 | 외관상 특징 | 미개봉 | 8.  포장단위 | 26 | 변이계수를 산출하여 기재한다.  | TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까?  | 제조일로부터 11개월 | 10건을 검사한다.  | DIAGNOSTICS | INOVA | SCIENTIFIC INC.  | ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC.  | INC. ",
        "original_sentence": "| 제조일로부터 11개월 | 10건을 검사한다. "
      }
    },
    {
      "chunk_id": "chunk_331",
      "text": "| DIAGNOSTICS | INOVA | SCIENTIFIC INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 330,
        "window_size": 3,
        "char_count": 40,
        "word_count": 7,
        "page_number": 12,
        "window_text": "포장단위 | 26 | 변이계수를 산출하여 기재한다.  | TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까?  | 제조일로부터 11개월 | 10건을 검사한다.  | DIAGNOSTICS | INOVA | SCIENTIFIC INC.  | ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC.  | INC.  |\n| SPR | 다. ",
        "original_sentence": "| DIAGNOSTICS | INOVA | SCIENTIFIC INC. "
      }
    },
    {
      "chunk_id": "chunk_332",
      "text": "| ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 331,
        "window_size": 3,
        "char_count": 197,
        "word_count": 45,
        "page_number": 3,
        "window_text": "| TEST KIT | IGG TEST | ANTOBODY IGG | 민원인을 구속하는 내용이 있습니까?  | 제조일로부터 11개월 | 10건을 검사한다.  | DIAGNOSTICS | INOVA | SCIENTIFIC INC.  | ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC.  | INC.  |\n| SPR | 다.  시험방법 | 라. ",
        "original_sentence": "| ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC. "
      }
    },
    {
      "chunk_id": "chunk_333",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 332,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 제조일로부터 11개월 | 10건을 검사한다.  | DIAGNOSTICS | INOVA | SCIENTIFIC INC.  | ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC.  | INC.  |\n| SPR | 다.  시험방법 | 라.  원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_334",
      "text": "|\n| SPR | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 333,
        "window_size": 3,
        "char_count": 13,
        "word_count": 5,
        "page_number": 24,
        "window_text": "| DIAGNOSTICS | INOVA | SCIENTIFIC INC.  | ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC.  | INC.  |\n| SPR | 다.  시험방법 | 라.  원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ.  참고문헌 | 63 | 근거를 제시한다. ",
        "original_sentence": "|\n| SPR | 다. "
      }
    },
    {
      "chunk_id": "chunk_335",
      "text": "시험방법 | 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 334,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 34,
        "window_text": "| ZEUS | MICROBIOLOGIC | 규격 | 1990 | 1985 | 1982 |\n| K913693 | K891081 | CMV ELISA TEST SYSTEM | Escherichia coli | Gardnerella vaginalis | 1) 일반사항 | 검체 10개 이상) | 양성 | 음성 | 전체 | DIAGNOSTICS | INC.  | INC.  |\n| SPR | 다.  시험방법 | 라.  원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ.  참고문헌 | 63 | 근거를 제시한다.  | 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC. ",
        "original_sentence": "시험방법 | 라. "
      }
    },
    {
      "chunk_id": "chunk_336",
      "text": "원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 335,
        "window_size": 3,
        "char_count": 47,
        "word_count": 14,
        "page_number": 4,
        "window_text": "| INC.  |\n| SPR | 다.  시험방법 | 라.  원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ.  참고문헌 | 63 | 근거를 제시한다.  | 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC.  | BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO. ",
        "original_sentence": "원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ. "
      }
    },
    {
      "chunk_id": "chunk_337",
      "text": "참고문헌 | 63 | 근거를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 336,
        "window_size": 3,
        "char_count": 22,
        "word_count": 6,
        "page_number": 3,
        "window_text": "|\n| SPR | 다.  시험방법 | 라.  원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ.  참고문헌 | 63 | 근거를 제시한다.  | 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC.  | BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO.  | SCIENTIFIC INC. ",
        "original_sentence": "참고문헌 | 63 | 근거를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_338",
      "text": "| 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 337,
        "window_size": 3,
        "char_count": 100,
        "word_count": 23,
        "page_number": 12,
        "window_text": "시험방법 | 라.  원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ.  참고문헌 | 63 | 근거를 제시한다.  | 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC.  | BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO.  | SCIENTIFIC INC.  | 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP. ",
        "original_sentence": "| 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC. "
      }
    },
    {
      "chunk_id": "chunk_339",
      "text": "| BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 338,
        "window_size": 3,
        "char_count": 149,
        "word_count": 34,
        "page_number": 3,
        "window_text": "원료물질의 품질 확인 근거자료 | 에 해당하는 자료 | 2) 분석적 특이도 | Ⅷ.  참고문헌 | 63 | 근거를 제시한다.  | 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC.  | BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO.  | SCIENTIFIC INC.  | 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP.  | DIAGNOSTICS | INC. ",
        "original_sentence": "| BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO. "
      }
    },
    {
      "chunk_id": "chunk_340",
      "text": "| SCIENTIFIC INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 339,
        "window_size": 3,
        "char_count": 18,
        "word_count": 3,
        "page_number": 12,
        "window_text": "참고문헌 | 63 | 근거를 제시한다.  | 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC.  | BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO.  | SCIENTIFIC INC.  | 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP.  | DIAGNOSTICS | INC.  | ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라. ",
        "original_sentence": "| SCIENTIFIC INC. "
      }
    },
    {
      "chunk_id": "chunk_341",
      "text": "| 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 340,
        "window_size": 3,
        "char_count": 106,
        "word_count": 25,
        "page_number": 3,
        "window_text": "| 반응정지제, 희석액 등) 성분은 적량으로 표시 가능 | 의 파우치) | ANTI-CMV/IGM | THE GOLDEN QUAD TEST | 2~8℃ | SYSTEMS INC.  | BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO.  | SCIENTIFIC INC.  | 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP.  | DIAGNOSTICS | INC.  | ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라.  결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다. ",
        "original_sentence": "| 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP. "
      }
    },
    {
      "chunk_id": "chunk_342",
      "text": "| DIAGNOSTICS | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 341,
        "window_size": 3,
        "char_count": 21,
        "word_count": 4,
        "page_number": 12,
        "window_text": "| BARTELS | 1999 | 1994 | 1992 |\n| K951851 | Haemophilis influenzae type A | Klebsiella pneumoniae | 항 | 모세관, 타액 및 기타 체액 등) | DIRECT | NEMOURS & CO.  | SCIENTIFIC INC.  | 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP.  | DIAGNOSTICS | INC.  | ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라.  결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다.  | 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다. ",
        "original_sentence": "| DIAGNOSTICS | INC. "
      }
    },
    {
      "chunk_id": "chunk_343",
      "text": "| ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 342,
        "window_size": 3,
        "char_count": 67,
        "word_count": 18,
        "page_number": 12,
        "window_text": "| SCIENTIFIC INC.  | 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP.  | DIAGNOSTICS | INC.  | ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라.  결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다.  | 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다.  | 1) 반복성 | 기술한다. ",
        "original_sentence": "| ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라. "
      }
    },
    {
      "chunk_id": "chunk_344",
      "text": "결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 343,
        "window_size": 3,
        "char_count": 50,
        "word_count": 9,
        "page_number": 2,
        "window_text": "| 1989 |\n| K971335 | QUANTA LITE CMV IGG ELISA | K861123 | 개봉 | 개봉일로부터 7개월 | IMX CMV IGG ANTIBODY | CORP.  | DIAGNOSTICS | INC.  | ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라.  결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다.  | 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다.  | 1) 반복성 | 기술한다.  | 9. ",
        "original_sentence": "결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다. "
      }
    },
    {
      "chunk_id": "chunk_345",
      "text": "| 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 344,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 2,
        "window_text": "| DIAGNOSTICS | INC.  | ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라.  결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다.  | 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다.  | 1) 반복성 | 기술한다.  | 9.  저장방법 및 사용기간 | 27 | photomultiplier가 측정한다. ",
        "original_sentence": "| 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_346",
      "text": "| 1) 반복성 | 기술한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 345,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| ABBOTT | GULL | AL RESEARCH | INSTITUTE |\n| 2 | 기술문서에 관한 자료 | 라.  결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다.  | 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다.  | 1) 반복성 | 기술한다.  | 9.  저장방법 및 사용기간 | 27 | photomultiplier가 측정한다.  | 포함되는 것을 권장한다. ",
        "original_sentence": "| 1) 반복성 | 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_347",
      "text": "| 9. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 346,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 32,
        "window_text": "결과판정 | abbreviated 510(k)s, 2005 | 허가받은 사항과 비교한다.  | 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다.  | 1) 반복성 | 기술한다.  | 9.  저장방법 및 사용기간 | 27 | photomultiplier가 측정한다.  | 포함되는 것을 권장한다.  | 등을 제시한다. ",
        "original_sentence": "| 9. "
      }
    },
    {
      "chunk_id": "chunk_348",
      "text": "저장방법 및 사용기간 | 27 | photomultiplier가 측정한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 347,
        "window_size": 3,
        "char_count": 42,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 1) 일반사항 | 1) 일반사항 | 1) 시험할 간섭물질의 목록을 작성한다.  | 1) 반복성 | 기술한다.  | 9.  저장방법 및 사용기간 | 27 | photomultiplier가 측정한다.  | 포함되는 것을 권장한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다. ",
        "original_sentence": "저장방법 및 사용기간 | 27 | photomultiplier가 측정한다. "
      }
    },
    {
      "chunk_id": "chunk_349",
      "text": "| 포함되는 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 348,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 30,
        "window_text": "| 1) 반복성 | 기술한다.  | 9.  저장방법 및 사용기간 | 27 | photomultiplier가 측정한다.  | 포함되는 것을 권장한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가. ",
        "original_sentence": "| 포함되는 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_350",
      "text": "| 등을 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 349,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 24,
        "window_text": "| 9.  저장방법 및 사용기간 | 27 | photomultiplier가 측정한다.  | 포함되는 것을 권장한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가.  체외진단용으로 사용해야 함을 명시한다. ",
        "original_sentence": "| 등을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_351",
      "text": "유병률을 구한 경우는 유병률도 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 350,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 24,
        "window_text": "저장방법 및 사용기간 | 27 | photomultiplier가 측정한다.  | 포함되는 것을 권장한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가.  체외진단용으로 사용해야 함을 명시한다.  | 기재한다. ",
        "original_sentence": "유병률을 구한 경우는 유병률도 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_352",
      "text": "| 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 351,
        "window_size": 3,
        "char_count": 70,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 포함되는 것을 권장한다.  | 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가.  체외진단용으로 사용해야 함을 명시한다.  | 기재한다.  | Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다. ",
        "original_sentence": "| 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가. "
      }
    },
    {
      "chunk_id": "chunk_353",
      "text": "체외진단용으로 사용해야 함을 명시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 352,
        "window_size": 3,
        "char_count": 22,
        "word_count": 4,
        "page_number": 30,
        "window_text": "| 등을 제시한다.  유병률을 구한 경우는 유병률도 제시한다.  | 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가.  체외진단용으로 사용해야 함을 명시한다.  | 기재한다.  | Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다. ",
        "original_sentence": "체외진단용으로 사용해야 함을 명시한다. "
      }
    },
    {
      "chunk_id": "chunk_354",
      "text": "| 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 353,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 25,
        "window_text": "유병률을 구한 경우는 유병률도 제시한다.  | 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가.  체외진단용으로 사용해야 함을 명시한다.  | 기재한다.  | Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다.  | 기재할 수 있다. ",
        "original_sentence": "| 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_355",
      "text": "| Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 354,
        "window_size": 3,
        "char_count": 185,
        "word_count": 31,
        "page_number": 12,
        "window_text": "| 샘플웰, 희석웰, 전세척웰, | 1996 |\n| K900474 | K843657 | CYTOMEGALOVIRUS | 가.  체외진단용으로 사용해야 함을 명시한다.  | 기재한다.  | Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다.  | 기재할 수 있다.  | Ⅸ. ",
        "original_sentence": "| Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_356",
      "text": "| 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 355,
        "window_size": 3,
        "char_count": 106,
        "word_count": 34,
        "page_number": 12,
        "window_text": "체외진단용으로 사용해야 함을 명시한다.  | 기재한다.  | Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다.  | 기재할 수 있다.  | Ⅸ.  부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC. ",
        "original_sentence": "| 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_357",
      "text": "| 기재할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 356,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 22,
        "window_text": "| 기재한다.  | Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다.  | 기재할 수 있다.  | Ⅸ.  부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC.  | INC. ",
        "original_sentence": "| 기재할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_358",
      "text": "| Ⅸ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 357,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| Legionella pneumophila | Moraxella cartarrhalis | 3) 정밀도(반복, 재현성 등) | Seegene Anyplex CMV Real-time | DETECTADOT SYSTEM 2000 | (CMV) | CYLOMEGALOVIRUS DIRECT | 서 제ㆍ개정 절차를 진행하시기 바랍니다.  | 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다.  | 기재할 수 있다.  | Ⅸ.  부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC.  | INC.  | ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP. ",
        "original_sentence": "| Ⅸ. "
      }
    },
    {
      "chunk_id": "chunk_359",
      "text": "부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 358,
        "window_size": 3,
        "char_count": 68,
        "word_count": 14,
        "page_number": 4,
        "window_text": "| 양성 | a | b | a + b | CMV IgG positive | IMMUNODIAGNO | 자사 | 1997 | 1987 |\n| 1 | Strip | 후보 | 요구 할 수 있다.  | 기재할 수 있다.  | Ⅸ.  부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC.  | INC.  | ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP.  | VIRION LTD. ",
        "original_sentence": "부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC. "
      }
    },
    {
      "chunk_id": "chunk_360",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 359,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 기재할 수 있다.  | Ⅸ.  부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC.  | INC.  | ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP.  | VIRION LTD.  | 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_361",
      "text": "| ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 360,
        "window_size": 3,
        "char_count": 159,
        "word_count": 38,
        "page_number": 3,
        "window_text": "| Ⅸ.  부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC.  | INC.  | ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP.  | VIRION LTD.  | 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가.  인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다. ",
        "original_sentence": "| ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP. "
      }
    },
    {
      "chunk_id": "chunk_362",
      "text": "| VIRION LTD. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 361,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 12,
        "window_text": "부록 | 66 | 모두 음성 | THE APTUS (AUTOMATED) | IMMUNOFLUORESCENCE | INC.  | INC.  | ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP.  | VIRION LTD.  | 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가.  인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다.  | 미개봉 | 10. ",
        "original_sentence": "| VIRION LTD. "
      }
    },
    {
      "chunk_id": "chunk_363",
      "text": "| 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 362,
        "window_size": 3,
        "char_count": 97,
        "word_count": 24,
        "page_number": 3,
        "window_text": "| INC.  | ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP.  | VIRION LTD.  | 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가.  인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다.  | 미개봉 | 10.  시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다. ",
        "original_sentence": "| 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가. "
      }
    },
    {
      "chunk_id": "chunk_364",
      "text": "인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 363,
        "window_size": 3,
        "char_count": 135,
        "word_count": 33,
        "page_number": 12,
        "window_text": "| ZEUS | PB |\n| 3 | S1 | 칼리브레이터 | 6 | 사용방법 | 5 | 상관성 평가 | K875159 | K820895 | ASSAY | VIRONOSTIKA(TM) | 세척완중웰, 컨쥬게이트, 큐벳 | LABORATORIES | LABORATORIES | CORP.  | VIRION LTD.  | 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가.  인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다.  | 미개봉 | 10.  시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다.  | Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등). ",
        "original_sentence": "인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_365",
      "text": "| 미개봉 | 10. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 364,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 3,
        "window_text": "| VIRION LTD.  | 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가.  인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다.  | 미개봉 | 10.  시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다.  | Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등).  | CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음. ",
        "original_sentence": "| 미개봉 | 10. "
      }
    },
    {
      "chunk_id": "chunk_366",
      "text": "시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 365,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 이루어진 플라스틱 스트립 | 5unit | SEEGENE | Korea | 1990 | 1985 |\n| K924096 | CMV ELISA TEST SYSTEM | 가.  인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다.  | 미개봉 | 10.  시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다.  | Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등).  | CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음.  | 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다. ",
        "original_sentence": "시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다. "
      }
    },
    {
      "chunk_id": "chunk_367",
      "text": "| Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등). ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 366,
        "window_size": 3,
        "char_count": 52,
        "word_count": 10,
        "page_number": 3,
        "window_text": "인정범위 | Mycoplasma hominis | Mycoplasma orale | ※ 예시 : CMV PCR 검사시 교차반응 시험 균주 | 지 않는 시험 및 잔여검체로 실시하는 시험은 제외) | 가) 측정범위는 정성검사는 생략할 수 있다.  | 미개봉 | 10.  시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다.  | Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등).  | CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음.  | 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다.  | 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다. ",
        "original_sentence": "| Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등). "
      }
    },
    {
      "chunk_id": "chunk_368",
      "text": "| CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 367,
        "window_size": 3,
        "char_count": 54,
        "word_count": 12,
        "page_number": 2,
        "window_text": "| 미개봉 | 10.  시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다.  | Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등).  | CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음.  | 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다.  | 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다.  | K890610 | ※ 예시 | 가. ",
        "original_sentence": "| CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음. "
      }
    },
    {
      "chunk_id": "chunk_369",
      "text": "| 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 368,
        "window_size": 3,
        "char_count": 121,
        "word_count": 27,
        "page_number": 3,
        "window_text": "시험규격 | 28 | 정기준치 미만)으로 나오는 환자의 비율이다.  | Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등).  | CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음.  | 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다.  | 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다.  | K890610 | ※ 예시 | 가.  식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다. ",
        "original_sentence": "| 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_370",
      "text": "| 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 369,
        "window_size": 3,
        "char_count": 282,
        "word_count": 57,
        "page_number": 3,
        "window_text": "| Seroconversion Panel | 측정횟수를 증가시킨다(예 : 20회 이상 등).  | CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음.  | 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다.  | 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다.  | K890610 | ※ 예시 | 가.  식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다.  | ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다. ",
        "original_sentence": "| 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_371",
      "text": "| K890610 | ※ 예시 | 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 370,
        "window_size": 3,
        "char_count": 22,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| CMV IGG TEST | FLUORESCENT ANTI | 상기 사항에 대하여 확인하였음.  | 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다.  | 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다.  | K890610 | ※ 예시 | 가.  식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다.  | ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다.  | SCIENTIFIC INC. ",
        "original_sentence": "| K890610 | ※ 예시 | 가. "
      }
    },
    {
      "chunk_id": "chunk_372",
      "text": "식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 371,
        "window_size": 3,
        "char_count": 75,
        "word_count": 19,
        "page_number": 4,
        "window_text": "| 제조일로부터 11개월 | ORGANON | STIC SUPPLIES | 1988 | 1982 |\n| K913080 | OPUS(R) ANTI CMV-M | 기준에 따라 설정된 안정성에 관한 시험성적서를 제출한다.  | 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다.  | K890610 | ※ 예시 | 가.  식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다.  | ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다.  | SCIENTIFIC INC.  | INC. ",
        "original_sentence": "식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_373",
      "text": "| ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 372,
        "window_size": 3,
        "char_count": 60,
        "word_count": 18,
        "page_number": 12,
        "window_text": "| 2012 | 검사법 | 전화번호: 043-719-4652~65 | Quantitation PCR kit | (품질관리용 냉동보관된 음성검체 | APPLICATION OF THE CMV | CMV ANTIGEN CONTROL | ASSAY | IMX CMV IGM ANTIBODY | CYTOMEGALOVIRUS IGG EIA | serum | VIRAL | DIAGNOSTICS | ABBOTT | LABSYSTEMS | 규격 |\n| method | S1 | 제5호서식’의 비교표를 기재하여야 한다.  | K890610 | ※ 예시 | 가.  식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다.  | ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다.  | SCIENTIFIC INC.  | INC.  | 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC. ",
        "original_sentence": "| ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다. "
      }
    },
    {
      "chunk_id": "chunk_374",
      "text": "| SCIENTIFIC INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 373,
        "window_size": 3,
        "char_count": 18,
        "word_count": 3,
        "page_number": 12,
        "window_text": "| K890610 | ※ 예시 | 가.  식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다.  | ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다.  | SCIENTIFIC INC.  | INC.  | 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC.  | K843189 | 다. ",
        "original_sentence": "| SCIENTIFIC INC. "
      }
    },
    {
      "chunk_id": "chunk_375",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 374,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "식약처장이 지정한 임상시험기관에서 시험한 자료 | 4) 정확도 | 및 활성도를 확인할 수 있는 자료 | 구체적, 개조식으로 기재한다.  | ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다.  | SCIENTIFIC INC.  | INC.  | 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC.  | K843189 | 다.  측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_376",
      "text": "| 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 375,
        "window_size": 3,
        "char_count": 110,
        "word_count": 26,
        "page_number": 2,
        "window_text": "| ANTI-CMV IGM MICROELISA | 음성 | c | d | c + d | 2~8℃ | 한다.  | SCIENTIFIC INC.  | INC.  | 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC.  | K843189 | 다.  측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다.  | 판단 표에 따라 제출자료가 면제될 수 있다. ",
        "original_sentence": "| 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC. "
      }
    },
    {
      "chunk_id": "chunk_377",
      "text": "| K843189 | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 376,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 3,
        "window_text": "| SCIENTIFIC INC.  | INC.  | 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC.  | K843189 | 다.  측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다.  | 판단 표에 따라 제출자료가 면제될 수 있다.  | 시험한 자료의 경우) | 11. ",
        "original_sentence": "| K843189 | 다. "
      }
    },
    {
      "chunk_id": "chunk_378",
      "text": "측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 377,
        "window_size": 3,
        "char_count": 167,
        "word_count": 31,
        "page_number": 12,
        "window_text": "| INC.  | 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC.  | K843189 | 다.  측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다.  | 판단 표에 따라 제출자료가 면제될 수 있다.  | 시험한 자료의 경우) | 11.  제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다. ",
        "original_sentence": "측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다. "
      }
    },
    {
      "chunk_id": "chunk_379",
      "text": "| 판단 표에 따라 제출자료가 면제될 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 378,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 4,
        "window_text": "| 1993 |\n| 2 | SPR | CMV 항원 (AD169)이 코팅된 | K964875 | K900473 | K860493 | CYTOTECH CMV IGG EIA | CYTOTECH INC.  | K843189 | 다.  측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다.  | 판단 표에 따라 제출자료가 면제될 수 있다.  | 시험한 자료의 경우) | 11.  제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다.  | 자료를 제시한다. ",
        "original_sentence": "| 판단 표에 따라 제출자료가 면제될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_380",
      "text": "| 시험한 자료의 경우) | 11. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 379,
        "window_size": 3,
        "char_count": 20,
        "word_count": 6,
        "page_number": 3,
        "window_text": "| K843189 | 다.  측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다.  | 판단 표에 따라 제출자료가 면제될 수 있다.  | 시험한 자료의 경우) | 11.  제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다.  | 자료를 제시한다.  | 하는 계획을 수립하여 시행한다. ",
        "original_sentence": "| 시험한 자료의 경우) | 11. "
      }
    },
    {
      "chunk_id": "chunk_381",
      "text": "제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 380,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 3,
        "window_text": "측정원리 : 측정에 사용된 검사원리 | Mycoplasma pneumoniae | Mycoplasma salivarium | 일제조사 제품에 한하여 가능함 | BioSewoom Real-Q CMV kit | BIOSEWOOM | Korea | 1991 |\n| 면역원(immunogen)과 결합한다.  | 판단 표에 따라 제출자료가 면제될 수 있다.  | 시험한 자료의 경우) | 11.  제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다.  | 자료를 제시한다.  | 하는 계획을 수립하여 시행한다.  | 30개 이상) | TEKNIKA CORP. ",
        "original_sentence": "제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_382",
      "text": "| 자료를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 381,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 4,
        "window_text": "| 판단 표에 따라 제출자료가 면제될 수 있다.  | 시험한 자료의 경우) | 11.  제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다.  | 자료를 제시한다.  | 하는 계획을 수립하여 시행한다.  | 30개 이상) | TEKNIKA CORP.  | INC. ",
        "original_sentence": "| 자료를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_383",
      "text": "| 하는 계획을 수립하여 시행한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 382,
        "window_size": 3,
        "char_count": 20,
        "word_count": 5,
        "page_number": 30,
        "window_text": "| 시험한 자료의 경우) | 11.  제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다.  | 자료를 제시한다.  | 하는 계획을 수립하여 시행한다.  | 30개 이상) | TEKNIKA CORP.  | INC.  | 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다. ",
        "original_sentence": "| 하는 계획을 수립하여 시행한다. "
      }
    },
    {
      "chunk_id": "chunk_384",
      "text": "| 30개 이상) | TEKNIKA CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 383,
        "window_size": 3,
        "char_count": 26,
        "word_count": 6,
        "page_number": 3,
        "window_text": "제조원 | 30 | 개봉 | 개봉일로부터 7개월 | 제시한다.  | 자료를 제시한다.  | 하는 계획을 수립하여 시행한다.  | 30개 이상) | TEKNIKA CORP.  | INC.  | 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다.  | 로 설정하는 것이 보편적이다. ",
        "original_sentence": "| 30개 이상) | TEKNIKA CORP. "
      }
    },
    {
      "chunk_id": "chunk_385",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 384,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 자료를 제시한다.  | 하는 계획을 수립하여 시행한다.  | 30개 이상) | TEKNIKA CORP.  | INC.  | 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다.  | 로 설정하는 것이 보편적이다.  | IGG ELISA TEST SYSTEM. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_386",
      "text": "| 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 385,
        "window_size": 3,
        "char_count": 180,
        "word_count": 36,
        "page_number": 3,
        "window_text": "| 하는 계획을 수립하여 시행한다.  | 30개 이상) | TEKNIKA CORP.  | INC.  | 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다.  | 로 설정하는 것이 보편적이다.  | IGG ELISA TEST SYSTEM.  AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC. ",
        "original_sentence": "| 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_387",
      "text": "| 로 설정하는 것이 보편적이다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 386,
        "window_size": 3,
        "char_count": 19,
        "word_count": 5,
        "page_number": 34,
        "window_text": "| 30개 이상) | TEKNIKA CORP.  | INC.  | 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다.  | 로 설정하는 것이 보편적이다.  | IGG ELISA TEST SYSTEM.  AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC.  | INC. ",
        "original_sentence": "| 로 설정하는 것이 보편적이다. "
      }
    },
    {
      "chunk_id": "chunk_388",
      "text": "| IGG ELISA TEST SYSTEM. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 387,
        "window_size": 3,
        "char_count": 25,
        "word_count": 5,
        "page_number": 75,
        "window_text": "| INC.  | 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다.  | 로 설정하는 것이 보편적이다.  | IGG ELISA TEST SYSTEM.  AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC.  | INC.  | LABORATORIES | MEDICAL | INC. ",
        "original_sentence": "| IGG ELISA TEST SYSTEM. "
      }
    },
    {
      "chunk_id": "chunk_389",
      "text": "AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 388,
        "window_size": 3,
        "char_count": 97,
        "word_count": 24,
        "page_number": 3,
        "window_text": "| 1989 |\n| Neisseria gonorrhoeae | Proteus mirabilis | Adenovirus Type 1 | Adenovirus Type 3 | 팩스번호: 043-719-4650 | 1) 식약처장이 지정한 시험검사기관에서 발급한 시험성적서 | 다음과 같은 물질에 대한 간섭 평가 자료를 제출한다.  | 로 설정하는 것이 보편적이다.  | IGG ELISA TEST SYSTEM.  AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC.  | INC.  | LABORATORIES | MEDICAL | INC.  | 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다. ",
        "original_sentence": "AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC. "
      }
    },
    {
      "chunk_id": "chunk_390",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 389,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 로 설정하는 것이 보편적이다.  | IGG ELISA TEST SYSTEM.  AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC.  | INC.  | LABORATORIES | MEDICAL | INC.  | 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다.  | 의해 구해진다. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_391",
      "text": "| LABORATORIES | MEDICAL | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 390,
        "window_size": 3,
        "char_count": 32,
        "word_count": 6,
        "page_number": 12,
        "window_text": "| IGG ELISA TEST SYSTEM.  AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC.  | INC.  | LABORATORIES | MEDICAL | INC.  | 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다.  | 의해 구해진다.  | 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다. ",
        "original_sentence": "| LABORATORIES | MEDICAL | INC. "
      }
    },
    {
      "chunk_id": "chunk_392",
      "text": "| 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 391,
        "window_size": 3,
        "char_count": 45,
        "word_count": 15,
        "page_number": 3,
        "window_text": "AN | SLIDES | ASSAY | TEST KIT | 2018 년    7 월   31  일 | CMV IgG positive | ZEUS | ANTIGENS INC.  | INC.  | LABORATORIES | MEDICAL | INC.  | 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다.  | 의해 구해진다.  | 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.  | 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다. ",
        "original_sentence": "| 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_393",
      "text": "| 의해 구해진다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 392,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 14,
        "window_text": "| INC.  | LABORATORIES | MEDICAL | INC.  | 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다.  | 의해 구해진다.  | 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.  | 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다.  | 료를 제출한다. ",
        "original_sentence": "| 의해 구해진다. "
      }
    },
    {
      "chunk_id": "chunk_394",
      "text": "| 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 393,
        "window_size": 3,
        "char_count": 47,
        "word_count": 14,
        "page_number": 2,
        "window_text": "| LABORATORIES | MEDICAL | INC.  | 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다.  | 의해 구해진다.  | 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.  | 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다.  | 료를 제출한다.  | MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다. ",
        "original_sentence": "| 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_395",
      "text": "| 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 394,
        "window_size": 3,
        "char_count": 156,
        "word_count": 34,
        "page_number": 12,
        "window_text": "| 자사 | 1997 | 1990 | 1986 | 1986 |\n| 일 수 있다.  | 의해 구해진다.  | 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.  | 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다.  | 료를 제출한다.  | MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다.  | BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다. ",
        "original_sentence": "| 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_396",
      "text": "| 료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 395,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 30,
        "window_text": "| 의해 구해진다.  | 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.  | 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다.  | 료를 제출한다.  | MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다.  | BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다.  | 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다. ",
        "original_sentence": "| 료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_397",
      "text": "| MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 396,
        "window_size": 3,
        "char_count": 194,
        "word_count": 42,
        "page_number": 73,
        "window_text": "| 5) 교차반응 | 물질 및 폐기물 등) 취급 시 안전 등의 주의사항을 기재한다.  | 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다.  | 료를 제출한다.  | MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다.  | BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다.  | 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.  | 를 산출하여 기재한다. ",
        "original_sentence": "| MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_398",
      "text": "| BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 397,
        "window_size": 3,
        "char_count": 154,
        "word_count": 31,
        "page_number": 12,
        "window_text": "| 제시 | BioSewoom Real-Q CMV quantification | CYTOMEGALOVIRUS DIRECT | SYSTEM | 에스피알 | BAXTER | 고형 팁 |\n| 4 | C1 | 양성대조액 | K984139 | 수행기관에서 수행한 결과를 포함하여야 한다.  | 료를 제출한다.  | MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다.  | BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다.  | 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.  | 를 산출하여 기재한다.  | 따라 통계적으로 의미 있는 검체수를 산정한다. ",
        "original_sentence": "| BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_399",
      "text": "| 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 398,
        "window_size": 3,
        "char_count": 76,
        "word_count": 19,
        "page_number": 3,
        "window_text": "| 료를 제출한다.  | MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다.  | BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다.  | 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.  | 를 산출하여 기재한다.  | 따라 통계적으로 의미 있는 검체수를 산정한다.  | Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다. ",
        "original_sentence": "| 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_400",
      "text": "| 를 산출하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 399,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 25,
        "window_text": "| MICROBIOLOGIC | MICROBIOLOGIC | BIOSEWOOM | Korea | 8unit |\n| Pseudomonas aeruginosa | Salmonella enteriditis | Adenovirus Type 5 | Adenovirus Type 6 | 전체 | a + c | b + d | n | 미개봉 | 등을 제시한다.  | BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다.  | 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.  | 를 산출하여 기재한다.  | 따라 통계적으로 의미 있는 검체수를 산정한다.  | Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다.  | ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC. ",
        "original_sentence": "| 를 산출하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_401",
      "text": "| 따라 통계적으로 의미 있는 검체수를 산정한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 400,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 26,
        "window_text": "| BARTELS CYTOMEGALOVIRUS | CYTOMEGALOVIRUS CONTROL | 제조일로부터 11개월 | BEHRING | LIGHT | GULL | DIFCO | DIAGNOSTIC |\n| 기기로 임상적 성능시험의 결과를 확인할 수 없는 시험 | 제시한다.  | 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.  | 를 산출하여 기재한다.  | 따라 통계적으로 의미 있는 검체수를 산정한다.  | Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다.  | ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC.  | ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나. ",
        "original_sentence": "| 따라 통계적으로 의미 있는 검체수를 산정한다. "
      }
    },
    {
      "chunk_id": "chunk_402",
      "text": "| Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 401,
        "window_size": 3,
        "char_count": 54,
        "word_count": 13,
        "page_number": 12,
        "window_text": "| 1) 시험시설개요 | 검체 처치에 첨가된 물질(보존제, 안정제 등) | 간섭물질을 함유한 검체 등) 등에 대한 실험방법을 제공한다.  | 를 산출하여 기재한다.  | 따라 통계적으로 의미 있는 검체수를 산정한다.  | Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다.  | ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC.  | ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나.  임상적 성능시험에 관한 자료 | 가. ",
        "original_sentence": "| Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다. "
      }
    },
    {
      "chunk_id": "chunk_403",
      "text": "| ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 402,
        "window_size": 3,
        "char_count": 81,
        "word_count": 15,
        "page_number": 12,
        "window_text": "| 를 산출하여 기재한다.  | 따라 통계적으로 의미 있는 검체수를 산정한다.  | Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다.  | ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC.  | ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나.  임상적 성능시험에 관한 자료 | 가.  시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다. ",
        "original_sentence": "| ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC. "
      }
    },
    {
      "chunk_id": "chunk_404",
      "text": "| ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 403,
        "window_size": 3,
        "char_count": 108,
        "word_count": 30,
        "page_number": 3,
        "window_text": "| 따라 통계적으로 의미 있는 검체수를 산정한다.  | Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다.  | ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC.  | ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나.  임상적 성능시험에 관한 자료 | 가.  시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다.  | OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다. ",
        "original_sentence": "| ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나. "
      }
    },
    {
      "chunk_id": "chunk_405",
      "text": "임상적 성능시험에 관한 자료 | 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 404,
        "window_size": 3,
        "char_count": 21,
        "word_count": 6,
        "page_number": 4,
        "window_text": "| Seroconversion Panel | kit | 재현해 낼 수 있는 농도 범위를 말한다.  | ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC.  | ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나.  임상적 성능시험에 관한 자료 | 가.  시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다.  | OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다.  | 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC. ",
        "original_sentence": "임상적 성능시험에 관한 자료 | 가. "
      }
    },
    {
      "chunk_id": "chunk_406",
      "text": "시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 405,
        "window_size": 3,
        "char_count": 44,
        "word_count": 12,
        "page_number": 4,
        "window_text": "| ENZYME LINKED | CMV IGM ELISA TEST | CYTOMEGALOVIRUS | serum | SCIENTIFIC INC.  | ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나.  임상적 성능시험에 관한 자료 | 가.  시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다.  | OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다.  | 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC.  | 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다. ",
        "original_sentence": "시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_407",
      "text": "| OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 406,
        "window_size": 3,
        "char_count": 424,
        "word_count": 85,
        "page_number": 12,
        "window_text": "| ZEUS | ZEUS | 규격 | 1999 |\n| C1 | 3 | S1 | 칼리브레이터 | 담황색의 액상시약 | K951821 | K922582 | K873114 | K811671 | 나.  임상적 성능시험에 관한 자료 | 가.  시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다.  | OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다.  | 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC.  | 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다.  | 한다. ",
        "original_sentence": "| OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다. "
      }
    },
    {
      "chunk_id": "chunk_408",
      "text": "| 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 407,
        "window_size": 3,
        "char_count": 215,
        "word_count": 37,
        "page_number": 12,
        "window_text": "임상적 성능시험에 관한 자료 | 가.  시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다.  | OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다.  | 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC.  | 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다.  | 한다.  | 측정하는 것을 권장한다. ",
        "original_sentence": "| 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC. "
      }
    },
    {
      "chunk_id": "chunk_409",
      "text": "| 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 408,
        "window_size": 3,
        "char_count": 149,
        "word_count": 39,
        "page_number": 3,
        "window_text": "시험물질 | 분자량 등) | 한 방법 및 측정원리를 설명하는 자료를 제출한다.  | OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다.  | 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC.  | 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다.  | 한다.  | 측정하는 것을 권장한다.  | SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC. ",
        "original_sentence": "| 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_410",
      "text": "| 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 409,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 30,
        "window_text": "| OPUS CMV TEST | IMMUNOFLUORESCENCE | 2~8℃ | DIAGNOSTICS |\n| K912592 | CMV-EA MAB TEST | K896355 | K860450 | THE CMV-IGM TEST | K843138 | CMV TEST | Salmonella typhimurium | Staphylococcus aureus | Adenovirus Type 7 | Adenovirus Type 8 | 1) 표준품 또는 기타 사용된 표준물질의 확인서(certificate) | 담당자 | 확  인(부서장) | LABORATORIES | AL RESEARCH | AL RESEARCH | 서 두 원 |\n| K963084 | K884842 | CMV-CUBE(TM) | 등에서 유전자를 추출하여 유전자를 검출하는 방법도 이용되고 있다.  | 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC.  | 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다.  | 한다.  | 측정하는 것을 권장한다.  | SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC.  | 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다. ",
        "original_sentence": "| 한다. "
      }
    },
    {
      "chunk_id": "chunk_411",
      "text": "| 측정하는 것을 권장한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 410,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 30,
        "window_text": "| 개봉 | 개봉일로부터 7개월 | Bioneer AccuPower® CMV Quantitative | IMMUNOSORBENT ASSAY | IGG EIA | SLIDES | ANTIBODY TEST SYSTEM | CMV IgG negative | DIAGNOSTICS | DIAGNOSTICS | LABORATORIES | TECHNOLOGIES | SCIENTIFIC INC.  | 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다.  | 한다.  | 측정하는 것을 권장한다.  | SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC.  | 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
        "original_sentence": "| 측정하는 것을 권장한다. "
      }
    },
    {
      "chunk_id": "chunk_412",
      "text": "| SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 411,
        "window_size": 3,
        "char_count": 49,
        "word_count": 7,
        "page_number": 12,
        "window_text": "| 0.5uni | 자사 | 1996 | 1993 | 1987 | 1981 |\n| 4 | C1 | 양성 대조액 | 담황색의 액상시약 | Virus Types 1 and 2 Serological Assays, 2011 | 5) 해당하는 경우 다음의 사항들을 기술한다.  | 한다.  | 측정하는 것을 권장한다.  | SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC.  | 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n ■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ. ",
        "original_sentence": "| SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC. "
      }
    },
    {
      "chunk_id": "chunk_413",
      "text": "| 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 412,
        "window_size": 3,
        "char_count": 107,
        "word_count": 25,
        "page_number": 3,
        "window_text": "| 한다.  | 측정하는 것을 권장한다.  | SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC.  | 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n ■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ.  기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n",
        "original_sentence": "| 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_414",
      "text": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 413,
        "window_size": 3,
        "char_count": 58,
        "word_count": 13,
        "page_number": 2,
        "window_text": "| 측정하는 것을 권장한다.  | SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC.  | 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n ■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ.  기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n <!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다. ",
        "original_sentence": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_415",
      "text": "■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 414,
        "window_size": 3,
        "char_count": 124,
        "word_count": 29,
        "page_number": 3,
        "window_text": "| SYSTEM-MODIFICATION | SYSTEM | SCIENTIFIC INC.  | 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n ■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ.  기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n <!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n",
        "original_sentence": "■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ. "
      }
    },
    {
      "chunk_id": "chunk_416",
      "text": "기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 415,
        "window_size": 3,
        "char_count": 258,
        "word_count": 51,
        "page_number": 4,
        "window_text": "| 1996 | 1991 | 1990 | 1986 | 1985 |\n\n**[표 끝]**\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적으로\n\n고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n ■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ.  기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n <!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\n",
        "original_sentence": "기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_417",
      "text": "<!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 416,
        "window_size": 3,
        "char_count": 172,
        "word_count": 34,
        "page_number": 5,
        "window_text": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이 필요한\n\n경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n ■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ.  기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n <!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\n Ⅰ. ",
        "original_sentence": "<!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_418",
      "text": "또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 417,
        "window_size": 3,
        "char_count": 178,
        "word_count": 41,
        "page_number": 5,
        "window_text": "■ 예(☞안내서)\n\n□ 아니오\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ안내\n\n이 원 규\n\n<!-- PAGE_3 -->\n## 목  차\n\n<!-- PAGE_4 -->\n###### Ⅵ.  기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n <!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\n Ⅰ.  개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1. ",
        "original_sentence": "또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_419",
      "text": "<!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 418,
        "window_size": 3,
        "char_count": 334,
        "word_count": 64,
        "page_number": 5,
        "window_text": "기술문서등의 심사를 위한 제출자료\n\n<!-- PAGE_4 -->\n###### 31\n\n<!-- PAGE_5 -->\n###### 이 안내서는 산전검사 중 거대세포바이러스(CMV) 체외진단\n\n<!-- PAGE_5 -->\n###### 용 의료기기의 허가심사 시 요구되는 신청서 작성 방법 및 제출\n\n<!-- PAGE_5 -->\n###### 자료 요건에 대하여 알기 쉽게 설명하거나 식품의약품안전처의\n\n<!-- PAGE_5 -->\n###### 입장을 기술한 것입니다.\n\n <!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\n Ⅰ.  개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1.  목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2. ",
        "original_sentence": "<!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_420",
      "text": "Ⅰ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 419,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 3,
        "window_text": "<!-- PAGE_5 -->\n###### 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문\n\n<!-- PAGE_5 -->\n###### 의 기술방식(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서\n\n<!-- PAGE_5 -->\n###### 반드시 준수하셔야 하는 사항이 아님을 알려드립니다.  또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\n Ⅰ.  개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1.  목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2.  적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다. ",
        "original_sentence": "Ⅰ. "
      }
    },
    {
      "chunk_id": "chunk_421",
      "text": "개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 420,
        "window_size": 3,
        "char_count": 66,
        "word_count": 17,
        "page_number": 6,
        "window_text": "또한, 본 안\n\n<!-- PAGE_5 -->\n###### 내서는 현재의 과학적ㆍ기술적 사실 및 유효한 법규를 토대로 작성\n\n<!-- PAGE_5 -->\n###### 되었으므로 이후 최신 개정 법규 내용 및 구체적인 사실관계 등에 따\n\n<!-- PAGE_5 -->\n###### 라 달리 적용될 수 있음을 알려드립니다.\n\n <!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\n Ⅰ.  개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1.  목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2.  적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다.  과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다. ",
        "original_sentence": "개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_422",
      "text": "목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 421,
        "window_size": 3,
        "char_count": 149,
        "word_count": 27,
        "page_number": 6,
        "window_text": "<!-- PAGE_5 -->\n###### ※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등\n\n<!-- PAGE_5 -->\n###### 을 알기 쉽게 풀어서 설명하거나 특정한 사안에 대하여 식품의약품\n\n<!-- PAGE_5 -->\n###### 안전처의 입장을 기술하는 것(식품의약품안전처 지침서등의 관리\n\n<!-- PAGE_5 -->\n###### 에 관한 규정 제2조)\n\n<!-- PAGE_5 -->\n###### ※ 본 안내서에 대한 의견이나 문의사항이 있을 경우 식품의약품안전처\n\n<!-- PAGE_5 -->\n###### 식품의약품안전평가원 체외진단기기과에 문의하시기 바랍니다.\n\n Ⅰ.  개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1.  목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2.  적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다.  과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다.  임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다. ",
        "original_sentence": "목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_423",
      "text": "적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 422,
        "window_size": 3,
        "char_count": 118,
        "word_count": 23,
        "page_number": 6,
        "window_text": "Ⅰ.  개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1.  목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2.  적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다.  과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다.  임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다.  선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1). ",
        "original_sentence": "적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다. "
      }
    },
    {
      "chunk_id": "chunk_424",
      "text": "과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 423,
        "window_size": 3,
        "char_count": 119,
        "word_count": 25,
        "page_number": 6,
        "window_text": "개요\n\n- - 1 -\n<!-- PAGE_6 -->\n## Ⅰ\n\n개  요\n\n<!-- PAGE_6 -->\n###### 1.  목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2.  적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다.  과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다.  임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다.  선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1).  산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다. ",
        "original_sentence": "과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다. "
      }
    },
    {
      "chunk_id": "chunk_425",
      "text": "임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 424,
        "window_size": 3,
        "char_count": 173,
        "word_count": 37,
        "page_number": 6,
        "window_text": "목적\n\n<!-- PAGE_6 -->\n###### 본 가이드라인은 거대세포바이러스(CMV) 체외진단용 의료기기의\n\n<!-- PAGE_6 -->\n###### 허가심사 시에 요구되는 제출자료 작성을 위한 참고자료로 활용하는\n\n<!-- PAGE_6 -->\n###### 2.  적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다.  과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다.  임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다.  선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1).  산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다.  선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.",
        "original_sentence": "임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다. "
      }
    },
    {
      "chunk_id": "chunk_426",
      "text": "선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1). ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 425,
        "window_size": 3,
        "char_count": 264,
        "word_count": 56,
        "page_number": 6,
        "window_text": "적용범위\n\n<!-- PAGE_6 -->\n###### 인체에서 유래하는 시료를 검체로 하여 CMV 항체(항원) 또는 유전자를\n\n<!-- PAGE_6 -->\n###### 검출하는 자동분석기용 시약을 대상으로 한다.  과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다.  임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다.  선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1).  산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다.  선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. **\n\n**[표 끝]**\n\nⅡ. ",
        "original_sentence": "선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1). "
      }
    },
    {
      "chunk_id": "chunk_427",
      "text": "산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 426,
        "window_size": 3,
        "char_count": 88,
        "word_count": 18,
        "page_number": 6,
        "window_text": "과거에는 선천 풍진\n\n<!-- PAGE_6 -->\n###### 증후군이 가장 흔하였으나, 풍진 예방접종으로 풍진 빈도가 감소함에\n\n<!-- PAGE_6 -->\n###### 따라 CMV 감염이 가장 흔하게 되었다.  임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다.  선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1).  산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다.  선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. **\n\n**[표 끝]**\n\nⅡ.  용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n",
        "original_sentence": "산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다. "
      }
    },
    {
      "chunk_id": "chunk_428",
      "text": "선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다.",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 427,
        "window_size": 3,
        "char_count": 336,
        "word_count": 56,
        "page_number": 6,
        "window_text": "임신 중 산모가 CMV에 1차\n\n<!-- PAGE_6 -->\n###### 감염되는 경우 약 40%에서 태아에 선천 CMV 감염을 일으키고 선천\n\n<!-- PAGE_6 -->\n###### CMV 감염 신생아의 90%는 출생시 증상이 없으나 10%에서는 증상을\n\n<!-- PAGE_6 -->\n###### 보인다.  선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1).  산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다.  선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. **\n\n**[표 끝]**\n\nⅡ.  용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n <!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ. ",
        "original_sentence": "선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다."
      }
    },
    {
      "chunk_id": "chunk_429",
      "text": "**\n\n**[표 끝]**\n\nⅡ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 428,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 1,
        "window_text": "선천 CMV 감염시 자궁내 성장 지연, 조산, 간비종대, 황달,\n\n<!-- PAGE_6 -->\n###### 혈소판 감소, 점혈반, 맥락망막염, 청력장애, 대뇌 석회화 및 작은 머리\n\n<!-- PAGE_6 -->\n###### 증 등이며, 증상이 있는 경우 사망률은 약 12-25%이고, 생존자의\n\n<!-- PAGE_6 -->\n###### 60-75%에서 시력장애, 청력장애, 경련, 운동 장애 등 영구 후유증이 남을\n\n<!-- PAGE_6 -->\n###### 수 있다1).  산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다.  선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. **\n\n**[표 끝]**\n\nⅡ.  용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n <!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ.  용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n",
        "original_sentence": "**\n\n**[표 끝]**\n\nⅡ. "
      }
    },
    {
      "chunk_id": "chunk_430",
      "text": "용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 429,
        "window_size": 3,
        "char_count": 1596,
        "word_count": 322,
        "page_number": 8,
        "window_text": "산모의 CMV 감염의 진단은 산모의 혈액에서 항체를 검출하는\n\n<!-- PAGE_6 -->\n###### 검사법과 양수에서 유전자를 검출하는 방법이 이용된다.  선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. **\n\n**[표 끝]**\n\nⅡ.  용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n <!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ.  용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n <!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n",
        "original_sentence": "용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_431",
      "text": "<!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 430,
        "window_size": 3,
        "char_count": 400,
        "word_count": 79,
        "page_number": 9,
        "window_text": "선천 CMV 감염의\n\n<!-- PAGE_6 -->\n###### 진단법은 신생아의 소변 및 타액의 CMV 배양이 표준방법이지만, 혈액\n\n1) http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 2 -\n<!-- PAGE_7 -->\n##### 산전검사 중 거대세포바이러스(CMV) 체외진단용\n\n<!-- PAGE_7 -->\n##### 의료기기 허가심사 가이드라인(민원인 안내서)\n\n**[표 시작]**\n\n**의료기기**\n**‘사용기간’ 항에 아래 표와 같이 저장방법과 사용기간을 기재한다. **\n\n**[표 끝]**\n\nⅡ.  용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n <!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ.  용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n <!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n <!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n",
        "original_sentence": "<!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ. "
      }
    },
    {
      "chunk_id": "chunk_432",
      "text": "용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 431,
        "window_size": 3,
        "char_count": 279,
        "word_count": 56,
        "page_number": 10,
        "window_text": "**\n\n**[표 끝]**\n\nⅡ.  용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n <!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ.  용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n <!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n <!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n <!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n",
        "original_sentence": "용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_433",
      "text": "<!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 432,
        "window_size": 3,
        "char_count": 119,
        "word_count": 19,
        "page_number": 10,
        "window_text": "용어의 정의\n\n- - 3 -\n<!-- PAGE_8 -->\n### Ⅱ  용어의 정의\n\n<!-- PAGE_8 -->\n###### ※ 본 가이드라인에서 사용되는 용어의 정의는 본 가이드라인의 이해를\n\n<!-- PAGE_8 -->\n###### 간섭 (Interference)\n\n<!-- PAGE_8 -->\n###### 분석물질의 농도나 강도가 명백함에도 검출시약이나 신호 자체에 비특이\n\n<!-- PAGE_8 -->\n###### 적으로 반응하는 물질의 존재로 인해 일어나는 인위적인 증가나 감소\n\n<!-- PAGE_8 -->\n###### ☞ 검출 시스템의 비특이성에서 기인하기도 하고, 반응지시약 반응의 억\n\n<!-- PAGE_8 -->\n###### 제, 분석 대상(효소)의 억제 또는 검체에 의해 발생하는 바이어스의\n\n<!-- PAGE_8 -->\n###### 경계 사이클 (Threshold cycle, Ct)\n\n<!-- PAGE_8 -->\n###### 배경값 수준의 형광신호를 벗어난 사이클 수를 의미하는 것\n\n<!-- PAGE_8 -->\n###### ☞ 정량 PCR에서 검출반응은 형광신호가 축적되는 것을 인식하는 방식으\n\n<!-- PAGE_8 -->\n###### ☞ 경계 사이클(Ct)은 배경값 수준의 형광신호를 벗어난 사이클 수를 의\n\n<!-- PAGE_8 -->\n###### 미하는 것으로 경계 사이클 수는 초기 검체량과 반비례의 관계를 가\n\n<!-- PAGE_8 -->\n###### 검출한계 (Limit of detection, LoD)\n\n<!-- PAGE_8 -->\n###### 검출될 수 있는 분석 물질의 최소량\n\n<!-- PAGE_8 -->\n###### 공란한계 (Limit of blank, LoB)\n\n<!-- PAGE_8 -->\n###### blank 검체에서 관찰 가능할 수 있는 가장 높은 측정치\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 4 -\n<!-- PAGE_9 -->\n###### 교차반응 (Cross-reactivity)\n\n<!-- PAGE_9 -->\n###### 항원 이외에 공유되었거나, 유사한 또는 동일한 항원결정기를 가진 항원\n\n<!-- PAGE_9 -->\n###### 과 항체가 반응하는 현상\n\n<!-- PAGE_9 -->\n###### 기질효과 (Matrix effect)\n\n<!-- PAGE_9 -->\n###### 측정하고자 하는 분석물질 이외에 검체의 특성이 분석물질의 측정에 영향\n\n<!-- PAGE_9 -->\n###### 을 미치는 경우\n\n<!-- PAGE_9 -->\n###### ☞ 검체의 점성, 표면장력, 혼탁도, 이온 강도, pH 등이 기질효과의 주된\n\n<!-- PAGE_9 -->\n###### 내부 대조물질 (Internal control)\n\n<!-- PAGE_9 -->\n###### 동일한 검체 튜브에 목표로 하지 않은 염기서열을 넣어서 목표로 하는 염\n\n<!-- PAGE_9 -->\n###### 기서열과 동시에 증폭되게 하여 thermal cycler의 오작동, 시약의 적절성\n\n<!-- PAGE_9 -->\n###### 또는 중합효소의 활성 또는 방해물질에 의한 증폭 방해를 동정하기 위한\n\n<!-- PAGE_9 -->\n###### 목적으로 사용한다.\n\n <!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ.  용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n <!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n <!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n <!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n <!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_434",
      "text": "<!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 433,
        "window_size": 3,
        "char_count": 114,
        "word_count": 21,
        "page_number": 10,
        "window_text": "<!-- PAGE_9 -->\n###### 대조물질 (Control / Control material)\n\n<!-- PAGE_9 -->\n###### 정도 관리를 위해 이용되는 물질\n\n<!-- PAGE_9 -->\n###### 면역분석법 (Immunoassay)\n\n<!-- PAGE_9 -->\n###### 분석물질에 결합 가능한 특이 항원이나 항체를 이용하는 리간드-결합 분석\n\n<!-- PAGE_9 -->\n###### ☞ 항체를 사용하여 물질을 측정하는 검사법으로 면역분석법은 경쟁적 또\n\n<!-- PAGE_9 -->\n###### 는 비경쟁적, 고체상 또는 액체상, 동위원소 또는 비동위원소, 항원표\n\n<!-- PAGE_9 -->\n###### 지 또는 항체표지, 단일 또는 이중 부위, 균질적 또는 비균질적 방법\n\nⅡ.  용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n <!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n <!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n <!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n <!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n <!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n",
        "original_sentence": "<!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_435",
      "text": "<!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 434,
        "window_size": 3,
        "char_count": 862,
        "word_count": 162,
        "page_number": 10,
        "window_text": "용어의 정의\n\n- - 5 -\n<!-- PAGE_10 -->\n###### 바이어스 (Bias)\n\n<!-- PAGE_10 -->\n###### 검사 결과의 예상치와 허용된 기준치 사이의 차이\n\n<!-- PAGE_10 -->\n###### 반응성 (Reactivity)\n\n<!-- PAGE_10 -->\n###### 항원 혹은 항체가 다른 물질과 결합하는 것에 대한 정성적 평가\n\n<!-- PAGE_10 -->\n###### ☞ 검사 결과를 보고할 때, 때때로 “양성(positive)”과 동의어로 사용된다.\n\n <!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n <!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n <!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n <!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n <!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n <!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ. ",
        "original_sentence": "<!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_436",
      "text": "<!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 435,
        "window_size": 3,
        "char_count": 94,
        "word_count": 18,
        "page_number": 11,
        "window_text": "<!-- PAGE_10 -->\n###### 반정량분석 (Semiquantitative assay)\n\n<!-- PAGE_10 -->\n###### 반정량 분석시스템은 정성검사법에 반응 강도의 추가 옵션을 제공한다.\n\n <!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n <!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n <!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n <!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n <!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ.  용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_437",
      "text": "<!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 436,
        "window_size": 3,
        "char_count": 370,
        "word_count": 69,
        "page_number": 11,
        "window_text": "<!-- PAGE_10 -->\n###### 검사법에 의해 검출된 양성 신호의 변이는 흔히 증가되는 정도(titer,\n\n<!-- PAGE_10 -->\n###### grade 또는 class)로 표현된다.\n\n <!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n <!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n <!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n <!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ.  용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n <!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n",
        "original_sentence": "<!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_438",
      "text": "<!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 437,
        "window_size": 3,
        "char_count": 538,
        "word_count": 103,
        "page_number": 11,
        "window_text": "<!-- PAGE_10 -->\n###### 방해물질 (Interfering substances)\n\n<!-- PAGE_10 -->\n###### 임상검체에 존재하는 내부물질(예 : 혈액 구성요소, acidic polysaccharides)\n\n<!-- PAGE_10 -->\n###### 또는 외부물질(예 : talc, 항응고제 등)으로 위양성 또는 위음성 결과를 야기\n\n<!-- PAGE_10 -->\n###### 할 수 있는 물질\n\n<!-- PAGE_10 -->\n###### 보정 (Calibration)\n\n<!-- PAGE_10 -->\n###### 특별한 조건하에서 측정 기기나 측정 시스템이 나타내는 값 또는 물질\n\n<!-- PAGE_10 -->\n###### 측정이나 참고물질에 의한 값과 표준물질에 상응하는 값 사이의 관계를\n\n<!-- PAGE_10 -->\n###### 확립하는 일련의 조작\n\n<!-- PAGE_10 -->\n###### 보정물질 (Calibration material / Calibrator)\n\n<!-- PAGE_10 -->\n###### 측정과정을 보정하기 위해서 또는 검체의 반응을 비교하기 위해서 사용되는\n\n<!-- PAGE_10 -->\n###### 알려진 정량적/정성적 특성(예 : 농도, 활성도, 강도, 반응성)을 갖는 물질\n\n<!-- PAGE_10 -->\n###### ☞ a) 보정물질에서 분석물질 양은 그의 제조과정에서 확인된 한계\n\n<!-- PAGE_10 -->\n###### (limit) 내에 있으며, 분석법의 반응과 측정되는 특성과의 관계를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 6 -\n<!-- PAGE_11 -->\n###### 설정하는데 사용될 수 있다.\n\n <!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n <!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n <!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ.  용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n <!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n <!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ. ",
        "original_sentence": "<!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ. "
      }
    },
    {
      "chunk_id": "chunk_439",
      "text": "용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 438,
        "window_size": 3,
        "char_count": 1042,
        "word_count": 179,
        "page_number": 12,
        "window_text": "<!-- PAGE_11 -->\n###### b) 보정물질은 국가 또는 국제 표준물질이나 참고물질에 소급성을\n\n<!-- PAGE_11 -->\n###### 가져야 한다.\n\n <!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n <!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ.  용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n <!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n <!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ.  용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n",
        "original_sentence": "용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_440",
      "text": "<!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 439,
        "window_size": 3,
        "char_count": 254,
        "word_count": 49,
        "page_number": 13,
        "window_text": "<!-- PAGE_11 -->\n###### c) 분석물질의 다른 양을 갖는 보정물질은 보정 곡선을 설정하는데\n\n<!-- PAGE_11 -->\n###### d) “일차”와 “이차표준”이란 용어는 보정물질을 지칭하는 용어로 WHO\n\n<!-- PAGE_11 -->\n###### 분석물질 (Analyte)\n\n<!-- PAGE_11 -->\n###### 검사실이 수행하는 검사의 물질 또는 구성요소\n\n<!-- PAGE_11 -->\n###### 비정밀도 (Imprecision)\n\n<!-- PAGE_11 -->\n###### 특별한 조건 하에서 얻어진 측정값의 독립적 결과들의 분산\n\n<!-- PAGE_11 -->\n###### ☞ 표준편차나 변이계수 등의 숫자로 표시된다.\n\n <!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ.  용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n <!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n <!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ.  용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n <!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ. ",
        "original_sentence": "<!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_441",
      "text": "<!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 440,
        "window_size": 3,
        "char_count": 569,
        "word_count": 104,
        "page_number": 13,
        "window_text": "<!-- PAGE_11 -->\n###### 비특이도 (Nonspecificity)\n\n<!-- PAGE_11 -->\n###### 분석하려는 물질 외에 다른 물질과 항원이 반응하는 정도\n\n<!-- PAGE_11 -->\n###### ☞ 비특이도는 보통 분석물질이 아닌 물질에 결합하고, 반응하는 항체,\n\n<!-- PAGE_11 -->\n###### 선별검사 (Screening test)\n\n<!-- PAGE_11 -->\n###### 특정질환의 증상이 없어 의학적 주의를 받지 못하는 사람들 중에 해당질\n\n<!-- PAGE_11 -->\n###### 환의 고위험군을 발견하여 추가적인 관찰이나 직접적 예방 활동을 하기\n\n<!-- PAGE_11 -->\n###### 위한 체계적인 검사\n\n<!-- PAGE_11 -->\n###### 신뢰구간 (Confidence interval)\n\n<!-- PAGE_11 -->\n###### 평균, 분율, 비율 등의 변수의 참값이 정해진 확률 범위 내에서 분포할\n\n<!-- PAGE_11 -->\n###### 것으로 예상되는 계산된 구간\n\nⅡ.  용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n <!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n <!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ.  용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n <!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ.  용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다. ",
        "original_sentence": "<!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ. "
      }
    },
    {
      "chunk_id": "chunk_442",
      "text": "용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 441,
        "window_size": 3,
        "char_count": 1674,
        "word_count": 327,
        "page_number": 14,
        "window_text": "용어의 정의\n\n- - 7 -\n<!-- PAGE_12 -->\n###### 실시간 PCR (Real time polymerase chain reaction)\n\n<!-- PAGE_12 -->\n###### 동일한 반응튜브에서 PCR과 증폭된 산물의 형광 탐색자 검출을 결합하여\n\n<!-- PAGE_12 -->\n###### 동시에 검출하는 PCR 방법\n\n<!-- PAGE_12 -->\n###### 양성 예측도 (Predictive value of positive result, PPV)\n\n<!-- PAGE_12 -->\n###### 표적 질환(진단 정확도 기준에 의해 결정되는)을 가지고 있는 환자에서\n\n<!-- PAGE_12 -->\n###### 양성 결과를 보이는 비율(100을 곱한 값)\n\n<!-- PAGE_12 -->\n###### ☞ a) 양성예측치(PPV)는 반드시 관심대상 조건(진단 정확도 기준에 의\n\n<!-- PAGE_12 -->\n###### b) PPV의 추정값[추정 유병률은 100x(TP+FN)/(TP+FP+FN+TN)]\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 8 -\n<!-- PAGE_13 -->\n###### 양성 일치율(Percent positive agreement, PPV)  = 100×a/(a+c)\n\n<!-- PAGE_13 -->\n###### 음성 일치율(Percent negative agreement, PNA) = 100×d/(b+d)\n\n<!-- PAGE_13 -->\n###### 총 일치율(Overall percent agreement)          = 100×(a+d)/n\n\n<!-- PAGE_13 -->\n###### 음성 예측도 (Predictive value of negative result, NPV)\n\n<!-- PAGE_13 -->\n###### 표적 질환을 가지지 않은 정상인에서 음성 결과를 보이는 비율(100을 곱\n\n<!-- PAGE_13 -->\n###### 한 값)\n\n<!-- PAGE_13 -->\n###### ☞ NPV의 추정값은 100×TN/(TN+FN)로 계산된다.\n\n <!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n <!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ.  용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n <!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ.  용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n",
        "original_sentence": "용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_443",
      "text": "<!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 442,
        "window_size": 3,
        "char_count": 564,
        "word_count": 107,
        "page_number": 15,
        "window_text": "<!-- PAGE_13 -->\n###### 역가 (Titer)\n\n<!-- PAGE_13 -->\n###### 주어진 시스템에서 정해진 결과를 내는데 필요한 희석율에 상당하는 수치\n\n<!-- PAGE_13 -->\n###### 또는 방사면역측정법에서 주어진 조건하에 방사표지 분석물질의 특정 백\n\n<!-- PAGE_13 -->\n###### 분율이 결합하는 항체의 희석율\n\n<!-- PAGE_13 -->\n###### ☞ 역가는 주로 분석물질 농도에 비례한다.\n\n <!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ.  용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n <!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ.  용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n <!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n",
        "original_sentence": "<!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ. "
      }
    },
    {
      "chunk_id": "chunk_444",
      "text": "용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 443,
        "window_size": 3,
        "char_count": 167,
        "word_count": 33,
        "page_number": 16,
        "window_text": "<!-- PAGE_13 -->\n###### 위양성 (False positive, FP)\n\n<!-- PAGE_13 -->\n###### 질병이나 증상이 없는 상태에서 이를 시사하는 양성검사 결과\n\n<!-- PAGE_13 -->\n###### ☞ 예시 : 질환에 이환되지 않은 개체에서 비정상 결과\n\n<!-- PAGE_13 -->\n###### 위음성 (False negative, FN)\n\n<!-- PAGE_13 -->\n###### 양성 환자나 양성 검체에서의 음성검사 결과\n\n<!-- PAGE_13 -->\n###### 임상적 민감도 (Clinical sensitivity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있는 사람들 중 검사 결과가 양성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 임상적 특이도 (Clinical specificity)\n\n<!-- PAGE_13 -->\n###### 특정질환을 가지고 있지 않은 사람들 중 검사 결과가 음성으로 나오는 비율\n\n<!-- PAGE_13 -->\n###### 재조합항원 (Recombinant-derived antigens)\n\nⅡ.  용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n <!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ.  용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n <!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n <!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n",
        "original_sentence": "용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다. "
      }
    },
    {
      "chunk_id": "chunk_445",
      "text": "정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 444,
        "window_size": 3,
        "char_count": 333,
        "word_count": 59,
        "page_number": 16,
        "window_text": "용어의 정의\n\n- - 9 -\n<!-- PAGE_14 -->\n###### 유전물질을 다른 속, 종 또는 개체에 넣어서 만들어낸 펩타이드 또는 단\n\n<!-- PAGE_14 -->\n###### 백질\n\n<!-- PAGE_14 -->\n###### 재현성 (Reproducibility)\n\n<!-- PAGE_14 -->\n###### 다른 측정조건에서 수행된 동일한 측정물의 결과값 사이의 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### 전지대효과 (Prozone effect) 또는 후크효과 (Hook effect)\n\n<!-- PAGE_14 -->\n###### 항체 또는 항원 과다로 최적 반응을 방해하여 항원-항체 반응이 최적 이\n\n<!-- PAGE_14 -->\n###### 하로 나타나는 현상\n\n<!-- PAGE_14 -->\n###### 정량분석 (Quantitative assay)\n\n<!-- PAGE_14 -->\n###### 검체에서 분석물질의 농도를 측정할 수 있는 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 정량 분석은 표준 참고 물질에 맞춘 보정곡선으로부터 동종 또는 이종\n\n<!-- PAGE_14 -->\n###### 정밀도 (Precision)\n\n<!-- PAGE_14 -->\n###### 규정된 조건 하에서 얻어진 독립적인 검사 결과들 가운데 일치도의 근접성\n\n<!-- PAGE_14 -->\n###### ☞ 정밀도는 전형적으로 수치로 표현되지 않지만 비정밀도는 반복 측정값\n\n<!-- PAGE_14 -->\n###### 정성분석 (Qualitative assay)\n\n<!-- PAGE_14 -->\n###### 분석물질의 농도가 아니라 단지 분석물질이 있고 없음을 알려주는 검사\n\n<!-- PAGE_14 -->\n###### 시스템\n\n<!-- PAGE_14 -->\n###### ☞ 양성 검사 결과는 검사 신호가 분석 역치를 넘는 것만을 의미하고\n\n<!-- PAGE_14 -->\n###### 판단기준치(cut-off value)는 진단 민감도와 특이도의 인위적 조합에\n\n2) 보간법 : 내삽이라고도 하며 그래프상의 알려진 두 값 사이의 특정값을 평균하여 추정하는 것을 의미\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 10 -\n<!-- PAGE_15 -->\n###### 정확도 (Accuracy)\n\n<!-- PAGE_15 -->\n###### 측정치와 참값 사이의 일치도\n\n<!-- PAGE_15 -->\n###### ☞ 평가대상 검사법에 의한 다수의 연속적인 결과 값들에서 얻은 평균값과\n\n<!-- PAGE_15 -->\n###### 공인된 참고값(accepted reference value) 사이의 일치 근접도\n\n<!-- PAGE_15 -->\n###### 직선성 (Linearity)\n\n<!-- PAGE_15 -->\n###### 실험 검체에 있는 분석물질의 농도(양)에 정비례하는 결과를 제공할 수\n\n<!-- PAGE_15 -->\n###### 있는 능력\n\n<!-- PAGE_15 -->\n###### 진단 검사 (Diagnostic test)\n\n<!-- PAGE_15 -->\n###### 특정 질환의 진단, 예방, 치료 또는 개개의 환자에서의 건강이나 건강의\n\n<!-- PAGE_15 -->\n###### 손상 정도를 평가하기 위한 목적\n\n<!-- PAGE_15 -->\n###### ☞ 진단적 검체의 측정 또는 검사를 칭한다.\n\n <!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ.  용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n <!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n <!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n <!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ. ",
        "original_sentence": "정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_446",
      "text": "<!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 445,
        "window_size": 3,
        "char_count": 143,
        "word_count": 26,
        "page_number": 16,
        "window_text": "<!-- PAGE_15 -->\n###### 진양성 (True positive, TP)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 양성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 진음성 (True negative, TN)\n\n<!-- PAGE_15 -->\n###### 환자의 질병 상태와 검사의 음성판정이 일치하는 결과\n\n<!-- PAGE_15 -->\n###### 측정가능범위 (Analytical measurement range, AMR)\n\n<!-- PAGE_15 -->\n###### 일상적인 측정 과정의 일부가 아닌 희석, 농축 또는 기타 전처리 없이\n\n<!-- PAGE_15 -->\n###### 어떤 검사법이 검체에서 직접 측정할 수 있는 분석물질 값의 범위\n\n<!-- PAGE_15 -->\n###### 분석적 특이도 (Analytical specificity)\n\n<!-- PAGE_15 -->\n###### 정량검사에서 측정하고자 하는 물질만 측정되고 검체 내 다른 물질은 측정\n\n<!-- PAGE_15 -->\n###### 되지 않는 분석법의 능력\n\nⅡ.  용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n <!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n <!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n <!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ.  관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ. ",
        "original_sentence": "<!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_447",
      "text": "<!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 446,
        "window_size": 3,
        "char_count": 687,
        "word_count": 135,
        "page_number": 16,
        "window_text": "용어의 정의\n\n- - 11 -\n<!-- PAGE_16 -->\n###### 판정기준치 (Cut-off Value)\n\n<!-- PAGE_16 -->\n###### 정성검사에서는 경계치 이상을 양성으로, 경계치 미만을 음성으로 보고할\n\n<!-- PAGE_16 -->\n###### 수 있는 경계값을 말한다.  정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n <!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n <!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n <!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ.  관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.  ",
        "original_sentence": "<!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_448",
      "text": "<!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 447,
        "window_size": 3,
        "char_count": 481,
        "word_count": 92,
        "page_number": 17,
        "window_text": "정량검사에서는 측정 결과가 임상적 또는 분석적\n\n<!-- PAGE_16 -->\n###### 결정점(Decision point)의 위 또는 아래에 있는지(양성 또는 음성) 결정\n\n<!-- PAGE_16 -->\n###### 하는데 사용되는 측정물질의 정량값\n\n<!-- PAGE_16 -->\n###### 프라이머 (Primer)\n\n<!-- PAGE_16 -->\n###### oligonucleotide로 목표 DNA와 상보적 결합을 하여 DNA 중합효소와\n\n<!-- PAGE_16 -->\n###### nucleotide triphosphates를 같이 사용하여 DNA 합성을 시작할 수 있게 한다.\n\n <!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n <!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n <!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ.  관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.   제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n",
        "original_sentence": "<!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ. "
      }
    },
    {
      "chunk_id": "chunk_449",
      "text": "관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 448,
        "window_size": 3,
        "char_count": 1366,
        "word_count": 257,
        "page_number": 18,
        "window_text": "<!-- PAGE_16 -->\n###### 프로브 (Probe)\n\n<!-- PAGE_16 -->\n###### 단일가닥 핵산으로 상보적 염기서열을 가지고 있는 특정 DNA나 RNA를\n\n<!-- PAGE_16 -->\n###### 동정하는 목적으로 사용된다.\n\n <!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n <!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ.  관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.   제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n <!-- PAGE_21 -->\n###### 가. ",
        "original_sentence": "관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ. "
      }
    },
    {
      "chunk_id": "chunk_450",
      "text": "신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.  ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 449,
        "window_size": 3,
        "char_count": 376,
        "word_count": 81,
        "page_number": 20,
        "window_text": "<!-- PAGE_16 -->\n###### 항원 (Antigen)\n\n<!-- PAGE_16 -->\n###### 생체 내 항체 생성을 유발하고 그들과 특이적으로 결합할 수 있는 물질\n\n<!-- PAGE_16 -->\n###### 항원결정인자 / 에피토프 (Antigenic determinant / epitope)\n\n<!-- PAGE_16 -->\n###### 항원 분자 중 항체가 결합할 수 있는 모든 부위의 총칭으로 특정 항체군을\n\n<!-- PAGE_16 -->\n###### 결정하는 부위의 화학적 구조\n\n<!-- PAGE_16 -->\n###### 항체 (Antibody)\n\n<!-- PAGE_16 -->\n###### 면역계 내에서 항원의 자극에 의하여 혈청이나 조직에 만들어지는 물질\n\n<!-- PAGE_16 -->\n###### ☞ 면역원 노출에 반응하여 B림프구에서 생산되는 특이 면역글로불린으로\n\n<!-- PAGE_16 -->\n###### 항혈청 (Antiserum)\n\n<!-- PAGE_16 -->\n###### 항체를 포함하는 혈청\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 12 -\n<!-- PAGE_17 -->\n###### ☞ 항원이 사람 및 실험동물의 체내에 들어가면 이에 대하여 특이적 반응을\n\n<!-- PAGE_17 -->\n###### 하는 항체가 혈청 중에 생긴다.\n\n <!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ.  관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.   제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n <!-- PAGE_21 -->\n###### 가.  제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나. ",
        "original_sentence": "신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.  "
      }
    },
    {
      "chunk_id": "chunk_451",
      "text": "제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 450,
        "window_size": 3,
        "char_count": 35,
        "word_count": 5,
        "page_number": 21,
        "window_text": "<!-- PAGE_17 -->\n###### 핵산추출 (Nucleic acid extraction)\n\n<!-- PAGE_17 -->\n###### 핵산을 증폭하고 분석하기 위해 핵산을 생물학적 물질로부터 분리하는 것\n\n<!-- PAGE_17 -->\n###### 허용 오차 (Allowable error)\n\n<!-- PAGE_17 -->\n###### 모든 가능한 요소들로부터 발생할 수 있는 분석적 변이의 정도 또는 검사\n\n<!-- PAGE_17 -->\n###### 시스템에서 사용자가 허용할 수 있는 정도로 검사의 임상적 요구사항을\n\n<!-- PAGE_17 -->\n###### 만족시킬 수 있는 변이의 정도\n\n<!-- PAGE_17 -->\n###### 혈청전환 (Seroconversion)\n\n<!-- PAGE_17 -->\n###### 의문되는 감염원에 대한 환자 혈청 내 항체 검사가 양성에서 음성으로의\n\n<!-- PAGE_17 -->\n###### 전환\n\nⅢ.  관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.   제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n <!-- PAGE_21 -->\n###### 가.  제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나.  제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다. ",
        "original_sentence": "제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_452",
      "text": "<!-- PAGE_21 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 451,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 21,
        "window_text": "관련규정\n\n- - 13 -\n<!-- PAGE_18 -->\n### Ⅲ  관련규정\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제6조 (제조업의 허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법」제15조 (수입업허가 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제5조 (제조허가의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제7조 (제조신고의 절차)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제9조 (기술문서 등의 심사)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기법 시행규칙」제30조 (수입허가 신청 등)\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 허가․신고․심사 등에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 품목 및 품목별 등급에 관한 규정」\n\n<!-- PAGE_18 -->\n###### ❍「의료기기 안정성시험 기준」\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 14 -\n<!-- PAGE_19 -->\n### Ⅳ\n\n<!-- PAGE_19 -->\n#### 신청서 기재 항목 및 기술문서 제출자료\n\n<!-- PAGE_19 -->\n###### 1\n\n<!-- PAGE_19 -->\n###### 제조․수입허가신청서\n\n<!-- PAGE_19 -->\n###### ❍ 명칭(제품명, 품목명, 모델명)\n\n<!-- PAGE_19 -->\n###### ❍ 분류번호(등급)\n\n<!-- PAGE_19 -->\n###### ❍ 모양 및 구조\n\n<!-- PAGE_19 -->\n###### ❍ 원재료\n\n<!-- PAGE_19 -->\n###### ❍ 제조방법\n\n<!-- PAGE_19 -->\n###### ❍ 성능\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적\n\n<!-- PAGE_19 -->\n###### ❍ 사용방법\n\n<!-- PAGE_19 -->\n###### ❍ 사용 시 주의사항\n\n<!-- PAGE_19 -->\n###### ❍ 포장단위\n\n<!-- PAGE_19 -->\n###### ❍ 저장방법 및 사용기간\n\n<!-- PAGE_19 -->\n###### ❍ 시험규격\n\n<!-- PAGE_19 -->\n###### ❍ 제조원(수입 또는 제조공정 전부 위탁의 경우)\n\n<!-- PAGE_19 -->\n###### ❍ 허가(인증)조건\n\n<!-- PAGE_19 -->\n###### ❍ 비고\n\n<!-- PAGE_19 -->\n###### ❍ 개발경위, 측정원리·방법 및 국내·외 사용현황에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 원재료 및 제조방법에 관한 자료\n\n<!-- PAGE_19 -->\n###### ❍ 사용목적에 관한 자료\n\nⅣ.  신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.   제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n <!-- PAGE_21 -->\n###### 가.  제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나.  제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다.  동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2. ",
        "original_sentence": "<!-- PAGE_21 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_453",
      "text": "제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 452,
        "window_size": 3,
        "char_count": 46,
        "word_count": 10,
        "page_number": 21,
        "window_text": "신청서 기재 항목 및 기술문서 제출자료\n\n- - 15 -\n<!-- PAGE_20 -->\n###### ❍ 저장방법과 사용기간 또는 유효기간에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 제품의 성능을 확인하기 위한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 체외진단용 의료기기의 취급자 안전에 관한 자료\n\n<!-- PAGE_20 -->\n###### ❍ 이미 허가·인증받은 제품과 비교한 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 16 -\n<!-- PAGE_21 -->\n## Ⅴ\n\n<!-- PAGE_21 -->\n### 제조․수입허가 신청서 기재 항목\n\n<!-- PAGE_21 -->\n###### 1.   제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n <!-- PAGE_21 -->\n###### 가.  제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나.  제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다.  동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2.  제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다. ",
        "original_sentence": "제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_454",
      "text": "제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 453,
        "window_size": 3,
        "char_count": 66,
        "word_count": 14,
        "page_number": 21,
        "window_text": "제조(수입)업소명·제품명, 품목명, 모델명을 각각 기재한다.\n\n <!-- PAGE_21 -->\n###### 가.  제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나.  제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다.  동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2.  제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다.  다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가. ",
        "original_sentence": "제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_455",
      "text": "동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 454,
        "window_size": 3,
        "char_count": 64,
        "word_count": 14,
        "page_number": 21,
        "window_text": "<!-- PAGE_21 -->\n###### 가.  제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나.  제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다.  동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2.  제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다.  다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가.  허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나. ",
        "original_sentence": "동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_456",
      "text": "제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 455,
        "window_size": 3,
        "char_count": 76,
        "word_count": 15,
        "page_number": 21,
        "window_text": "제품명이 없는 경우, 생략 가능\n\n<!-- PAGE_21 -->\n###### 나.  제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다.  동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2.  제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다.  다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가.  허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나.  동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다. ",
        "original_sentence": "제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다. "
      }
    },
    {
      "chunk_id": "chunk_457",
      "text": "다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 456,
        "window_size": 3,
        "char_count": 53,
        "word_count": 11,
        "page_number": 21,
        "window_text": "제품명은 이미 허가를 받거나 신고한 의료기기의 명칭과 동일해선 안됨\n\n<!-- PAGE_21 -->\n###### 다.  동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2.  제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다.  다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가.  허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나.  동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다.  서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ. ",
        "original_sentence": "다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_458",
      "text": "허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 457,
        "window_size": 3,
        "char_count": 66,
        "word_count": 13,
        "page_number": 21,
        "window_text": "동일제품에 대하여 두 개 이상의 다른 제품명(또는 모델명) 인정\n\n<!-- PAGE_21 -->\n###### 2.  제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다.  다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가.  허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나.  동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다.  서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1. ",
        "original_sentence": "허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_459",
      "text": "동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 458,
        "window_size": 3,
        "char_count": 70,
        "word_count": 13,
        "page_number": 21,
        "window_text": "제품명은 이미 허가(신고)를 받거나 받았었던 의료기기의 제품명과 동일\n\n<!-- PAGE_21 -->\n###### 하여서는 아니 된다.  다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가.  허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나.  동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다.  서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1.  모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n",
        "original_sentence": "동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_460",
      "text": "서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 459,
        "window_size": 3,
        "char_count": 164,
        "word_count": 38,
        "page_number": 21,
        "window_text": "다만, 다음의 어느 하나에 해당하는 경우에는\n\n<!-- PAGE_21 -->\n###### 가.  허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나.  동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다.  서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1.  모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n <!-- PAGE_22 -->\n###### 가. ",
        "original_sentence": "서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_461",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 460,
        "window_size": 3,
        "char_count": 145,
        "word_count": 27,
        "page_number": 22,
        "window_text": "허가(신고)가 최소된 의료기기와 사용목적, 작용원리 및 원재료 등이\n\n<!-- PAGE_21 -->\n###### 나.  동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다.  서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1.  모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n <!-- PAGE_22 -->\n###### 가.  임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_462",
      "text": "모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 461,
        "window_size": 3,
        "char_count": 184,
        "word_count": 38,
        "page_number": 22,
        "window_text": "동일한 제조(수입)업자가 허가(신고) 취하 후 동일한 제품을 허가(신고)하\n\n<!-- PAGE_21 -->\n###### 다.  서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1.  모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n <!-- PAGE_22 -->\n###### 가.  임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다.  전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다. ",
        "original_sentence": "모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_463",
      "text": "<!-- PAGE_22 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 462,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 22,
        "window_text": "서로 다른 수입업자가 제조원이 같은 동일한 제품을 수입하는 경우에\n\n<!-- PAGE_21 -->\n###### ※ 다만, 기 허가 제품과 사용목적이 유사하여 허가 받은 제품의\n\n<!-- PAGE_21 -->\n###### 상품명에 문자, 단어, 숫자 등을 붙여 상품명을 기재하는 것은 동\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1.  모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n <!-- PAGE_22 -->\n###### 가.  임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다.  전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다.  태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다. ",
        "original_sentence": "<!-- PAGE_22 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_464",
      "text": "임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 463,
        "window_size": 3,
        "char_count": 137,
        "word_count": 26,
        "page_number": 22,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 17 -\n<!-- PAGE_22 -->\n###### ※ 별첨 기재시의 예\n\n㈜오송진단\n\n고위험성감염체면역검사시약\n\nCMV\n\n(제조․수입업소명)\n\n(품목명)\n\n(모델명)\n\n<!-- PAGE_22 -->\n###### 1.  모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n <!-- PAGE_22 -->\n###### 가.  임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다.  전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다.  태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다.  생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다. ",
        "original_sentence": "임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다. "
      }
    },
    {
      "chunk_id": "chunk_465",
      "text": "전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 464,
        "window_size": 3,
        "char_count": 68,
        "word_count": 14,
        "page_number": 22,
        "window_text": "모양 및 구조 - 작용원리\n\n<!-- PAGE_22 -->\n###### 제품의 용도 및 배경을 포함하여, 해당 제품을 개발하기 위하여 적용한\n\n<!-- PAGE_22 -->\n###### 측정원리, 적용되는 체외진단의료기기, 필요한 경우 검사 결과의 임상의의\n\n<!-- PAGE_22 -->\n###### 등을 포함하여 기재한다.\n\n <!-- PAGE_22 -->\n###### 가.  임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다.  전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다.  태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다.  생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다.  한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다. ",
        "original_sentence": "전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다. "
      }
    },
    {
      "chunk_id": "chunk_466",
      "text": "태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 465,
        "window_size": 3,
        "char_count": 136,
        "word_count": 29,
        "page_number": 23,
        "window_text": "<!-- PAGE_22 -->\n###### 가.  임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다.  전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다.  태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다.  생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다.  한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다.  그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나. ",
        "original_sentence": "태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다. "
      }
    },
    {
      "chunk_id": "chunk_467",
      "text": "생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 466,
        "window_size": 3,
        "char_count": 128,
        "word_count": 24,
        "page_number": 23,
        "window_text": "임상의의(배경) : 필요에 따라 해당 검사의 임상의의(배경) 등을\n\n<!-- PAGE_22 -->\n###### CMV는 HSV, VZV, EVB와 같이 Herpesvirus에 속하는 그룹에 속\n\n<!-- PAGE_22 -->\n###### 한다.  전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다.  태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다.  생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다.  한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다.  그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n",
        "original_sentence": "생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다. "
      }
    },
    {
      "chunk_id": "chunk_468",
      "text": "한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 467,
        "window_size": 3,
        "char_count": 106,
        "word_count": 21,
        "page_number": 23,
        "window_text": "전세계 지역에 확산되어 있으며 40세 이상 미국인 50~85%\n\n<!-- PAGE_22 -->\n###### 가 감염자다.  태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다.  생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다.  한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다.  그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n <!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n",
        "original_sentence": "한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다. "
      }
    },
    {
      "chunk_id": "chunk_469",
      "text": "그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 468,
        "window_size": 3,
        "char_count": 114,
        "word_count": 23,
        "page_number": 23,
        "window_text": "태아 감염율이 매우 높고 저개발국가와 사회경제적 상황\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 18 -\n<!-- PAGE_23 -->\n###### 이 좋지 않은 지역에서의 감염율은 타지역보다 높다.  생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다.  한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다.  그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n <!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n <!-- PAGE_23 -->\n###### 2. ",
        "original_sentence": "그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_470",
      "text": "작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 469,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 23,
        "window_text": "생후 감염된\n\n<!-- PAGE_23 -->\n###### 대부분의 정상인은 별다른 증세가 없이 건강을 유지하나 일부는 단\n\n<!-- PAGE_23 -->\n###### 핵구증 유사 증세(mononucleosis)를 보이기도 한다.  한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다.  그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n <!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n <!-- PAGE_23 -->\n###### 2.  모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가. ",
        "original_sentence": "작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_471",
      "text": "<!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 470,
        "window_size": 3,
        "char_count": 488,
        "word_count": 81,
        "page_number": 23,
        "window_text": "한번 감염되면\n\n<!-- PAGE_23 -->\n###### 평생 바이러스를 갖게 되고 치료약물이나 질환으로 면역력이 낮아\n\n<!-- PAGE_23 -->\n###### 지면 질환이 재발한다.  그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n <!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n <!-- PAGE_23 -->\n###### 2.  모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ. ",
        "original_sentence": "<!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_472",
      "text": "<!-- PAGE_23 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 471,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 23,
        "window_text": "그러므로 대부분의 정상인에서 CMV 감염은\n\n<!-- PAGE_23 -->\n###### 그렇게 심각하지 않지만 태아나 특정 고위험 환자에서는 황달, 간비\n\n<!-- PAGE_23 -->\n###### 나.  작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n <!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n <!-- PAGE_23 -->\n###### 2.  모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n",
        "original_sentence": "<!-- PAGE_23 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_473",
      "text": "모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 472,
        "window_size": 3,
        "char_count": 41,
        "word_count": 10,
        "page_number": 23,
        "window_text": "작용원리 : 해당 진단의 측정 원리를 아래의 예와 같이 작성한다.\n\n <!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n <!-- PAGE_23 -->\n###### 2.  모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n <!-- PAGE_24 -->\n###### 나. ",
        "original_sentence": "모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_474",
      "text": "외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 473,
        "window_size": 3,
        "char_count": 42,
        "word_count": 12,
        "page_number": 12,
        "window_text": "<!-- PAGE_23 -->\n###### 본 진단제품에는 화학발광면역분석법(CLIA, Chemiluminescence\n\n<!-- PAGE_23 -->\n###### 1) 1차 incubation : 샘플 내의 α항체는 첨가된 시약 중의 β항원과\n\n<!-- PAGE_23 -->\n###### 2) 2차 incubation : biotinylated 항체와 Substrate로 표지된 α항체\n\n<!-- PAGE_23 -->\n###### 를 첨가한 후 streptavidin으로 코팅된 미세입자를 넣어주면\n\n<!-- PAGE_23 -->\n###### 이 복합체는 biotin-streptavidin결합을 통해 solid phase로 결합된\n\n<!-- PAGE_23 -->\n###### 3) solid phase의 화합물은 ∼∼∼(중략)∼∼∼일어나고 이를\n\n<!-- PAGE_23 -->\n###### 4) 검사 결과는 해당 기기의 software에 의해서 자동적으로 산출된다.\n\n <!-- PAGE_23 -->\n###### 2.  모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n <!-- PAGE_24 -->\n###### 나.  외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다. ",
        "original_sentence": "외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_475",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 474,
        "window_size": 3,
        "char_count": 81,
        "word_count": 19,
        "page_number": 24,
        "window_text": "<!-- PAGE_23 -->\n###### 2.  모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n <!-- PAGE_24 -->\n###### 나.  외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다.  구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_476",
      "text": "<!-- PAGE_24 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 475,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 24,
        "window_text": "모양 및 구조 - 외형\n\n<!-- PAGE_23 -->\n###### 가.  외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n <!-- PAGE_24 -->\n###### 나.  외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다.  구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1.  구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나. ",
        "original_sentence": "<!-- PAGE_24 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_477",
      "text": "외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 476,
        "window_size": 3,
        "char_count": 121,
        "word_count": 27,
        "page_number": 24,
        "window_text": "외형사진 : 제품을 육안으로 식별할 수 있도록 제품의 전체 및 구성\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n <!-- PAGE_24 -->\n###### 나.  외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다.  구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1.  구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나.  검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴). ",
        "original_sentence": "외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_478",
      "text": "구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 477,
        "window_size": 3,
        "char_count": 126,
        "word_count": 27,
        "page_number": 24,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 19 -\n<!-- PAGE_24 -->\n###### 하는 시약을 확인할 수 있는 컬러사진을 첨부한다.\n\n <!-- PAGE_24 -->\n###### 나.  외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다.  구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1.  구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나.  검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴).  | Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1. ",
        "original_sentence": "구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1. "
      }
    },
    {
      "chunk_id": "chunk_479",
      "text": "구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 478,
        "window_size": 3,
        "char_count": 54,
        "word_count": 11,
        "page_number": 3,
        "window_text": "<!-- PAGE_24 -->\n###### 나.  외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다.  구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1.  구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나.  검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴).  | Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n\n",
        "original_sentence": "구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나. "
      }
    },
    {
      "chunk_id": "chunk_480",
      "text": "검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴). ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 479,
        "window_size": 3,
        "char_count": 119,
        "word_count": 31,
        "page_number": 2,
        "window_text": "외관설명 : 고형의 구성제품에 대해서는 모양․ 구조․ 중량 등을\n\n<!-- PAGE_24 -->\n###### 액상 또는 분말의 시약에 대해서는 색, 성상, 액성, 냄\n\n<!-- PAGE_24 -->\n###### 다.  구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1.  구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나.  검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴).  | Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n\n <!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n",
        "original_sentence": "검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴). "
      }
    },
    {
      "chunk_id": "chunk_481",
      "text": "| Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 480,
        "window_size": 3,
        "char_count": 252,
        "word_count": 57,
        "page_number": 25,
        "window_text": "구성 : 만일 체외진단용 의료기기와 별도의 구성품을 포함하고자\n\n<!-- PAGE_24 -->\n###### 할 경우, 별도판매 구성품에 대하여 추가로 외관사진 및 구성표를\n\n<!-- PAGE_24 -->\n###### 표 1.  구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나.  검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴).  | Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n\n <!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n <!-- PAGE_25 -->\n###### 가. ",
        "original_sentence": "| Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_482",
      "text": "원재료는 다음 양식의 표를 사용하여 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 481,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 25,
        "window_text": "구성표의 예\n\n일련\n\n번호\n\n**[표 시작]**\n\n**10개의 웰(액상시약 함유)로**\n| 나.  검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴).  | Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n\n <!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n <!-- PAGE_25 -->\n###### 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n",
        "original_sentence": "원재료는 다음 양식의 표를 사용하여 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_483",
      "text": "<!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 482,
        "window_size": 3,
        "char_count": 62,
        "word_count": 13,
        "page_number": 25,
        "window_text": "검사항목 : 검출대상이 되는 물질(해당 바이러스의 특정 항체, 항원 등) | Apr 02 |\n| 음성 대조물질 30건을 검사 | 2mlx1병 |\n| 한다(예 : 높은 농도의 X물질은 분석물질의 결과를 감소시킴).  | Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n\n <!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n <!-- PAGE_25 -->\n###### 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n <!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나. ",
        "original_sentence": "<!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_484",
      "text": "<!-- PAGE_25 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 483,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 25,
        "window_text": "| Oct 28 | Jun 23 |\n| Mar 18 | Jan 08 | Jul 27 |\n**무색 투명한 분말이 흡착된**\n**Jan 11**\n\n**[표 끝]**\n\n5\n\nC2\n\n음성 대조액\n\n담황색의 액상시약\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 20 -\n<!-- PAGE_25 -->\n###### 3\n\n<!-- PAGE_25 -->\n###### 원재료\n\n<!-- PAGE_25 -->\n###### 1.  원재료는 다음 양식의 표를 사용하여 기재한다.\n\n <!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n <!-- PAGE_25 -->\n###### 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n <!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나.  배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다. ",
        "original_sentence": "<!-- PAGE_25 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_485",
      "text": "명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 484,
        "window_size": 3,
        "char_count": 39,
        "word_count": 8,
        "page_number": 2,
        "window_text": "원재료는 다음 양식의 표를 사용하여 기재한다.\n\n <!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n <!-- PAGE_25 -->\n###### 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n <!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나.  배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마. ",
        "original_sentence": "명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_486",
      "text": "<!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 485,
        "window_size": 3,
        "char_count": 84,
        "word_count": 17,
        "page_number": 25,
        "window_text": "<!-- PAGE_25 -->\n###### ※ 별도 포장판매 구성품이 있을 경우에는 원재료를 함께 기재한다.\n\n <!-- PAGE_25 -->\n###### 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n <!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나.  배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n",
        "original_sentence": "<!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_487",
      "text": "배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 486,
        "window_size": 3,
        "char_count": 64,
        "word_count": 14,
        "page_number": 25,
        "window_text": "<!-- PAGE_25 -->\n###### 가.  명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n <!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나.  배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n 일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ. ",
        "original_sentence": "배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_488",
      "text": "원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 487,
        "window_size": 3,
        "char_count": 324,
        "word_count": 66,
        "page_number": 25,
        "window_text": "명칭 : 보조시약을 포함하여 해당 구성시약별로 일반명칭을 기재한다.\n\n <!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나.  배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n 일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바. ",
        "original_sentence": "원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마. "
      }
    },
    {
      "chunk_id": "chunk_489",
      "text": "규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 488,
        "window_size": 3,
        "char_count": 96,
        "word_count": 22,
        "page_number": 25,
        "window_text": "<!-- PAGE_25 -->\n###### 두 세트 이상이 함께 사용되어 하나의 사용목적을 달성하는\n\n<!-- PAGE_25 -->\n###### 나.  배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n 일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바.  비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n",
        "original_sentence": "규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_490",
      "text": "일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 489,
        "window_size": 3,
        "char_count": 21,
        "word_count": 5,
        "page_number": 2,
        "window_text": "배합목적 : 체외진단용 의료기기의 특성에 맞게 각 성분의 배합목\n\n<!-- PAGE_25 -->\n###### 다.  원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n 일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바.  비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n <!-- PAGE_26 -->\n###### 표 2. ",
        "original_sentence": "일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_491",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 490,
        "window_size": 3,
        "char_count": 55,
        "word_count": 13,
        "page_number": 26,
        "window_text": "원재료명 또는 성분명 : 각 구성 시약의 원재료명 또는 성분명을\n\n<!-- PAGE_25 -->\n###### 1) 반응주성분에 대하여 해당분량을 명시하고 항체의 경우 가급적\n\n<!-- PAGE_25 -->\n###### 2) 제품의 특성에 따라 그 외의(반응보조제, 보존제, 반응안정제,\n\n<!-- PAGE_25 -->\n###### 3) 단위는 ml, v/v, w/v, w/w 등으로 기재하고 범위의 설정도 가능\n\n<!-- PAGE_25 -->\n###### 4) 중합효소의 경우, 활성도(unit/λ 등)를 기재하고 단위의 정의도\n\n<!-- PAGE_25 -->\n###### 마.  규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n 일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바.  비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n <!-- PAGE_26 -->\n###### 표 2.  원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바. "
      }
    },
    {
      "chunk_id": "chunk_492",
      "text": "비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 491,
        "window_size": 3,
        "char_count": 38,
        "word_count": 11,
        "page_number": 25,
        "window_text": "규격 : 원재료에 대한 규격이 있는 경우 당해 규격(KP, USP 등)을\n\n<!-- PAGE_25 -->\n###### 기재하고 규격이 없는 경우 자사규격 등을 기재한다.\n\n 일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바.  비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n <!-- PAGE_26 -->\n###### 표 2.  원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다. ",
        "original_sentence": "비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_493",
      "text": "<!-- PAGE_26 -->\n###### 표 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 492,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 26,
        "window_text": "일련\n\n번호\n\n명칭\n\n배합목적\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바.  비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n <!-- PAGE_26 -->\n###### 표 2.  원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다. ",
        "original_sentence": "<!-- PAGE_26 -->\n###### 표 2. "
      }
    },
    {
      "chunk_id": "chunk_494",
      "text": "원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 493,
        "window_size": 3,
        "char_count": 194,
        "word_count": 62,
        "page_number": 3,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 21 -\n<!-- PAGE_26 -->\n###### 바.  비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n <!-- PAGE_26 -->\n###### 표 2.  원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다.",
        "original_sentence": "원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가. "
      }
    },
    {
      "chunk_id": "chunk_495",
      "text": "국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 494,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 2,
        "window_text": "비고 : 비고란에는 각 구성 시약의 용량 및 수량 등을 기재한다.\n\n <!-- PAGE_26 -->\n###### 표 2.  원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다. **\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다. ",
        "original_sentence": "국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_496",
      "text": "| 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 495,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 30,
        "window_text": "<!-- PAGE_26 -->\n###### 표 2.  원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다. **\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다.  | Apr 21 | Jul 14 |\n**Oct 16**\n**1. ",
        "original_sentence": "| 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_497",
      "text": "|\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다.",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 496,
        "window_size": 3,
        "char_count": 459,
        "word_count": 127,
        "page_number": 7,
        "window_text": "원재료 작성의 예\n\n**[표 시작]**\n\n| 일련 | 10 | 시험규격 | 검사법 | 품명 | 제조사 | 제조국 | 비고(용량 | Dec 17 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 검체 처리 과정에 통상적으로 첨가될 | Feb 04 | Jan 30 | Jul 10 |\n| 가.  국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다. **\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다.  | Apr 21 | Jul 14 |\n**Oct 16**\n**1.  외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2. ",
        "original_sentence": "|\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다."
      }
    },
    {
      "chunk_id": "chunk_498",
      "text": "**\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 497,
        "window_size": 3,
        "char_count": 234,
        "word_count": 68,
        "page_number": 3,
        "window_text": "국내․외에서 사용현황에 관해 제출할 자료는 다음의 사항을 포함한다.  | 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다. **\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다.  | Apr 21 | Jul 14 |\n**Oct 16**\n**1.  외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2.  검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.",
        "original_sentence": "**\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_499",
      "text": "| Apr 21 | Jul 14 |\n**Oct 16**\n**1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 498,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 다) 표준물질 농도는 가능하면 임상적으로 중요한 농도여야 한다.  |\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다. **\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다.  | Apr 21 | Jul 14 |\n**Oct 16**\n**1.  외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2.  검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. **\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다. ",
        "original_sentence": "| Apr 21 | Jul 14 |\n**Oct 16**\n**1. "
      }
    },
    {
      "chunk_id": "chunk_500",
      "text": "외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 499,
        "window_size": 3,
        "char_count": 315,
        "word_count": 82,
        "page_number": 2,
        "window_text": "|\n| 번호 | Vidas CMV IgG/IgM | BIOMERIEUX | France | 및 수량) | Dec 04 |\n| 물질 | Sep 07 |\n| Feb 08 | Sep 16 | Jul 27 |\n| Elecsys CMV IgG/IgM | Roche | Germany | May 13 |\n| 드물지 않게 볼 수 있는 특이 검체에 | Aug 10 | Sep 15 |\n| Enzygnost Anti-CMV IgG/IgM | BEHRING | Germany | Dec 17 | Jul 22 |\n| 포함된 물질 | Feb 05 | Jun 17 |\n| Aug 07 | Dec 05 |\n| Architect CMV IgG/IgM | ABBOTT | Ireland |\n| 비정상적으로 백혈구가 매우 높은 검 | Nov 16 | Jan 13 |\n**Feb 12**\n**검체의 반복 측정 수가 각각 최소 60회가 될 것을 권장한다. **\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다.  | Apr 21 | Jul 14 |\n**Oct 16**\n**1.  외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2.  검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. **\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.  | Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3. ",
        "original_sentence": "외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2. "
      }
    },
    {
      "chunk_id": "chunk_501",
      "text": "검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다.",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 500,
        "window_size": 3,
        "char_count": 129,
        "word_count": 38,
        "page_number": 12,
        "window_text": "**\n| 체 | May 02 | Jul 14 |\n**Apr 03**\n**Jun 13**\n| Hematocrit이 매우 높은 검체 | - | Aug 03 | Feb 19 | Jul 22 |\n| Dec 14 | Feb 20 |\n| Rheumatoid factor 양성인 검체 | - | Nov 13 |\n| Oct 27 | Jul 16 | Jul 27 |\n| 제시하고, 정량검사인 경우, 정량값 판정 등의 기준을 제시한다.  | Apr 21 | Jul 14 |\n**Oct 16**\n**1.  외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2.  검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. **\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.  | Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3.  정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다.",
        "original_sentence": "검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다."
      }
    },
    {
      "chunk_id": "chunk_502",
      "text": "**\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 501,
        "window_size": 3,
        "char_count": 131,
        "word_count": 40,
        "page_number": 3,
        "window_text": "| Apr 21 | Jul 14 |\n**Oct 16**\n**1.  외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2.  검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. **\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.  | Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3.  정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다. **\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다. ",
        "original_sentence": "**\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_503",
      "text": "| Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 502,
        "window_size": 3,
        "char_count": 75,
        "word_count": 26,
        "page_number": 3,
        "window_text": "외관검사**\n**Feb 02**\n**Nov 25**\n| 높은 자가면역항체를 가진 검체 | 규정한 요건에 적합한 시험자가 시험하였는지에 대한 자료를 제출 | Aug 01 | Jun 30 |\n| Mar 24 | Nov 07 | Oct 27 | Jul 14 |\n**Feb 14**\n**Jun 13**\n| human anti-mouse antibodies(HAMA) 등 | 품질관리를 위해 냉동보관된 |\n| Dec 17 | Apr 14 |\n| 환자혈청을 2배씩 계단희석 | Sep 21 |\n**Jun 03**\n| Nov 14 | Feb 23 | Jul 25 |\n| 2.  검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. **\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.  | Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3.  정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다. **\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다.  | Nov 01 | Apr 26 | Sep 16 |\n| 다. ",
        "original_sentence": "| Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3. "
      }
    },
    {
      "chunk_id": "chunk_504",
      "text": "정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다.",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 503,
        "window_size": 3,
        "char_count": 176,
        "word_count": 49,
        "page_number": 3,
        "window_text": "검출한계 | 하여 대조용 시약키트와 동시 | May 05 | Aug 08 |\n| May 04 | Jun 01 |\n| 에 검사하여 검출한계를 비교 | Sep 29 |\n**영어 외의 외국어 자료는 공증된 전체 번역문을 첨부하여야 한다. **\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.  | Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3.  정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다. **\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다.  | Nov 01 | Apr 26 | Sep 16 |\n| 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4. ",
        "original_sentence": "정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다."
      }
    },
    {
      "chunk_id": "chunk_505",
      "text": "**\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 504,
        "window_size": 3,
        "char_count": 127,
        "word_count": 32,
        "page_number": 3,
        "window_text": "**\n| May 20 | May 09 | Mar 27 | Sep 20 | Jul 20 |\n| Aug 07 | Nov 12 | Dec 18 |\n**Mar 04**\n| 4) 필요한 경우, 보정물질에 대한 설명 및 방법에 대하여 기재한다.  | Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3.  정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다. **\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다.  | Nov 01 | Apr 26 | Sep 16 |\n| 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4.  민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다. ",
        "original_sentence": "**\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다. "
      }
    },
    {
      "chunk_id": "chunk_506",
      "text": "| Nov 01 | Apr 26 | Sep 16 |\n| 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 505,
        "window_size": 3,
        "char_count": 34,
        "word_count": 12,
        "page_number": 3,
        "window_text": "| Mar 25 |\n| May 01 | Dec 28 |\n| 품질관리용 고, 중, 저 환자 | Apr 19 | Oct 01 |\n| 3.  정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다. **\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다.  | Nov 01 | Apr 26 | Sep 16 |\n| 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4.  민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다. ",
        "original_sentence": "| Nov 01 | Apr 26 | Sep 16 |\n| 다. "
      }
    },
    {
      "chunk_id": "chunk_507",
      "text": "원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 506,
        "window_size": 3,
        "char_count": 63,
        "word_count": 12,
        "page_number": 2,
        "window_text": "정밀도 | May 02 | Nov 16 |\n| Dec 16 | Sep 16 |\n**Apr 28**\n| Feb 15 | Jun 23 |\n| Platelia CMV IgG/IgM | BIO-RAD | France | Aug 02 | Jul 21 |\n**배경이 포함된 논문, 문헌, 기초 연구 결과 등의 자료를 제출한다. **\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다.  | Nov 01 | Apr 26 | Sep 16 |\n| 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4.  민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.  | QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다. ",
        "original_sentence": "원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4. "
      }
    },
    {
      "chunk_id": "chunk_508",
      "text": "민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 507,
        "window_size": 3,
        "char_count": 128,
        "word_count": 35,
        "page_number": 12,
        "window_text": "**\n| Strip | 냉암소보관 | May 13 | Aug 22 |\n| QIAGEN artus CMV LC PCR kit | QIAGEN | Germany |\n| 사 결과가 양성(판정기준치 이상)으로 나오는 환자의 비율이다.  | Nov 01 | Apr 26 | Sep 16 |\n| 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4.  민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.  | QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다.  | May 06 | May 03 |\n**Molecular**\n| 5. ",
        "original_sentence": "민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_509",
      "text": "| Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 508,
        "window_size": 3,
        "char_count": 51,
        "word_count": 15,
        "page_number": 12,
        "window_text": "| Nov 01 | Apr 26 | Sep 16 |\n| 다.  원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4.  민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.  | QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다.  | May 06 | May 03 |\n**Molecular**\n| 5.  특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가. ",
        "original_sentence": "| Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다. "
      }
    },
    {
      "chunk_id": "chunk_510",
      "text": "| QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 509,
        "window_size": 3,
        "char_count": 181,
        "word_count": 48,
        "page_number": 12,
        "window_text": "원료물질(단클론항체)의 기원에 관한 자료-기원 생물체, 클론번호 | 품질관리용 혈청(LOD+2SD) |\n| 4.  민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.  | QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다.  | May 06 | May 03 |\n**Molecular**\n| 5.  특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가.  일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다. ",
        "original_sentence": "| QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_511",
      "text": "| May 06 | May 03 |\n**Molecular**\n| 5. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 510,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 3,
        "window_text": "민감도 | QIAGEN artus CMV RG PCR kit | QIAGEN | Germany | Jun 28 | Jul 12 |\n| 동결건조 | Feb 27 |\n| 한계를 넘지 않는 결과를 보인 최대 간섭물질 농도를 기재한다.  | Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.  | QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다.  | May 06 | May 03 |\n**Molecular**\n| 5.  특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가.  일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다.  | Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC. ",
        "original_sentence": "| May 06 | May 03 |\n**Molecular**\n| 5. "
      }
    },
    {
      "chunk_id": "chunk_512",
      "text": "특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 511,
        "window_size": 3,
        "char_count": 176,
        "word_count": 55,
        "page_number": 3,
        "window_text": "| Jun 02 |\n| 사용 검체의 종류가 두 가지 이상인 경우 검체의 종류별로 시험한다.  | QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다.  | May 06 | May 03 |\n**Molecular**\n| 5.  특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가.  일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다.  | Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC.  | 1.5mlx1병 | 1989 |\n| 나. ",
        "original_sentence": "특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가. "
      }
    },
    {
      "chunk_id": "chunk_513",
      "text": "일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 512,
        "window_size": 3,
        "char_count": 64,
        "word_count": 9,
        "page_number": 2,
        "window_text": "| QIAGEN artus CMV TM PCR kit | QIAGEN | Germany | Jul 24 |\n| Dec 01 | Feb 02 |\n| QIAGEN CMV PCR kit | QIAGEN | Germany | Sep 26 | Jul 27 |\n| ❍ 임상적 성능시험자료는 다음의 어느 하나에 해당하는 자료여야 한다.  | May 06 | May 03 |\n**Molecular**\n| 5.  특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가.  일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다.  | Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC.  | 1.5mlx1병 | 1989 |\n| 나.  제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다. ",
        "original_sentence": "일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다. "
      }
    },
    {
      "chunk_id": "chunk_514",
      "text": "| Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 513,
        "window_size": 3,
        "char_count": 92,
        "word_count": 21,
        "page_number": 3,
        "window_text": "| May 06 | May 03 |\n**Molecular**\n| 5.  특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가.  일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다.  | Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC.  | 1.5mlx1병 | 1989 |\n| 나.  제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다.  | 1) 임상적 민감도 | 한다. ",
        "original_sentence": "| Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC. "
      }
    },
    {
      "chunk_id": "chunk_515",
      "text": "| 1.5mlx1병 | 1989 |\n| 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 514,
        "window_size": 3,
        "char_count": 25,
        "word_count": 7,
        "page_number": 3,
        "window_text": "특이도 | May 20 |\n**1.5mlx1병**\n| Apr 08 | Sep 25 | Jun 07 |\n| May 13 | Feb 27 | Sep 16 | Jan 29 |\n| Dec 04 | Apr 11 | Oct 09 |\n| PCR Kit | BIONEER | Korea |\n| 5 | C2 | 음성대조액 | 가.  일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다.  | Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC.  | 1.5mlx1병 | 1989 |\n| 나.  제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다.  | 1) 임상적 민감도 | 한다.  | 이에 준하는 것으로 인정되는 시험자료 | 기재한다. ",
        "original_sentence": "| 1.5mlx1병 | 1989 |\n| 나. "
      }
    },
    {
      "chunk_id": "chunk_516",
      "text": "제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 515,
        "window_size": 3,
        "char_count": 32,
        "word_count": 7,
        "page_number": 4,
        "window_text": "일반사항 | Streptococcus agalactiae | Streptococcus pneumoniae | 다.  | Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC.  | 1.5mlx1병 | 1989 |\n| 나.  제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다.  | 1) 임상적 민감도 | 한다.  | 이에 준하는 것으로 인정되는 시험자료 | 기재한다.  | INC. ",
        "original_sentence": "제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_517",
      "text": "| 1) 임상적 민감도 | 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 516,
        "window_size": 3,
        "char_count": 19,
        "word_count": 6,
        "page_number": 3,
        "window_text": "| Adenovirus Type 10 | Adenovirus Type 13 | 검체에 포함될 수 있는 물질(혈색소, 지질, 빌리루빈 등) | ASSAY | INC.  | 1.5mlx1병 | 1989 |\n| 나.  제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다.  | 1) 임상적 민감도 | 한다.  | 이에 준하는 것으로 인정되는 시험자료 | 기재한다.  | INC.  | INC. ",
        "original_sentence": "| 1) 임상적 민감도 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_518",
      "text": "| 이에 준하는 것으로 인정되는 시험자료 | 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 517,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 4,
        "window_text": "| 1.5mlx1병 | 1989 |\n| 나.  제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다.  | 1) 임상적 민감도 | 한다.  | 이에 준하는 것으로 인정되는 시험자료 | 기재한다.  | INC.  | INC.  | CORP. ",
        "original_sentence": "| 이에 준하는 것으로 인정되는 시험자료 | 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_519",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 518,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "제품개발 및 자사제품 성능에 관련된 문헌자료를 제출한다.  | 1) 임상적 민감도 | 한다.  | 이에 준하는 것으로 인정되는 시험자료 | 기재한다.  | INC.  | INC.  | CORP.  | CORP. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_520",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 519,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| 1) 임상적 민감도 | 한다.  | 이에 준하는 것으로 인정되는 시험자료 | 기재한다.  | INC.  | INC.  | CORP.  | CORP.  |\n| serum | INC. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_521",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 520,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 74,
        "window_text": "| 이에 준하는 것으로 인정되는 시험자료 | 기재한다.  | INC.  | INC.  | CORP.  | CORP.  |\n| serum | INC.  | INC. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_522",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 521,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 74,
        "window_text": "| INC.  | INC.  | CORP.  | CORP.  |\n| serum | INC.  | INC.  | t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_523",
      "text": "|\n| serum | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 522,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 12,
        "window_text": "| INC.  | CORP.  | CORP.  |\n| serum | INC.  | INC.  | t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1.  ‘제조원의 제조방법에 따른다.’라고 기재한다. ",
        "original_sentence": "|\n| serum | INC. "
      }
    },
    {
      "chunk_id": "chunk_524",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 523,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| CORP.  | CORP.  |\n| serum | INC.  | INC.  | t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1.  ‘제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_525",
      "text": "| t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 524,
        "window_size": 3,
        "char_count": 159,
        "word_count": 33,
        "page_number": 27,
        "window_text": "| CORP.  |\n| serum | INC.  | INC.  | t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1.  ‘제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1. ",
        "original_sentence": "| t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_526",
      "text": "‘제조원의 제조방법에 따른다.’라고 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 525,
        "window_size": 3,
        "char_count": 26,
        "word_count": 4,
        "page_number": 25,
        "window_text": "|\n| serum | INC.  | INC.  | t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1.  ‘제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n",
        "original_sentence": "‘제조원의 제조방법에 따른다.’라고 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_527",
      "text": "다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 526,
        "window_size": 3,
        "char_count": 43,
        "word_count": 10,
        "page_number": 27,
        "window_text": "| INC.  | t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1.  ‘제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n <!-- PAGE_27 -->\n###### 2. ",
        "original_sentence": "다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_528",
      "text": "멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 527,
        "window_size": 3,
        "char_count": 122,
        "word_count": 21,
        "page_number": 27,
        "window_text": "| t | 규격 |\n\n**[표 끝]**\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 22 -\n<!-- PAGE_27 -->\n###### 4\n\n<!-- PAGE_27 -->\n###### 제조방법\n\n<!-- PAGE_27 -->\n###### 1.  ‘제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n <!-- PAGE_27 -->\n###### 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가. ",
        "original_sentence": "멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_529",
      "text": "사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 528,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 25,
        "window_text": "‘제조원의 제조방법에 따른다.’라고 기재한다.  다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n <!-- PAGE_27 -->\n###### 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가.  검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ. ",
        "original_sentence": "사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_530",
      "text": "<!-- PAGE_27 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 529,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 27,
        "window_text": "다만, 다음 각 호에 해당\n\n<!-- PAGE_27 -->\n###### 가.  멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n <!-- PAGE_27 -->\n###### 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가.  검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3. ",
        "original_sentence": "<!-- PAGE_27 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_531",
      "text": "사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 530,
        "window_size": 3,
        "char_count": 208,
        "word_count": 37,
        "page_number": 27,
        "window_text": "멸균의료기기의 제조방법의 경우 멸균방법은 식약처장이 인정하는\n\n<!-- PAGE_27 -->\n###### 멸균의료기기의 멸균방법[의료기기 허가신고심사 등에 관한 규정,\n\n<!-- PAGE_27 -->\n###### 1.  사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n <!-- PAGE_27 -->\n###### 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가.  검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3.  성능\n\n<!-- PAGE_28 -->\n###### 가. ",
        "original_sentence": "사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_532",
      "text": "검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 531,
        "window_size": 3,
        "char_count": 104,
        "word_count": 22,
        "page_number": 27,
        "window_text": "사용목적은 성능을 포함하여 다음에 따라 기재한다.\n\n <!-- PAGE_27 -->\n###### 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가.  검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3.  성능\n\n<!-- PAGE_28 -->\n###### 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나. ",
        "original_sentence": "검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_533",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 532,
        "window_size": 3,
        "char_count": 369,
        "word_count": 61,
        "page_number": 28,
        "window_text": "<!-- PAGE_27 -->\n###### 2.  사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가.  검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3.  성능\n\n<!-- PAGE_28 -->\n###### 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나.  사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_534",
      "text": "성능\n\n<!-- PAGE_28 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 533,
        "window_size": 3,
        "char_count": 31,
        "word_count": 6,
        "page_number": 28,
        "window_text": "사용목적은 근거자료에 따라 검사대상, 검체종류, 검사항목, 측정원리\n\n<!-- PAGE_27 -->\n###### ※ 예시 : 사람의 혈청 및 혈장에서 CMV에 대한 특이적 IgG항체를 효소\n\n<!-- PAGE_27 -->\n###### 면역형광측정법(Enzyme Linked Fluorescent Assay, ELFA)으로\n\n<!-- PAGE_27 -->\n###### 가.  검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3.  성능\n\n<!-- PAGE_28 -->\n###### 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나.  사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다.  헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1. ",
        "original_sentence": "성능\n\n<!-- PAGE_28 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_535",
      "text": "근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 534,
        "window_size": 3,
        "char_count": 138,
        "word_count": 25,
        "page_number": 28,
        "window_text": "검체종류 : 인체에서 유래된 검체를 대상으로 함을 명기하고, 해당\n\n<!-- PAGE_27 -->\n###### 제품의 적용이 가능한 검체의 종류(사람의 혈청, 혈장, 전혈-정맥·\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3.  성능\n\n<!-- PAGE_28 -->\n###### 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나.  사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다.  헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n",
        "original_sentence": "근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_536",
      "text": "사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 535,
        "window_size": 3,
        "char_count": 78,
        "word_count": 18,
        "page_number": 25,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 23 -\n<!-- PAGE_28 -->\n###### ※ 예시 : 면역화학발광법(Chemiluminescent microparticle immunoassay,\n\n<!-- PAGE_28 -->\n###### CMIA),\n\n<!-- PAGE_28 -->\n###### 효소형광법(Enzyme\n\n<!-- PAGE_28 -->\n###### Linked\n\n<!-- PAGE_28 -->\n###### Fluorescent\n\n<!-- PAGE_28 -->\n###### Assay,\n\n<!-- PAGE_28 -->\n###### ELFA) 등 (정성, 정량, 반정량 등의 검사 특성 구분)\n\n<!-- PAGE_28 -->\n###### 3.  성능\n\n<!-- PAGE_28 -->\n###### 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나.  사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다.  헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n <!-- PAGE_29 -->\n###### 가. ",
        "original_sentence": "사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다. "
      }
    },
    {
      "chunk_id": "chunk_537",
      "text": "헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 536,
        "window_size": 3,
        "char_count": 198,
        "word_count": 44,
        "page_number": 28,
        "window_text": "성능\n\n<!-- PAGE_28 -->\n###### 가.  근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나.  사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다.  헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n <!-- PAGE_29 -->\n###### 가.  검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ. ",
        "original_sentence": "헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_538",
      "text": "검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 537,
        "window_size": 3,
        "char_count": 211,
        "word_count": 43,
        "page_number": 28,
        "window_text": "근거자료를 바탕으로 사용설명서(Instruction for user, IFU)에 수\n\n<!-- PAGE_28 -->\n###### 1) 당해 제품의 특성에 맞는 성능을 기재하되, 추상적이고 불명확한\n\n<!-- PAGE_28 -->\n###### 나.  사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다.  헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n <!-- PAGE_29 -->\n###### 가.  검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n",
        "original_sentence": "검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_539",
      "text": "<!-- PAGE_29 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 538,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 29,
        "window_text": "사용설명서에 제시된 성능이 없거나 사용설명서가 제작 전인 경우,\n\n본 제품은 아래의 물질의 이하 농도에서는 간섭 반응을\n\n일으키지 않는다.  헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n <!-- PAGE_29 -->\n###### 가.  검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n <!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n",
        "original_sentence": "<!-- PAGE_29 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_540",
      "text": "검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 539,
        "window_size": 3,
        "char_count": 528,
        "word_count": 99,
        "page_number": 29,
        "window_text": "헤모글로빈 : 1000mg/dL, 인지질 :\n\n3\n\n임상적 특이도\n\n건강한 헌혈자 검체 OO 개 중 OO 음성 99.87 %\n\n4\n\n임상적 민감도\n\n양성 환자 검체 OO 개 모두 양성 판정 100.00 %\n\n5\n\n상관성\n\n- 99.80%(Compare with Other company's product)\n<!-- PAGE_28 -->\n###### 1.  검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n <!-- PAGE_29 -->\n###### 가.  검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n <!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n <!-- PAGE_30 -->\n###### 1. ",
        "original_sentence": "검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_541",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 540,
        "window_size": 3,
        "char_count": 84,
        "word_count": 19,
        "page_number": 30,
        "window_text": "검체준비 및 저장방법, 검사 전 준비사항, 검사과정, 결과판정 및 정도\n\n<!-- PAGE_28 -->\n###### 관리, 장비(해당 장비의 제조사, 모델명) 등이 아래와 같이 포함하여\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 24 -\n<!-- PAGE_29 -->\n###### 체외진단용 의료기기를 중심으로 사용방법을 기술한다.\n\n <!-- PAGE_29 -->\n###### 가.  검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n <!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n <!-- PAGE_30 -->\n###### 1.  다음의 사항을 포함하여 기재한다.\n\n",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_542",
      "text": "<!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 541,
        "window_size": 3,
        "char_count": 426,
        "word_count": 87,
        "page_number": 30,
        "window_text": "<!-- PAGE_29 -->\n###### 가.  검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n <!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n <!-- PAGE_30 -->\n###### 1.  다음의 사항을 포함하여 기재한다.\n\n <!-- PAGE_30 -->\n###### 나. ",
        "original_sentence": "<!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_543",
      "text": "<!-- PAGE_30 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 542,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 30,
        "window_text": "검체준비 및 저장방법\n\n<!-- PAGE_29 -->\n###### 1) 검체대상 및 채취방법 등\n\n<!-- PAGE_29 -->\n###### 시험 전 시약 조제가 필요한 경우 조제 방법 및 조건, 검사에 필요한\n\n<!-- PAGE_29 -->\n###### 3) 필요한 경우, 시약의 성능과 판정에 영향을 줄 수 있는 기기 및\n\n<!-- PAGE_29 -->\n###### 시험방법이 구분되어 있는 경우는 각각을 구분하여 검사과정(반응\n\n<!-- PAGE_29 -->\n###### 시간, 온도조건, 세척과정 및 건조조건 등) 및 결과판독과정(파장,\n\n<!-- PAGE_29 -->\n###### 양성, 음성, 경계값(equivocal), 미확정(indeterminate), 무효(invalid)\n\n<!-- PAGE_29 -->\n###### 등의 예측되는 모든 경우의 시험 결과를 판정하는 기준과 해석을\n\n<!-- PAGE_29 -->\n###### 1) 경계값(equivocal), 미확정(indeterminate) 또는 무효(invalid)\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n <!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n <!-- PAGE_30 -->\n###### 1.  다음의 사항을 포함하여 기재한다.\n\n <!-- PAGE_30 -->\n###### 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다. ",
        "original_sentence": "<!-- PAGE_30 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_544",
      "text": "다음의 사항을 포함하여 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 543,
        "window_size": 3,
        "char_count": 20,
        "word_count": 4,
        "page_number": 2,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 25 -\n<!-- PAGE_30 -->\n###### 결과를 어떻게 처리해야 하는지에 대한 지침을 제시한다.\n\n <!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n <!-- PAGE_30 -->\n###### 1.  다음의 사항을 포함하여 기재한다.\n\n <!-- PAGE_30 -->\n###### 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다.  구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라. ",
        "original_sentence": "다음의 사항을 포함하여 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_545",
      "text": "<!-- PAGE_30 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 544,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 30,
        "window_text": "<!-- PAGE_30 -->\n###### 가) 그대로 보고하는지 재검사가 필요한지 여부\n\n<!-- PAGE_30 -->\n###### 나) 재검사는 동일검체로 하는지, 동일 원검체를 다시 처리하는지,\n\n<!-- PAGE_30 -->\n###### 다) 처음의 결과와 재검 결과를 조합하여 결과를 판독하는 경우의\n\n<!-- PAGE_30 -->\n###### 2) 환자검체의 검사결과를 판독하기 전에 확인해야 할, 대조물질\n\n<!-- PAGE_30 -->\n###### 3) 검사의 검출한계 또는 정량한계 등에 따른 보고가능범위에 대하여\n\n<!-- PAGE_30 -->\n###### 2) 제공하는 정도관리물질과 그 물질의 목표값이 있을 경우, 제시된\n\n<!-- PAGE_30 -->\n###### 3) 정도관리결과가 적합하지 않을 때 제시할 수 있는 대책을 기술한다.\n\n <!-- PAGE_30 -->\n###### 1.  다음의 사항을 포함하여 기재한다.\n\n <!-- PAGE_30 -->\n###### 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다.  구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라.  사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n",
        "original_sentence": "<!-- PAGE_30 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_546",
      "text": "일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 545,
        "window_size": 3,
        "char_count": 65,
        "word_count": 13,
        "page_number": 30,
        "window_text": "<!-- PAGE_30 -->\n###### 1.  다음의 사항을 포함하여 기재한다.\n\n <!-- PAGE_30 -->\n###### 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다.  구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라.  사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n <!-- PAGE_31 -->\n###### 마. ",
        "original_sentence": "일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_547",
      "text": "구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 546,
        "window_size": 3,
        "char_count": 116,
        "word_count": 26,
        "page_number": 31,
        "window_text": "다음의 사항을 포함하여 기재한다.\n\n <!-- PAGE_30 -->\n###### 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다.  구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라.  사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n <!-- PAGE_31 -->\n###### 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n",
        "original_sentence": "구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라. "
      }
    },
    {
      "chunk_id": "chunk_548",
      "text": "사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 547,
        "window_size": 3,
        "char_count": 39,
        "word_count": 11,
        "page_number": 2,
        "window_text": "<!-- PAGE_30 -->\n###### 나.  일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다.  구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라.  사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n <!-- PAGE_31 -->\n###### 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n <!-- PAGE_31 -->\n###### 바. ",
        "original_sentence": "사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_549",
      "text": "<!-- PAGE_31 -->\n###### 마. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 548,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 31,
        "window_text": "일반적인 실험실 안전지침 및 생물학적 위험물질(검체, 감염 가능성\n\n<!-- PAGE_30 -->\n###### 다.  구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라.  사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n <!-- PAGE_31 -->\n###### 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n <!-- PAGE_31 -->\n###### 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사. ",
        "original_sentence": "<!-- PAGE_31 -->\n###### 마. "
      }
    },
    {
      "chunk_id": "chunk_550",
      "text": "경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 549,
        "window_size": 3,
        "char_count": 82,
        "word_count": 18,
        "page_number": 31,
        "window_text": "구성 시약 중 유해물질이 포함될 경우 이에 대한 경고사항을 기재\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 26 -\n<!-- PAGE_31 -->\n###### 라.  사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n <!-- PAGE_31 -->\n###### 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n <!-- PAGE_31 -->\n###### 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사.  검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다. ",
        "original_sentence": "경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_551",
      "text": "<!-- PAGE_31 -->\n###### 바. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 550,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 31,
        "window_text": "사용한 검체 및 키트의 처리 및 폐기 방법 및 주의사항을 기재한다.\n\n <!-- PAGE_31 -->\n###### 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n <!-- PAGE_31 -->\n###### 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사.  검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다.  또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아. ",
        "original_sentence": "<!-- PAGE_31 -->\n###### 바. "
      }
    },
    {
      "chunk_id": "chunk_552",
      "text": "임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 551,
        "window_size": 3,
        "char_count": 64,
        "word_count": 15,
        "page_number": 31,
        "window_text": "<!-- PAGE_31 -->\n###### 마.  경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n <!-- PAGE_31 -->\n###### 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사.  검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다.  또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1. ",
        "original_sentence": "임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사. "
      }
    },
    {
      "chunk_id": "chunk_553",
      "text": "검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 552,
        "window_size": 3,
        "char_count": 142,
        "word_count": 33,
        "page_number": 31,
        "window_text": "경고사항을 포함하여 검체 및 키트 취급 및 보관상의 주의사항\n\n<!-- PAGE_31 -->\n###### (온도, 습도의 영향 등)을 명시한다.\n\n <!-- PAGE_31 -->\n###### 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사.  검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다.  또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1.  체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ. ",
        "original_sentence": "검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_554",
      "text": "또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 553,
        "window_size": 3,
        "char_count": 94,
        "word_count": 17,
        "page_number": 31,
        "window_text": "<!-- PAGE_31 -->\n###### 바.  임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사.  검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다.  또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1.  체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1. ",
        "original_sentence": "또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아. "
      }
    },
    {
      "chunk_id": "chunk_555",
      "text": "다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 554,
        "window_size": 3,
        "char_count": 61,
        "word_count": 13,
        "page_number": 31,
        "window_text": "임상 적용 대상 및 미적용 대상을 포함하여 적용상의 주의사항 및\n\n<!-- PAGE_31 -->\n###### 사.  검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다.  또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1.  체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1.  저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가. ",
        "original_sentence": "다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_556",
      "text": "체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 555,
        "window_size": 3,
        "char_count": 106,
        "word_count": 21,
        "page_number": 31,
        "window_text": "검사에 영향을 미치는 내용(검체 조건, 간섭 및 교차반응물질,\n\n<!-- PAGE_31 -->\n###### ※ 예시 : 용혈성 검체, 황달에 걸린 검체 또는 지방질 검체는\n\n<!-- PAGE_31 -->\n###### 검사의 결과에 영향을 미칠 수 있다.  또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1.  체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1.  저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n",
        "original_sentence": "체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_557",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 556,
        "window_size": 3,
        "char_count": 119,
        "word_count": 25,
        "page_number": 32,
        "window_text": "또한 비정상적인\n\n<!-- PAGE_31 -->\n###### 면역글로블린 G (IgG)와 류마토이드 인자(RF) 항체\n\n<!-- PAGE_31 -->\n###### 아.  다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1.  체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1.  저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n <!-- PAGE_32 -->\n###### 나. ",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_558",
      "text": "저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 557,
        "window_size": 3,
        "char_count": 65,
        "word_count": 13,
        "page_number": 32,
        "window_text": "다른 의료기기와 결합하여 사용하는 경우 적절한 조합에 대한\n\n<!-- PAGE_31 -->\n###### 1.  체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1.  저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n <!-- PAGE_32 -->\n###### 나.  일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다. ",
        "original_sentence": "저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_559",
      "text": "키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 558,
        "window_size": 3,
        "char_count": 100,
        "word_count": 20,
        "page_number": 32,
        "window_text": "체외진단용 의료기기의 포장단위는 취급상 용이한 최소 단위로 기재하되\n\n<!-- PAGE_31 -->\n###### 제조의 경우 “자사 포장단위”, 수입의 경우는 “제조원의 포장단위”로\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1.  저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n <!-- PAGE_32 -->\n###### 나.  일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다.  시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라. ",
        "original_sentence": "키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_560",
      "text": "<!-- PAGE_32 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 559,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 32,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 27 -\n<!-- PAGE_32 -->\n###### 9\n\n<!-- PAGE_32 -->\n###### 저장방법 및 사용기간\n\n<!-- PAGE_32 -->\n###### 1.  저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n <!-- PAGE_32 -->\n###### 나.  일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다.  시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4. ",
        "original_sentence": "<!-- PAGE_32 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_561",
      "text": "일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 560,
        "window_size": 3,
        "char_count": 128,
        "word_count": 26,
        "page_number": 32,
        "window_text": "저장방법은 및 사용기간은 「의료기기의 안전성시험 기준」에 따라 저\n\n<!-- PAGE_32 -->\n###### 가.  키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n <!-- PAGE_32 -->\n###### 나.  일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다.  시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4.  저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1. ",
        "original_sentence": "일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_562",
      "text": "시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 561,
        "window_size": 3,
        "char_count": 63,
        "word_count": 14,
        "page_number": 32,
        "window_text": "키트 또는 세트의 제품인 경우, 구성품별로 보관조건을 기재하고,\n\n<!-- PAGE_32 -->\n###### 사용기간(유효기간)이 서로 다른 경우 가장 짧은 기한으로 기재한다.\n\n <!-- PAGE_32 -->\n###### 나.  일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다.  시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4.  저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2. ",
        "original_sentence": "시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라. "
      }
    },
    {
      "chunk_id": "chunk_563",
      "text": "전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 562,
        "window_size": 3,
        "char_count": 67,
        "word_count": 13,
        "page_number": 32,
        "window_text": "<!-- PAGE_32 -->\n###### 나.  일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다.  시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4.  저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ. ",
        "original_sentence": "전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4. "
      }
    },
    {
      "chunk_id": "chunk_564",
      "text": "저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 563,
        "window_size": 3,
        "char_count": 104,
        "word_count": 21,
        "page_number": 33,
        "window_text": "일회용 체외진단용 의료기기가 아닐 경우, 개봉 후 시약의 저장방\n\n<!-- PAGE_32 -->\n###### 법(온도, 습도, 차광, 밀폐, 보관용기 등) 및 사용기간(유효기간)\n\n<!-- PAGE_32 -->\n###### 다.  시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4.  저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n",
        "original_sentence": "저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_565",
      "text": "시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 564,
        "window_size": 3,
        "char_count": 129,
        "word_count": 25,
        "page_number": 33,
        "window_text": "시약의 조제가 필요할 경우 조제 후 보관조건 및 사용기간(유효\n\n<!-- PAGE_32 -->\n###### 라.  전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4.  저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n <!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5. ",
        "original_sentence": "시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_566",
      "text": "시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 565,
        "window_size": 3,
        "char_count": 452,
        "word_count": 94,
        "page_number": 33,
        "window_text": "전자민원 접수시 ‘저장방법’ 항은 ‘사용기간에 따름’으로 표기하고\n\n<!-- PAGE_32 -->\n###### 표 4.  저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n <!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5.  시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1. ",
        "original_sentence": "시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ. "
      }
    },
    {
      "chunk_id": "chunk_567",
      "text": "제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 566,
        "window_size": 3,
        "char_count": 121,
        "word_count": 26,
        "page_number": 34,
        "window_text": "저장방법 및 사용기간(유효기간) 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 28 -\n<!-- PAGE_33 -->\n###### 1.  시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n <!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5.  시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1.  수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n",
        "original_sentence": "제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_568",
      "text": "<!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 567,
        "window_size": 3,
        "char_count": 90,
        "word_count": 17,
        "page_number": 34,
        "window_text": "시약의 품질관리에 적정을 기할 수 있도록 제품의 특성에 따라 성능\n\n<!-- PAGE_33 -->\n###### 등을 고려하여, 제조단위별·제조단계별로 안전성·성능을 검증하기 위하여\n\n<!-- PAGE_33 -->\n###### 2.  시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n <!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5.  시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1.  수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n <!-- PAGE_35 -->\n###### 2. ",
        "original_sentence": "<!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5. "
      }
    },
    {
      "chunk_id": "chunk_569",
      "text": "시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 568,
        "window_size": 3,
        "char_count": 148,
        "word_count": 29,
        "page_number": 35,
        "window_text": "시험규격은 제조사의 품질관리시험 자료에 따라 자사가 설정한 시험\n\n<!-- PAGE_33 -->\n###### 2) 분석적 성능시험(민감도, 특이도, 정밀도 등)을 포함하는 것을\n\n<!-- PAGE_33 -->\n###### 1) 시험결과의 적부판정의 기준이 되는 기준치의 허용 범위를 명확\n\n<!-- PAGE_33 -->\n###### 하게 기재하여야 하며 시험결과가 온도․ 습도 등 주위조건에\n\n<!-- PAGE_33 -->\n###### 1) 시험방법은 순서에 따라 시험결과를 정확히 산출할 수 있도록\n\n<!-- PAGE_33 -->\n###### 2) 표준물질이 사용된 경우, 고, 중, 저 역가를 포함한 각각 최소 3개\n\n<!-- PAGE_33 -->\n###### 이상의 표준물질을 사용할 것을 권장하고 해당 표준물질명을\n\nC2\n\n미개봉\n\n2~8℃\n\n제조일로부터 11개월\n\n개봉\n\n개봉일로부터 7개월\n\nⅤ.  제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n <!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5.  시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1.  수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n <!-- PAGE_35 -->\n###### 2.  모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다. ",
        "original_sentence": "시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_570",
      "text": "수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 569,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 25,
        "window_text": "제조․수입허가 신청서 기재 항목\n\n- - 29 -\n<!-- PAGE_34 -->\n###### 가) 저농도 표준물질인 경우, 정량 및 정성검출한계를 근거로\n\n<!-- PAGE_34 -->\n###### 하여 설정한다.\n\n <!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5.  시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1.  수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n <!-- PAGE_35 -->\n###### 2.  모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다.  다만, 제조자가 외국회사일 경우에는\n\nⅥ. ",
        "original_sentence": "수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_571",
      "text": "<!-- PAGE_35 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 570,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 35,
        "window_text": "<!-- PAGE_34 -->\n###### 나) 표준물질의 농도는 정밀도, 직선성, 최소검출한계를 고려하여\n\n<!-- PAGE_34 -->\n###### 표 5.  시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1.  수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n <!-- PAGE_35 -->\n###### 2.  모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다.  다만, 제조자가 외국회사일 경우에는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1. ",
        "original_sentence": "<!-- PAGE_35 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_572",
      "text": "모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 571,
        "window_size": 3,
        "char_count": 78,
        "word_count": 15,
        "page_number": 35,
        "window_text": "시험규격 작성의 예\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 30 -\n<!-- PAGE_35 -->\n###### 11\n\n<!-- PAGE_35 -->\n###### 제조원\n\n<!-- PAGE_35 -->\n###### 1.  수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n <!-- PAGE_35 -->\n###### 2.  모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다.  다만, 제조자가 외국회사일 경우에는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1.  원칙\n\n<!-- PAGE_36 -->\n###### 가. ",
        "original_sentence": "모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_573",
      "text": "다만, 제조자가 외국회사일 경우에는\n\nⅥ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 572,
        "window_size": 3,
        "char_count": 24,
        "word_count": 5,
        "page_number": 36,
        "window_text": "수입의 경우 제조원의 제조국, 제조사명 및 주소를 기재한다.\n\n <!-- PAGE_35 -->\n###### 2.  모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다.  다만, 제조자가 외국회사일 경우에는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1.  원칙\n\n<!-- PAGE_36 -->\n###### 가.  기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나. ",
        "original_sentence": "다만, 제조자가 외국회사일 경우에는\n\nⅥ. "
      }
    },
    {
      "chunk_id": "chunk_574",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 573,
        "window_size": 3,
        "char_count": 123,
        "word_count": 28,
        "page_number": 36,
        "window_text": "<!-- PAGE_35 -->\n###### 2.  모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다.  다만, 제조자가 외국회사일 경우에는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1.  원칙\n\n<!-- PAGE_36 -->\n###### 가.  기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다. ",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_575",
      "text": "원칙\n\n<!-- PAGE_36 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 574,
        "window_size": 3,
        "char_count": 31,
        "word_count": 6,
        "page_number": 36,
        "window_text": "모든 제조공정을 위탁하여 제조하는 경우에는 제조의뢰자와 제조자의\n\n<!-- PAGE_35 -->\n###### 상호와 주소를 모두 기재한다.  다만, 제조자가 외국회사일 경우에는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1.  원칙\n\n<!-- PAGE_36 -->\n###### 가.  기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라. ",
        "original_sentence": "원칙\n\n<!-- PAGE_36 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_576",
      "text": "기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 575,
        "window_size": 3,
        "char_count": 126,
        "word_count": 26,
        "page_number": 36,
        "window_text": "다만, 제조자가 외국회사일 경우에는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1.  원칙\n\n<!-- PAGE_36 -->\n###### 가.  기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. ",
        "original_sentence": "기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_577",
      "text": "첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 576,
        "window_size": 3,
        "char_count": 63,
        "word_count": 11,
        "page_number": 36,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n- - 31 -\n<!-- PAGE_36 -->\n## Ⅵ\n\n<!-- PAGE_36 -->\n#### 기술문서 등의 심사를 위한 제출자료\n\n<!-- PAGE_36 -->\n###### 1.  원칙\n\n<!-- PAGE_36 -->\n###### 가.  기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n<!-- PAGE_36 -->\n###### 마. ",
        "original_sentence": "첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_578",
      "text": "해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 577,
        "window_size": 3,
        "char_count": 64,
        "word_count": 14,
        "page_number": 36,
        "window_text": "원칙\n\n<!-- PAGE_36 -->\n###### 가.  기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n<!-- PAGE_36 -->\n###### 마.  이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2. ",
        "original_sentence": "해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라. "
      }
    },
    {
      "chunk_id": "chunk_579",
      "text": "외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 578,
        "window_size": 3,
        "char_count": 94,
        "word_count": 22,
        "page_number": 36,
        "window_text": "기술문서 등의 심사를 받고자 하는 자는 의료기기 시행규칙 별지\n\n<!-- PAGE_36 -->\n###### 제8호 서식에 따라 ‘의료기기 기술문서 등 심사의뢰서’를 작성하여야\n\n<!-- PAGE_36 -->\n###### 나.  첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n<!-- PAGE_36 -->\n###### 마.  이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2.  이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가. ",
        "original_sentence": "외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_580",
      "text": "다만,\n\n<!-- PAGE_36 -->\n###### 마. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 579,
        "window_size": 3,
        "char_count": 32,
        "word_count": 6,
        "page_number": 36,
        "window_text": "첨부자료 등을 식품의약품안전처장이 정한 전용프로그램으로 작성된\n\n<!-- PAGE_36 -->\n###### 다.  해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n<!-- PAGE_36 -->\n###### 마.  이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2.  이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가.  제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n",
        "original_sentence": "다만,\n\n<!-- PAGE_36 -->\n###### 마. "
      }
    },
    {
      "chunk_id": "chunk_581",
      "text": "이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 580,
        "window_size": 3,
        "char_count": 63,
        "word_count": 12,
        "page_number": 36,
        "window_text": "해당 제품의 특성상 첨부자료의 일부가 불필요한 경우, 그 사유를\n\n<!-- PAGE_36 -->\n###### 라.  외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n<!-- PAGE_36 -->\n###### 마.  이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2.  이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가.  제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n <!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3. ",
        "original_sentence": "이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_582",
      "text": "이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 581,
        "window_size": 3,
        "char_count": 46,
        "word_count": 9,
        "page_number": 36,
        "window_text": "외국의 자료는 주요사항을 발췌한 한글 요약문 및 원문을 첨부하\n\n<!-- PAGE_36 -->\n###### 여야 하며, 필요한 경우에 한하여 번역물을 요구할 수 있다.  다만,\n\n<!-- PAGE_36 -->\n###### 마.  이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2.  이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가.  제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n <!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3.  시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ. ",
        "original_sentence": "이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_583",
      "text": "제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 582,
        "window_size": 3,
        "char_count": 127,
        "word_count": 24,
        "page_number": 36,
        "window_text": "다만,\n\n<!-- PAGE_36 -->\n###### 마.  이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2.  이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가.  제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n <!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3.  시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다. ",
        "original_sentence": "제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n"
      }
    },
    {
      "chunk_id": "chunk_584",
      "text": "<!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 583,
        "window_size": 3,
        "char_count": 207,
        "word_count": 41,
        "page_number": 36,
        "window_text": "이미 허가·인증받은 제품과 비교한 본질적 동등비교표를 제출하여\n\n<!-- PAGE_36 -->\n###### 2.  이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가.  제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n <!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3.  시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다.  추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1. ",
        "original_sentence": "<!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_585",
      "text": "시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 584,
        "window_size": 3,
        "char_count": 155,
        "word_count": 34,
        "page_number": 37,
        "window_text": "이미 허가받은 제품과의 동등비교\n\n<!-- PAGE_36 -->\n###### 가.  제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n <!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3.  시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다.  추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1.  개발경위\n\n<!-- PAGE_39 -->\n###### 가. ",
        "original_sentence": "시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ. "
      }
    },
    {
      "chunk_id": "chunk_586",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 585,
        "window_size": 3,
        "char_count": 593,
        "word_count": 124,
        "page_number": 38,
        "window_text": "제출되는 ‘이미 허가받은 제품과 비교한 자료([별지 제5호 서식］의\n\n<!-- PAGE_36 -->\n###### 체외진단용 의료기기의 본질적 동등품목 비교표)를 이용하여 이미\n\n<!-- PAGE_36 -->\n###### 나.\n\n <!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3.  시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다.  추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1.  개발경위\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2. ",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_587",
      "text": "추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 586,
        "window_size": 3,
        "char_count": 495,
        "word_count": 98,
        "page_number": 38,
        "window_text": "<!-- PAGE_36 -->\n###### 규정 [별표 8］‘체외진단용 의료기기의 기술문서 등 제출 자료의 범위’\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 32 -\n<!-- PAGE_37 -->\n###### ※ 거대세포바이러스 체외진단용 의료기기에 적용되는 제출 자료의 범위\n\n<!-- PAGE_37 -->\n###### 3.  시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다.  추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1.  개발경위\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2.  측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가. ",
        "original_sentence": "추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_588",
      "text": "개발경위\n\n<!-- PAGE_39 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 587,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 39,
        "window_text": "시험 자료의 요건 (임상 시험 자료 요건은 별도 제시)\n\n<!-- PAGE_37 -->\n###### 2) 해당 의료기기에 대하여 경제협력기구(OECD) 회원국에 허가\n\n<!-- PAGE_37 -->\n###### 당시 제출되어 평가된 시험에 관한 자료로서 해당 정부 또는\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다.  추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1.  개발경위\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2.  측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ. ",
        "original_sentence": "개발경위\n\n<!-- PAGE_39 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_589",
      "text": "거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 588,
        "window_size": 3,
        "char_count": 124,
        "word_count": 26,
        "page_number": 39,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n- - 33 -\n<!-- PAGE_38 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_38 -->\n###### 확인한 자료 또는 이를 공증한 자료\n\n<!-- PAGE_38 -->\n###### 3) 「의료기기 제조·수입 및 품질관리기준」또는 이와 동등 이상의\n\n<!-- PAGE_38 -->\n###### 규격에 따른 제조사의 품질관리시스템 하에서 실시된 시험성적\n\n<!-- PAGE_38 -->\n###### 4) 대학 또는 연구기관 등 국내·외의 전문기관에서 시험한 것으로서\n\n<!-- PAGE_38 -->\n###### 해당 전문기관의 장이 발급하고 그 내용(전문기관의 시험시설\n\n<!-- PAGE_38 -->\n###### 개요, 주요설비, 연구인력 구성, 시험자의 연구경력 등을 포함한다)\n\n<!-- PAGE_38 -->\n###### 6) 시험기준 및 시험방법 단, 규격이 없는 경우 이에 대한 설정 사유\n\n<!-- PAGE_38 -->\n###### 7) 시험검사품 채취 및 방법에 대한 사항(시험을 위한 별도 전처리가\n\n<!-- PAGE_38 -->\n###### 다.  추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1.  개발경위\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2.  측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다. ",
        "original_sentence": "거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_590",
      "text": "측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 589,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 39,
        "window_text": "추가 기재내용 (대학 또는 연구기관 등 국내·외 전문기관에서\n\n<!-- PAGE_38 -->\n###### 전문기관의 명칭, 주소, 인증현황, 검사기능 분야, 연구인력구성,\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 34 -\n<!-- PAGE_39 -->\n###### 주요설비 목록 등이 기재되어 있어야 함\n\n<!-- PAGE_39 -->\n###### 2) 주요설비\n\n<!-- PAGE_39 -->\n###### 시험검사에 사용된 장비명칭, 장비사양, 검·교정 기록서 등에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 전문기관 담당부서에 속한 연구인력들에 대한\n\n<!-- PAGE_39 -->\n###### 시험검사를 실시한 시험자가 해당 검사를 하기에 적합한 전공,\n\n<!-- PAGE_39 -->\n###### 경력 등을 가지고 있는지에 대해 기재하고, 해당 전문기관에서\n\n<!-- PAGE_39 -->\n###### 1.  개발경위\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2.  측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다.  제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n",
        "original_sentence": "측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_591",
      "text": "거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 590,
        "window_size": 3,
        "char_count": 41,
        "word_count": 8,
        "page_number": 2,
        "window_text": "개발경위\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2.  측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다.  제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n <!-- PAGE_40 -->\n###### 3. ",
        "original_sentence": "거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ. "
      }
    },
    {
      "chunk_id": "chunk_592",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 591,
        "window_size": 3,
        "char_count": 57,
        "word_count": 14,
        "page_number": 40,
        "window_text": "거대세포바이러스 감염과 관련된 증후군의 설명 자료 및 개발\n\n<!-- PAGE_39 -->\n###### 1) 프라이머·프로브, 항원, 항체 등을 설정한 방법과 표적 선택의\n\n<!-- PAGE_39 -->\n###### 2.  측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다.  제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n <!-- PAGE_40 -->\n###### 3.  국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1. ",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_593",
      "text": "제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 592,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 4,
        "window_text": "측정원리 ․ 방법\n\n<!-- PAGE_39 -->\n###### 가.  거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다.  제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n <!-- PAGE_40 -->\n###### 3.  국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나. ",
        "original_sentence": "제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_594",
      "text": "<!-- PAGE_40 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 593,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 40,
        "window_text": "거대세포바이러스의 검출 대상(항체, DNA 등)을 검출하는데 사용\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다.  제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n <!-- PAGE_40 -->\n###### 3.  국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마. ",
        "original_sentence": "<!-- PAGE_40 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_595",
      "text": "국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 594,
        "window_size": 3,
        "char_count": 166,
        "word_count": 36,
        "page_number": 40,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n- - 35 -\n<!-- PAGE_40 -->\n###### 다.  제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n <!-- PAGE_40 -->\n###### 3.  국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마.  분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바. ",
        "original_sentence": "국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_596",
      "text": "원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 595,
        "window_size": 3,
        "char_count": 57,
        "word_count": 13,
        "page_number": 40,
        "window_text": "제품 검사원리에 대한 기술 및 관련 외국규정 등의 자료를 제출한다.\n\n <!-- PAGE_40 -->\n###### 3.  국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마.  분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바.  프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2. ",
        "original_sentence": "원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_597",
      "text": "원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 596,
        "window_size": 3,
        "char_count": 65,
        "word_count": 12,
        "page_number": 40,
        "window_text": "<!-- PAGE_40 -->\n###### 3.  국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마.  분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바.  프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가. ",
        "original_sentence": "원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마. "
      }
    },
    {
      "chunk_id": "chunk_598",
      "text": "분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 597,
        "window_size": 3,
        "char_count": 63,
        "word_count": 12,
        "page_number": 40,
        "window_text": "국내․외에서 사용현황\n\n<!-- PAGE_40 -->\n###### 1) 외국의 판매 또는 허가현황 및 제조허가(인증) 경위 등과 관련\n\n<!-- PAGE_40 -->\n###### 2) 사용 시 보고된 측정오류 : 외국에서 시판 중인 제품의 경우,\n\n<!-- PAGE_40 -->\n###### 1.  원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마.  분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바.  프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나. ",
        "original_sentence": "분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바. "
      }
    },
    {
      "chunk_id": "chunk_599",
      "text": "프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 598,
        "window_size": 3,
        "char_count": 116,
        "word_count": 22,
        "page_number": 41,
        "window_text": "원재료의 성분 또는 분량을 확인할 수 있는 근거자료\n\n<!-- PAGE_40 -->\n###### 나.  원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마.  분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바.  프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나.  원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다. ",
        "original_sentence": "프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_600",
      "text": "제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 599,
        "window_size": 3,
        "char_count": 55,
        "word_count": 11,
        "page_number": 41,
        "window_text": "원료물질(항원)이 재조합, 합성인 경우, 아미노산서열을 확인할 수\n\n<!-- PAGE_40 -->\n###### 마.  분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바.  프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나.  원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1. ",
        "original_sentence": "제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_601",
      "text": "제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 600,
        "window_size": 3,
        "char_count": 128,
        "word_count": 28,
        "page_number": 41,
        "window_text": "분자진단제품의 경우, 원료물질의 주반응시약 중 중합효소의 기원\n\n<!-- PAGE_40 -->\n###### 바.  프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나.  원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2. ",
        "original_sentence": "제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_602",
      "text": "원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 601,
        "window_size": 3,
        "char_count": 132,
        "word_count": 28,
        "page_number": 41,
        "window_text": "프라이머, 프로브에 대한 자료(염기서열자료, 염기서열의 염기수와\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 36 -\n<!-- PAGE_41 -->\n###### 2.  제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나.  원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2.  해당제품의 제품설명서(insert)를 제출한다.\n\n",
        "original_sentence": "원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_603",
      "text": "일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 602,
        "window_size": 3,
        "char_count": 65,
        "word_count": 12,
        "page_number": 41,
        "window_text": "제조공정의 흐름도를 포함한 제조공정에 관한 자료\n\n<!-- PAGE_41 -->\n###### 가.  제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나.  원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2.  해당제품의 제품설명서(insert)를 제출한다.\n\n <!-- PAGE_41 -->\n###### 1. ",
        "original_sentence": "일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_604",
      "text": "허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 603,
        "window_size": 3,
        "char_count": 131,
        "word_count": 27,
        "page_number": 41,
        "window_text": "제조공정의 흐름을 파악할 수 있는 자료를 제출(제조공정상의 제조\n\n<!-- PAGE_41 -->\n###### 단계별 시험 및 완제품 품질관리 시험의 단계를 확인할 수 있는 자료)\n\n<!-- PAGE_41 -->\n###### 나.  원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2.  해당제품의 제품설명서(insert)를 제출한다.\n\n <!-- PAGE_41 -->\n###### 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2. ",
        "original_sentence": "허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_605",
      "text": "해당제품의 제품설명서(insert)를 제출한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 604,
        "window_size": 3,
        "char_count": 28,
        "word_count": 3,
        "page_number": 12,
        "window_text": "원료물질(항원, 항체, 프라이머, 프로브, 효소 등)의 제조방법을 간략\n\n<!-- PAGE_41 -->\n###### 하게 기술하고, 이를 구매한 경우, 이를 확인할 수 있는 자료를 제출\n\n<!-- PAGE_41 -->\n###### 다.  일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2.  해당제품의 제품설명서(insert)를 제출한다.\n\n <!-- PAGE_41 -->\n###### 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n",
        "original_sentence": "해당제품의 제품설명서(insert)를 제출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_606",
      "text": "<!-- PAGE_41 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 605,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 41,
        "window_text": "일부 구성제품이 OEM제조품인 경우, 구성품의 제조원(제조자의 상\n\n<!-- PAGE_41 -->\n###### 1.  허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2.  해당제품의 제품설명서(insert)를 제출한다.\n\n <!-- PAGE_41 -->\n###### 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n <!-- PAGE_41 -->\n###### 3. ",
        "original_sentence": "<!-- PAGE_41 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_607",
      "text": "완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 606,
        "window_size": 3,
        "char_count": 65,
        "word_count": 15,
        "page_number": 41,
        "window_text": "허가신청서에 기재한 해당 제품의 사용목적의 세부 사항(검사대상, 검체\n\n<!-- PAGE_41 -->\n###### 종류, 검사항목, 측정원리 및 정성 또는 정량 등)에 대한 근거자료를\n\n<!-- PAGE_41 -->\n###### 2.  해당제품의 제품설명서(insert)를 제출한다.\n\n <!-- PAGE_41 -->\n###### 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n <!-- PAGE_41 -->\n###### 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ. ",
        "original_sentence": "완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_608",
      "text": "구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 607,
        "window_size": 3,
        "char_count": 31,
        "word_count": 7,
        "page_number": 2,
        "window_text": "해당제품의 제품설명서(insert)를 제출한다.\n\n <!-- PAGE_41 -->\n###### 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n <!-- PAGE_41 -->\n###### 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4. ",
        "original_sentence": "구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_609",
      "text": "<!-- PAGE_41 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 608,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 41,
        "window_text": "<!-- PAGE_41 -->\n###### 1.  완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n <!-- PAGE_41 -->\n###### 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4.  안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n",
        "original_sentence": "<!-- PAGE_41 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_610",
      "text": "시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 609,
        "window_size": 3,
        "char_count": 43,
        "word_count": 9,
        "page_number": 34,
        "window_text": "완제품 및 개봉 후 시약의 안정성에 관한 자료로서 식약처장이 정한\n\n<!-- PAGE_41 -->\n###### 2.  구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n <!-- PAGE_41 -->\n###### 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4.  안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n <!-- PAGE_42 -->\n###### 5. ",
        "original_sentence": "시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ. "
      }
    },
    {
      "chunk_id": "chunk_611",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 610,
        "window_size": 3,
        "char_count": 57,
        "word_count": 14,
        "page_number": 42,
        "window_text": "구성 제품별로 구분하여 안정성 시험 자료를 제출한다.\n\n <!-- PAGE_41 -->\n###### 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4.  안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n <!-- PAGE_42 -->\n###### 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6. ",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_612",
      "text": "안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 611,
        "window_size": 3,
        "char_count": 71,
        "word_count": 15,
        "page_number": 42,
        "window_text": "<!-- PAGE_41 -->\n###### 3.  시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4.  안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n <!-- PAGE_42 -->\n###### 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6.  일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7. ",
        "original_sentence": "안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_613",
      "text": "<!-- PAGE_42 -->\n###### 5. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 612,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 42,
        "window_text": "시험성적서는 평가계획, 시험간격, 허용기준, 결과 등의 내용을 포함한\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4.  안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n <!-- PAGE_42 -->\n###### 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6.  일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7.  수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8. ",
        "original_sentence": "<!-- PAGE_42 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_614",
      "text": "저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 613,
        "window_size": 3,
        "char_count": 69,
        "word_count": 16,
        "page_number": 42,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n- - 37 -\n<!-- PAGE_42 -->\n###### 4.  안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n <!-- PAGE_42 -->\n###### 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6.  일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7.  수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1. ",
        "original_sentence": "저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6. "
      }
    },
    {
      "chunk_id": "chunk_615",
      "text": "일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 614,
        "window_size": 3,
        "char_count": 154,
        "word_count": 25,
        "page_number": 42,
        "window_text": "안정성 시험 시에는 식약처 「의료기기의 안정성 시험 기준」의 내용\n\n<!-- PAGE_42 -->\n###### 을 참고한다.\n\n <!-- PAGE_42 -->\n###### 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6.  일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7.  수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n",
        "original_sentence": "일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7. "
      }
    },
    {
      "chunk_id": "chunk_616",
      "text": "수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 615,
        "window_size": 3,
        "char_count": 66,
        "word_count": 14,
        "page_number": 42,
        "window_text": "<!-- PAGE_42 -->\n###### 5.  저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6.  일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7.  수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n <!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다. ",
        "original_sentence": "수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8. "
      }
    },
    {
      "chunk_id": "chunk_617",
      "text": "저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 616,
        "window_size": 3,
        "char_count": 63,
        "word_count": 11,
        "page_number": 42,
        "window_text": "저장 및 사용기간(유효기간)에 대한 시험은 완제품 3 로트, 개봉 후 1\n\n<!-- PAGE_42 -->\n###### 6.  일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7.  수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n <!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1. ",
        "original_sentence": "저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_618",
      "text": "제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 617,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 4,
        "window_text": "일회용으로 낱개 포장되어 있는 체외진단용 의료기기를 제외하고, 개\n\n<!-- PAGE_42 -->\n###### 봉 후(on-board, reconstitution, open vial/bottle stability) 안정성 자\n\n<!-- PAGE_42 -->\n###### 7.  수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n <!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2. ",
        "original_sentence": "제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_619",
      "text": "<!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 618,
        "window_size": 3,
        "char_count": 184,
        "word_count": 33,
        "page_number": 42,
        "window_text": "수송조건(환경 및 운반조건 변화)을 고려한 안정성 자료의 제출을 권\n\n<!-- PAGE_42 -->\n###### 8.  저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n <!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1. ",
        "original_sentence": "<!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_620",
      "text": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 619,
        "window_size": 3,
        "char_count": 107,
        "word_count": 23,
        "page_number": 43,
        "window_text": "저장방법 및 사용기간(유효기간)에 대한 시험자료는 시험성적서의\n\n<!-- PAGE_42 -->\n###### 1.  제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n <!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1.  이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ. ",
        "original_sentence": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_621",
      "text": "구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 620,
        "window_size": 3,
        "char_count": 131,
        "word_count": 20,
        "page_number": 43,
        "window_text": "제품의 성능을 확인하기 위한 자료는 다음의 자료를 포함한다.\n\n <!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1.  이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1. ",
        "original_sentence": "구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_622",
      "text": "유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 621,
        "window_size": 3,
        "char_count": 67,
        "word_count": 15,
        "page_number": 43,
        "window_text": "<!-- PAGE_42 -->\n###### 1) 분석적 민감도(판정기준치(cut-off value), 최소검출한계, 측정\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 38 -\n<!-- PAGE_43 -->\n###### 2) 임상적 특이도\n\n<!-- PAGE_43 -->\n###### 다.  완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1.  이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1.  분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ. ",
        "original_sentence": "유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_623",
      "text": "이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 622,
        "window_size": 3,
        "char_count": 118,
        "word_count": 24,
        "page_number": 43,
        "window_text": "완제품의 품질관리 시험성적서 또는 시험에 관한 자료(3배치 1회 이\n\n<!-- PAGE_43 -->\n###### 상 또는 1배치 3회 이상)\n\n<!-- PAGE_43 -->\n###### 1.  구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1.  이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1.  분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n",
        "original_sentence": "이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ. "
      }
    },
    {
      "chunk_id": "chunk_624",
      "text": "기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 623,
        "window_size": 3,
        "char_count": 476,
        "word_count": 106,
        "page_number": 45,
        "window_text": "구성시약 중 인간혈액 유래물질이 포함되었을 경우 사람면역결핍바이\n\n<!-- PAGE_43 -->\n###### 러스(HIV), C형간염바이러스(HCV), B형간염바이러스(HBV)가 음성\n\n<!-- PAGE_43 -->\n###### 2.  유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1.  이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1.  분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n <!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다. ",
        "original_sentence": "기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_625",
      "text": "분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 624,
        "window_size": 3,
        "char_count": 408,
        "word_count": 79,
        "page_number": 45,
        "window_text": "유해물질(독성, 가연성 등) 등 취급자 안전 및 적합성을 확인한 자료\n\n<!-- PAGE_43 -->\n###### 1.  이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1.  분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n <!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다.  사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다. ",
        "original_sentence": "분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_626",
      "text": "성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 625,
        "window_size": 3,
        "char_count": 55,
        "word_count": 12,
        "page_number": 46,
        "window_text": "이미 허가 받은 제품과 명칭(품목명, 모델명), 제조(수입)업소명, 제조원 및\n\n<!-- PAGE_43 -->\n###### 소재지, 허가번호, 사용목적, 작용원리, 원재료, 성능 등을 비교한 ‘규정 별지\n\nⅥ.  기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1.  분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n <!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다.  사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다.  컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_627",
      "text": "<!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 626,
        "window_size": 3,
        "char_count": 707,
        "word_count": 130,
        "page_number": 46,
        "window_text": "기술문서 등의 심사를 위한 제출자료\n\n- - 39 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 40 -\n<!-- PAGE_45 -->\n## Ⅶ\n\n<!-- PAGE_45 -->\n### 성능시험에 대한 상세사항\n\n<!-- PAGE_45 -->\n###### ※ 분석적 성능시험자료의 작성 시 권장사항\n\n<!-- PAGE_45 -->\n###### ❍ 혈청과 혈장을 모두 검사할 수 있는 시약의 경우 성능 평가 시에 최\n\n<!-- PAGE_45 -->\n###### 소 50개(25개 양성, 25개 음성) 이상의 검체를 이용하여 혈청과 혈\n\n<!-- PAGE_45 -->\n###### ❍ 혈장을 사용하고자 하는 경우에는 제조사가 사용 가능한 것으로 표\n\n<!-- PAGE_45 -->\n###### 기한 모든 종류의 항응고제에 대해 최소 50개(25개 양성, 25개 음\n\n<!-- PAGE_45 -->\n###### 1.  분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n <!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다.  사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다.  컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다.  검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n",
        "original_sentence": "<!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_628",
      "text": "사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 627,
        "window_size": 3,
        "char_count": 193,
        "word_count": 35,
        "page_number": 46,
        "window_text": "분석적 민감도 (최소검출한계, 측정범위, 컷오프농도 등)\n\n<!-- PAGE_45 -->\n###### 체외진단분석기용 정성, 반정량 또는 정량시약에 적용되는 내용으로서\n\n<!-- PAGE_45 -->\n###### 사용시약에 따라 적용에 차이가 있을 수 있고, 정성 혹은 반정량 분석인\n\n<!-- PAGE_45 -->\n###### 가) 표준물질을 이용하여 측정할 것을 권장하며 95% 검출률을\n\n<!-- PAGE_45 -->\n###### 보이는 최저 농도를 최소검출한계(limit of detection, LoD)\n\n<!-- PAGE_45 -->\n###### 나) 표준물질, 국제표준품을 구할 수 없는 항목이나 아형의 경우\n\n<!-- PAGE_45 -->\n###### 에는 국내·외 허가된 체외진단용 의료기기와의 비교시험을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n <!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다.  사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다.  컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다.  검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n <!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다. ",
        "original_sentence": "사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다. "
      }
    },
    {
      "chunk_id": "chunk_629",
      "text": "컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 628,
        "window_size": 3,
        "char_count": 117,
        "word_count": 24,
        "page_number": 46,
        "window_text": "성능시험에 대한 상세사항\n\n- - 41 -\n<!-- PAGE_46 -->\n###### 권장한다.\n\n <!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다.  사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다.  컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다.  검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n <!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다.  최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ. ",
        "original_sentence": "컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_630",
      "text": "검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 629,
        "window_size": 3,
        "char_count": 187,
        "word_count": 39,
        "page_number": 46,
        "window_text": "<!-- PAGE_46 -->\n###### 2) 시험물질\n\n<!-- PAGE_46 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_46 -->\n###### (matrix)에 분석대상물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_46 -->\n###### 나) 추정되는 검출한계 전후의 농도값을 포함하여 최소 5단계\n\n<!-- PAGE_46 -->\n###### 다)\n\n<!-- PAGE_46 -->\n###### 핵산추출시약이\n\n<!-- PAGE_46 -->\n###### 포함되지\n\n<!-- PAGE_46 -->\n###### 않은\n\n<!-- PAGE_46 -->\n###### PCR검사\n\n<!-- PAGE_46 -->\n###### 키트인\n\n<!-- PAGE_46 -->\n###### 경우\n\n<!-- PAGE_46 -->\n###### 라) 희석 시에는 바이러스 음성인 사람의 검체(혈청, 혈장, 전혈\n\n<!-- PAGE_46 -->\n###### 등)를 희석액으로 사용하고 측정 가능한 검체(혈청, 혈장,\n\n<!-- PAGE_46 -->\n###### 가) 검체종류와 검체 준비과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_46 -->\n###### 나) 시험방법은 참고한 부분에 한해서 문헌 기호를 인용하여 실\n\n<!-- PAGE_46 -->\n###### 험방법을 요약 제출할 수 있다.  사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다.  컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다.  검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n <!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다.  최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n",
        "original_sentence": "검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_631",
      "text": "<!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 630,
        "window_size": 3,
        "char_count": 660,
        "word_count": 108,
        "page_number": 47,
        "window_text": "사용가능한 것으로 제시된\n\n<!-- PAGE_46 -->\n###### 검체가 여러 종류라면 검체별(예 : 소변, 혈액 등)로 LoD 농\n\n<!-- PAGE_46 -->\n###### 다) 측정범위는 계단희석(serial dilution)한 5 농도 이상의 검체를\n\n<!-- PAGE_46 -->\n###### 이중(duplicate)으로 측정한다.  컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다.  검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n <!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다.  최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n <!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n",
        "original_sentence": "<!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_632",
      "text": "최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 631,
        "window_size": 3,
        "char_count": 449,
        "word_count": 88,
        "page_number": 47,
        "window_text": "컷오프 근처의 농도에서는\n\n<!-- PAGE_46 -->\n###### 라) 최소검출한계는 검사 시행 중 95%이상 양성결과를 나타내는\n\n<!-- PAGE_46 -->\n###### 최소 농도로 제시할 수 있다.  검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n <!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다.  최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n <!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n <!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ. ",
        "original_sentence": "최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_633",
      "text": "성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 632,
        "window_size": 3,
        "char_count": 61,
        "word_count": 14,
        "page_number": 48,
        "window_text": "검출한계에 영향을 줄 수 있는\n\n<!-- PAGE_46 -->\n###### 여러 변수를 고려하기 위해 검사일은 3-5일 이상, 하루에\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 42 -\n<!-- PAGE_47 -->\n###### 2번 측정(run), 측정시 2번 이상 반복검사를 권장한다.\n\n <!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다.  최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n <!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n <!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_634",
      "text": "<!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 633,
        "window_size": 3,
        "char_count": 823,
        "word_count": 154,
        "page_number": 48,
        "window_text": "<!-- PAGE_47 -->\n###### 마) 참고: CLSI 지침(EP17-A2)에서는 LOB (limit of blank),\n\n<!-- PAGE_47 -->\n###### LOD (limit of detection), LOQ (limit of quantitation)를\n\n<!-- PAGE_47 -->\n###### 확립하기 위한 방법이 기술되어 있으며, LOD측정에 3가지\n\n<!-- PAGE_47 -->\n###### 방법(classical approach, precision profile approach, probit\n\n<!-- PAGE_47 -->\n###### approach)이\n\n<!-- PAGE_47 -->\n###### 있는데\n\n<!-- PAGE_47 -->\n###### 그\n\n<!-- PAGE_47 -->\n###### 중\n\n<!-- PAGE_47 -->\n###### 전통적인\n\n<!-- PAGE_47 -->\n###### 방법(classical\n\n<!-- PAGE_47 -->\n###### approach)은 blank 검체와 최소검출한계 근처의 low level\n\n<!-- PAGE_47 -->\n###### 가) 통계적으로 유효한 검출 한계치와 설정에 사용된 검체의 종류,\n\n<!-- PAGE_47 -->\n###### 검체수, 반복횟수, 계산법을 함께 제시한다.  최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n <!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n <!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2. ",
        "original_sentence": "<!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_635",
      "text": "<!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 634,
        "window_size": 3,
        "char_count": 906,
        "word_count": 194,
        "page_number": 49,
        "window_text": "최소검출한계는\n\n<!-- PAGE_47 -->\n###### 검사 시행 중 95%이상 양성결과를 나타내는 최소 농도로 제\n\n<!-- PAGE_47 -->\n###### 나) 면역검사 시약의 최소검출한계는 해당 검사 항목에 따라 ‘ml\n\n<!-- PAGE_47 -->\n###### 다) 유전자분석용 시약의 최소검출한계는 IU/ml로 표시하는 것을\n\n<!-- PAGE_47 -->\n###### 권장하나, IU로 표기할 수 없는 항목은 copies/ml 또는 U/ml\n\n<!-- PAGE_47 -->\n###### 가) 양성과 음성의 판정기준치(cut-off value)를 결정한 근거\n\n<!-- PAGE_47 -->\n###### 나) 측정항목, 측정원리, 판독방법 등에 따라 cut-off value의\n\n<!-- PAGE_47 -->\n###### 설정 방법이 달라질 수 있으므로 전문가 그룹의 자문 등을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n <!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n <!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2.  분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n",
        "original_sentence": "<!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_636",
      "text": "성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 635,
        "window_size": 3,
        "char_count": 345,
        "word_count": 71,
        "page_number": 50,
        "window_text": "성능시험에 대한 상세사항\n\n- - 43 -\n<!-- PAGE_48 -->\n###### 거칠 것을 권장한다.\n\n <!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n <!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2.  분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n <!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다. "
      }
    },
    {
      "chunk_id": "chunk_637",
      "text": "희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 636,
        "window_size": 3,
        "char_count": 220,
        "word_count": 44,
        "page_number": 50,
        "window_text": "<!-- PAGE_48 -->\n###### 다) 질병의 진단이 목적이 아니라, 양성 환자의 모니터링 등을\n\n<!-- PAGE_48 -->\n###### 목적으로 하는 정량검사에서는 정량검사 자료로 대체할 수\n\n<!-- PAGE_48 -->\n###### 라) 판정기준치가 검출한계(limit of detection, LoD)의 산출을\n\n<!-- PAGE_48 -->\n###### 마) 판정기준치가 공란한계(limit of blank, LoB)의 산출을 근거\n\n<!-- PAGE_48 -->\n###### 바) 판정기준치를 실시간중합효소연쇄반응에서 Ct값으로 설정한\n\n<!-- PAGE_48 -->\n###### 아) 경계범위(gray zone 또는 equivocal zone)가 있을 경우, 이를\n\n<!-- PAGE_48 -->\n###### ※ 판정기준치의설정이 임상적 판정기준치(민감도, 특이도)를\n\n<!-- PAGE_48 -->\n###### 바탕으로 한 경우, 타당한 임상적 근거를 제시한다(임상적\n\n<!-- PAGE_48 -->\n###### 나) 측정범위는 기존의 알려진 농도값을 해당 검사가 정확하게\n\n<!-- PAGE_48 -->\n###### 다) 측정항목, 측정원리, 결과산출방법 등에 따라 측정범위를\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 44 -\n<!-- PAGE_49 -->\n###### 평가할 때 사용하는 물질과 희석방법, 결과평가방법이 달라질\n\n<!-- PAGE_49 -->\n###### 수 있으므로 시험을 고려할 때 전문가 그룹의 자문 등을 거칠\n\n<!-- PAGE_49 -->\n###### 것을 권장한다.\n\n <!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2.  분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n <!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6.  혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ. ",
        "original_sentence": "희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_638",
      "text": "분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 637,
        "window_size": 3,
        "char_count": 70,
        "word_count": 15,
        "page_number": 50,
        "window_text": "<!-- PAGE_49 -->\n###### 라) 측정범위 이상의 값을 희석하여 보고할 수 있는지 여부와 희\n\n<!-- PAGE_49 -->\n###### 석에 사용할 수 있는 희석액을 명시하고, 그 근거를 제시해야\n\n<!-- PAGE_49 -->\n###### 마) 고역가 검체에 의한 전지대효과(prozone effect) 등에 대한\n\n<!-- PAGE_49 -->\n###### 가) 제조사에서 제시하는 검체와 호환되는(commutable) 기질\n\n<!-- PAGE_49 -->\n###### (matrix)에 분석 대상 물질을 일정량 첨가한 검체, 표준물질\n\n<!-- PAGE_49 -->\n###### 나) 핵산추출 시약이 포함되지 않은 PCR 검사 키트인 경우\n\n<!-- PAGE_49 -->\n###### 다) 직선성 범위 측정에 사용되는 검체는 임상 검사에 사용되는\n\n<!-- PAGE_49 -->\n###### 검체와 유사한 특성을 가져야 하며, 알려진 간섭 현상이\n\n<!-- PAGE_49 -->\n###### 라) 직선성 평가에 사용 가능한 검체 및 기질로 추천하는 우선\n\n<!-- PAGE_49 -->\n###### 환자 검체 풀 > 권장 희석액으로 희석된 환자 검체 풀 > 분석\n\n<!-- PAGE_49 -->\n###### 물질을 첨가한 환자 검체 풀 > 낮은 농도가 되도록 처리한\n\n<!-- PAGE_49 -->\n###### 물질로 희석한 풀이나 풀을 처리한 물질 > 상품화된 정도관리\n\n<!-- PAGE_49 -->\n###### 물질/칼리브레이터/직선성 평가용 물질 >권장 희석액이 아닌\n\n<!-- PAGE_49 -->\n###### 다른 희석액이나 생리 식염수로 희석한 풀 > 과소/과다 희석한\n\n<!-- PAGE_49 -->\n###### 상품화된 정도관리 물질 > 수용액 > 다른 용매를 사용한 용액\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2.  분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n <!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6.  혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n",
        "original_sentence": "분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_639",
      "text": "<!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 638,
        "window_size": 3,
        "char_count": 202,
        "word_count": 44,
        "page_number": 50,
        "window_text": "성능시험에 대한 상세사항\n\n- - 45 -\n<!-- PAGE_50 -->\n###### 3) 시험방법\n\n<!-- PAGE_50 -->\n###### 가) 검체 종류와 검체 준비 과정(검체종류, 기질, 검체수, 측정횟수,\n\n<!-- PAGE_50 -->\n###### 나) 제시하는 직선성 범위를 포괄하는(예상되는 측정범위보다\n\n<!-- PAGE_50 -->\n###### 20-30% 더 넓은 범위를 포함할 것을 권장한다) 최소 7개 이\n\n<!-- PAGE_50 -->\n###### 상의 알려진 농도를 가지는 시리즈 검체를 이용하거나 희석을\n\n<!-- PAGE_50 -->\n###### 통해 농도가 확립된 검체를 이용한다.  희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2.  분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n <!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6.  혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n <!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n",
        "original_sentence": "<!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6. "
      }
    },
    {
      "chunk_id": "chunk_640",
      "text": "혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 639,
        "window_size": 3,
        "char_count": 303,
        "word_count": 64,
        "page_number": 51,
        "window_text": "희석은 고농도와 저농\n\n<!-- PAGE_50 -->\n###### 도 검체를 비율적으로 혼합하여 같은 간격으로 중간 농도의\n\n<!-- PAGE_50 -->\n###### 검체를 만드는 것이 권장되나 농도간의 간격이 일정하지 않을\n\n<!-- PAGE_50 -->\n###### 나) 비선형 calibration 모델을 사용하는 제품에 대하여는 근거\n\n<!-- PAGE_50 -->\n###### 2.  분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n <!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6.  혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n <!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n <!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다. ",
        "original_sentence": "혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_641",
      "text": "성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 640,
        "window_size": 3,
        "char_count": 61,
        "word_count": 14,
        "page_number": 52,
        "window_text": "분석적 특이도\n\n<!-- PAGE_50 -->\n###### 1) 측정 대상이 되는 검체와 호환되는 기질의 검체를 이용한다.\n\n <!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6.  혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n <!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n <!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_642",
      "text": "<!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 641,
        "window_size": 3,
        "char_count": 106,
        "word_count": 20,
        "page_number": 52,
        "window_text": "<!-- PAGE_50 -->\n###### 2) 간섭물질은 내부 또는 외부 요인일 수 있고 측정법에 따라 다양\n\n<!-- PAGE_50 -->\n###### 하므로, 검사법에 따라 결과에 영향을 미칠 것으로 예측되는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 46 -\n<!-- PAGE_51 -->\n###### 표 6.  혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n <!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n <!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n",
        "original_sentence": "<!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_643",
      "text": "<!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 642,
        "window_size": 3,
        "char_count": 522,
        "word_count": 103,
        "page_number": 52,
        "window_text": "혈청을 이용한 항체검사에서 간섭물질 예\n\n<!-- PAGE_51 -->\n###### 3) 각 분석물질에 대한 각 간섭물질의 영향을 평가하기 위해 다음\n\n<!-- PAGE_51 -->\n###### 2) 검체의 종류, 간섭물질의 종류, 간섭물질의 농도, 분석물질의 농도,\n\n<!-- PAGE_51 -->\n###### 검체의 제조 방법(예 : 간섭물질을 혼합한 검체, 자연적으로 높은\n\n<!-- PAGE_51 -->\n###### 3) 간섭물질의 농도는 임상검체에서 보일 수 있는 최대농도의 3배\n\n간섭물질\n\n예시\n\n외인성 물질\n\n일반의약품\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n <!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n <!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n <!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ. ",
        "original_sentence": "<!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_644",
      "text": "대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 643,
        "window_size": 3,
        "char_count": 171,
        "word_count": 35,
        "page_number": 52,
        "window_text": "성능시험에 대한 상세사항\n\n- - 47 -\n<!-- PAGE_52 -->\n###### 이상이 되도록 한다.\n\n <!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n <!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n <!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n",
        "original_sentence": "대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_645",
      "text": "정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 644,
        "window_size": 3,
        "char_count": 168,
        "word_count": 35,
        "page_number": 53,
        "window_text": "<!-- PAGE_52 -->\n###### 4) 간섭물질이 포함된 검체와 포함되지 않은 검체 간의 결과 차이의\n\n<!-- PAGE_52 -->\n###### 허용범위(dmax)를 결정한다.\n\n <!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n <!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n <!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다. ",
        "original_sentence": "정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_646",
      "text": "<!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 645,
        "window_size": 3,
        "char_count": 625,
        "word_count": 128,
        "page_number": 53,
        "window_text": "<!-- PAGE_52 -->\n###### 6) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 7) 높은 농도의 간섭물질에 영향을 받지 않는 경우는 더 이상의\n\n<!-- PAGE_52 -->\n###### 평가를 시행하지 않아도 되고, 영향을 받는 경우는 간섭물질의\n\n<!-- PAGE_52 -->\n###### 농도에 따른 영향을 보기위해 용량-반응 검사(dose-response\n\n<!-- PAGE_52 -->\n###### 1) 간섭물질을 함유한 검체와 간섭물질을 함유하지 않은 검체의\n\n<!-- PAGE_52 -->\n###### 결과값을 제시하고, 정량검사의 경우는 결과를 비교하여 bias가\n\n<!-- PAGE_52 -->\n###### 있는지 확인하고 두 값의 차이가 허용범위(dmax) 보다 작은지\n\n<!-- PAGE_52 -->\n###### 2) 간섭이 확인된 물질의 경우 간섭을 보이는 구체적 농도와 결과\n\n<!-- PAGE_52 -->\n###### 차이를 기술한다.  대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n <!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n <!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다.  정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4. ",
        "original_sentence": "<!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_647",
      "text": "성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 646,
        "window_size": 3,
        "char_count": 164,
        "word_count": 36,
        "page_number": 54,
        "window_text": "대상측정물질을 함유하지 않고 간섭 가능한\n\n<!-- PAGE_52 -->\n###### 물질만 포함된 검체의 실측한 자료를 바탕으로 공란한계와 검출\n\n<!-- PAGE_52 -->\n###### 3) 간섭물질에 대한 분석물질 결과에 경향이 있다면 경향을 기술\n\n<!-- PAGE_52 -->\n###### 3.  정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n <!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n <!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다.  정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4.  정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_648",
      "text": "<!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 647,
        "window_size": 3,
        "char_count": 569,
        "word_count": 117,
        "page_number": 54,
        "window_text": "정밀도 (반복성, 재현성 등)\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 48 -\n<!-- PAGE_53 -->\n###### 1) 동일 검체를 일정기간 동안 반복 측정한 결과를 분석하여 정밀도\n\n<!-- PAGE_53 -->\n###### 자료를 제시한다.\n\n <!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n <!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다.  정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4.  정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라. ",
        "original_sentence": "<!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_649",
      "text": "정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 648,
        "window_size": 3,
        "char_count": 345,
        "word_count": 66,
        "page_number": 54,
        "window_text": "<!-- PAGE_53 -->\n###### 2) 단일 기관에서 실시한 정밀도(반복성)와 다수의 기관에서 실시한\n\n<!-- PAGE_53 -->\n###### 3) 각 평가 수행기관은 평가를 시행하기 전에 검사방법에 익숙해지는\n\n<!-- PAGE_53 -->\n###### 1) 제조사에서 제시하는 검체와 호환되는 기질에 분석 물질이 존재\n\n<!-- PAGE_53 -->\n###### 하는 검체로서 임상검체, 표준물질 또는 정도관리물질을 이용할\n\n<!-- PAGE_53 -->\n###### 수 있으며 제조사가 제시하는 측정가능범위 전체를 대표할 수\n\n<!-- PAGE_53 -->\n###### 2) 핵산추출시약이 포함되지 않은 PCR검사 키트인 경우 plasmid\n\n<!-- PAGE_53 -->\n###### 4) 정량검사는 고농도, 저농도, 판정기준치 근처 농도 등 3가지의\n\n<!-- PAGE_53 -->\n###### 농도로 구성하는 것을 권장하며, 정성검사는 강양성, 약양성, 음성\n\n<!-- PAGE_53 -->\n###### 가) 시행기관은 검사특성에 맞추어 일정기간동안 매일 반복 측정\n\n<!-- PAGE_53 -->\n###### 나) 20일 이상 동안 매일 2회의 run, 각 run 당 2회 이상 반복\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n <!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다.  정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4.  정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마. ",
        "original_sentence": "정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_650",
      "text": "정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 649,
        "window_size": 3,
        "char_count": 174,
        "word_count": 33,
        "page_number": 55,
        "window_text": "성능시험에 대한 상세사항\n\n- - 49 -\n<!-- PAGE_54 -->\n###### 2) 재현성\n\n<!-- PAGE_54 -->\n###### 가) 로트 간 정밀도 평가에는 최소 3개의 서로 다른 로트의 시약\n\n<!-- PAGE_54 -->\n###### 이나 칼리브레이터가 사용되어야 한다.\n\n <!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다.  정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4.  정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마.  양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5. ",
        "original_sentence": "정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_651",
      "text": "표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 650,
        "window_size": 3,
        "char_count": 61,
        "word_count": 12,
        "page_number": 55,
        "window_text": "<!-- PAGE_54 -->\n###### 나) 장소 간 정밀도를 위해 2곳 이상의 기관(제조사 포함)에서\n\n<!-- PAGE_54 -->\n###### 다) 5일 이상, 매일 2회 이상, 매 검사마다 2회 이상 반복 검사를\n\n<!-- PAGE_54 -->\n###### 마) 여러 추출법이 적용되는 경우 다양한 추출법이 평가에 포함\n\n<!-- PAGE_54 -->\n###### 1) 반복성 : 검사 내 정밀도(within-run), 검사 간 정밀도\n\n<!-- PAGE_54 -->\n###### (between-run), 날짜 간 정밀도(between-day), 검사실 내 정\n\n<!-- PAGE_54 -->\n###### 2) 재현성 : 각 검사실 별로 반복성 결과를 기재하고, 모든 검사실\n\n<!-- PAGE_54 -->\n###### 결과를 합한 반복성 결과와 검사기관 간(between-site) 결과를\n\n<!-- PAGE_54 -->\n###### 3) 정량검사는 각 정밀도 항목에 대해 농도별로 표준편차 또는\n\n<!-- PAGE_54 -->\n###### 4) 정성검사의 경우는 검체별 결과 일치율을 %로 기재한다.  정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4.  정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마.  양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5.  교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ. ",
        "original_sentence": "표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라. "
      }
    },
    {
      "chunk_id": "chunk_652",
      "text": "보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 651,
        "window_size": 3,
        "char_count": 74,
        "word_count": 9,
        "page_number": 55,
        "window_text": "정성\n\n<!-- PAGE_54 -->\n###### 검사가 정량적인 시그널로 측정될 경우에는 정량검사와 동일하게\n\n<!-- PAGE_54 -->\n###### 검사하며 판정기준치 근처 농도(시그널)의 표준편차나 변이계수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 50 -\n<!-- PAGE_55 -->\n###### 가) 검사를 시행한 검체의 농도\n\n<!-- PAGE_55 -->\n###### 나) 각각의 농도에서의 반복정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 다) 각각의 농도에서의 검사실내 정밀도 표준편차\n\n<!-- PAGE_55 -->\n###### 4.  정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마.  양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5.  교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n",
        "original_sentence": "보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마. "
      }
    },
    {
      "chunk_id": "chunk_653",
      "text": "양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 652,
        "window_size": 3,
        "char_count": 65,
        "word_count": 15,
        "page_number": 55,
        "window_text": "정확도\n\n<!-- PAGE_55 -->\n###### 가. WHO international reference standard 물질 등 국제표준품, 상용\n\n<!-- PAGE_55 -->\n###### 패널, 배양액 등 특성이 명시되어 있는 물질을 사용하여 평가할 것\n\n<!-- PAGE_55 -->\n###### 나.  표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마.  양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5.  교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n <!-- PAGE_56 -->\n###### 나. ",
        "original_sentence": "양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_654",
      "text": "교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 653,
        "window_size": 3,
        "char_count": 71,
        "word_count": 17,
        "page_number": 55,
        "window_text": "표준물질의 목표 결과와 실측 결과(정량검사의 경우 결과값과\n\n<!-- PAGE_55 -->\n###### 라.  보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마.  양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5.  교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n <!-- PAGE_56 -->\n###### 나.  시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ. ",
        "original_sentence": "교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_655",
      "text": "성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 654,
        "window_size": 3,
        "char_count": 63,
        "word_count": 14,
        "page_number": 56,
        "window_text": "보정물질(calibrator)의 설정농도, 소급성(traceability)에 대해\n\n<!-- PAGE_55 -->\n###### 마.  양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5.  교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n <!-- PAGE_56 -->\n###### 나.  시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_656",
      "text": "<!-- PAGE_56 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 655,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 56,
        "window_text": "양성 및 음성대조물질의 제조방법, 설정 농도 및 반복 측정 결과를\n\n<!-- PAGE_55 -->\n###### 5.  교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n <!-- PAGE_56 -->\n###### 나.  시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다.  결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다. ",
        "original_sentence": "<!-- PAGE_56 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_657",
      "text": "시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 656,
        "window_size": 3,
        "char_count": 1328,
        "word_count": 224,
        "page_number": 56,
        "window_text": "교차반응\n\n<!-- PAGE_55 -->\n###### 1) 다른 바이러스 감염 검체 등의 다양한 교차 반응 가능 물질이\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n <!-- PAGE_56 -->\n###### 나.  시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다.  결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다. ",
        "original_sentence": "시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_658",
      "text": "성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 657,
        "window_size": 3,
        "char_count": 51,
        "word_count": 12,
        "page_number": 58,
        "window_text": "성능시험에 대한 상세사항\n\n- - 51 -\n<!-- PAGE_56 -->\n###### 포함된 검체를 이용한다.\n\n <!-- PAGE_56 -->\n###### 나.  시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다.  결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다.  민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_659",
      "text": "결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 658,
        "window_size": 3,
        "char_count": 355,
        "word_count": 74,
        "page_number": 58,
        "window_text": "<!-- PAGE_56 -->\n###### 나.  시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다.  결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다.  민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다. ",
        "original_sentence": "결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다. "
      }
    },
    {
      "chunk_id": "chunk_660",
      "text": "이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 659,
        "window_size": 3,
        "char_count": 100,
        "word_count": 22,
        "page_number": 58,
        "window_text": "시험방법\n\n<!-- PAGE_56 -->\n###### 2) 검체 종류, 교차반응 물질의 종류 및 농도, 검체준비과정 등을\n\n<!-- PAGE_56 -->\n###### 3) 항체검사의 경우 교차반응을 일으킬 수 있는 항체를 포함하는\n\n<!-- PAGE_56 -->\n###### 임상검체를 이용하여 교차반응성을 평가하며, 임상적으로 나타\n\n<!-- PAGE_56 -->\n###### 4) 교차반응평가를 위해 세균이나 바이러스를 이용한다면 세균의\n\n<!-- PAGE_56 -->\n###### 농도는 106 CFU/ml 이상, 바이러스는 105 PFU/ml 이상을 권장\n\n<!-- PAGE_56 -->\n###### Epstein-Barr virus(EBV) Ab, herpes simplex virus (HSV) Ab,\n\n<!-- PAGE_56 -->\n###### Rubella virus Ab, Parvovirus BI9 Ab, Hepatitis A (HAV) Ab,\n\n<!-- PAGE_56 -->\n###### Hepatitis B (HBV) Ab, Hepatitis C (HCV) Ab, Toxoplasma\n\n<!-- PAGE_56 -->\n###### gondii Ab, varicella zoster virus (VZV) Ab, hyperpolyclonal\n\n<!-- PAGE_56 -->\n###### IgM, hyperpolyclonal IgG, human anti-mouse antibody, influenza\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 52 -\n<!-- PAGE_57 -->\n###### Adenovirus Type 14\n\n<!-- PAGE_57 -->\n###### Adenovirus Type 31\n\n<!-- PAGE_57 -->\n###### Influenza A Aichi\n\n<!-- PAGE_57 -->\n###### Influenza A Malaya\n\n<!-- PAGE_57 -->\n###### Influenza A Hong Kong\n\n<!-- PAGE_57 -->\n###### Influenza A Denver\n\n<!-- PAGE_57 -->\n###### Influenza A Port Chalmers\n\n<!-- PAGE_57 -->\n###### Influenza A Victoria\n\n<!-- PAGE_57 -->\n###### Influenza A New Jersey\n\n<!-- PAGE_57 -->\n###### Influenza A PR\n\n<!-- PAGE_57 -->\n###### Mumps\n\n<!-- PAGE_57 -->\n###### Echovirus Types 4, 6, 9, 11,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다.  결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다.  민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험. ",
        "original_sentence": "이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다. "
      }
    },
    {
      "chunk_id": "chunk_661",
      "text": "민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 660,
        "window_size": 3,
        "char_count": 633,
        "word_count": 114,
        "page_number": 58,
        "window_text": "성능시험에 대한 상세사항\n\n- - 53 -\n<!-- PAGE_58 -->\n###### 다.  결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다.  민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ. ",
        "original_sentence": "민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다. "
      }
    },
    {
      "chunk_id": "chunk_662",
      "text": "질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 661,
        "window_size": 3,
        "char_count": 237,
        "word_count": 51,
        "page_number": 59,
        "window_text": "결과제시\n\n<!-- PAGE_58 -->\n###### 1) 교차반응 평가에 사용된 양성물질의 종류, 농도, 측정한 raw\n\n<!-- PAGE_58 -->\n###### ※ 임상적 성능시험 자료의 작성 시 준수사항\n\n<!-- PAGE_58 -->\n###### ❍ 체외진단용 의료기기의 성능 및 유효성을 증명하기 위하여 사람에서\n\n<!-- PAGE_58 -->\n###### ❍ 외국에서 외국인을 대상으로 시험한 임상시험 성적도 제출할 수\n\n<!-- PAGE_58 -->\n###### 있으나 수출용이 아닌 내수용일 경우는 국내에서 우리나라 사람을\n\n<!-- PAGE_58 -->\n###### 대상으로 한 자료를 제출하는 것을 원칙으로 한다.  이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다.  민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나. ",
        "original_sentence": "질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_663",
      "text": "종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 662,
        "window_size": 3,
        "char_count": 693,
        "word_count": 149,
        "page_number": 59,
        "window_text": "이는 인종 및\n\n<!-- PAGE_58 -->\n###### 지역에 따라 유행하는 바이러스 아형이나 유병률이 다를 수 있기 때\n\n<!-- PAGE_58 -->\n###### 문이다.  민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다. ",
        "original_sentence": "종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험. "
      }
    },
    {
      "chunk_id": "chunk_664",
      "text": "다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 663,
        "window_size": 3,
        "char_count": 161,
        "word_count": 34,
        "page_number": 59,
        "window_text": "민족적 요인의 차이가 있어 외국 임상적 성능시험을 그대로\n\n<!-- PAGE_58 -->\n###### 적용하기가 어렵다고 판단되는 경우, 식약처장은 국내에 거주하는 한\n\n<!-- PAGE_58 -->\n###### 국인으로부터 유래한 검체를 대상으로 한 자료를 추가 제출할 것을\n\n<!-- PAGE_58 -->\n###### ❍ 제조사가 아닌 임상기관에서 임상시험이 수행되어야 하며, 임상시험\n\n<!-- PAGE_58 -->\n###### ❍ 질환이 있음과 없음(“임상적 참값”)을 규명한 방법, 대상군(환자 선\n\n<!-- PAGE_58 -->\n###### 택기준/배제기준, 환자 수), 검체종류, 검사방법, 통계 방법 등에 대\n\n<!-- PAGE_58 -->\n###### Streptococcus pyogenes\n\n<!-- PAGE_58 -->\n###### Ureaplasma urealyticum\n\n<!-- PAGE_58 -->\n###### Candida glabrata\n\n<!-- PAGE_58 -->\n###### Trichomonas vaginalis\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 54 -\n<!-- PAGE_59 -->\n###### 한 자세한 실험프로토콜을 제공해야한다.  질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라. ",
        "original_sentence": "다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_665",
      "text": "성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 664,
        "window_size": 3,
        "char_count": 722,
        "word_count": 145,
        "page_number": 60,
        "window_text": "질환이 있음을 규명한 참고\n\n<!-- PAGE_59 -->\n###### 표준방법은 표적물질의 유무를 알기 위해 시행되는 한 가지 방법일\n\n<!-- PAGE_59 -->\n###### 수도 있고 여러 방법(진단검사의학 검사, 영상의학 검사, 병리 검사,\n\n<!-- PAGE_59 -->\n###### 임상 소견, 두 가지 이상의 기허가 제품으로 확인 등)을 종합한\n\n<!-- PAGE_59 -->\n###### 방법일 수도 있다.  종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라.  과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_666",
      "text": "외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 665,
        "window_size": 3,
        "char_count": 173,
        "word_count": 34,
        "page_number": 60,
        "window_text": "종합한 방법일 경우 참값으로 규정한 알고리즘을\n\n<!-- PAGE_59 -->\n###### ❍ 감염을 확증할만한 참고 검사법이 없으며 임상 증상으로 확진이\n\n<!-- PAGE_59 -->\n###### 어려운 경우 임상적 민감도 및 임상적 특이도 대신 기존 검사법과의\n\n<!-- PAGE_59 -->\n###### 상관성(총일치율, 양성일치율, 음성일치율)과 각각의 95% 신뢰구\n\n<!-- PAGE_59 -->\n###### ❍ 신선 검체를 사용하는 것을 원칙으로 하나, 충분한 수의 신선 검체를\n\n<!-- PAGE_59 -->\n###### ❍ 아래의 1)부터 4) 중 어느 하나에 해당하는 시험의 경우에는 법 제\n\n<!-- PAGE_59 -->\n###### 10조에 따라 실시한 임상적 성능시험에 관한 자료를 제출하여야 한\n\n<!-- PAGE_59 -->\n###### 2) 인체로부터 검체를 채취하는 방법의 위해도가 큰 시험(검체의 채취\n\n<!-- PAGE_59 -->\n###### 방법이 인체의 피부, 점막, 안구, 요도를 침투 또는 관통하거나, 외\n\n<!-- PAGE_59 -->\n###### 이도 외비공, 인두, 직장 또는 자궁경부를 넘어서 외비공, 인두, 직\n\n<!-- PAGE_59 -->\n###### 장 또는 자궁경부를 넘어서 귀, 코 입, 항문관 또는 질에 들어가는\n\n<!-- PAGE_59 -->\n###### 침습적인 시험.  다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라.  과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1.  임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등. ",
        "original_sentence": "외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_667",
      "text": "해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 666,
        "window_size": 3,
        "char_count": 182,
        "word_count": 35,
        "page_number": 61,
        "window_text": "다만, 정맥채혈 등 피험자에게 중대한 위험을 미치\n\n<!-- PAGE_59 -->\n###### 3) 이미 확립된 의학적 진단방법 또는 허가·인증받은 체외진단용 의료\n\n<!-- PAGE_59 -->\n###### 4) 의약품 등과 함께 동반하여 진단하는 시험(다만, 이미 허가·인증받\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라.  과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1.  임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다. ",
        "original_sentence": "해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라. "
      }
    },
    {
      "chunk_id": "chunk_668",
      "text": "과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 667,
        "window_size": 3,
        "char_count": 73,
        "word_count": 10,
        "page_number": 61,
        "window_text": "성능시험에 대한 상세사항\n\n- - 55 -\n<!-- PAGE_60 -->\n###### 은 의료기기와 사용목적, 작용원리 등이 동등하지 아니한 체외진단\n\n<!-- PAGE_60 -->\n###### 용 의료기기의 시험에 한함)\n\n<!-- PAGE_60 -->\n###### (※ 상기의 1)부터 4)까지는 식약처장의 임상시험계획승인 및 임상\n\n<!-- PAGE_60 -->\n###### ❍ 상기의 1)부터 4)까지에 해당하지 않는 임상시험의 경우에는 아래의\n\n<!-- PAGE_60 -->\n###### 가)부터 다)까지 중 어느 하나에 해당하는 임상적 성능시험에 관한 자\n\n<!-- PAGE_60 -->\n###### (※ 하기의 가)부터 나)까지는 식약처장의 임상시험계획승인은 제외되\n\n<!-- PAGE_60 -->\n###### 가) 다음 각 단의 어느 하나에 해당하는 기관에서 「임상적 성능시험\n\n<!-- PAGE_60 -->\n###### ①「감염병의 예방 및 관리에 관한 시행규칙」제4조제9호에 해당하\n\n<!-- PAGE_60 -->\n###### 나) 외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「임상적 성능시험 관리기준」(고시 별표 14)에 의하여 실시한 시\n\n<!-- PAGE_60 -->\n###### 다) 임상적 성능시험에 관한 자료 요건(가.부터 라.까지) 중 어느 하나\n\n<!-- PAGE_60 -->\n###### 나.  외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라.  과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1.  임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다.  또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ. ",
        "original_sentence": "과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_669",
      "text": "임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 668,
        "window_size": 3,
        "char_count": 239,
        "word_count": 50,
        "page_number": 61,
        "window_text": "외국자료로서 그 내용을 검토하여 실시기관의 신뢰성이 인정되고\n\n<!-- PAGE_60 -->\n###### 「의료기기 임상시험 관리기준」에 의하여 실시한 시험자료 또는\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 56 -\n<!-- PAGE_61 -->\n###### 다.  해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라.  과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1.  임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다.  또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n",
        "original_sentence": "임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등. "
      }
    },
    {
      "chunk_id": "chunk_670",
      "text": "평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 669,
        "window_size": 3,
        "char_count": 104,
        "word_count": 23,
        "page_number": 61,
        "window_text": "해당 의료기기에 대하여 경제협력개발기구(OECD) 회원국에 허가\n\n<!-- PAGE_61 -->\n###### 당시 제출되어 평가된 임상시험에 관한 자료로서 해당 정부 또는\n\n<!-- PAGE_61 -->\n###### 정부가 허가 업무를 위임한 등록기관이 제출받아 승인하였음을\n\n<!-- PAGE_61 -->\n###### 라.  과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1.  임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다.  또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n <!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n",
        "original_sentence": "평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_671",
      "text": "또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 670,
        "window_size": 3,
        "char_count": 220,
        "word_count": 46,
        "page_number": 61,
        "window_text": "과학논문인용색인(Science citation index)에 등재된 전문학회지에\n\n<!-- PAGE_61 -->\n###### 1.  임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다.  또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n <!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n <!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n",
        "original_sentence": "또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_672",
      "text": "성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 671,
        "window_size": 3,
        "char_count": 117,
        "word_count": 24,
        "page_number": 62,
        "window_text": "임상적 민감도\n\n<!-- PAGE_61 -->\n###### 1) 다양한 농도를 포함한 양성 임상검체와 상용화된 혈청 패널을\n\n<!-- PAGE_61 -->\n###### 2) 임상검체인 경우, 양성 또는 음성임을 확인한 방법을 기술한\n\n<!-- PAGE_61 -->\n###### 기허가 진단제품 또는 확진검사방법 등으로 확인하였음을 기술\n\n<!-- PAGE_61 -->\n###### 한 자료 또는 양성임을 증명하는 임상자료 등.  평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다.  또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n <!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n <!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n <!-- PAGE_63 -->\n###### 2. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_673",
      "text": "<!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 672,
        "window_size": 3,
        "char_count": 441,
        "word_count": 92,
        "page_number": 62,
        "window_text": "평가대상 제품의\n\n<!-- PAGE_61 -->\n###### 3) 양성 검체는 각 질환의 다양한 임상단계 및 항체 양상이 포함되\n\n<!-- PAGE_61 -->\n###### 도록 한다.  또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n <!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n <!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n <!-- PAGE_63 -->\n###### 2.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다. ",
        "original_sentence": "<!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_674",
      "text": "<!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 673,
        "window_size": 3,
        "char_count": 465,
        "word_count": 99,
        "page_number": 62,
        "window_text": "또한 다양한 아형(유전자형, 변이체, 혈청형 등)이\n\n<!-- PAGE_61 -->\n###### 4) 검사의 목적, 유병률과 제품의 분석능에 따라 통계적으로 의미\n\n<!-- PAGE_61 -->\n###### 있는 검체수가 다르므로 검사의 목적, 유병률, 제품의 분석능에\n\n<!-- PAGE_61 -->\n###### 5) 신선한 검체를 이용할 것을 권장하지만, 유병률이 너무 낮은 경우,\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n <!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n <!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n <!-- PAGE_63 -->\n###### 2.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ. ",
        "original_sentence": "<!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_675",
      "text": "<!-- PAGE_63 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 674,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 63,
        "window_text": "성능시험에 대한 상세사항\n\n- - 57 -\n<!-- PAGE_62 -->\n###### 제조사에서 냉동검체의 안정성을 보장한다면 냉동검체를 일부\n\n<!-- PAGE_62 -->\n###### 이용할 수도 있다.\n\n <!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n <!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n <!-- PAGE_63 -->\n###### 2.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n",
        "original_sentence": "<!-- PAGE_63 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_676",
      "text": "임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 675,
        "window_size": 3,
        "char_count": 363,
        "word_count": 71,
        "page_number": 63,
        "window_text": "<!-- PAGE_62 -->\n###### 1) 피험자 선정/제외 기준, 검체의 종류와 수, 유전자형 및 아형별\n\n<!-- PAGE_62 -->\n###### 수, 시험 상 주의사항, 통계분석법 등에 대한 자세한 실험프로토콜\n\n<!-- PAGE_62 -->\n###### 2) 신선한 검체를 이용할 것을 권장하지만, 확진된 보관검체로\n\n<!-- PAGE_62 -->\n###### 4) 평가 전에 결과 해석에 대한 알고리즘 및 불일치한 경우 추가\n\n<!-- PAGE_62 -->\n###### 5) 감염에 합당한 증상을 가진 집단이나 새로운 시약으로 검사를\n\n<!-- PAGE_62 -->\n###### 1) 임상적 민감도 및 95% 신뢰구간(측정원리상 95% 이상 설정이\n\n<!-- PAGE_62 -->\n###### 어려운 Immunoblot, ELISA 방식의 제품 등은 제외)을 제시한다.\n\n <!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n <!-- PAGE_63 -->\n###### 2.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n <!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1. ",
        "original_sentence": "임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_677",
      "text": "임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 676,
        "window_size": 3,
        "char_count": 198,
        "word_count": 44,
        "page_number": 63,
        "window_text": "<!-- PAGE_62 -->\n###### 임상적 민감도란 질병이나 특정 상태를 가지는 대상군에서 검\n\n<!-- PAGE_62 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_62 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고 해석을\n\n<!-- PAGE_62 -->\n###### 4) 전향적으로 목표하는 검체 수가 될 때까지 모든 양성 및 음성 검\n\n<!-- PAGE_62 -->\n###### 체를 수집하였을 경우 유병률, 양성예측도, 음성예측도를 구할 수\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 58 -\n<!-- PAGE_63 -->\n###### 있으므로 임상적 민감도, 임상적 특이도와 함께 유병률, 양성예\n\n<!-- PAGE_63 -->\n###### 측도, 음성예측도 제시를 권장한다.\n\n <!-- PAGE_63 -->\n###### 2.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n <!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1.  연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2. ",
        "original_sentence": "임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_678",
      "text": "성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 677,
        "window_size": 3,
        "char_count": 55,
        "word_count": 12,
        "page_number": 64,
        "window_text": "<!-- PAGE_63 -->\n###### 2.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n <!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1.  연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_679",
      "text": "<!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 678,
        "window_size": 3,
        "char_count": 157,
        "word_count": 31,
        "page_number": 64,
        "window_text": "임상적 특이도\n\n<!-- PAGE_63 -->\n###### 2) 임상검체인 경우, 임상적 참값(음성)에 대한 특성이 규명된\n\n<!-- PAGE_63 -->\n###### 환자검체를 이용하고, 임상적 참값을 확인한 방법을 기술한\n\n<!-- PAGE_63 -->\n###### 자료를 제출한다(기허가 진단제품 또는 확진검사방법 등으로\n\n<!-- PAGE_63 -->\n###### 1) 검체종류, 검사방법, 통계방법 등에 대한 자세한 실험프로토콜을\n\n<!-- PAGE_63 -->\n###### 2) 가능한 전향적으로 신선한 검체를 대상으로 시행하는 것이 좋으나\n\n<!-- PAGE_63 -->\n###### 1) 임상적 특이도 및 95% 신뢰구간을 제시한다.  임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n <!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1.  연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1. ",
        "original_sentence": "<!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_680",
      "text": "연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 679,
        "window_size": 3,
        "char_count": 69,
        "word_count": 16,
        "page_number": 64,
        "window_text": "임상적 특이도\n\n<!-- PAGE_63 -->\n###### 란 질병이나 특정 상태가 아닌 대상군에서 검사 결과가 음성(판\n\n<!-- PAGE_63 -->\n###### 2) 전체 결과, 특이 결과, 구별되는 소견이 있는 세부 집단별 결과\n\n<!-- PAGE_63 -->\n###### 3) 불일치한 검체에 대해 원인을 분석한 자료를 제출하고, 해석을\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n <!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1.  연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가. ",
        "original_sentence": "연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_681",
      "text": "시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 680,
        "window_size": 3,
        "char_count": 128,
        "word_count": 27,
        "page_number": 64,
        "window_text": "성능시험에 대한 상세사항\n\n- - 59 -\n<!-- PAGE_64 -->\n###### 제시한다.\n\n <!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1.  연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나. ",
        "original_sentence": "시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_682",
      "text": "시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 681,
        "window_size": 3,
        "char_count": 66,
        "word_count": 14,
        "page_number": 64,
        "window_text": "<!-- PAGE_64 -->\n###### 3\n\n<!-- PAGE_64 -->\n###### 완제품의 품질관리 시험성적서 또는 시험에 관한 자료\n\n<!-- PAGE_64 -->\n###### (3배치 1회이상 또는 1배치 3회 이상)\n\n<!-- PAGE_64 -->\n###### 1.  연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n",
        "original_sentence": "시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_683",
      "text": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 682,
        "window_size": 3,
        "char_count": 57,
        "word_count": 12,
        "page_number": 64,
        "window_text": "연속적인 3회(3배치 각 1회 이상 또는 1배치 3회 이상)에 대해 시험\n\n<!-- PAGE_64 -->\n###### 2.  시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n <!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가. ",
        "original_sentence": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_684",
      "text": "표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 683,
        "window_size": 3,
        "char_count": 155,
        "word_count": 34,
        "page_number": 64,
        "window_text": "시험규격 설정에 따른 시험 기준 및 방법에 관한자료와 표준물질이\n\n<!-- PAGE_64 -->\n###### 사용된 경우, 이에 관한 자료를 제출한다(단, 표준물질에 관한 자료와\n\n<!-- PAGE_64 -->\n###### 3.  시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n <!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. ",
        "original_sentence": "표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_685",
      "text": "자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 684,
        "window_size": 3,
        "char_count": 37,
        "word_count": 8,
        "page_number": 4,
        "window_text": "시험 항목은 품질의 동등성을 입증할 수 있는 항목(민감도, 특이도,\n\n<!-- PAGE_64 -->\n###### 1.  완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n <!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나. ",
        "original_sentence": "자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_686",
      "text": "<!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 685,
        "window_size": 3,
        "char_count": 185,
        "word_count": 41,
        "page_number": 65,
        "window_text": "완제품 품질관리 시험에 사용된 표준물질에 관한 자료\n\n<!-- PAGE_64 -->\n###### 가.  표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n <!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다. ",
        "original_sentence": "<!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_687",
      "text": "시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 686,
        "window_size": 3,
        "char_count": 97,
        "word_count": 21,
        "page_number": 65,
        "window_text": "표준물질 혹은 타사 표준물질을 구매하여 사용한 경우, 아래의 자\n\n<!-- PAGE_64 -->\n###### 2) 출처 및 근거 자료\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 60 -\n<!-- PAGE_65 -->\n###### 나.  자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n <!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다. ",
        "original_sentence": "시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_688",
      "text": "이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 687,
        "window_size": 3,
        "char_count": 93,
        "word_count": 21,
        "page_number": 65,
        "window_text": "자사 표준물질을 제작하여 사용할 경우, 다음의 자료를 제출한다.\n\n <!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다. ",
        "original_sentence": "이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_689",
      "text": "검체 취급 및 보관조건에 대한 시험 결과를 제시한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 688,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 24,
        "window_text": "<!-- PAGE_65 -->\n###### 1) 표준물질의 농도별 설정 기준을 입증할 수 있는 시험 자료 및\n\n<!-- PAGE_65 -->\n###### 결과 분석 자료\n\n<!-- PAGE_65 -->\n###### 2.검체 보관 및 취급상(온도, 습도 등)의 조건 설정 근거 자료\n\n<!-- PAGE_65 -->\n###### 가.  시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1. ",
        "original_sentence": "검체 취급 및 보관조건에 대한 시험 결과를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_690",
      "text": "이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 689,
        "window_size": 3,
        "char_count": 126,
        "word_count": 29,
        "page_number": 65,
        "window_text": "시험결과를 근거로 하여, 검사에 이용할 수 있는 검체의 취급방법,\n\n<!-- PAGE_65 -->\n###### 보관조건 및 방법, 사용기간, 주의사항 등에 대하여 기재한다.  이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1.  일반사항\n\n<!-- PAGE_65 -->\n###### 가. ",
        "original_sentence": "이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_691",
      "text": "이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 690,
        "window_size": 3,
        "char_count": 156,
        "word_count": 33,
        "page_number": 65,
        "window_text": "이는\n\n<!-- PAGE_65 -->\n###### 원심분리 조건 등을 포함한 검체 전처리과정 및 냉동 및 해동된 검\n\n<!-- PAGE_65 -->\n###### 나.  검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1.  일반사항\n\n<!-- PAGE_65 -->\n###### 가.  국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ. ",
        "original_sentence": "이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_692",
      "text": "시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 691,
        "window_size": 3,
        "char_count": 67,
        "word_count": 15,
        "page_number": 65,
        "window_text": "검체 취급 및 보관조건에 대한 시험 결과를 제시한다.  이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1.  일반사항\n\n<!-- PAGE_65 -->\n###### 가.  국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다. ",
        "original_sentence": "시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_693",
      "text": "일반사항\n\n<!-- PAGE_65 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 692,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 65,
        "window_text": "이는 제시된\n\n<!-- PAGE_65 -->\n###### 시간, 온도, 습도 등의 항목에 대해 유효하다고 제시된 구간 중 몇\n\n<!-- PAGE_65 -->\n###### 단계에 대해 동일한 검사 결과를 보임을 입증해야 한다.  이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1.  일반사항\n\n<!-- PAGE_65 -->\n###### 가.  국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n",
        "original_sentence": "일반사항\n\n<!-- PAGE_65 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_694",
      "text": "국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 693,
        "window_size": 3,
        "char_count": 40,
        "word_count": 9,
        "page_number": 1,
        "window_text": "이 시험은\n\n<!-- PAGE_65 -->\n###### 제시된 구간의 양측 한계치 이상에서 평가된 결과이어야 하며, 조\n\n<!-- PAGE_65 -->\n###### 건 변화에 따른 결과의 변화를 제시하고 평가에 사용된 만족기준을\n\n<!-- PAGE_65 -->\n###### 다.  시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1.  일반사항\n\n<!-- PAGE_65 -->\n###### 가.  국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n <!-- PAGE_66 -->\n###### 나. ",
        "original_sentence": "국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ. "
      }
    },
    {
      "chunk_id": "chunk_695",
      "text": "성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 694,
        "window_size": 3,
        "char_count": 67,
        "word_count": 14,
        "page_number": 66,
        "window_text": "시험에 사용된 방법, 검체수, 검체 범위, 표준 농도, 계산법, 통계\n\n<!-- PAGE_65 -->\n###### 1.  일반사항\n\n<!-- PAGE_65 -->\n###### 가.  국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n <!-- PAGE_66 -->\n###### 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. ",
        "original_sentence": "성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_696",
      "text": "다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 695,
        "window_size": 3,
        "char_count": 76,
        "word_count": 16,
        "page_number": 66,
        "window_text": "일반사항\n\n<!-- PAGE_65 -->\n###### 가.  국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n <!-- PAGE_66 -->\n###### 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다. ",
        "original_sentence": "다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_697",
      "text": "<!-- PAGE_66 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 696,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 66,
        "window_text": "국내‧외 허가된 체외진단용 의료기기와의 상관성을 확인할 수 있는\n\nⅦ.  성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n <!-- PAGE_66 -->\n###### 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다.  거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2. ",
        "original_sentence": "<!-- PAGE_66 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_698",
      "text": "임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 697,
        "window_size": 3,
        "char_count": 152,
        "word_count": 31,
        "page_number": 66,
        "window_text": "성능시험에 대한 상세사항\n\n- - 61 -\n<!-- PAGE_66 -->\n###### 비교시험성적서를 포함하여야 한다.  다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n <!-- PAGE_66 -->\n###### 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다.  거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2.  시험물질\n\n<!-- PAGE_66 -->\n###### 가. ",
        "original_sentence": "임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_699",
      "text": "분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 698,
        "window_size": 3,
        "char_count": 95,
        "word_count": 19,
        "page_number": 66,
        "window_text": "다만, 측정원리 및 측정항목이\n\n<!-- PAGE_66 -->\n###### 새로운 경우 동일목적으로 사용되는 제품과 비교할 수 있다.\n\n <!-- PAGE_66 -->\n###### 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다.  거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2.  시험물질\n\n<!-- PAGE_66 -->\n###### 가.  다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나. ",
        "original_sentence": "분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_700",
      "text": "거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 699,
        "window_size": 3,
        "char_count": 122,
        "word_count": 23,
        "page_number": 66,
        "window_text": "<!-- PAGE_66 -->\n###### 나.  임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다.  거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2.  시험물질\n\n<!-- PAGE_66 -->\n###### 가.  다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나.  임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다. ",
        "original_sentence": "거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_701",
      "text": "시험물질\n\n<!-- PAGE_66 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 700,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 66,
        "window_text": "임상적 민감도와 임상적 특이도를 산출하기 위해 시행한 검사에서\n\n<!-- PAGE_66 -->\n###### 기존검사법(기허가 제품)을 병행하여 검사하였을 경우, 도출된 두\n\n<!-- PAGE_66 -->\n###### 검사 결과를 정리하여 상관성의 자료로 제시할 수 있다.  분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다.  거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2.  시험물질\n\n<!-- PAGE_66 -->\n###### 가.  다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나.  임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다.  정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라. ",
        "original_sentence": "시험물질\n\n<!-- PAGE_66 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_702",
      "text": "다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 701,
        "window_size": 3,
        "char_count": 62,
        "word_count": 12,
        "page_number": 66,
        "window_text": "분석적 성\n\n<!-- PAGE_66 -->\n###### 능시험 과정에서 기존검사법과의 비교 자료가 있을 경우에도 상관성\n\n<!-- PAGE_66 -->\n###### 다.  거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2.  시험물질\n\n<!-- PAGE_66 -->\n###### 가.  다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나.  임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다.  정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라.  정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3. ",
        "original_sentence": "다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_703",
      "text": "임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 702,
        "window_size": 3,
        "char_count": 62,
        "word_count": 12,
        "page_number": 66,
        "window_text": "거대세포바이러스 감염의 경우 감염을 확증할만한 참고 검사법이\n\n<!-- PAGE_66 -->\n###### 없으며 임상증상으로도 확진이 어려우므로 임상적 민감도와 임상적\n\n<!-- PAGE_66 -->\n###### 2.  시험물질\n\n<!-- PAGE_66 -->\n###### 가.  다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나.  임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다.  정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라.  정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3.  시험방법\n\n<!-- PAGE_66 -->\n###### 가. ",
        "original_sentence": "임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_704",
      "text": "정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 703,
        "window_size": 3,
        "char_count": 63,
        "word_count": 13,
        "page_number": 66,
        "window_text": "시험물질\n\n<!-- PAGE_66 -->\n###### 가.  다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나.  임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다.  정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라.  정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3.  시험방법\n\n<!-- PAGE_66 -->\n###### 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나. ",
        "original_sentence": "정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라. "
      }
    },
    {
      "chunk_id": "chunk_705",
      "text": "정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 704,
        "window_size": 3,
        "char_count": 62,
        "word_count": 12,
        "page_number": 66,
        "window_text": "다양한 역가의 표준물질과 통계적으로 해석 가능한 임상검체수를\n\n<!-- PAGE_66 -->\n###### 나.  임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다.  정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라.  정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3.  시험방법\n\n<!-- PAGE_66 -->\n###### 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n",
        "original_sentence": "정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_706",
      "text": "시험방법\n\n<!-- PAGE_66 -->\n###### 가. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 705,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 66,
        "window_text": "임상검체는 기허가된 방법이거나 여타 검증된 방법으로 검사되어\n\n<!-- PAGE_66 -->\n###### 다.  정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라.  정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3.  시험방법\n\n<!-- PAGE_66 -->\n###### 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n <!-- PAGE_67 -->\n###### 다. ",
        "original_sentence": "시험방법\n\n<!-- PAGE_66 -->\n###### 가. "
      }
    },
    {
      "chunk_id": "chunk_707",
      "text": "해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 706,
        "window_size": 3,
        "char_count": 178,
        "word_count": 40,
        "page_number": 66,
        "window_text": "정성검사의 임상검체의 경우 다양한 임상상을 포함하는 검체를 포\n\n<!-- PAGE_66 -->\n###### 라.  정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3.  시험방법\n\n<!-- PAGE_66 -->\n###### 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n <!-- PAGE_67 -->\n###### 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n",
        "original_sentence": "해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_708",
      "text": "가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 707,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 19,
        "window_text": "정량검사의 임상검체는 측정범위 내의 다양한 농도가 포함되도록\n\n<!-- PAGE_66 -->\n###### 3.  시험방법\n\n<!-- PAGE_66 -->\n###### 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n <!-- PAGE_67 -->\n###### 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n <!-- PAGE_67 -->\n###### 라. ",
        "original_sentence": "가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_709",
      "text": "<!-- PAGE_67 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 708,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 67,
        "window_text": "시험방법\n\n<!-- PAGE_66 -->\n###### 가.  해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n <!-- PAGE_67 -->\n###### 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n <!-- PAGE_67 -->\n###### 라.  정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n",
        "original_sentence": "<!-- PAGE_67 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_710",
      "text": "비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 709,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 28,
        "window_text": "해당 제품과 측정 원리 및 항목이 가장 유사한 국내 허가제품 또\n\n<!-- PAGE_66 -->\n###### 는 외국 허가제품(국내 허가 제품이 없을 시)과의 비교시험을 실시\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 62 -\n<!-- PAGE_67 -->\n###### 나.  가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n <!-- PAGE_67 -->\n###### 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n <!-- PAGE_67 -->\n###### 라.  정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n <!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다. ",
        "original_sentence": "비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_711",
      "text": "<!-- PAGE_67 -->\n###### 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 710,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 67,
        "window_text": "가능한 2개 이상의 회사 제품과 비교시험 할 것을 권장한다.\n\n <!-- PAGE_67 -->\n###### 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n <!-- PAGE_67 -->\n###### 라.  정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n <!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다.  불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4. ",
        "original_sentence": "<!-- PAGE_67 -->\n###### 라. "
      }
    },
    {
      "chunk_id": "chunk_712",
      "text": "정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 711,
        "window_size": 3,
        "char_count": 34,
        "word_count": 8,
        "page_number": 19,
        "window_text": "<!-- PAGE_67 -->\n###### 다.  비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n <!-- PAGE_67 -->\n###### 라.  정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n <!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다.  불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4.  결과제시\n\n<!-- PAGE_67 -->\n###### 나. ",
        "original_sentence": "정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_713",
      "text": "<!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 712,
        "window_size": 3,
        "char_count": 111,
        "word_count": 24,
        "page_number": 67,
        "window_text": "비교 제품은 각 제품의 사용방법에 따라서 시험한다.\n\n <!-- PAGE_67 -->\n###### 라.  정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n <!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다.  불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4.  결과제시\n\n<!-- PAGE_67 -->\n###### 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다. ",
        "original_sentence": "<!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_714",
      "text": "불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 713,
        "window_size": 3,
        "char_count": 41,
        "word_count": 8,
        "page_number": 67,
        "window_text": "<!-- PAGE_67 -->\n###### 라.  정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n <!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다.  불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4.  결과제시\n\n<!-- PAGE_67 -->\n###### 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다.  정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라. ",
        "original_sentence": "불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_715",
      "text": "결과제시\n\n<!-- PAGE_67 -->\n###### 나. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 714,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 67,
        "window_text": "정량검사의 경우 각 검사를 2회 이상 반복수행을 권장한다.\n\n <!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다.  불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4.  결과제시\n\n<!-- PAGE_67 -->\n###### 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다.  정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라.  결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\n",
        "original_sentence": "결과제시\n\n<!-- PAGE_67 -->\n###### 나. "
      }
    },
    {
      "chunk_id": "chunk_716",
      "text": "정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 715,
        "window_size": 3,
        "char_count": 65,
        "word_count": 12,
        "page_number": 67,
        "window_text": "<!-- PAGE_67 -->\n###### 마, 결과가 불일치하는 경우, 다른 검사를 통해 불일치의 원인을 분석\n\n<!-- PAGE_67 -->\n###### 하고 이에 대한 자료를 제공하여야 한다.  불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4.  결과제시\n\n<!-- PAGE_67 -->\n###### 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다.  정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라.  결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\n Ⅷ. ",
        "original_sentence": "정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다. "
      }
    },
    {
      "chunk_id": "chunk_717",
      "text": "정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 716,
        "window_size": 3,
        "char_count": 63,
        "word_count": 14,
        "page_number": 67,
        "window_text": "불일치의 원인을 분석할\n\n<!-- PAGE_67 -->\n###### 4.  결과제시\n\n<!-- PAGE_67 -->\n###### 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다.  정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라.  결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\n Ⅷ.  참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1. ",
        "original_sentence": "정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라. "
      }
    },
    {
      "chunk_id": "chunk_718",
      "text": "결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 717,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 4,
        "window_text": "결과제시\n\n<!-- PAGE_67 -->\n###### 나.  정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다.  정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라.  결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\n Ⅷ.  참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1.  CLSI. ",
        "original_sentence": "결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_719",
      "text": "Ⅷ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 718,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 4,
        "window_text": "정량검사에 대해서는 기울기, 절편(신뢰구간과 함께), 상관계수 및\n\n<!-- PAGE_67 -->\n###### 다.  정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라.  결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\n Ⅷ.  참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline. ",
        "original_sentence": "Ⅷ. "
      }
    },
    {
      "chunk_id": "chunk_720",
      "text": "참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 719,
        "window_size": 3,
        "char_count": 92,
        "word_count": 20,
        "page_number": 68,
        "window_text": "정성 또는 반정량검사에 대해서는 양성과 음성 검체에 대한 비교\n\n<!-- PAGE_67 -->\n###### 라.  결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\n Ⅷ.  참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline.  CLSI document EP25-A. ",
        "original_sentence": "참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_721",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 720,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 68,
        "window_text": "결과가 불일치하는 경우 불일치의 원인분석에 대한 자료를 제출한다.\n\n Ⅷ.  참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_722",
      "text": "Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 721,
        "window_size": 3,
        "char_count": 102,
        "word_count": 14,
        "page_number": 68,
        "window_text": "Ⅷ.  참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n",
        "original_sentence": "Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline. "
      }
    },
    {
      "chunk_id": "chunk_723",
      "text": "CLSI document EP25-A. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 722,
        "window_size": 3,
        "char_count": 22,
        "word_count": 3,
        "page_number": 3,
        "window_text": "참고문헌\n\n- - 63 -\n<!-- PAGE_68 -->\n## Ⅷ\n\n<!-- PAGE_68 -->\n### 참고문헌\n\n<!-- PAGE_68 -->\n###### 1.  CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n",
        "original_sentence": "CLSI document EP25-A. "
      }
    },
    {
      "chunk_id": "chunk_724",
      "text": "Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 723,
        "window_size": 3,
        "char_count": 48,
        "word_count": 8,
        "page_number": 68,
        "window_text": "CLSI.  Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n <!-- PAGE_68 -->\n###### CLSI document EP5-A2. ",
        "original_sentence": "Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n"
      }
    },
    {
      "chunk_id": "chunk_725",
      "text": "<!-- PAGE_68 -->\n###### CLSI.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 724,
        "window_size": 3,
        "char_count": 31,
        "word_count": 5,
        "page_number": 68,
        "window_text": "Evaluation of Stability of In Vitro Diagnostic Reagents;\n\n<!-- PAGE_68 -->\n###### Approved Guideline.  CLSI document EP25-A.  Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n <!-- PAGE_68 -->\n###### CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n",
        "original_sentence": "<!-- PAGE_68 -->\n###### CLSI.\n\n"
      }
    },
    {
      "chunk_id": "chunk_726",
      "text": "<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 725,
        "window_size": 3,
        "char_count": 285,
        "word_count": 41,
        "page_number": 68,
        "window_text": "CLSI document EP25-A.  Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n <!-- PAGE_68 -->\n###### CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n",
        "original_sentence": "<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n"
      }
    },
    {
      "chunk_id": "chunk_727",
      "text": "<!-- PAGE_68 -->\n###### CLSI document EP5-A2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 726,
        "window_size": 3,
        "char_count": 46,
        "word_count": 7,
        "page_number": 68,
        "window_text": "Wayne, PA: Cinical\n\n<!-- PAGE_68 -->\n###### 2.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n <!-- PAGE_68 -->\n###### CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n",
        "original_sentence": "<!-- PAGE_68 -->\n###### CLSI document EP5-A2. "
      }
    },
    {
      "chunk_id": "chunk_728",
      "text": "Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 727,
        "window_size": 3,
        "char_count": 63,
        "word_count": 10,
        "page_number": 68,
        "window_text": "<!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n <!-- PAGE_68 -->\n###### CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n <!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2. ",
        "original_sentence": "Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n"
      }
    },
    {
      "chunk_id": "chunk_729",
      "text": "<!-- PAGE_68 -->\n###### CLSI.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 728,
        "window_size": 3,
        "char_count": 31,
        "word_count": 5,
        "page_number": 68,
        "window_text": "<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Precision\n\n<!-- PAGE_68 -->\n###### Performance\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Quantitative\n\n<!-- PAGE_68 -->\n###### Measurement Methods; Approved Guideline - Second Edition.\n\n <!-- PAGE_68 -->\n###### CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n <!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4. ",
        "original_sentence": "<!-- PAGE_68 -->\n###### CLSI.\n\n"
      }
    },
    {
      "chunk_id": "chunk_730",
      "text": "<!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 729,
        "window_size": 3,
        "char_count": 424,
        "word_count": 65,
        "page_number": 68,
        "window_text": "<!-- PAGE_68 -->\n###### CLSI document EP5-A2.  Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n <!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4.  CLSI. ",
        "original_sentence": "<!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n"
      }
    },
    {
      "chunk_id": "chunk_731",
      "text": "<!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 730,
        "window_size": 3,
        "char_count": 72,
        "word_count": 11,
        "page_number": 68,
        "window_text": "Wayne, PA: Cinical and Laboratory\n\n<!-- PAGE_68 -->\n###### 3.\n\n <!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n <!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4.  CLSI.  Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline. ",
        "original_sentence": "<!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2. "
      }
    },
    {
      "chunk_id": "chunk_732",
      "text": "Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 731,
        "window_size": 3,
        "char_count": 71,
        "word_count": 11,
        "page_number": 68,
        "window_text": "<!-- PAGE_68 -->\n###### CLSI.\n\n <!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n <!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4.  CLSI.  Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline.  CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2. ",
        "original_sentence": "Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_733",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 732,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 68,
        "window_text": "<!-- PAGE_68 -->\n###### User\n\n<!-- PAGE_68 -->\n###### Protocol\n\n<!-- PAGE_68 -->\n###### for\n\n<!-- PAGE_68 -->\n###### Evaluation\n\n<!-- PAGE_68 -->\n###### of\n\n<!-- PAGE_68 -->\n###### Qualitative\n\n<!-- PAGE_68 -->\n###### Test\n\n<!-- PAGE_68 -->\n###### Performance;\n\n<!-- PAGE_68 -->\n###### Approved\n\n<!-- PAGE_68 -->\n###### Guideline\n\n<!-- PAGE_68 -->\n###### -\n\n<!-- PAGE_68 -->\n###### Second\n\n<!-- PAGE_68 -->\n###### Edition.\n\n <!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4.  CLSI.  Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline.  CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2.  Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5. ",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_734",
      "text": "Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 733,
        "window_size": 3,
        "char_count": 124,
        "word_count": 17,
        "page_number": 68,
        "window_text": "<!-- PAGE_68 -->\n###### CLSI\n\n<!-- PAGE_68 -->\n###### document EP12-A2.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4.  CLSI.  Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline.  CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2.  Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5.  CLSI. ",
        "original_sentence": "Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline. "
      }
    },
    {
      "chunk_id": "chunk_735",
      "text": "CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 734,
        "window_size": 3,
        "char_count": 48,
        "word_count": 7,
        "page_number": 68,
        "window_text": "Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_68 -->\n###### 4.  CLSI.  Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline.  CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2.  Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline. ",
        "original_sentence": "CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2. "
      }
    },
    {
      "chunk_id": "chunk_736",
      "text": "Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 735,
        "window_size": 3,
        "char_count": 82,
        "word_count": 12,
        "page_number": 68,
        "window_text": "CLSI.  Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline.  CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2.  Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline.  CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A. ",
        "original_sentence": "Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_737",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 736,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 68,
        "window_text": "Protocols for Determination of Limits of Detection and\n\n<!-- PAGE_68 -->\n###### Limits of Quantitation; Approved Guideline.  CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2.  Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline.  CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6. ",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_738",
      "text": "Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 737,
        "window_size": 3,
        "char_count": 137,
        "word_count": 17,
        "page_number": 68,
        "window_text": "CLSI document\n\n<!-- PAGE_68 -->\n###### EP17-A2.  Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline.  CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6.  CLSI. ",
        "original_sentence": "Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline. "
      }
    },
    {
      "chunk_id": "chunk_739",
      "text": "CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 738,
        "window_size": 3,
        "char_count": 98,
        "word_count": 18,
        "page_number": 69,
        "window_text": "Wayne, PA: Cinical and Laboratory Standard Institute;\n\n<!-- PAGE_68 -->\n###### 5.  CLSI.  Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline.  CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision). ",
        "original_sentence": "CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A. "
      }
    },
    {
      "chunk_id": "chunk_740",
      "text": "Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 739,
        "window_size": 3,
        "char_count": 112,
        "word_count": 17,
        "page_number": 69,
        "window_text": "CLSI.  Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline.  CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision).  CLSI document EP9-A2-IR. ",
        "original_sentence": "Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6. "
      }
    },
    {
      "chunk_id": "chunk_741",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 740,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 68,
        "window_text": "Evaluation of the Linearity of Quantitative Measurement\n\n<!-- PAGE_68 -->\n###### Procedures: A Statistical Approach; Approved Guideline.  CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision).  CLSI document EP9-A2-IR.  Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7. ",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_742",
      "text": "Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision). ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 741,
        "window_size": 3,
        "char_count": 317,
        "word_count": 47,
        "page_number": 69,
        "window_text": "CLSI\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 64 -\n<!-- PAGE_69 -->\n###### document EP6-A.  Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision).  CLSI document EP9-A2-IR.  Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7.  CLSI. ",
        "original_sentence": "Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision). "
      }
    },
    {
      "chunk_id": "chunk_743",
      "text": "CLSI document EP9-A2-IR. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 742,
        "window_size": 3,
        "char_count": 25,
        "word_count": 3,
        "page_number": 12,
        "window_text": "Wayne, PA: Cinical and Laboratory Standard\n\n<!-- PAGE_69 -->\n###### Institute; 2003\n\n<!-- PAGE_69 -->\n###### 6.  CLSI.  Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision).  CLSI document EP9-A2-IR.  Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition. ",
        "original_sentence": "CLSI document EP9-A2-IR. "
      }
    },
    {
      "chunk_id": "chunk_744",
      "text": "Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 743,
        "window_size": 3,
        "char_count": 51,
        "word_count": 9,
        "page_number": 69,
        "window_text": "CLSI.  Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision).  CLSI document EP9-A2-IR.  Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition.  CLSI document EP7-A. ",
        "original_sentence": "Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7. "
      }
    },
    {
      "chunk_id": "chunk_745",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 744,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 68,
        "window_text": "Method Comparison and Bias Estimation Using Patient\n\n<!-- PAGE_69 -->\n###### Samples;\n\n<!-- PAGE_69 -->\n###### Approved\n\n<!-- PAGE_69 -->\n###### Guideline\n\n<!-- PAGE_69 -->\n###### -\n\n<!-- PAGE_69 -->\n###### Second\n\n<!-- PAGE_69 -->\n###### Edition\n\n<!-- PAGE_69 -->\n###### (Interim\n\n<!-- PAGE_69 -->\n###### Revision).  CLSI document EP9-A2-IR.  Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8. ",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_746",
      "text": "Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 745,
        "window_size": 3,
        "char_count": 106,
        "word_count": 14,
        "page_number": 69,
        "window_text": "CLSI document EP9-A2-IR.  Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8.  CLSI. ",
        "original_sentence": "Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition. "
      }
    },
    {
      "chunk_id": "chunk_747",
      "text": "CLSI document EP7-A. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 746,
        "window_size": 3,
        "char_count": 21,
        "word_count": 3,
        "page_number": 12,
        "window_text": "Wayne, PA: Cinical and\n\n<!-- PAGE_69 -->\n###### 7.  CLSI.  Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8.  CLSI.  Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition. ",
        "original_sentence": "CLSI document EP7-A. "
      }
    },
    {
      "chunk_id": "chunk_748",
      "text": "Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 747,
        "window_size": 3,
        "char_count": 39,
        "word_count": 7,
        "page_number": 69,
        "window_text": "CLSI.  Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8.  CLSI.  Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition.  CLSI document MM3-A2.\n\n",
        "original_sentence": "Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8. "
      }
    },
    {
      "chunk_id": "chunk_749",
      "text": "CLSI. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 748,
        "window_size": 3,
        "char_count": 6,
        "word_count": 1,
        "page_number": 68,
        "window_text": "Interference Testing in Clinical Chemistry; Approved\n\n<!-- PAGE_69 -->\n###### Guideline - Second Edition.  CLSI document EP7-A.  Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8.  CLSI.  Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition.  CLSI document MM3-A2.\n\n <!-- PAGE_69 -->\n###### 9. ",
        "original_sentence": "CLSI. "
      }
    },
    {
      "chunk_id": "chunk_750",
      "text": "Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 749,
        "window_size": 3,
        "char_count": 116,
        "word_count": 15,
        "page_number": 69,
        "window_text": "CLSI document EP7-A.  Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8.  CLSI.  Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition.  CLSI document MM3-A2.\n\n <!-- PAGE_69 -->\n###### 9.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10. ",
        "original_sentence": "Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition. "
      }
    },
    {
      "chunk_id": "chunk_751",
      "text": "CLSI document MM3-A2.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 750,
        "window_size": 3,
        "char_count": 23,
        "word_count": 3,
        "page_number": 3,
        "window_text": "Wayne, PA:\n\n<!-- PAGE_69 -->\n###### 8.  CLSI.  Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition.  CLSI document MM3-A2.\n\n <!-- PAGE_69 -->\n###### 9.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10.  Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11. ",
        "original_sentence": "CLSI document MM3-A2.\n\n"
      }
    },
    {
      "chunk_id": "chunk_752",
      "text": "<!-- PAGE_69 -->\n###### 9. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 751,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 69,
        "window_text": "CLSI.  Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition.  CLSI document MM3-A2.\n\n <!-- PAGE_69 -->\n###### 9.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10.  Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11.  Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ. ",
        "original_sentence": "<!-- PAGE_69 -->\n###### 9. "
      }
    },
    {
      "chunk_id": "chunk_753",
      "text": "Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 752,
        "window_size": 3,
        "char_count": 92,
        "word_count": 15,
        "page_number": 69,
        "window_text": "Molecular Diagnostic Methods for Infectious Diseases;\n\n<!-- PAGE_69 -->\n###### Approved Guideline - Second Edition.  CLSI document MM3-A2.\n\n <!-- PAGE_69 -->\n###### 9.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10.  Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11.  Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ.  참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12. ",
        "original_sentence": "Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10. "
      }
    },
    {
      "chunk_id": "chunk_754",
      "text": "Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 753,
        "window_size": 3,
        "char_count": 93,
        "word_count": 15,
        "page_number": 69,
        "window_text": "CLSI document MM3-A2.\n\n <!-- PAGE_69 -->\n###### 9.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10.  Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11.  Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ.  참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection. ",
        "original_sentence": "Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11. "
      }
    },
    {
      "chunk_id": "chunk_755",
      "text": "Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 754,
        "window_size": 3,
        "char_count": 150,
        "word_count": 22,
        "page_number": 69,
        "window_text": "<!-- PAGE_69 -->\n###### 9.  Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10.  Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11.  Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ.  참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection.  Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1. ",
        "original_sentence": "Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ. "
      }
    },
    {
      "chunk_id": "chunk_756",
      "text": "참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 755,
        "window_size": 3,
        "char_count": 43,
        "word_count": 10,
        "page_number": 70,
        "window_text": "Guidance for Industry and FDA Staff: In Vitro Diagnostic (IVD)\n\n<!-- PAGE_69 -->\n###### 10.  Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11.  Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ.  참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection.  Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1.  CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n",
        "original_sentence": "참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12. "
      }
    },
    {
      "chunk_id": "chunk_757",
      "text": "Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 756,
        "window_size": 3,
        "char_count": 133,
        "word_count": 20,
        "page_number": 70,
        "window_text": "Guidance for industry and FDA staff/ Format for traditional and\n\n<!-- PAGE_69 -->\n###### 11.  Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ.  참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection.  Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1.  CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n <!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX. ",
        "original_sentence": "Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection. "
      }
    },
    {
      "chunk_id": "chunk_758",
      "text": "Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 757,
        "window_size": 3,
        "char_count": 205,
        "word_count": 30,
        "page_number": 70,
        "window_text": "Guidance for Industry and Food and Drug Administration Staff\n\n<!-- PAGE_69 -->\n###### Class II Special Controls Guidance Document: Herpes Simplex\n\nⅧ.  참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection.  Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1.  CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n <!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX.  부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2. ",
        "original_sentence": "Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_759",
      "text": "CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 758,
        "window_size": 3,
        "char_count": 100,
        "word_count": 14,
        "page_number": 71,
        "window_text": "참고문헌\n\n- - 65 -\n<!-- PAGE_70 -->\n###### 12.  Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection.  Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1.  CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n <!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX.  부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2.  CMV 제품 국내 제조 및 수입 현황\n\nIX. ",
        "original_sentence": "CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n"
      }
    },
    {
      "chunk_id": "chunk_760",
      "text": "<!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 759,
        "window_size": 3,
        "char_count": 1010,
        "word_count": 102,
        "page_number": 71,
        "window_text": "Linnet, K and Kondratovich, M. A Partly Noparametric Approach\n\n<!-- PAGE_70 -->\n###### for Determination of the Llimit of Detection.  Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1.  CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n <!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX.  부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2.  CMV 제품 국내 제조 및 수입 현황\n\nIX.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3. ",
        "original_sentence": "<!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX. "
      }
    },
    {
      "chunk_id": "chunk_761",
      "text": "부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 760,
        "window_size": 3,
        "char_count": 667,
        "word_count": 105,
        "page_number": 72,
        "window_text": "Clinical Chemistry\n\n<!-- PAGE_70 -->\n###### 13. http://www.cdc.gov/cmv/congenital-infection.html\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 66 -\n<!-- PAGE_71 -->\n### Ⅸ  부록\n\n<!-- PAGE_71 -->\n###### 1.  CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n <!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX.  부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2.  CMV 제품 국내 제조 및 수입 현황\n\nIX.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3.  미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM. ",
        "original_sentence": "부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_762",
      "text": "CMV 제품 국내 제조 및 수입 현황\n\nIX. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 761,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 22,
        "window_text": "CMV 표준물질 현황\n\n<!-- PAGE_71 -->\n###### 1) Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.\n\n <!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX.  부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2.  CMV 제품 국내 제조 및 수입 현황\n\nIX.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3.  미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM.  AN | ZEUS | INC. ",
        "original_sentence": "CMV 제품 국내 제조 및 수입 현황\n\nIX. "
      }
    },
    {
      "chunk_id": "chunk_763",
      "text": "부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 762,
        "window_size": 3,
        "char_count": 40,
        "word_count": 10,
        "page_number": 74,
        "window_text": "<!-- PAGE_71 -->\n###### 1st\n\n<!-- PAGE_71 -->\n###### International Standard, 2010,\n\n<!-- PAGE_71 -->\n###### 2008\n\n<!-- PAGE_71 -->\n###### NIBSC\n\n<!-- PAGE_71 -->\n###### 09/162\n\n<!-- PAGE_71 -->\n###### 1) QCRCMVQC1- Anti-CMV Quality Control Reagent Sample 1\n\n<!-- PAGE_71 -->\n###### 2) Human Cytomegalovirus for Nucleic Acid Amplification\n\n<!-- PAGE_71 -->\n###### 1) ACCURUN 1 Series 2600, 2700, 3000, 4000, 4100, 4400,\n\n<!-- PAGE_71 -->\n###### 5100, 5600, 8100 Multi-Analyte Positive Control: for use\n\n<!-- PAGE_71 -->\n###### with in vitro diagnostic test kits for the detection of\n\n3) http://www.who.int/bloodproducts/catalogue/AlphMay2011.pdf\n\n4)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=10/B599-02\n\n5)\n\nhttp://www.nibsc.ac.uk/products/biological_reference_materials/product_catalogue/detail_pa\n\nge.aspx?catid=08/314-004\n\n6)\n\nhttp://www.seracarecatalog.com/Default.aspx?tabid=219&txtSearch=cmv&List=1&SortField\n\n=ProductName,ProductName\n\nIX.  부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2.  CMV 제품 국내 제조 및 수입 현황\n\nIX.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3.  미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM.  AN | ZEUS | INC.  | Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC. ",
        "original_sentence": "부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_764",
      "text": "미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 763,
        "window_size": 3,
        "char_count": 225,
        "word_count": 43,
        "page_number": 3,
        "window_text": "부록\n\n- - 67 -\n<!-- PAGE_72 -->\n###### 2) ACCURUN 145, 146 CMV IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 3) ACCURUN 146 CMV IgM Positive Control\n\n<!-- PAGE_72 -->\n###### 4) ACCURUN 25, 26 Series 5000 ToRCH IgG Positive Control\n\n<!-- PAGE_72 -->\n###### 1) AcroMetrix CMV Controls(negative, low positive, high\n\n<!-- PAGE_72 -->\n###### 1) VR-538, -807, -977, -1578, -1590, -1780, -2356,\n\n<!-- PAGE_72 -->\n###### 1) SCP-CMV-001 Cytomegalovirus IgM and IgG Antibody\n\n<!-- PAGE_72 -->\n###### 2) SCP-CMV-002 Cytomegalovirus IgM and IgG Antibody\n\n7) http://www.seracarepanels.com/default.aspx\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 68 -\n<!-- PAGE_73 -->\n###### 2.  CMV 제품 국내 제조 및 수입 현황\n\nIX.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3.  미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM.  AN | ZEUS | INC.  | Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC.  | CORP. ",
        "original_sentence": "미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM. "
      }
    },
    {
      "chunk_id": "chunk_765",
      "text": "AN | ZEUS | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 764,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 12,
        "window_text": "CMV 제품 국내 제조 및 수입 현황\n\nIX.  부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3.  미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM.  AN | ZEUS | INC.  | Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC.  | CORP.  |\n| MODEL 8530 | SYSTEMS INC. ",
        "original_sentence": "AN | ZEUS | INC. "
      }
    },
    {
      "chunk_id": "chunk_766",
      "text": "| Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 765,
        "window_size": 3,
        "char_count": 117,
        "word_count": 32,
        "page_number": 3,
        "window_text": "부록\n\n- - 69 -\n<!-- PAGE_74 -->\n###### 3.  미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM.  AN | ZEUS | INC.  | Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC.  | CORP.  |\n| MODEL 8530 | SYSTEMS INC.  | MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC. ",
        "original_sentence": "| Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC. "
      }
    },
    {
      "chunk_id": "chunk_767",
      "text": "| CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 766,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 74,
        "window_text": "미국 FDA 등록 CMV 제품 목록(2012년 10월 현재)\n\nDocument No\n\nDevice name\n\nCompany\n\nDate\n\nApprived\n\n(ELISA) FOR THE\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 70 -\n**[표 시작]**\n\n| K905257 | OPUS CMV TEST SYSTEM | IGM ELISA TEST SYSTEM.  AN | ZEUS | INC.  | Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC.  | CORP.  |\n| MODEL 8530 | SYSTEMS INC.  | MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC.  | INC. ",
        "original_sentence": "| CORP. "
      }
    },
    {
      "chunk_id": "chunk_768",
      "text": "|\n| MODEL 8530 | SYSTEMS INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 767,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 3,
        "window_text": "AN | ZEUS | INC.  | Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC.  | CORP.  |\n| MODEL 8530 | SYSTEMS INC.  | MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC.  | INC.  | INC. ",
        "original_sentence": "|\n| MODEL 8530 | SYSTEMS INC. "
      }
    },
    {
      "chunk_id": "chunk_769",
      "text": "| MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 768,
        "window_size": 3,
        "char_count": 85,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| Dec 14 | 1996 |\n| --- | --- | --- | --- | --- | --- | --- |\n| K983803 | K842529 | AMIZYME-CMV KIT | AMICO LAB INC.  | CORP.  |\n| MODEL 8530 | SYSTEMS INC.  | MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC.  | INC.  | INC.  | 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX. ",
        "original_sentence": "| MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC. "
      }
    },
    {
      "chunk_id": "chunk_770",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 769,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "| CORP.  |\n| MODEL 8530 | SYSTEMS INC.  | MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC.  | INC.  | INC.  | 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX.  부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_771",
      "text": "| INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 770,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 12,
        "window_text": "|\n| MODEL 8530 | SYSTEMS INC.  | MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC.  | INC.  | INC.  | 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX.  부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP.  | PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD. ",
        "original_sentence": "| INC. "
      }
    },
    {
      "chunk_id": "chunk_772",
      "text": "| 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 771,
        "window_size": 3,
        "char_count": 188,
        "word_count": 39,
        "page_number": 3,
        "window_text": "| MERCIA | ABBOTT | IMMUNO-DIAGN | May 13 | 1991 |\n| ENZYME LINKED | SCIENTIFIC INC.  | INC.  | INC.  | 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX.  부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP.  | PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD.  | INTERNATIONAL | STIC SUPPLIES | INC. ",
        "original_sentence": "| 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX. "
      }
    },
    {
      "chunk_id": "chunk_773",
      "text": "부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 772,
        "window_size": 3,
        "char_count": 87,
        "word_count": 20,
        "page_number": 3,
        "window_text": "| INC.  | INC.  | 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX.  부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP.  | PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD.  | INTERNATIONAL | STIC SUPPLIES | INC.  | Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC. ",
        "original_sentence": "부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP. "
      }
    },
    {
      "chunk_id": "chunk_774",
      "text": "| PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 773,
        "window_size": 3,
        "char_count": 142,
        "word_count": 37,
        "page_number": 3,
        "window_text": "| INC.  | 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX.  부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP.  | PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD.  | INTERNATIONAL | STIC SUPPLIES | INC.  | Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC.  | 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX. ",
        "original_sentence": "| PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD. "
      }
    },
    {
      "chunk_id": "chunk_775",
      "text": "| INTERNATIONAL | STIC SUPPLIES | INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 774,
        "window_size": 3,
        "char_count": 39,
        "word_count": 7,
        "page_number": 12,
        "window_text": "| 1998 | 1985 |\n| K872881 | ABBOTT CMV-M EIA KIT | CMV-VUE(TM) CMV ANTIGEN | Aug 11 | Mar 06 | Oct 23 |\n**ORTHO**\n**Mar 27**\n\n**[표 끝]**\n\nTHE APTUS (AUTOMATED)\n\nAPPLICATION OF THE CMV\n\nIX.  부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP.  | PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD.  | INTERNATIONAL | STIC SUPPLIES | INC.  | Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC.  | 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX.  부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC. ",
        "original_sentence": "| INTERNATIONAL | STIC SUPPLIES | INC. "
      }
    },
    {
      "chunk_id": "chunk_776",
      "text": "| Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 775,
        "window_size": 3,
        "char_count": 521,
        "word_count": 106,
        "page_number": 3,
        "window_text": "부록\n\n- - 71 -\n**[표 시작]**\n\n| K960434 | IGM CAPTURE ELISA ASSAY | IGM EIA | INCSTAR CORP.  | PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD.  | INTERNATIONAL | STIC SUPPLIES | INC.  | Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC.  | 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX.  부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC.  | CLINICAL | AMICO LAB INC. ",
        "original_sentence": "| Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC. "
      }
    },
    {
      "chunk_id": "chunk_777",
      "text": "| 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 776,
        "window_size": 3,
        "char_count": 48,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| PB DIAGNOSTIC | Apr 17 | 1993 |\n| --- | --- | --- | --- | --- | --- | --- |\n| CONTROLS | CMV IGG TEST KIT | FLUORESCENT ANTIBODY KIT | LTD.  | INTERNATIONAL | STIC SUPPLIES | INC.  | Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC.  | 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX.  부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC.  | CLINICAL | AMICO LAB INC.  | Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX. ",
        "original_sentence": "| 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX. "
      }
    },
    {
      "chunk_id": "chunk_778",
      "text": "부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 777,
        "window_size": 3,
        "char_count": 389,
        "word_count": 86,
        "page_number": 3,
        "window_text": "| INTERNATIONAL | STIC SUPPLIES | INC.  | Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC.  | 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX.  부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC.  | CLINICAL | AMICO LAB INC.  | Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX.  부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX. ",
        "original_sentence": "부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC. "
      }
    },
    {
      "chunk_id": "chunk_779",
      "text": "| CLINICAL | AMICO LAB INC. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 778,
        "window_size": 3,
        "char_count": 28,
        "word_count": 6,
        "page_number": 12,
        "window_text": "| Dec 06 | 1995 | 1989 | 1986 |\n\n**[표 끝]**\n\nINCSTAR CYTOMEGALOVIRUS\n\nOct 17\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 72 -\n**[표 시작]**\n\n| CMV IGG HUMAN SERUM | Nov 16 |\n| --- | --- |\n| K896295 | CAPTIA(R) CMV-M | K872942 | K802930 | ANTIBODY SCREEN | MODIFIED DDI SEROCARD | CYTOMEGALOVIRUS DIRECT | KIT | DIAGNOSTICS | DETECTION | IMMUNODIAGNO | DIAGNOSTICA | May 13 | Apr 10 | 1991 | 1985 |\n| K951800 | K922580 | BIOLOGICAL | DIAGNOSTICS |\n| K884248 | K860279 | TEST SYSTEM NUMBER: 5530 | CONTROLS | SCIENCES INC.  | 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX.  부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC.  | CLINICAL | AMICO LAB INC.  | Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX.  부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX.  부록\n\n- - 77 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 78 -\nIX. ",
        "original_sentence": "| CLINICAL | AMICO LAB INC. "
      }
    },
    {
      "chunk_id": "chunk_780",
      "text": "| Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 779,
        "window_size": 3,
        "char_count": 45,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| 1990 | 1988 | 1981 |\n\n**[표 끝]**\n\nPYRAMID\n\nIX.  부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC.  | CLINICAL | AMICO LAB INC.  | Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX.  부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX.  부록\n\n- - 77 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 78 -\nIX.  부록\n\n- - 79 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 80 -\nIX. ",
        "original_sentence": "| Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX. "
      }
    },
    {
      "chunk_id": "chunk_781",
      "text": "부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 780,
        "window_size": 3,
        "char_count": 69,
        "word_count": 17,
        "page_number": 1,
        "window_text": "부록\n\n- - 73 -\n**[표 시작]**\n\n| BARTELS CYTOMEGALOVIRUS | Apr 08 |\n| --- | --- |\n\n**[표 끝]**\n\nBAXTER\n\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 74 -\n**[표 시작]**\n\n| CYTOMEGALOVIRUS | ANTI-CYTOMEGALOVIRUS | MERCIA | DISEASE | BARTELS | ORION | Mar 20 | Dec 06 |\n| --- | --- | --- | --- | --- | --- | --- | --- |\n| K910003 | K842661 | IGM CMV CLIN-ELISA(TM) | CYTOMEGALO VIRUS & | IMMUCOR INC.  | CLINICAL | AMICO LAB INC.  | Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX.  부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX.  부록\n\n- - 77 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 78 -\nIX.  부록\n\n- - 79 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 80 -\nIX.  부록\n",
        "original_sentence": "부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX. "
      }
    },
    {
      "chunk_id": "chunk_782",
      "text": "부록\n\n- - 77 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 78 -\nIX. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 781,
        "window_size": 3,
        "char_count": 69,
        "word_count": 17,
        "page_number": 1,
        "window_text": "| CLINICAL | AMICO LAB INC.  | Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX.  부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX.  부록\n\n- - 77 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 78 -\nIX.  부록\n\n- - 79 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 80 -\nIX.  부록\n",
        "original_sentence": "부록\n\n- - 77 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 78 -\nIX. "
      }
    },
    {
      "chunk_id": "chunk_783",
      "text": "부록\n\n- - 79 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 80 -\nIX. ",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 782,
        "window_size": 3,
        "char_count": 69,
        "word_count": 17,
        "page_number": 1,
        "window_text": "| Mar 06 | Jan 11 | Jan 09 |\n\n**[표 끝]**\n\nIX.  부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX.  부록\n\n- - 77 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 78 -\nIX.  부록\n\n- - 79 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 80 -\nIX.  부록\n",
        "original_sentence": "부록\n\n- - 79 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 80 -\nIX. "
      }
    },
    {
      "chunk_id": "chunk_784",
      "text": "부록\n",
      "metadata": {
        "source": "(안내서-0649-02)산전검사_중_거대세포바이러스(CMV)_체외진단용_의료기기_허가심사_가이드라인(민원인_안내서).pdf",
        "chunk_index": 783,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 4,
        "window_text": "부록\n\n- - 75 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 76 -\nIX.  부록\n\n- - 77 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 78 -\nIX.  부록\n\n- - 79 -\n거대세포바이러스 체외진단용 의료기기의 허가심사 가이드라인 [민원인 안내서]\n\n- - 80 -\nIX.  부록\n",
        "original_sentence": "부록\n"
      }
    }
  ],
  "chunking_analysis": {
    "total_chunks": 784,
    "avg_chunk_length": 106.76913265306122,
    "min_chunk_length": 3,
    "max_chunk_length": 1674,
    "total_characters": 83707,
    "total_words": 17377,
    "window_size": 3
  },
  "statistics": {
    "total_text_blocks": 3089,
    "heading_count": 882,
    "paragraph_count": 156,
    "list_item_count": 82,
    "table_cell_count": 1969,
    "tables_detected": 19,
    "chunks_generated": 784
  }
}